Elisabetta Manduchi
Emily Greenfest-Allen
Chris Stoeckert
Jie Zheng
The ontology is built based on OBI release 2015-04-13
This file is based on checkout of our SVN repository revision $Revision: 204$
https://github.com/obi-bcgo/bcgo
BFO OWL specification label
Relates an entity in the ontology to the name of the variable that is used to represent it in the code that generates the BFO OWL file from the lispy specification.
Really of interest to developers only
BFO OWL specification label
BFO CLIF specification label
Relates an entity in the ontology to the term that is used to represent it in the the CLIF specification of BFO2
Person:Alan Ruttenberg
Really of interest to developers only
BFO CLIF specification label
editor preferred label
editor preferred term
The concise, meaningful, and human-friendly name for a class or property preferred by the ontology developers. (US-English)
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
editor preferred label
editor preferred term
editor preferred term
example
example of usage
A phrase describing how a class name should be used. May also include other kinds of examples that facilitate immediate understanding of a class semantics, such as widely known prototypical subclasses or instances of the class. Although essential for high level terms, examples for low level terms (e.g., Affymetrix HU133 array) are not
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
example of usage
has curation status
PERSON:Alan Ruttenberg
PERSON:Bill Bug
PERSON:Melanie Courtot
OBI_0000281
has curation status
definition
definition
The official OBI definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.
The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.
2012-04-05:
Barry Smith
The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions' is terrible.
Can you fix to something like:
A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property.
Alan Ruttenberg
Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria.
On the specifics of the proposed definition:
We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition.
Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable.
We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with.
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
definition
definition
textual definition
editor note
An administrative note intended for its editor. It may not be included in the publication version of the ontology, so it should contain nothing necessary for end users to understand the ontology.
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obfoundry.org/obo/obi>
IAO:0000116
uberon
editor_note
1
editor_note
editor note
editor note
term editor
Name of editor entering the term in the file. The term editor is a point of contact for information regarding the term. The term editor may be, but is not always, the author of the definition, which may have been worked upon by several people
20110707, MC: label update to term editor and definition modified accordingly. See http://code.google.com/p/information-artifact-ontology/issues/detail?id=115.
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
term editor
alternative term
An alternative name for a class or property which means the same thing as the preferred name (semantically equivalent)
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
alternative term
definition source
formal citation, e.g. identifier in external database to indicate / attribute source(s) for the definition. Free text indicate / attribute source(s) for the definition. EXAMPLE: Author Name, URI, MeSH Term C04, PUBMED ID, Wiki uri on 31.01.2007
PERSON:Daniel Schober
Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
definition source
has obsolescence reason
Relates an annotation property to an obsolescence reason. The values of obsolescence reasons come from a list of predefined terms, instances of the class obsolescence reason specification.
PERSON:Alan Ruttenberg
PERSON:Melanie Courtot
has obsolescence reason
curator note
An administrative note of use for a curator but of no use for a user
PERSON:Alan Ruttenberg
IAO:0000232
uberon
curator_notes
1
curator_notes
curator note
curator notes
imported from
For external terms/classes, the ontology from which the term was imported
PERSON:Alan Ruttenberg
PERSON:Melanie Courtot
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
imported from
imported from
expand expression to
expand expression to
expand assertion to
first order logic expression
elucidation
person:Alan Ruttenberg
Person:Barry Smith
Primitive terms in a highest-level ontology such as BFO are terms which are so basic to our understanding of reality that there is no way of defining them in a non-circular fashion. For these, therefore, we can provide only elucidations, supplemented by examples and by axioms
elucidation
has associated axiom(nl)
Person:Alan Ruttenberg
Person:Alan Ruttenberg
An axiom associated with a term expressed using natural language
has associated axiom(nl)
has associated axiom(fol)
Person:Alan Ruttenberg
Person:Alan Ruttenberg
An axiom expressed in first order logic using CLIF syntax
has associated axiom(fol)
has axiom label
term replaced by
Add as annotation triples in the granting ontology
Use on obsolete terms, relating the term to another term that can be used as a substitute
Person:Alan Ruttenberg
Person:Alan Ruttenberg
term replaced by
ISA alternative term
An alternative term used by the ISA tools project (http://isa-tools.org).
Requested by Alejandra Gonzalez-Beltran
https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891&atid=886178
Person: Alejandra Gonzalez-Beltran
Person: Philippe Rocca-Serra
ISA tools project (http://isa-tools.org)
ISA alternative term
NIAID GSCID-BRC alternative term
An alternative term used by the National Institute of Allergy and Infectious Diseases (NIAID) Genomic Sequencing Centers for Infectious Diseases (GSCID) and Bioinformatics Resource Centers (BRC).
PERSON: Chris Stoeckert, Jie Zheng
NIAID GSCID-BRC metadata working group
NIAID GSCID-BRC alternative term
IEDB alternative term
An alternative term used by the IEDB.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
IEDB alternative term
temporal interpretation
temporal interpretation
https://code.google.com/p/obo-relations/wiki/ROAndTime
Abnormal/normal slim
Attribute slim
cell_quality
Disposition slim
Pathology slim
Relational slim: types of quality that require an additional entity in order to exist
Scalar slim
Value slim
abstract upper-level terms not directly useful for analysis
Description may include but is not limited to: an abstract,
table of contents, reference to a graphical representation
of content or a free-text account of the content.
An account of the content of the resource.
Description
Description
The present resource may be derived from the Source resource
in whole or in part. Recommended best practice is to reference
the resource by means of a string or number conforming to a
formal identification system.
A reference to a resource from which the present resource
is derived.
Source
Source
subset_property
has_alternative_id
has_broad_synonym
database_cross_reference
has_exact_synonym
has_narrow_synonym
has_obo_namespace
has_related_synonym
in_subset
shorthand
label
strain a has genetic backgroud as strain b is that strain a is derived from strain b and genetic make-up (all its alleles at all loci) of strain a is same to strain b except the mutated gene of interest and a very small amount of other genetic material, generally from one or two other strains. For example, the genetic background of the mutant strains NOD.129S7(B6)-Rag1tm1Mom/J (003729) and NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/SzJ (004848) is NOD.
Person: Jie Zheng
has_genetic_background_of
a produces_no b if some process that occurs_in a and has_no_output b, where a and b are material entities.
Person: Jie Zheng
not_produce
relates an entity to a person or an organization that can be contacted for information regarding the entity.
has contact
relates an entity to the information about it in an external database.
has external resource
relates an entity to an identifier assigned by an external resource which denotes the entity.
has external identifier
a instance-level relation between a person or an organization to an email address the person or organization has.
Person: Jie Zheng
has email address
shortcut relation of a planned process realizes or concretizes some plan specification
executes
relates an investigation to an experimental factor which is a study independent variable specified in a study design. An experimental factor can be a material entity (such as treated and untreated specimen), a quality (such as sex of an organism), a process (such as developmental stage of an organism), or an information about a process (such as duration of a treatment), etc.
has experimental factor
relates experimental factor (could be anything that a study independent variable specification is about) to its values
For example, biological sex can be a study independent variable, potential values can be male or female.
has experimental factor value
relates experimental factor values to its factor type (could be anything that a study independent variable specification is about)
For example, male/female could be values for biological sex, 0, 0.01, 0.02 mg/L for glucose concentation, 1,5,20 minutes for treatment duration, etc.
value of experimental factor
relates an invesitigation to any biologically-related entity that is examined as part of that process, such as a protein, a biological process, etc.
examines
Person: Jie Zheng
a instance-level relation between an entity to a PubMed ID that denotes a publication associated with the entity.
associated PubMed ID
relates an information artifact to the species of an organism that it is about.
Person: Jie Zheng
is about organism species
is denoted by is an instance-level, relation obtaining between an entity to an information content entity that is created to specifically refer to something. It is the inverse relation of 'denotes'.
Person: Jie Zheng
is denoted by
relates an information artifact to the genotype of an organism that it is about.
Person: Jie Zheng
is about genotype
relates an information artifact to the type of a cell that it is about.
Person: Jie Zheng
is about cell type
relates an information artifact to the cell line that it is about.
Person: Jie Zheng
is about cell line
relates an information artifact to the tissue of an organism that it is about.
Person: Jie Zheng
is about tissue
relates the member (a data item) of a gene list (a data set) to the gene that it is about.
has gene member
relates an information artifact to the strain of an organism that it is about.
is about strain
relates an information artifact to the phenotype born by an organism that it is about.
is about phenotype
relates an information artifact to the development stage of an organism that it is about.
is about development stage
relates an information artifact to the treatment that it is about. For specimens in an assay, the treatment referred to was performed prior to specimen collection.
is about treatment
relates a process to a time-measurement-datum that represents the duration of the process
has duration
relates a molecular entity to its concentration measurement datum that is the measurement of its concentration quality
has concentration
relates a gene that has protein binding to the biological context in which that binding was identified.
binding context
relates a gene that is differentially expressed to the biological context in which that differential expression was identified.
differential expression context
relates a biological context (e.g., cell, developmental stage, etc.) to a gene whose protein binding was identified in this specific context.
context of differential expression
relates the context to a gene that protein binding is identified in this specific context
context of binding
is part of
my brain is part of my body (continuant parthood, two material entities)
my stomach cavity is part of my stomach (continuant parthood, immaterial entity is part of material entity)
this day is part of this year (occurrent parthood)
a core relation that holds between a part and its whole
Everything is part of itself. Any part of any part of a thing is itself part of that thing. Two distinct things cannot be part of each other.
Occurrents are not subject to change and so parthood between occurrents holds for all the times that the part exists. Many continuants are subject to change, so parthood between continuants will only hold at certain times, but this is difficult to specify in OWL. See https://code.google.com/p/obo-relations/wiki/ROAndTime
Parthood requires the part and the whole to have compatible classes: only an occurrent can be part of an occurrent; only a process can be part of a process; only a continuant can be part of a continuant; only an independent continuant can be part of an independent continuant; only an immaterial entity can be part of an immaterial entity; only a specifically dependent continuant can be part of a specifically dependent continuant; only a generically dependent continuant can be part of a generically dependent continuant. (This list is not exhaustive.)
A continuant cannot be part of an occurrent: use 'participates in'. An occurrent cannot be part of a continuant: use 'has participant'. A material entity cannot be part of an immaterial entity: use 'has location'. A specifically dependent continuant cannot be part of an independent continuant: use 'inheres in'. An independent continuant cannot be part of a specifically dependent continuant: use 'bearer of'.
part_of
part of
http://www.obofoundry.org/ro/#OBO_REL:part_of
realized in
this disease is realized in this disease course
this fragility is realized in this shattering
this investigator role is realized in this investigation
is realized by
realized_in
[copied from inverse property 'realizes'] to say that b realizes c at t is to assert that there is some material entity d & b is a process which has participant d at t & c is a disposition or role of which d is bearer_of at t& the type instantiated by b is correlated with the type instantiated by c. (axiom label in BFO2 Reference: [059-003])
Paraphrase of elucidation: a relation between a realizable entity and a process, where there is some material entity that is bearer of the realizable entity and participates in the process, and the realizable entity comes to be realized in the course of the process
realized in
occurs in
b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t
occurs_in
unfolds in
unfolds_in
Paraphrase of definition: a relation between a process and an independent continuant, in which the process takes place entirely within the independent continuant
occurs in
site of
[copied from inverse property 'occurs in'] b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t
Paraphrase of definition: a relation between an independent continuant and a process, in which the process takes place entirely within the independent continuant
contains process
Jie Zheng, Yongqun He, Yu Lin, Allen Xiang
has disease
has measurement unit label
has measurement unit label
denotes
A person's name denotes the person. A variable name in a computer program denotes some piece of memory. Lexically equivalent strings can denote different things, for instance "Alan" can denote different people. In each case of use, there is a case of the denotation relation obtaining, between "Alan" and the person that is being named.
denotes is a primitive, instance-level, relation obtaining between an information content entity and some portion of reality. Denotation is what happens when someone creates an information content entity E in order to specifically refer to something. The only relation between E and the thing is that E can be used to 'pick out' the thing. This relation connects those two together. Freedictionary.com sense 3: To signify directly; refer to specifically
2009-11-10 Alan Ruttenberg. Old definition said the following to emphasize the generic nature of this relation. We no longer have 'specifically denotes', which would have been primitive, so make this relation primitive.
g denotes r =def
r is a portion of reality
there is some c that is a concretization of g
every c that is a concretization of g specifically denotes r
person:Alan Ruttenberg
Conversations with Barry Smith, Werner Ceusters, Bjoern Peters, Michel Dumontier, Melanie Courtot, James Malone, Bill Hogan
denotes
is duration of
relates a process to a time-measurement-datum that represents the duration of the process
Person:Alan Ruttenberg
is duration of
is_manufactured_by
http://www.affymetrix.com/products/arrays/specific/hgu133.affx is_manufactered_by http://www.affymetrix.com/ (if we decide to use these URIs for the actual entities)
c is_manufactured_by o means that there was a process p in which c was built in which a person, or set of people or machines did the work(bore the "Manufacturer Role", and those people/and or machines were members or of directed by the organization to do this.
Alan Ruttenberg
Liju Fan
has_make
has_manufacturer
is_manufactured_by
supplies
A relation between an organisation or person and a material entity who owned or has license to the material entity and there was a legal transfer of ownership or licensing of the material entity to the current owner.
GROUP: Relations branch
supplies
has_supplier
A relation between a material entity and an organisation or person who owned or has license to the material entity and there was a legal transfer of ownership or licensing of the material entity to the current owner.
PERSON: Alan Rutternberg
PERSON: Cristian Cocos
PERSON: Frank Gibson
PERSON: Melanie Courtot
has_supplier
objective_achieved_by
This relation obtains between a a objective specification and a planned process when the criteria specified in the objective specification are met at the end of the planned process.
OBI
OBI
objective_achieved_by
is member of organization
Relating a legal person or organization to an organization in the case where the legal person or organization has a role as member of the organization.
2009/10/01 Alan Ruttenberg. Barry prefers generic is-member-of. Question of what the range should be. For now organization. Is organization a population? Would the same relation be used to record members of a population
JZ: Discussed on May 7, 2012 OBI dev call. Bjoern points out that we need to allow for organizations to be members of organizations. And agreed by the other OBI developers. So, human and organization were specified in 'Domains'. The textual definition was updated based on it.
Person:Alan Ruttenberg
Person:Helen Parkinson
Person:Alan Ruttenberg
Person:Helen Parkinson
2009/09/28 Alan Ruttenberg. Fucoidan-use-case
is member of organization
A journal article is an information artifact that inheres in some number of printed journals. For each copy of the printed journal there is some quality that carries the journal article, such as a pattern of ink. The journal article (a generically dependent continuant) is concretized as the quality (a specifically dependent continuant), and both depend on that copy of the printed journal (an independent continuant).
An investigator reads a protocol and forms a plan to carry out an assay. The plan is a realizable entity (a specifically dependent continuant) that concretizes the protocol (a generically dependent continuant), and both depend on the investigator (an independent continuant). The plan is then realized by the assay (a process).
A relationship between a generically dependent continuant and a specifically dependent continuant, in which the generically dependent continuant depends on some independent continuant in virtue of the fact that the specifically dependent continuant also depends on that same independent continuant. A generically dependent continuant may be concretized as multiple specifically dependent continuants.
is concretized as
A journal article is an information artifact that inheres in some number of printed journals. For each copy of the printed journal there is some quality that carries the journal article, such as a pattern of ink. The quality (a specifically dependent continuant) concretizes the journal article (a generically dependent continuant), and both depend on that copy of the printed journal (an independent continuant).
An investigator reads a protocol and forms a plan to carry out an assay. The plan is a realizable entity (a specifically dependent continuant) that concretizes the protocol (a generically dependent continuant), and both depend on the investigator (an independent continuant). The plan is then realized by the assay (a process).
A relationship between a specifically dependent continuant and a generically dependent continuant, in which the generically dependent continuant depends on some independent continuant in virtue of the fact that the specifically dependent continuant also depends on that same independent continuant. Multiple specifically dependent continuants can concretize the same generically dependent continuant.
concretizes
this red color is a quality of this apple
a relation between a quality and an independent continuant (the bearer), in which the quality specifically depends on the bearer for its existence
A quality inheres in its bearer at all times for which the quality exists.
is quality of
quality_of
quality of
this investigator role is a role of this person
a relation between a role and an independent continuant (the bearer), in which the role specifically depends on the bearer for its existence
A role inheres in its bearer at all times for which the role exists, however the role need not be realized at all the times that the role exists.
is role of
role_of
role of
this apple has quality this red color
a relation between an independent continuant (the bearer) and a quality, in which the quality specifically depends on the bearer for its existence
A bearer can have many qualities, and its qualities can exist for different periods of time, but none of its qualities can exist when the bearer does not exist.
has_quality
has quality
this parent cell derives into this cell (cell division)
this parent nucleus derives into this nucleus (nuclear division)
a relation between two distinct material entities, the old entity and the new entity, in which the new entity begins to exist when the old entity ceases to exist, and the new entity inherits the significant portion of the matter of the old entity
This is a very general relation. More specific relations are preferred when applicable, such as 'directly develops into'. To avoid making statements about a future that may not come to pass, it is often better to use the backward-looking 'derives from' rather than the forward-looking 'derives into'.
derives_into
derives into
is location of
my head is the location of my brain
this cage is the location of this rat
a relation between two independent continuants, the location and the target, in which the target is entirely within the location
Most location relations will only hold at certain times, but this is difficult to specify in OWL. See https://code.google.com/p/obo-relations/wiki/ROAndTime
location_of
location of
located in
my brain is located in my head
this rat is located in this cage
a relation between two independent continuants, the target and the location, in which the target is entirely within the location
Location as a relation between instances: The primitive instance-level relation c located_in r at t reflects the fact that each continuant is at any given time associated with exactly one spatial region, namely its exact location. Following we can use this relation to define a further instance-level location relation - not between a continuant and the region which it exactly occupies, but rather between one continuant and another. c is located in c1, in this sense, whenever the spatial region occupied by c is part_of the spatial region occupied by c1. Note that this relation comprehends both the relation of exact location between one continuant and another which obtains when r and r1 are identical (for example, when a portion of fluid exactly fills a cavity), as well as those sorts of inexact location relations which obtain, for example, between brain and head or between ovum and uterus
Most location relations will only hold at certain times, but this is difficult to specify in OWL. See https://code.google.com/p/obo-relations/wiki/ROAndTime
located_in
http://www.obofoundry.org/ro/#OBO_REL:located_in
located in
the surface of my skin is a 2D boundary of my body
a relation between a 2D immaterial entity (the boundary) and a material entity, in which the boundary delimits the material entity
A 2D boundary may have holes and gaps, but it must be a single connected entity, not an aggregate of several disconnected parts.
Although the boundary is two-dimensional, it exists in three-dimensional space and thus has a 3D shape.
2D_boundary_of
boundary of
is 2D boundary of
is boundary of
2D boundary of
my body has 2D boundary the surface of my skin
a relation between a material entity and a 2D immaterial entity (the boundary), in which the boundary delimits the material entity
A 2D boundary may have holes and gaps, but it must be a single connected entity, not an aggregate of several disconnected parts.
Although the boundary is two-dimensional, it exists in three-dimensional space and thus has a 3D shape.
has boundary
has_2D_boundary
has 2D boundary
David Osumi-Sutherland
ends_at_start_of
meets
X immediately_precedes_Y iff: end(X) simultaneous_with start(Y)
immediately precedes
x develops from y if and only if either (a) x directly develops from y or (b) there exists some z such that x directly develops from z and z develops from y
Chris Mungall
David Osumi-Sutherland
Melissa Haendel
Terry Meehan
This is the transitive form of the develops from relation
develops from
'human p53 protein' SubClassOf some ('has prototype' some ('participates in' some 'DNA repair'))
heart SubClassOf 'has prototype' some ('participates in' some 'blood circulation')
x has prototype y if and only if x is an instance of C and y is a prototypical instance of C. For example, every instance of heart, both normal and abnormal is related by the has prototype relation to some instance of a "canonical" heart, which participates in blood circulation.
Chris Mungall
Experimental. In future there may be a formalization in which this relation is treated as a shortcut to some modal logic axiom. We may decide to obsolete this and adopt a more specific evolutionary relationship (e.g. evolved from)
has prototype
x actively participates in y if and only if x participates in y and x realizes some active role
agent in
actively participates in
'heart development' has active development some Shh protein
x has participant y if and only if x realizes some active role that inheres in y
This may be obsoleted and replaced by the original 'has agent' relation
has agent
has active participant
move to BFO?
Allen
A relation that holds between two occurrents. This is a grouping relation that collects together all the Allen relations.
temporal relation
An organism that is a member of a population of organisms
is member of is a mereological relation between a item and a collection.
is member of
member part of
SIO
member of
has member is a mereological relation between a collection and an item.
SIO
has member
x has the potential to develop into y iff x develops into y or if x is capable of developing into y
has potential to develop into
a produces b if some process that occurs_in a has_output b, where a and b are material entities. Examples: hybridoma cell line produces monoclonal antibody reagent; chondroblast produces avascular GAG-rich matrix.
Melissa Haendel
Note that this definition doesn't quite distinguish the output of a transformation process from a production process, which is related to the identity/granularity issue.
produces
Melissa Haendel
produced by
Inverse of translation _of.
kareneilbeck
Wed Aug 19 00:11:53 PDT 2009
Example: codon translates_to amino_acid.
translates_to
X is translation of Y if X is translated by ribosome to create Y.
kareneilbeck
Wed Aug 19 00:09:59 PDT 2009
Example: Polypeptide translation_of CDS.
translation_of
q1 different_in_magnitude_relative_to q2 if and only if magnitude(q1) NOT =~ magnitude(q2). Here, magnitude(q) is a function that maps a quality to a unit-invariant scale.
quality
different_in_magnitude_relative_to
different_in_magnitude_relative_to
has NCBI gene id
differential expression pattern
has measurement value
has measurement value
has specified value
A relation between a value specification and a number that quantifies it.
A range of 'real' might be better than 'float'. For now we follow 'has measurement value' until we can consider technical issues with SPARQL queries and reasoning.
PERSON: James A. Overton
OBI
has specified value
Called Family Name in vCard
has last name
called Given Name invCard
first name
BCGO:0000002
Mus musculus that is bred to have some uniform behavioral, morphological, physiological, or genetic characteristics with similarly bred organism.
Person: Jie Zheng
mouse strain
BCGO:0000003
Rattus norvegicus that is bred to have some uniform behavioral, morphological, physiological, or genetic characteristics with similarly bred organism.
Person: Jie Zheng
rat strain
BCGO:0000004
a cell that expresses a gene for insulin.
insulin expressing cell
BCGO:0000010
A data transformation that attaches quantified values to specific sequence features, e.g. transcript, exon, etc.
Person: Chris Stoeckert, Jie Zheng, Elisabetta Manduchi
UPenn Group
sequence feature quantification
BCGO:0000011
a data transformation that aligns sequencing reads to reference sequence.
Person: Chris Stoeckert, Jie Zheng
EFO_0004917 high throughput sequence alignment protocol
high throughput sequence alignment
BCGO:0000012
A mouse strain containing a transgene in which EGFP (transgene) is driven by the Ins1 promoter (NCBI Gene ID: 16333). Hemizygous mice show expression of EGFP in beta lineage cells of the pancreas.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
MIP-GFP mouse strain
RES188 mouse strain
STOCK Tg(Ins1-EGFP/GH1)14Hara/Mmmh mouse strain
Tg(Ins1-EGFP/GH1)14Hara
Vanderbilt University Medical Center
Tg(Ins1-EGFP/GH1)14Hara mouse strain
BCGO:0000013
A mouse strain that is a laboratory mouse generated from long inbreeding with nearly identical genotype. C57BL/6 mouse has a dark brown, nearly black coat, and an easily irritable temperament. It has a good reproductive performance and is the most widely used "genetic background" for genetically modified mice for use as models of human disease.
Person:Jie Zheng
C57
C57 black 6
black 6
http://en.wikipedia.org/wiki/C57BL/6
C57BL/6 mouse strain
BCGO:0000014
A cell that has all features and genetic signatures as functional beta cell. It may not be part of pancreas.
functional beta cell like cell
BCGO:0000016
A mouse strain in which part or all of the targeted gene, SRY-box containing gene 17 (NCBI Gene ID: 20671) is replaced to create Sox17{GFPCre} using the Loxed Cassette Acceptor allele Sox17{tm1(LCA)}). Using an RMCE strategy, we inserted a GFP-Cre (Green fluorescent protein-Cre-recombinase) fusion protein into a Sox17 LCA allele thereby replacing Sox17 coding sequences. The Sox17{GFPCre} mice may be used to track Sox17-expressing cells and their early progeny, or to conditionally inactivate genes in Sox17-expressing cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
RES1681 mouse strain
STOCK Sox17tm2(EGFP/cre)Mgn/Mmnc mouse strain
Sox17tm1.3(Cre.GFP)Mgn mouse strain
Sox17{(GFPCre)Mgn}
Vanderbilt University Medical Center
Sox17{(GFPCre)Mgn} mouse strain
BCGO:0000017
A mouse strain in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1{tm1.2(CFP)} using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). This mouse contains a cyan fluorescent protein (CFP, Cerulean), tagged with 3 copies of an SV40 NLS knocked into the endogenous Pdx1 gene. This mouse strain enables pre-pancreatic endoderm to be easily identified in the developing mouse embryo and the isolation of Pdx1(+) cells by FACS.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
B6.129S6-Pdx1tm2Mgn/Mmnc mouse strain
Pdx1CFP mouse strain
Pdx1{(CFP)Mgn}
RES1301 mouse strain
Vanderbilt University Medical Center
Pdx1{(CFP)Mgn} mouse strain
BCGO:0000018
A mouse strain in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create ptf1a{tm1.1(YFP)} using the Loxed Cassette Acceptor allele Ptf1a{tm1(LCA)}). <p>Ptf1a{YFP} mice may be used to visualize yellow fluorescent protein (YFP) expression from the ptf1a allele. Ptf1a is expressedin pancreatic buds beginning at E9.5 andplays a vital role in the growth and lineage specification of pancreatic multipotent progenitor cells (MPCs). Ptf1a is also expressed in the neuronal precursors of the cerebellum, spinal cord, and retina where it also performs fate determining roles.</p>
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ptf1a{tm1Mgn}
RES236 mouse strain
STOCK Ptf1atm1.1Mgn/Mmmh mouse strain
ptf1aYFP mouse strain
Vanderbilt University Medical Center
Ptf1a{tm1Mgn} mouse strain
BCGO:0000019
A mouse strain in which the targeted gene, Neurogenin 3 (NCBI Gene ID: 11925), has been modified (allele type: Gene Replacement) to targeted mutation 1, Klaus H Kaestner (MGI ID: Neurog3{tm1(EGFP)Khk}). A targeted mutation at the Neurogenin 3 locus where EGFP replaces entire coding region of Neurogenin3. The basic phenotype is EGFP expression in developing endocrine cells of pancreas and in glandular regions of the stomach.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
B6.129S-Neurog3tm1(EGFP)Khk/Mmcd mouse strain
B6.129S-Neurog3{tm1(EGFP)Khk}/Mmcd
RES176 mouse strain
ngn3-EGFP mouse strain
Vanderbilt University Medical Center
B6.129S-Neurog3{tm1(EGFP)Khk}/Mmcd mouse strain
BCGO:0000020
A mouse strain contains a GFP-Cre fusion protein which replaces the Insm1 coding sequence. These mice express green fluorescent protein (GFP) under control of the Insm1 gene locus. Insm1 is expressed in pancreatic primordium starting at E9.5. Insm1 is also expressed in neural precursor cells and tumors of may be used for lineage tracing of Insm1-positive cells in both wild-type and Insm1-null mice.
http://www.betacell.org/resource/view/resource_id/661/ provide the definition of 'Insm1tm1.1Mgn mouse strain' which might be the early version of 'Insm1tm2Mgn mouse strain'. However, we are not clear the difference between two strains. We borrowed the definition of 'Insm1tm1.1Mgn mouse strain'. In the webpage, it has strain name 'Mouse Strain RES661' and common name 'lnsm1GFP.Cre mouse strain'. We added 'lnsm1GFP.Cre mouse strain' as alternative term which is true to 'Insm1tm2Mgn mouse strain' too .
Person: Jie Zheng, Chris Stoeckert
Insm1GFP.Cre mouse strain
RES661 mouse strain
http://www.betacell.org/resource/view/resource_id/661/
Insm1tm2Mgn mouse strain
BCGO:0000021
Person: Jie Zheng
MIP-GFP mouse strain
RES188 mouse strain
http://www.betacell.org/resource/view/resource_id/188/
http://purl.obolibrary.org/obo/BCGO_0000012
A mouse strain which is hemizygous and shows expression of EGFP in beta lineage cells of the pancreas.
obsolete_STOCK Tg(Tnpo1-EGFP)6729Hara/Mmmh mouse strain
true
BCGO:0000028
A mouse strain that is a laboratory mouse generated from inbreeding. It has white-bellied, pink-eyed, light chinchilla (off-white) or albino or white-bellied, pink-eyed, light chinchilla (light tan). It has a good reproductive performance and is widely used in the production of targeted mutations due to the availability of multiple embryonic stem cell lines derived from them.
Person:Jie Zheng
129/SvJ
129X1
http://www.informatics.jax.org/mgihome/nomen/strain_129.shtml
http://jaxmice.jax.org/strain/000691.html
129X1/SvJ mouse strain
BCGO:0000030
A mouse strain that Inbred from F130 to F170 depending on substrain original generated from a cross of a Bagg albino female and a DBA male by Strong in 1920. It has Agouti coat color. Most substrains have a good reproductive performance. It is widely used in a wide variety of research areas including cancer, immunology and inflammation, sensorineural, and cardiovascular biology.
Person:Jie Zheng
http://www.informatics.jax.org/external/festing/mouse/docs/C3H.shtml
http://www.criver.com/EN-US/PRODSERV/BYTYPE/RESMODOVER/RESMOD/Pages/C3HMouse.aspx
C3H mouse strain
BCGO:0000031
Person: Jie Zheng
black swiss mouse strain
BCGO:0000046
an endodermal cell that is part of the definitive endoderm and expresses a gene for SOX-17
Person: Chris Stoeckert, Jie Zheng
Sox17 expressing cell from the embryo body proper
Chris Stoeckert
Sox17-expressing definitive endodermal cell
BCGO:0000047
an epithelial cell that is part of the ventral pancreatic bud, expresses a gene for SOX-17 and has Epcam in the plasma membrane.
Person: Chris Stoeckert, Jie Zheng
Sox17 expressing cell in ventral pancreatic bud
Chris Stoeckert
Sox17-expressing Epcam+ pancreatic epithelial cell
BCGO:0000048
an endodermal cell that is part of the foregut endoderm and expresses the gene for pancreas/duodenum homeobox protein 1
Person: Chris Stoeckert, Jie Zheng
Pdx1-expressing endoderm cell
Chris Stoeckert
Pdx1-expressing foregut endodermal cell
BCGO:0000049
a non-terminally differentiated cell that is part of the pancreatic bud, participates in pancreas development and expresses the gene for pancreas transcription factor 1 subunit alpha.
Person: Chris Stoeckert, Jie Zheng
Ptf1a-expressing cell
Chris Stoeckert
Ptf1a-expressing multipotent pancreatic cell
BCGO:0000050
a non-terminally differentiated cell that is part of the pancreatic bud but lacks pancreas transcription factor 1 subunit alpha.
Person: Chris Stoeckert, Jie Zheng
Ptf1a-null cell
Chris Stoeckert
Ptf1a-lacking pancreatic progenitor cell
BCGO:0000051
a non-terminally differentiated cell that participates in endocrine pancreas developement and expresses the gene for neurogenin-3.
Person: Chris Stoeckert, Jie Zheng
Ngn3-expressing cell
Chris Stoeckert
neurogenin-3-expressing endocrine progenitor cell
BCGO:0000052
a non-terminally differentiated cell that is part of the pancreas, participates in pancreas development and lacks neurogenin-3.
Person: Chris Stoeckert, Jie Zheng
Ngn3-null cell
Chris Stoeckert
neurogenin-3-lacking pancreatic progenitor cell
BCGO:0000053
a non-terminally differentiated cell that participates in endocrine pancreas development and expresses a gene for insulinoma-associated protein 1
Person: Chris Stoeckert, Jie Zheng
Insm1 expressing pancreatic endocrine cell
Chris Stoeckert
Insm1-expressing endocrine progenitor cell
BCGO:0000054
a non-terminally differentiated cell that is part of the endocrine pancreas and lacks insulinoma-associated protein 1
Person: Chris Stoeckert, Jie Zheng
Non-functional Insm1 expressing pancreatic endocrine cell
Chris Stoeckert
Insm1-lacking endocrine progenitor cell
BCGO:0000055
a type B pancreatic cell that is immature and expresses a gene for insulin
Person: Chris Stoeckert, Jie Zheng
insulin-expressing nascent beta cells
Chris Stoeckert
insulin-expressing immature beta cell
BCGO:0000056
a type B pancreatic cell that is mature and expresses a gene for insulin
Person: Chris Stoeckert, Jie Zheng
insulin-expressing mature beta cells
Chris Stoeckert
insulin-expressing mature beta cell
BCGO:0000057
A Insm1-expressing endocrine progenitor cell that expresses the gene for pancreas/duodenum homeobox protein 1 at a high level.
Person: Jie Zheng, Chris Stoeckert
Insm1-expressing Pdx1 high-positive pancreatic endocrine progenitor cell
BCGO:0000058
A Insm1-expressing endocrine progenitor cell that expresses the gene for pancreas/duodenum homeobox protein 1 at a low level.
Person: Jie Zheng, Chris Stoeckert
Insm1-expressing Pdx1 low-positive pancreatic endocrine progenitor cell
BCGO:0000059
A mouse strain that is the result of mating between a Insm1GFPCre/+ mouse and a Pdx1CFP/+ mouse both on a CD-1 background
Person: Chris Stoeckert, Anna Osipovich
Insm1tm2(GFP.Cre)Mgn/Pdx1tm2(CFP)Mgn mouse strain
BCGO:0000060
A software implementing a higher level analysis protocol of type differential expresssion.
GBCO
differential expression software
BCGO:0000061
A mouse strain that is genetically modified expressing Enhanced Green Fluorescent Protein (EGFP) under the control of the mouse insulin 1 promoter. Fluorescence is detected in tissues where insulin I is normally expressed; fluorescent protein expression in pancreatic beta-cells is evident from embryonic day (E)13.5 through adulthood. The fluorescence expression pattern is similar to the patterns seen in two other strains STOCK Tg(Ins1-Cerulean)24Hara/J and STOCK Tg(Ins1-DsRed*T4)32Hara/J. This mutant mouse strain exhits normal glucose tolerance and pancreatic insulin levels and may be useful in studies of diabetes and pancreatic beta islet cell biology.
Person: Jie Zheng
http://jaxmice.jax.org/strain/006864.html
B6.Cg-Tg(Ins1-EGFP)1Hara/J mouse strain
BCGO:0000068
A CRID symbol assigned by ArrayExpress to uniquely identify a study in ArrayExpress
ArrayExpress ID
BCGO:0000069
A CRID symbol assigned by Gene Expression Omnibus (GEO) to uniquely identify a study in GEO.
GEO ID
BCGO:0000070
A gene expression that produces cellular surface proteins that can be used to identify and isolate specific cells.
Person: Chris Stoeckert, Jie Zheng
Penn Group
Beta Cell Biology Consoritum
cellular marker expression
BCGO:0000071
A material entity that could be whole pancreas, part of pancreas (including a single cell type (e.g., beta cell), or precursor to pancreas.
Person: Chris Stoeckert, Jie Zheng
Penn Group
Beta Cell Biology Consoritum
pancreatic material
BCGO:0000076
A cellular feature identification objective that aims to examine or characterize cell development or differentiation.
Person: Chris Stoeckert, Jie Zheng
Penn group
Beta Cell Biology Consoritum
characterization of cell differentiation objective
BCGO:0000077
A characterization of cell differentiation objective that aims to examine the influence of specific protocols with regard to generating insulin-producing cells from putative progenitors or other mechanisms (e.g., transdifferentiation).
Person: Chris Stoeckert, Jie Zheng
Penn group
Beta Cell Biology Consoritum
characterization of differentiation of insulin-producing cells objective
BCGO:0000078
A characterization of cell stimulation or injury objective that aims to address the effects of compounds, hormones, or cell manipulations on the ability of islets and/or beta-cells to secrete insulin or respond to glucose levels.
Person: Chris Stoeckert, Jie Zheng
Penn group
Beta Cell Biology Consoritum
characterization of islet/beta-cell stimulation/injury objective
BCGO:0000079
A biological feature identification objective that aims to examine changes in gene expression and/or epigenome during pancreas development or regeneration.
Person: Chris Stoeckert, Jie Zheng
Penn group
Beta Cell Biology Consoritum
characterization of pancreas development and growth objective
BCGO:0000080
A cellular feature identification objective that aims to address the effects of compounds, hormones, or cell manipulations on the ability of tissues or specific cell types to perform their normal functions or respond to insult.
Person: Chris Stoeckert, Jie Zheng
Penn group
Beta Cell Biology Consoritum
characterization of cell stimulation or injury objective
BCGO:0000081
A molecular feature identification objective that aims to identify genes and processes regulated by transcription factors, co-activators, and other types of transcriptional regulators.
Person: Chris Stoeckert, Jie Zheng
Penn group
Beta Cell Biology Consoritum
targets and roles of transcriptional regulators objective
BCGO:0000082
A biological feature identification objective that aims to address the question of what genes are expressed in a given tissue or cell type or the expression of genes across multiple cells and tissues.
Person: Chris Stoeckert, Jie Zheng
Penn group
Beta Cell Biology Consoritum
tissue expression survey objective
BCGO:0000083
A biological process of generating epigenetic modifications, such as DNA methylation and histone modifications.
Person: Chris Stoeckert, Jie Zheng
Penn Group
Beta Cell Biology Consoritum
epigenetic modification process
BCGO:0000084
A planned process that aims to expand islets in culture and redifferentiate them to insulin producing cells.
Person: Chris Stoeckert, Jie Zheng
Penn Group
Beta Cell Biology Consoritum
islet expansion in vitro
BCGO:0000085
islet of Langerhans that is part of a person who has diabetes.
Person: Chris Stoeckert, Jie Zheng
Penn Group
Will add following axiom after import 'has disease' from CLO
'is part of' some ('Homo sapiens' and 'has disease' some 'diabetes mellitus')
Beta Cell Biology Consoritum
islets in diabetes
BCGO:0000086
A ncRNA which is transcribed, non-protein coding, and longer than 200 nucleotides.
Person: Chris Stoeckert, Jie Zheng
lncRNA
http://en.wikipedia.org/wiki/Long_non-coding_RNA
Beta Cell Biology Consoritum
long non-coding RNA
BCGO:0000087
Person: Chris Stoeckert, Jie Zheng
Penn Group
Beta Cell Biology Consoritum
stress and apoptosis in islets or beta cells
BCGO:0000088
An assay that uses chromatin immunoprecipitation combined with serial analysis of chromatin occupancy (SACO) to identify binding sites for transcription factors.
Person: Chris Stoeckert, Jie Zheng
TF Binding SACO
Penn group
Beta Cell Biology Consoritum
transcription factor binding site identification by SACO assay
BCGO:0000089
An assay that aims to measure abundance of transcripts using high-quality RNA isolated from cells following intracellular antibody staining and fluorescence-activated cell sorting (FACS).
Person: Chris Stoeckert, Jie Zheng
MARIS
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0089459
Beta Cell Biology Consoritum
transcriptional profiling by MARIS assay
BCGO:0000095
A data item of age. It could be measurement datum like 10 weeks, 2 years, or categorical datum like young, adult.
age datum
BCGO:0000097
A data item of how much of a given substance there is mixed with another substance.Annotations. It could be measurement datum like 10 mM, or categorical datum like low, high concentration.
concentration datum
BCGO:0000105
Person: Jie Zheng, Chris Stoeckert
BTBR
PMID: 25034792, Nephron Exp Nephrol. 2014;126(4):191-5. doi: 10.1159/000363300. "Recent advances in animal models of diabetic nephropathy."
A mouse strain that is deficient for the leptin receptor (ob/ob) which is naturally insulin resistant and develops many of the pathological features of human Diabetic nephropathy.
Black and tan, brachyury mouse strain
BCGO:0000106
Person: Chris Stoeckert
large duct cell
http://www.sciencedirect.com/science/article/pii/S1357272504002717
A pancreatic ductal cell of the large pancreatic duct.
large pancreatic ductal cell
BCGO:0000107
Person: Chris Stoeckert
small duct cell
http://www.sciencedirect.com/science/article/pii/S1357272504002717
A pancreatic ductal cell of a small interlobular pancreatic duct.
small pancreatic ductal cell'
BCGO:0000108
Person: Jie Zheng, Chris Stoeckert
ES (Tet-On/Ngn3)
Penn Group
An embryonic stem cell line that contains a ‘tet-on’ operon system and expresses Ngn3 in the presence of Tetracycline.
Tet-On/Ngn3 embryonic stem cell
BCGO:0000109
Person: Jie Zheng, Chris Stoeckert
GKP2
BCBC (http://www.betacell.org/resource/view/resource_id/1038)
An immortal animal cell line cell which was derived from an insulinoma and expresses insulin and pdx1.
GKP2 cell
BCGO:0000110
Person: Jie Zheng, Chris Stoeckert
GKP4
BCBC (http://www.betacell.org/resource/view/resource_id/1038)
An immortal animal cell line cell which was derived from a periductal tumor that did not express insulin or pdx1 but expressed genes of the endocrine lineage, such as Isl1 and Nkx2.2.
GKP4 cell
BCGO:0000111
Person: Jie Zheng, Chris Stoeckert
BCBC (http://www.betacell.org/resource/view/resource_id/4216)
A H9 cell that expresses Sox17.
Sox17 expressiong H9 cell
BCGO:0000112
Person: Jie Zheng, Chris Stoeckert
PMID:17185391
An INS-1 cell which is poorly responsive to glucose. It is a mixture of INS-1 (832/1) and INS-1 (832/2).
INS-1 (832/1 and 832/2)
BCGO:0000113
Person: Jie Zheng, Chris Stoeckert
PMID:17185391
An INS-1 cell which is poorly responsive to glucose.
INS-1 (832/1) cell
BCGO:0000114
Person: Jie Zheng, Chris Stoeckert
PMID:17185391
An INS-1 cell which is highly responsive to glucose. It is a mixture of INS-1 (832/13) and INS-1 (832/15).
INS-1 (832/13 and 833/15)
BCGO:0000115
Person: Jie Zheng, Chris Stoeckert
PMID:17185391
An INS-1 cell which is highly responsive to glucose.
INS-1 (832/13) cell
BCGO:0000116
Person: Jie Zheng, Chris Stoeckert
PMID:17185391
An INS-1 cellwhich is poorly responsive to glucose.
INS-1 (832/2) cell
BCGO:0000117
Person: Jie Zheng, Chris Stoeckert
BCBC
An INS-1 cell which is cytokine resistant.
INS-1 (833/117) cell
BCGO:0000118
Person: Jie Zheng, Chris Stoeckert
BCBC
An INS-1 cell which is cytokine resistant and highly glucose-responsive.
INS-1 (833/15) cell
BCGO:0000119
Person: Jie Zheng, Chris Stoeckert
BCBC
An INS-1 cell which is cytokine sensitive.
INS-1 (834/40) cell
BCGO:0000120
Person: Jie Zheng, Chris Stoeckert
PMID: 10037448
An INS-1 cell which has high insulin secretion in responses to glucose.
INS-1E
BCGO:0000121
Person: Jie Zheng, Chris Stoeckert
mPAC L20
PMID: 15340143
An immortal animal cell line cell which is a pancreatic duct cell and contains an Ngn3-expressing adenovirus.
mPAC L20 cell
BCGO:0000122
Person: Jie Zheng, Chris Stoeckert
PANC-1
http://www.sigmaaldrich.com/catalog/product/sigma/87092802
An immortal animal cell line cell which was established from a pancreatic carcinoma of ductal origin from a 56-year-old Caucasian male. The cell possesses the type B phenotype for G6PD.
PANC-1 cell
BCGO:0000123
Person: Jie Zheng, Chris Stoeckert
R7T1
PMID: 19164755
An immortal animal cell line cell that is a rat beta-cell line.
R7T1 cell
BCGO:9000177
A mouse strain containing a transgene in which Cre (transgene) is driven by the Gcg promoter (NCBI Gene ID: 14526). <p>A transgenic alteration consisting of a SacI fragment containing the glucagon promoter, inserted at SacI of pBS-beta globin-Cre, resulting in Cre expression in pancreatic lineage cells.</p>
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
B6.CBA-{Tg(Gcg-cre)1Herr}/Mmnc
Vanderbilt University Medical Center
B6.CBA-{Tg(Gcg-cre)1Herr}/Mmnc mouse strain
BCGO:9000178
A mouse strain containing a transgene in which EGFP (transgene) is driven by the Ipf1 promoter (NCBI Gene ID: 18609). This strain allows Expression of EGFP in pancreatic precursor populations.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
B6.CBA-{Tg(Ipf1-EGFP)1Herr}/Mmnc
Vanderbilt University Medical Center
B6.CBA-{Tg(Ipf1-EGFP)1Herr}/Mmnc mouse strain
BCGO:9000179
A mouse strain containing a transgene in which Cre (transgene) is driven by the Ins1 promoter (NCBI Gene ID: 24505). This strain relies on the recombination of floxed DNA in insulin-producing beta cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
B6;D2-Tg(Ins-cre)23Herr
Vanderbilt University Medical Center
B6;D2-Tg(Ins-cre)23Herr mouse strain
BCGO:9000180
A mouse strain containing a transgene in which Cre (transgene) is driven by the Neurog3 promoter (NCBI Gene ID: 11925). <p>All islet endocrine cells inherit a recombination event, if a segment of DNA is loxP-flanked. Transgene encoding Cre recombinase under the control of a human Neurogenin3 promoter.</p>
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
B6;D2-Tg(NEUROG3-cre)1Herr
Vanderbilt University Medical Center
B6;D2-Tg(NEUROG3-cre)1Herr mouse strain
BCGO:9000181
A mouse strain containing a transgene in which LacZ-Neo (transgene) is driven by the Neurod1 promoter (NCBI Gene ID: 18012). Homozygous phenotype: Postnatal lethal due to neonatal diabetes Pancreas--5% insulin production, no islet formation Gut--no CCK or secretin production Inner ear defects resulting in deafness--no cochlear ganglia and poor vestibular ganglia formation Cerebellar defect resulting in ataxia-- >90% depletion of cerebellar granule cells Hippocampal defects--no dentate gyrus.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
BX129-Neurod1{tmAK71(lacZ)Jle/Mmcd}
Vanderbilt University Medical Center
BX129-Neurod1{tmAK71(lacZ)Jle/Mmcd} mouse strain
BCGO:9000182
A mouse strain in which the targeted gene, insulin promoter factor 1, homeodomain transcription factor (NCBI Gene ID: 18609), has been modified (allele type: Global Null) to targeted mutation 1, Christopher V E Wright (MGI ID: Ipf1{tm1Cvw}).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
STOCK Ipf1{tm1Cvw}
Vanderbilt University Medical Center
STOCK Ipf1{tm1Cvw} mouse strain
BCGO:9000183
A mouse strain in which the targeted gene, insulin promoter factor 1, homeodomain transcription factor (NCBI Gene ID: 18609), has been modified (allele type: Gene Replacement) to insulin promoter factor 1, homeodomain transcription factor / targeted mutation 2, Christopher V E Wright (MGI ID: Ipf1{tm2Cvw}). The homozygous phenotype of these animals show growth retardation and dehydration with lack of gastric emptying; ie. a-pancreatic. Heterozygous phenotype includes expression of beta-galactosidase in developing stomach, bile duct and cystic ducts and early pancreatic buds.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
STOCK Ipf1{tm2Cvw}/Mmnc
Vanderbilt University Medical Center
STOCK Ipf1{tm2Cvw}/Mmnc mouse strain
BCGO:9000184
A mouse strain in which the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213), has been modified (allele type: Gene Replacement) to targeted mutation 1.1, Christopher VE Wright (MGI ID: Ptf1a{tm1.1(cre)Cvw}). <p>Homozygous phenotype is altered pancreatic development with loss of exocrine acini.</p>
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
STOCK Ptf1a{tm1(cre)Cvw}
Vanderbilt University Medical Center
STOCK Ptf1a{tm1(cre)Cvw} mouse strain
BCGO:9000185
A mouse strain containing a transgene in which Cre (transgene) is driven by the Foxa3 promoter (NCBI Gene ID: 15377).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
STOCK Tg(Foxa3-cre)1Khk
Vanderbilt University Medical Center
STOCK Tg(Foxa3-cre)1Khk mouse strain
BCGO:9000186
A mouse strain containing a transgene in which Cre (transgene) is driven by the Ipf1 promoter (NCBI Gene ID: 18609).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
STOCK Tg(Ipf1-cre/Esr1)1Dam/Mmcd
Vanderbilt University Medical Center
STOCK Tg(Ipf1-cre/Esr1)1Dam/Mmcd mouse strain
BCGO:9000189
A mouse strain containing a transgene in which Cre (transgene) is driven by the Ipf1 promoter (NCBI Gene ID: 18609).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
STOCK-Tg(Ipf1-cre)89.1Dam/Mmcd
Vanderbilt University Medical Center
STOCK-Tg(Ipf1-cre)89.1Dam/Mmcd mouse strain
BCGO:9000190
A mouse strain containing a transgene in which Cre (transgene) is driven by the Neurog3 promoter (NCBI Gene ID: 11925).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
STOCK Tg(Neurog3-cre)1Dam/Mmcd
Vanderbilt University Medical Center
STOCK Tg(Neurog3-cre)1Dam/Mmcd mouse strain
BCGO:9000191
A mouse strain in which the targeted gene, Glucokinase (NCBI Gene ID: 103988), has been modified (allele type: Global Mutation) to targeted mutation 3 (MGI ID: Gck{tm3Mgn}). This line of mice provides a model for Persistant Hyperinsulinemic Hypoglycemia of Infancy, or PHHI-GK, a rare genetic disease of humans. A gk{A456V} mutation, originally identified in a human pedigree with PHHI-GK, was introduced into these mice by gene knock-in. These mice may be useful for studies of sustained hypoglycemia. The mutation has been bred into a C57BL/6J strain thereby facilitating direct comparisons to both wild type C57BL/6J animals and to animals with a gk{K414E} mutation.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Gck{tm3Mgn}
Vanderbilt University Medical Center
Gck{tm3Mgn} mouse strain
BCGO:9000192
A mouse strain in which the targeted gene, Glucokinase (NCBI Gene ID: 103988), has been modified (allele type: Global Mutation) to targeted mutation 2 (MGI ID: Gck{tm2Mgn}). This line of mice contains a gk{K414E} point mutation that was introduced by gene knock-in. This point mutation wasidentified in aMODY-GK pedigree. These mice will be useful for studies of sustained hyperglycemia since they contain only a single mutation and are congenic with the C57BL/6J strain.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Gck{tm2Mgn}
Vanderbilt University Medical Center
Gck{tm2Mgn} mouse strain
BCGO:9000193
A mouse strain in which the targeted gene, Glucokinase (NCBI Gene ID: 103988), has been modified (allele type: Conditional Null) to targeted mutation 1.1 (MGI ID: Gck{tm1.1Mgn}). Gk{lox} mice may be used to generate cell specific knock-outs of glucokinase, depending which cre-expressing transgenic mouse is used. In humans, glucokinase gene mutations cause maturity onset diabetes of the young (MODY-GK), a disease that is characterized by early onset and persistent hyperglycemia. Thus, these mice are useful in determining how diminished experssion of glucokinase in specific cells causes hyperglycemia.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Gck{tm1.1Mgn}
Vanderbilt University Medical Center
Gck{tm1.1Mgn} mouse strain
BCGO:9000194
A mouse strain in which the targeted gene, phosphoenolpyruvate carboxykinase 1 (NCBI Gene ID: 18534), has been modified (allele type: Conditional Null) to targeted mutation 1.1, Mark A Magnuson (MGI ID: Pck1{tm1.1Mgn} ). These mice may be used to study tissue-specific functions of phosphoenolpyruvate carboxykinase (Pck1). This enzyme is essential for gluconeogenesis and also is important for regulating anapleurosis/catapleurosis of TCA cycle intermediates. By generating mice that are homozygous for the pck{lox} allele and that contain a tissue-specific Cre transgene, Pck1 can be deleted from various sites.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
pck{tm1.1Mgn}
Vanderbilt University Medical Center
pck{tm1.1Mgn} mouse strain
BCGO:9000195
A mouse strain in which the targeted gene, Rictor (NCBI Gene ID: 78757), has been modified (allele type: Global Null) to targeted mutation 1.3 (MGI ID: 4921505C17Rik{tm2Mgn}). Rictor is an essential part of mTOR complex 2 (mTORC2). mTORC2 phosphorylates Ser473 of Akt/PKB. Eliminating this gene disrupts the function of mTORC2, thereby preventing growth factor mediated activation of Akt/PKB. Thus, these mice have utility for studying both the sites of expression and function of rictor.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rik{tm1.3Mgn}
Vanderbilt University Medical Center
Rik{tm1.3Mgn} mouse strain
BCGO:9000196
A mouse strain in which the targeted gene, Rictor (NCBI Gene ID: 78757), has been modified (allele type: Conditional Null) to targeted mutation 1.1 (MGI ID: 4921505C17Rik{tm1.1Mgn}). These mice carrya conditional allele for Rictor, a component mTOR complex 2 (mTORC2). Disruption of the Rictor gene attenuates phosphorylation ofSer473 of Akt/PKB, which is important for a normal response to growth factor stimulation acting through the PI3-kinase signaling pathway.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rik{tm1.1Mgn}
Vanderbilt University Medical Center
Rik{tm1.1Mgn} mouse strain
BCGO:9000197
A mouse strain in which the targeted gene, Peroxisome proliferator-activated receptor gamma (NCBI Gene ID: 19016), has been modified (allele type: Conditional Null) to targeted mutation 1.1Mgn (MGI ID: Pparg{tm1.1Mgn}). These mice carry a conditional allele for PPARgamma that can be used in combination with various cre-expressing transgenes.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pparg{tm1.1Mgn}
Vanderbilt University Medical Center
Pparg{tm1.1Mgn} mouse strain
BCGO:9000198
A mouse strain in which the targeted gene, ATP-binding cassette, sub-family C (CFTR/MRP), member 8 (NCBI Gene ID: 20927), has been modified (allele type: Global Null) to targeted mutation 1.1Mgn (MGI ID: Sur1{neotm1.1Mgn}). These mice contain a global knock-out of the sulfonylurea receptor (Sur1), which is part of the ATP-dependent potassium channel. In humans, mutations in Sur1 cause persistent hyperinsulinemic hypoglycemia of infancy (PHHI).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
B6.129X1-Abcc8{tm1.1Mgn}
Vanderbilt University Medical Center
B6.129X1-Abcc8{tm1.1Mgn} mouse strain
BCGO:9000199
A mouse strain containing a transgene in which Neurog3-ER (transgene) is driven by the Pdx1 promoter (NCBI Gene ID: 18609). The transgene is driven by the Pdx1 promoter whcih targets it in pancreas progenitor during development. These mice express a fusion protein between the pro-endocrine transcription factor Ngn3 and the tamoxifen responsive estrogen receptor. An IRES site allows GFP to be co-expressed with Ngn3-ER. The protein is active only upon tamoxifen injection.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Tg(Pdx1-Neurog3-ER)1Agb
Vanderbilt University Medical Center
Tg(Pdx1-Neurog3-ER)1Agb mouse strain
BCGO:9000203
A mouse strain containing a transgene in which rtTA (transgene) is driven by the Gcg promoter (NCBI Gene ID: 14562). These mice expresses the rtTA (tetracycline transactivator) in islet alpha cells upon treatment with doxicycline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Glucagon:rtta
Vanderbilt University Medical Center
Glucagon:rtta mouse strain
BCGO:9000204
A mouse strain in which the targeted gene, hypoxanthine guanine phosphoribosyl transferase 1 (NCBI Gene ID: 15452), has been modified (allele type: Gene Replacement) to (MGI ID: ). C57/CBAJ-Hprt{tm3(Ins2-HBEGF)Ugfm} carries a transgene encoding the human diphtheria toxin receptor under the control of rat insulin II promoter, was inserted by homologous recombination at the Hprt locus of the X chromosome. It provides a model for depletion of 50% of beta cells using Diphtheria toxin.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
C57/CBAJ-Hprt{tm3(Ins2-HBEGF)Ugfm}
Vanderbilt University Medical Center
C57/CBAJ-Hprt{tm3(Ins2-HBEGF)Ugfm} mouse strain
BCGO:9000205
A mouse strain in which the targeted gene, Nkx6.1 (NCBI Gene ID: 18096), has been modified (allele type: Global Null) to targeted mutation (MGI ID: Nkx6.1{tm1(DsRed2)}). An IRES-DsRed2 cassette was introduced into exon 1 of the Nkx6.1 genomic sequence. The insertion generates a null allele. DsRed2 expression is not detected in these mice.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
B6-Nkx6-1{tm1Msan}
Vanderbilt University Medical Center
B6-Nkx6-1{tm1Msan} mouse strain
BCGO:9000206
A mouse strain containing a transgene in which CreER (transgene) is driven by the Ins promoter (NCBI Gene ID: 16333). A transgenic mouse expression tamoxifen-inducible Cre recombinase under rat insulin promoter. Upon the injection of tamoxifen, loxP-flanked DNA sequences in beta cells will be deleted.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Tg(RIP-Cre/ESR1){Ydor}
Vanderbilt University Medical Center
Tg(RIP-Cre/ESR1){Ydor} mouse strain
BCGO:9000207
A mouse strain in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create Ptf1a{tTA} using the Loxed Cassette Acceptor allele Ptf1a{tm1(LCA)}). Mice heterozygous for the tTA replacement of the Ptf1a gene are viable, fertile, of normal size, and do not display any behavioral abnormalities. The replacement places the expression of tTAoff (Gossen & Bujard, PNAS 89:5547, 1992) under the control of the regulatory sequences of the endogenous Ptf1a gene. This mouse was initially designed to be mated to a mouse (see BCBC #M461) bearing a bicistronic Ptf1a-lacZ transgene driven by the tetracycline-regulatory element (TRE: 7 copies of tetO with the CMV minimal promoter). For offspring homozygous for the tTA allele of Ptf1a and hemi- or homozygous for the transgene, the production of PTF1a is due solely to tTA-activation of the transgene, which is repressed by administration of tetracycline/doxycycline. This strategy allows embryonic developmental arrest at desired stages or cessation of gene function in adult mice for the pancreas (similar to that for Pdx1 described in Holland et al., PNAS 99:12236, 2002) and also for the cerebellum, retina, dorsal spinal cord and possibly hypothalamus. This transgenic mouse may be useful in studies of pancreatic endocrine/exocrine development and function, diabetes, and certain defects of the CNS. This tissue-specific expresser of tTA can also be bred with strains bearing other TRE-transgenes for organ-specific conditional expression analyses. Nearly all of the Ptf1a transcription unit has been replaced by a tTAoff coding sequence with accessory translational and RNA-processing signals, as follows, from 5' to 3': the Ptf1a gene transcriptional start and 49-bp of its 5'UTR; the Xenopus laevis beta-globin 5'UTR with Kozak initiator codon; the tTA coding sequence; and a 990-bp rabbit beta-globin gene fragment encoding the last 14-bp of its second exon, the 573-bp second intron, and the 364-bp last exon including a 98-bp 3'UTR with the polyA addition signal and addition site, and 39-bp of 3' beta-globin gene flanking sequence. The Ptf1a locus was modified by recombination-mediated cassette exchange using the cassette exchange allele in Ptf1a-LCA ES cells (Burlison et al., submitted).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ptf1a{tm1(tTAoff)Macd}
Vanderbilt University Medical Center
Ptf1a{tm1(tTAoff)Macd} mouse strain
BCGO:9000209
A mouse strain containing a transgene in which DTR (transgene) is driven by the RIP promoter (NCBI Gene ID: ). NOD-Prkdc{scid} IL2rg{null}Tg(Ins2-HBEGF){6832Ugfm} mice are deficient in mature lymphocytes and NK cells, survive beyond 16 months of age, and even after sublethal irradiation resist lymphoma development. They can be induced to become hypoglycemic when Diphtheria toxin is used. 100% of beta cells will be depleted upon administration of diphtheria toxin.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl} Tg(Ins2-HBEGF){6832Ugfm}/Sz
Vanderbilt University Medical Center
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl} Tg(Ins2-HBEGF){6832Ugfm}/Sz mouse strain
BCGO:9000210
A mouse strain containing a transgene in which DTR (transgene) is driven by the RIP promoter (NCBI Gene ID: ). NOD-scid IL2rg{null}Hprt{tm3(Ins2-HBEGF)Ugfm} mice are deficient in mature lymphocytes and NK cells, survive beyond 16 months of age, and even after sublethal irradiation resist lymphoma development. They can be induced to become hypoglycemic when Diphtheria toxin is used. 50% of beta cells will be depleted after diphtheria toxin administration.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl}Hprt{tm3(Ins2-HBEGF)Ugfm}/Sz
Vanderbilt University Medical Center
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl}Hprt{tm3(Ins2-HBEGF)Ugfm}/Sz mouse strain
BCGO:9000211
A mouse strain in which the targeted gene, recombination activating gene 1 (NCBI Gene ID: 19373), has been modified (allele type: Global Null) to (MGI ID: ). The NOD-Rag1{null} Prf1{null} Ins2{Akita} mouse is the first immunodeficient, spontaneously hyperglycemic mouse strain described that is based on the Ins2{Akita} mutation. This strain is suitable as hosts for human islet and human beta stem and progenitor cell transplantation in the absence of the need for pharmacological induction of diabetes. This strain of mice also has low levels of innate immunity and can be engrafted with a human immune system for the study of human islet allograft rejection.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Rag1{tm1Mom} Ins2{Akita} Prf1{tm1Sdz}/Sz
Vanderbilt University Medical Center
NOD.Cg-Rag1{tm1Mom} Ins2{Akita} Prf1{tm1Sdz}/Sz mouse strain
BCGO:9000212
A mouse strain in which the targeted gene, interleukin 2 receptor, gamma chain (NCBI Gene ID: 16186), has been modified (allele type: Global Null) to (MGI ID: Il2rg{tm1Wjl}). Backcrossing of the Rag1 null allele onto the NOD/Lt strain background (NOD-Rag1{null} mice) provided a radio-resistant and longer-lived model for human-cell engraftment. Mutations in X-chromosome-linked Il2rg gene cause X-linked severe combined immunodeficiency (XSCID). Immunodeficient NOD-Rag1{null} IL2rg {null}mice tolerated much higher levels of irradiation conditioning than did NOD-Prkdc{scid} IL2rg {null} mice.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Rag1{tm1Mom} Il2rg{tm1Wjl}/Sz
Vanderbilt University Medical Center
NOD.Cg-Rag1{tm1Mom} Il2rg{tm1Wjl}/Sz mouse strain
BCGO:9000214
A mouse strain in which the targeted gene, interleukin 2 receptor, gamma chain (NCBI Gene ID: 16186), has been modified (allele type: Global Null) to targeted mutation 1 (MGI ID: Il2rg{tm1Wjl}). NOD.Cg-Prkdc{scid}Il2rg{tm1Wjl}Tg(Ins1-EGFP/GH1){14Hara}/Sz is a immunodeficient mouse carries a GFP transgene under the control of mouse insulin promoter 1, which leads to expression of eGFP in the beta cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl} Tg(Ins1-EGFP/GH1){14Hara}/Sz
Vanderbilt University Medical Center
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl} Tg(Ins1-EGFP/GH1){14Hara}/Sz mouse strain
BCGO:9000215
A mouse strain in which the targeted gene, Neurogenin 3 (NCBI Gene ID: 11925), has been modified (allele type: Other) to targeted mutation 1 (MGI ID: Ngn3{EYFP/+}). A targeting construct was designed to insert an IRES-EYFP and a floxed puro downstream of the coding sequence. Crossing with mice expressing Cre in the germ line excised the puromycin resistance gene. Coding region for Ngn3 is kept intact consequentely homozygous mice express Ngn3 protein , do not develop diabetes and behave like wild-types. in these mice, Ngn3-positive progenitors express EYFP and can be purified by FACS.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Neurog3{tm1Ggr}
Vanderbilt University Medical Center
Neurog3{tm1Ggr} mouse strain
BCGO:9000216
A mouse strain containing a transgene in which bicistronic Ptf1a-lacZ (transgene) is driven by the TRE promoter (NCBI Gene ID: ). Mice hemi- or homozygous for the transgene are viable, fertile, normal size, and do not display any behavioral abnormalities. Expression of the bicistronic transgene is directed by a heptameric tetO repeat linked to the CMV minimal promoter (collectively the tetracycline-response element). The mice do not express lacZ until a tetracycline-gransactivator (tTA) protein is produced; thereafter Ptf1a and lacZ genes are highly expressed. This mouse was designed to be mated to an apancreatic targeted mutant with tTAoff in place of the Ptf1a coding sequence (see BCBC strain M321). The combined genetic alterations provide normal pancreatic development and function until doxycycline-administration render the mice conditionally null of Ptf1a. This approach allows embryonic developmental arrest at desired stages or cessation of gene function in adult mice for the pancreas, cerebellum, retina, dorsal spinal cord and possibly hypothalamus. This transgenic mouse may be useful in studies of pancreatic endocrine/exocrine development and function, diabetes, and and certain defects of the CNS. This transgenic can also be bred with other tTA strains for conditional mutation analysis.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Tg(tetO-Ptf1a,lacZ)Macd
Vanderbilt University Medical Center
Tg(tetO-Ptf1a,lacZ)Macd mouse strain
BCGO:9000218
A mouse strain in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create Ptf1a{tm2(W298A)} using the Loxed Cassette Acceptor allele Ptf1a{tm1(LCA)}). This mouse strain has a 2-bp site-directed mutation in the endogenous Ptf1a locus that changes codon 298 from tryptophan to alanine. The mutation disrupts the ability of the PTF1a protein to bind RBPJ. Mice heterozygous for the mutation are viable, fertile, of normal size, and do not display any behavioral abnormalities. Mice homozygous for the mutation phenocopy the homozygous Ptf1a-null. Newborn homozygotes are apancreatic, devoid of the dI4 and dILA GABAergic dorsal interneurons, have an incomplete cerebellum, and die shortly after birth.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ptf1a{tm2(W298A)Macd}
Vanderbilt University Medical Center
Ptf1a{tm2(W298A)Macd} mouse strain
BCGO:9000219
A mouse strain in which the targeted gene, Recombination signal binding protein for immunoglobulin kappa J region-like (NCBI Gene ID: 19668), has been modified (allele type: Global Mutation) to Rbpjl{tm1Macd} (MGI ID: Rbpjl{tm1(lacZ)}). This mouse strain has the Rbpjl gene region spanning exons 7, 8, and 9 replaced with lacZ in-frame. A pgk-neo resistance cassette has been removed by Cre-loxP deletion from the founder. Mice heterozygous and homozygous for the lacZ replacement are viable, fertile, of normal size, and do not display any behavioral abnormalities. In mature mice, the pancreas is one-third smaller than normal, due to less acinar tissue. Expression of the lacZ, measured by bet-galactosidase histostaining is very low.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rbpjl{tm1(lacZ)Macd}
Vanderbilt University Medical Center
Rbpjl{tm1(lacZ)Macd} mouse strain
BCGO:9000220
A mouse strain in which the targeted gene, Pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609), has been modified (allele type: Gene Replacement) to targeted mutation 1 (MGI ID: Pdx1{tmd1Macd}). Mice homozygous for the targeted mutation fail to develop a pancreas. Heterozygous mice have normal pancreatic development, but have partially impaired glucose tolerance in adulthood. The substitution of the targeted Ipf1/Pdx1 gene with tTAoff inactivates the endogenous allele and places tTAoff expression under the control of the endogenous transcriptional regulatory sequences of the Pdx1 locus. Identical to the endogenous allele, mutant locus expression is detectable in the pancreas and adjacent duodenum but not in other visceral organs or salivary glands. This mutant may be useful to direct tetracycline-regulated expression of responder transgenes in studies of pancreatic endocrine/exocrine development and function and diabetes. This mutant can also be bred with other tetO/TRE strains for pancreas-specific applications. This mutant was originally designed to be mated with mice engineered with a heptameric tetracycline operator (tetO)-controlled bicistronic transgene coding for a normal PDX1 protein and with a beta-galactosidase or EGFP reporter (see BCBC mouse M561). The combined modifications allow normal pancreatic development and function until doxycycline-administration renders the mouse conditionally null of the Pdx1 gene. This configuration for conditional expression of Pdx1is most effective when the transgene locus is homozygous. This allows embryonic developmental arrest at desired stages or cessation of function in adult mice by tetracycline administration.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
STOCK Pdx1{tm1Macd}/J
Vanderbilt University Medical Center
STOCK Pdx1{tm1Macd}/J mouse strain
BCGO:9000221
A mouse strain containing a transgene in which bicistronic Pdx1-lacZ (transgene) is driven by the TRE promoter (NCBI Gene ID: ). Mice hemizygous and homozygous for the transgenic insert are viable, fertile, of normal size, and do not display any behavioral abnormalities. Expression of the bicistronic transgene is directed by a heptameric tetO repeat fused to a minimal promoter (collectively the tetracycline-response element, or TRE). Transgenic mice do not express lacZ until a tetracycline-transactivator (tTA) protein is introduced; thereafter Pdx1 and lacZ from the transgene are expressed. All cells expressing transgenic Pdx1 coexpress the reporter. Further, mRNA levels of the transgene and endogenous Pdx1 fluctuate in concert during development. This mouse was originally designed to be mated to an apancreatic targeted mutant with the coding sequence of the Pdx1 locus replaced with that for tTAoff (see BCBC #M541). The combined mutations allow normal pancreatic development and function until doxycycline treatments render the mouse conditionally null of the endogenous gene. For this configuration, rescue of pancreatic development is most effective when the transgene locus is homozygous. This allows embryonic developmental arrest at desired stages or cessation of function in adult mice by administration of tetracycline/doxycycline. This transgenic strain may be useful in studies of pancreatic development and endocrine/exocrine function and diabetes. This strain can also be bred with other tTA strains for regulating Pdx1 expression in other contexts.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
STOCK Tg(tetO-Pdx1,lacZ)958.1Macd
Vanderbilt University Medical Center
STOCK Tg(tetO-Pdx1,lacZ)958.1Macd mouse strain
BCGO:9000222
A mouse strain in which the targeted gene, Neurogenin 3 (NCBI Gene ID: 11925), has been modified (allele type: Other) to targeted mutation 2 (MGI ID: Neurog3{tm2(EGFP)Ggr). A targeting construct was designed to insert an IRES-EGFP and a floxed puro downstream of the coding sequence. Crossing with mice expressing Cre in the germ line excised the puromycin resistance gene. Homozygous mice express Ngn3 protein, do not develop diabetes and behave like wild-types. Ngn3-positive cells are labeled with EGFP and can be purified by FACS.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Neurog3{tm2(EGFP)Ggr}
Vanderbilt University Medical Center
Neurog3{tm2(EGFP)Ggr} mouse strain
BCGO:9000223
A mouse strain containing a transgene in which LacZ (transgene) is driven by the Neurog3 promoter (NCBI Gene ID: 11925). Transgenic mice where Ngn3-positive cell are labeled with beta-galactosidase. Due to the stability of beta-galactosidase protein, the early descendants of Ngn3-positve cells are also labeled. To generate the Ngn3 promoter::LacZ construct, a 6.86 kb XbaI-XhoI fragment (6696 bp of 5' genomic and untranslated region sequences and 176 bp of ngn3 coding region) of mouse ngn3 genomic DNA was cloned upstream of the IRES-NLS-LacZ-pA sequence in pBS-INL vector resulting in plasmid pngn3(6.8)-INL. The 10.6 kb Ngn3-IRES-NLS-LacZ insert was released by NotI digestion and microinjected into murine oocyte pronuclei, and transgenic line was generated and maintained by crossing into a CD1 outbred background.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Tg(Neurog3-IRES-NLS-LacZ)1Ggr
Vanderbilt University Medical Center
Tg(Neurog3-IRES-NLS-LacZ)1Ggr mouse strain
BCGO:9000224
A mouse strain containing a transgene in which mRFP (transgene) is driven by the Ins1 promoter (NCBI Gene ID: 1633). These transgenic mice express the monomeric red fluorescent protein under the control of Ins1 gene (BAC) regulatory elements.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Tg(Ins1-mRFP)2Ggr
Vanderbilt University Medical Center
Tg(Ins1-mRFP)2Ggr mouse strain
BCGO:9000225
A mouse strain in which the targeted gene, Arx (NCBI Gene ID: 11878), has been modified (allele type: Gene Replacement) to targeted mutation 1 (MGI ID: Arx{tm1Pgr}). These mice were created by insertion of the LacZ gene (with nuclear localization signal) into the Arx locus by homologous recombination in embryonic stem cells. The Arx gene is localized on the X chromosome. Knockout mice die after birth with due to hypoglycemia. Therefore male mice die at day 2 past birth. The colony has to be propagated with female mice. Arx-deficient mice do not produce alpha cells in the islets of Langerhans.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Arx{tm1Pgr}
Vanderbilt University Medical Center
Arx{tm1Pgr} mouse strain
BCGO:9000228
A mouse strain in which the targeted gene, v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) (NCBI Gene ID: 378435), has been modified (allele type: Conditional Null) to targeted mutation 1.1 (MGI ID: Mafa{tm1.1(lox)}). Mafa is a basic leucine-zipper containing member of the large Maf transcription factor family.It is part of the RIPE3b1 activator complex and functions as a key activator of insulin and pdx-1 gene transcription. Mafa{lox} mice may be used to generate both global and cell-specific Mafa null mice, depending on which cre-expressing transgenic mouse is used. Removal of Mafa gene might have a profound effect on beta cell function; thus we can closely monitor the expression of islet hormones, transcription functions and the glucose sensing machinery immunohistochemically. The experiment will provide us with the information about the role of Mafa plays in vivo in islet beta cells and the developing pancreas, thus helping us to understand how transcription activator contribute to the pathogenesis and the treatment of diabetes.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Mafa{tm1.1Rwst}
Vanderbilt University Medical Center
Mafa{tm1.1Rwst} mouse strain
BCGO:9000229
A mouse strain in which the targeted gene, Myt1 (myelin transcriptioin factor 1) (NCBI Gene ID: 1100535 ), has been modified (allele type: Conditional Null) to targeted mutation 1.1 (MGI ID: Myt1{tm1.1Ggu}). Two loxP sites flank exon 6 of Myt1b. The allele behaves as wild type allele without Cre-mediated deletion. Cre-mediated deletion creates null Myt1 allele. The homozygous null is neonatal lethal. Myt1 null pancreas has abnormal islet cell differentiation, ie. single cells produce multiple hormones. Pancreatic-specific Myt1 deletion results in glucose intolerance in males.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Myt1{tm1.1Ggu}
Vanderbilt University Medical Center
Myt1{tm1.1Ggu} mouse strain
BCGO:9000230
A mouse strain in which the targeted gene, Onecut1 (NCBI Gene ID: 15379), has been modified (allele type: Conditional Null) to targeted mutation 1.1 (MGI ID: OC-1{tm1.1Mga}). This line of mice allows for conditional inactivation of the OC-1 (HNF6) gene using Cre recombinase. Thus, HNF6 function can be assessed in the different tissues in which it is expressed.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
OC-1{tm1.1Mga}
Vanderbilt University Medical Center
OC-1{tm1.1Mga} mouse strain
BCGO:9000231
A mouse strain in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2(TNmut) using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). These mice contain mutations in the central core of the Nkx2.2 TN domain (putative groucho-interaction domain).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx2-2{tm3Suss}
Vanderbilt University Medical Center
Nkx2-2{tm3Suss} mouse strain
BCGO:9000232
A mouse strain in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2:rtTA using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). The reverse tetracycline transactivator (rtTA) is knocked into the Nkx2.2 coding region, effectively knocking out one Nkx2.2 allele.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx2-2{tm2Suss}
Vanderbilt University Medical Center
Nkx2-2{tm2Suss} mouse strain
BCGO:9000233
A mouse strain containing a transgene in which Diphtheria Toxin Receptor (transgene) is driven by the Gcg promoter (NCBI Gene ID: 14526). Transgenic strain (generated by pronuclear microinjection) of a transgene containing the rat glucagon promoter (1.6kb fragment) upstream of a rabbit beta-globin intron and the coding sequence of the human diphtheria toxin receptor (heparin-binding epidermal growth factor, membrane form). Downstream, there is a rabbit beta-globin stop codon and the polyadenylation signal.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
C57/CBAJ-TgN(Glucagon- hHB EGF)Ugfm
Vanderbilt University Medical Center
C57/CBAJ-TgN(Glucagon- hHB EGF)Ugfm mouse strain
BCGO:9000234
A mouse strain containing a transgene in which rtTA (transgene) is driven by the Gcg promoter (NCBI Gene ID: 14526). Transgenic strain (generated by pronuclear microinjection) of a transgene containing the rat glucagon promoter (1.6kb fragment) upstream of the coding region of the reverse transactivator doxycycline-dependent. The rtTA is flanked by a rabbit beta-globin intron and downstream there is a stop and polyA signal from the same rabbit beta-globin gene.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
C57/CBAJ-TgN(Glucagon- rtTA)Ugfm
Vanderbilt University Medical Center
C57/CBAJ-TgN(Glucagon- rtTA)Ugfm mouse strain
BCGO:9000235
A mouse strain containing a transgene in which DTR (transgene) is driven by the Ins promoter (NCBI Gene ID: 16333). Transgenic mice generated by pronuclear microinjection of a transgene encoding the human diphtheria toxin receptor (heparin binding epidermal growth factor, also termed DTR) under the control of the rat insulin II gene promoter (0.6kb-long fragment). The DTR coding sequence is flanked by the rabbit beta-globin intron and stop/polyA sequences.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
C57/CBAJ-Tg(Ins2- HBEGF){6832Ugfm}
Vanderbilt University Medical Center
C57/CBAJ-Tg(Ins2- HBEGF){6832Ugfm} mouse strain
BCGO:9000237
A mouse strain containing a transgene in which Luc (transgene) is driven by the MIP promoter (NCBI Gene ID: 16333). We generated a transgenic mouse expressing the luciferase optical reporter under control of the mouse insulin I promoter (MIP-Luc-VU) and characterized this model in mice with increased or decreased beta-cell mass and after islet transplantation. MIP-Luc-VU mice emitted strong and consistent bioluminescence emanating exclusively from beta-cells of the pancreatic islet. MIP-Luc-VU islets had normal islet architecture and secreted insulin normally in vivo and in vitro. By tracking changes in β cell mass using bioluminescence imaging (BLI) and post-mortem metrics, streptozotocin-induced, diabetic MIP-Luc-VU mice had a progressive decline in bioluminescence that correlated with a decrease in pancreatic insulin content and beta-cell mass. MIP-Luc-VU animals fed a high fat diet displayed a progressive increase in bioluminescence that reflected an immunohistochemically verified increase in beta-cell mass. MIP-Luc-VU islets transplanted beneath the renal capsule or into the liver emitted bioluminescence proportional to the number of islets transplanted and graft insulin content and could be imaged for more than a year. Since bioluminescence in the MIP-Luc-VU mouse model is proportional to beta-cell mass in the setting of increased and decreased beta-cell mass and after transplantation, this approach should be useful for non-invasively assessing beta-cell mass in pre-clinical mouse models of glucose homeostasis, beta-cell growth and regeneration, and diabetes.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
FVB/NJ-Tg(MIP-Luc-VU)3Pwrs/J
Vanderbilt University Medical Center
FVB/NJ-Tg(MIP-Luc-VU)3Pwrs/J mouse strain
BCGO:9000238
A mouse strain in which the targeted gene, ROSA26 (NCBI Gene ID: 14910), has been modified (allele type: Conditional Activating) to ROSA26-loxp-STOP-loxp-Myt1 (MGI ID: Not yet available). Targeted insertion of a LoxP-STOP-LoxP-Myt1 casette into the ROSA26 locus. The presence of Cre recombinase will lead to activation of the 7 zinc finger isoform of Myt1.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Gt(ROSA)26Sor{tm1(Myt1*)Hri}
Vanderbilt University Medical Center
Gt(ROSA)26Sor{tm1(Myt1*)Hri} mouse strain
BCGO:9000239
A mouse strain in which the targeted gene, Neurogenin 3 (NCBI Gene ID: 11925), has been modified (allele type: Gene Replacement) to Ngn3 tTA knockin (MGI ID: Ngn3tTA). The mouse contains a Ngn3 knock-in allele. IRES-tTA-rabbit beta globin polyA signal replaced the entire Ngn3 cDNA coding sequence. This is therefore also a Ngn3 null allele. Ngn3 is a bHLH transcription factor that is required for the differentiation of endocrine islet and some neuronal cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ngn3{tm1(tTA)Hri}
Vanderbilt University Medical Center
Ngn3{tm1(tTA)Hri} mouse strain
BCGO:9000240
A mouse strain in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2:LacZ using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). The lacZ gene has been knocked in to the Nkx2.2 genomic locus using RMCE, effectively replacing the two coding exons.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx2-2{tm1Suss}
Vanderbilt University Medical Center
Nkx2-2{tm1Suss} mouse strain
BCGO:9000241
A mouse strain in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2-NK2 mutation using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). The strain carries a mutant Nkx2.2 allele in which conserved residues of the NK2 domain are mutated to alanines.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx2-2{tm4Suss}
Vanderbilt University Medical Center
Nkx2-2{tm4Suss} mouse strain
BCGO:9000242
A mouse strain in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1{AIId} using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). This is a targeted deletion of Area II 5' cis-regulatory region of Pdx1.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pdx1{tm6Cvw}
Vanderbilt University Medical Center
Pdx1{tm6Cvw} mouse strain
BCGO:9000243
A mouse strain in which the targeted gene, Pancreatic and Duodenal homeobox 1 (NCBI Gene ID: 18609), has been modified (allele type: Conditional Null) to targeted mutation 4 (MGI ID: Pdx1{tm4(E2)}). This is a conditional null allele of Pdx1. LoxP sites for Cre recombinase were inserted to flank exon 2 of the gene.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pdx1{tm4Cvw}
Vanderbilt University Medical Center
Pdx1{tm4Cvw} mouse strain
BCGO:9000244
A mouse strain in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create Ptf1a{tm2(cre/ESR1)} using the Loxed Cassette Acceptor allele Ptf1a{tm1(LCA)}). CreER knock-in into Ptf1a locus replacing part of the exon1 at the translation initiator ATG position using RMCE method.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ptf1a{tm2(cre/ESR1)Cvw}
Vanderbilt University Medical Center
Ptf1a{tm2(cre/ESR1)Cvw} mouse strain
BCGO:9000245
A mouse strain in which the targeted gene, Pancreatic and Duodenal homeobox 1 (NCBI Gene ID: 18609), has been modified (allele type: Other) to targeted mutation 5 (MGI ID: Pdx1{tm5(AI-II-III)}). LoxP sites for cre recombinase were inserted to flank Area I-II-III, a conserved 5' cis-regulatory region of Pdx1. This allele was shown to be a conditional hypomorph by Fujitani et al. (2006) (PMID 16418487). Pdx1{tm3Cvw} (Pdx1{deltaI-II-III}) is generated by Cre-mediated recombination in the germline of this allele.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pdx1{tm5Cvw}
Vanderbilt University Medical Center
Pdx1{tm5Cvw} mouse strain
BCGO:9000246
A mouse strain in which the targeted gene, Delta-like 1 (NCBI Gene ID: 13388), has been modified (allele type: Conditional Null) to targeted mutation 1 (MGI ID: Dll1{tm1Hri}). This is a targeted mutation of the Notch ligand Dll1, introducing two loxP sites flanking the exons encoding the DSL domain.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Dll1{tm1Hri}
Vanderbilt University Medical Center
Dll1{tm1Hri} mouse strain
BCGO:9000247
A mouse strain in which the targeted gene, Pancreatic and Duodenal homeobox 1 (NCBI Gene ID: 18609), has been modified (allele type: Global Mutation) to targeted mutation 3 (MGI ID: Pdx1{tm3(deltaI-II-III)). Area I-II-III, a conserved 5' cis-regulatory region of Pdx1, was removed by Cre mediated recombination in the germline of Pdx1{tm5Cvw} (Pdx1{Flox123}) by crossing to deleter Cre mice. This allele was shown to be a hypomorph.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pdx1{tm3Cvw}
Vanderbilt University Medical Center
Pdx1{tm3Cvw} mouse strain
BCGO:9000248
A mouse strain in which the targeted gene, Pancreas Specific Transcription Factor, 1a (NCBI Gene ID: 19213), has been modified (allele type: Cassette Acceptor) to Targeted Mutation 3 (MGI ID: Ptf1a{tm3Cvw}). This mouse strain is a conditional null allele of Ptf1a. LoxP sites flanking exon 1 and 2 (entire coding region of Ptf1a).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ptf1a{tm3Cvw}
Vanderbilt University Medical Center
Ptf1a{tm3Cvw} mouse strain
BCGO:9000253
A mouse ESC line in which the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213), has been modified (allele type: Cassette Acceptor) to targeted mutation 1 (MGI ID: Ptf1a{tm1(LCA)}). This ES cell line contains a loxed cassette acceptor (LCA) allele in which a 4.1 kb region of this gene (including the proximal promoter and both exons 1 and 2) was replaced with a loxP site, an inverted loxP site, and both positive and negative selectable markers. This enables the use of Recombinase-Mediated Cassette Exchange (RMCE) to easily insert various reporter genes or to make other modifications of the Ptf1a gene locus.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ptf1a{LCA} mouse ESC line
BCGO:9000254
A mouse ESC line in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create Ptf1a{LCA} using the Loxed Cassette Acceptor allele Ptf1a{tm1.1(YFP)}). This ES cell line contains YFP inserted into a Ptf1a{LCA} allele by recombinase mediated cassette exchange. These cells may be useful for identifying pancreatic progenitor cells in cultures that have been stimulated to differentiate towards endodermal and pancreatic fates.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ptf1a{YFP} mouse ESC line
BCGO:9000255
A mouse ESC line in which the targeted gene, glucokinase (NCBI Gene ID: 19213), has been modified (allele type: Cassette Acceptor) to targeted mutation 4 (MGI ID: gk{tm4(LCA)}). This ES cell line contains a loxed cassette acceptor (LCA) allele that may be utilized for the exchange of DNAs of interest into the glucokinase locus by recombinase mediated cassette exchange (RMCE). This LCA uses a loxP/inverted loxP strategy for RMCE and allows sequences between - 6 kb and + 5 kb (relevative to the hepatic-specific promoter) to be manipulated. This enables a variety of different types of experiments to be performed using a range of cassette designs.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Gck{LCA} mouse ESC line
BCGO:9000256
A mouse ESC line in which the targeted gene, insulinoma-associated 1 (NCBI Gene ID: 53626), has been modified (allele type: Cassette Acceptor) to targeted mutation 1 (MGI ID: Insm1{tm1(LCA)}). This ES cell line contains a loxed cassette acceptor(LCA)allele that may be utilized for the exchange of DNAs of interest into the Insm1 gene locus by recombinase mediated cassette exchange (RMCE). This LCA uses a lox 66/71 and lox 2272 strategy for RMCE and allows a ~5.2 kb region of this single exon gene to be manipulated. This enables a variety of different types of experiments to be performed using a range of cassette designs.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Insm1{LCA} mouse ESC line
BCGO:9000257
A mouse ESC line in which the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088), has been modified (allele type: Cassette Acceptor) to targeted mutation 1 (MGI ID: Nkx2.2{tm1(LCA)}). This ES cell line contains a loxed cassette acceptor (LCA) allele that may be utilized for the exchange of DNAs of interest into the Nkx2.2 locus by recombinase mediated cassette exchange (RMCE). This LCA uses a Lox71/66 and Lox2272 strategy for RMCE and allows for manipulation of a 5.1 kb region of the gene (contains promoter, exon 1, and exon 2). This leads to a variety of experiments that can be performed using a wide range of cassette designs.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Nkx2.2{LCA} mouse ESC line
BCGO:9000260
A mouse ESC line containing a transgene in which Gfp (transgene) is driven by the Ins1 promoter (NCBI Gene ID: 16333). New ESC line derived from MIP-GFP mice (Hara et al. 2003,Am J Physiol Endocrinol Metab. 284: E177-83). Genetic background is C57Bl6/J. When injected into E3.5 mouse blastocysts this line contributes to chimeras and Insulin+/GFP+ double positive cells are found in E14.5 embryonic pancreas. No GFP+ cells are seen outside the pancreas.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
MIP-GFP mouse ESC line
BCGO:9000261
A mouse ESC line containing a transgene in which Gfp (transgene) is driven by the Neurog3 promoter (NCBI Gene ID: 11925). Mouse ESC line derived from Ngn3-GFP transgenic mice (Gradwohl et al. unpublished). Genetic background is CD1.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ngn3-GFP mouse ESC line
BCGO:9000262
A mouse ESC line in which the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910), has been modified (allele type: Cassette Acceptor) to targeted mutation 1 (MGI ID: Rosa26{tm1(LCA)}). This ES cell line contains a loxed cassette acceptor (LCA) allele in which a 5.17 kb region of the gene has been replaced by a Lox66 site, a puromycin-(delta)-thymidine kinase fusion gene driven by the mouse phosphoglycerol kinase promoter, a kanamycin resistance gene driven by the bacterial EM7 promoter, and a Lox2272 site. These features enable use of Recombinase-Mediated Cassette Exchange for the rapid insertion of various DNAs into the Rosa26 gene locus.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{LCA} mouse ESC line
BCGO:9000263
A mouse ESC line in which the targeted gene, SRY-box containing gene 17 (NCBI Gene ID: 20671), has been modified (allele type: Cassette Acceptor) to targeted mutation 1 (MGI ID: Sox17{tm1(LCA)}). This mouse ES cell line contains a loxed cassette acceptor (LCA) allele that may be utilized for the exchange of DNAs of interest into the Sox17 gene locus by recombinase mediated cassette exchange (RMCE). A 3.79 kb region of the gene (exons 3-5) was replaced by tandemly oriented lox66 and lox2272 sites as well as both positive and negative selectable markers.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Sox17{LCA} mouse ESC line
BCGO:9000266
A polyclonal antibody raised in rabbit that targets the rat "IAPP" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat IAPP raised in rabbit
BCGO:9000267
A polyclonal antibody raised in rabbit that targets the rat "C-peptide 2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat C-peptide 2 raised in rabbit
BCGO:9000268
A polyclonal antibody raised in rabbit that targets the rat "C-peptide 1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat C-peptide 1 raised in rabbit
BCGO:9000269
A polyclonal antibody raised in rabbit that targets the mouse "C-peptide 1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse C-peptide 1 raised in rabbit
BCGO:9000270
A monoclonal antibody raised in mouse that targets the human "Insulin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Insulin raised in mouse
BCGO:9000271
A polyclonal antibody raised in rabbit that targets the rat "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat PDX1 raised in rabbit
BCGO:9000272
A polyclonal antibody raised in rabbit that targets the rat "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat PDX1 raised in rabbit
BCGO:9000273
A polyclonal antibody raised in rabbit that targets the rat "Nkx6.1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat Nkx6.1 raised in rabbit
BCGO:9000274
A polyclonal antibody raised in goat that targets the human "Nkx2.2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Nkx2.2 raised in goat
BCGO:9000275
A polyclonal antibody raised in goat that targets the human "ghrelin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human ghrelin raised in goat
BCGO:9000276
A polyclonal antibody raised in rabbit that targets the mouse "Pax6" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Pax6 raised in rabbit
BCGO:9000277
A polyclonal antibody raised in goat that targets the human "b-catenin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human b-catenin raised in goat
BCGO:9000278
A monoclonal antibody raised in mouse that targets the mouse "smooth muscle actin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse smooth muscle actin raised in mouse
BCGO:9000279
A polyclonal antibody raised in rabbit that targets the human "amylase" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human amylase raised in rabbit
BCGO:9000280
A polyclonal antibody raised in rabbit that targets the human "c-myc" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human c-myc raised in rabbit
BCGO:9000281
A polyclonal antibody raised in rabbit that targets the rat "Glut-2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat Glut-2 raised in rabbit
BCGO:9000282
A polyclonal antibody raised in rabbit that targets the bovine "Carboxypeptidase A" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal bovine Carboxypeptidase A raised in rabbit
BCGO:9000283
A polyclonal antibody raised in rabbit that targets the human "Chromogranin A" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Chromogranin A raised in rabbit
BCGO:9000284
A monoclonal antibody raised in mouse that targets the human "Chromogranin A" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Chromogranin A raised in mouse
BCGO:9000285
A monoclonal antibody raised in mouse that targets the human "Cytokeratin 7" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Cytokeratin 7 raised in mouse
BCGO:9000286
A monoclonal antibody raised in mouse that targets the human "PECAM-1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human PECAM-1 raised in mouse
BCGO:9000287
A polyclonal antibody raised in rabbit that targets the aequorea victoria "Green Fluorescent Protein" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal aequorea victoria Green Fluorescent Protein raised in rabbit
BCGO:9000288
A monoclonal antibody raised in mouse that targets the chicken "Nkx2.2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal chicken Nkx2.2 raised in mouse
BCGO:9000289
A polyclonal antibody raised in rabbit that targets the rat "ghrelin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat ghrelin raised in rabbit
BCGO:9000290
A monoclonal antibody raised in mouse that targets the chicken "Islet-1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal chicken Islet-1 raised in mouse
BCGO:9000291
A polyclonal antibody raised in rabbit that targets the human "GATA-4" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human GATA-4 raised in rabbit
BCGO:9000292
A polyclonal antibody raised in rabbit that targets the mouse "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse PDX1 raised in rabbit
BCGO:9000294
A polyclonal antibody raised in chicken that targets the mouse "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse PDX1 raised in chicken
BCGO:9000295
A monoclonal antibody raised in mouse that targets the human "Glucagon" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Glucagon raised in mouse
BCGO:9000296
A monoclonal antibody raised in mouse that targets the human "Somatostatin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Somatostatin raised in mouse
BCGO:9000297
A monoclonal antibody raised in mouse that targets the rat "Pancreatic Ducts" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Pancreatic Ducts raised in mouse
BCGO:9000298
A monoclonal antibody raised in mouse that targets the rat "Pancreatic Ducts" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Pancreatic Ducts raised in mouse
BCGO:9000299
A monoclonal antibody raised in rat that targets the rat "Islet Delta Cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Islet Delta Cells raised in rat
BCGO:9000300
A monoclonal antibody raised in rat that targets the rat "Pancreatic Ducts" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Pancreatic Ducts raised in rat
BCGO:9000301
A monoclonal antibody raised in mouse that targets the human "Pro-Insulin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pro-Insulin raised in mouse
BCGO:9000302
A polyclonal antibody raised in rabbit that targets the mouse "Ngn3" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Ngn3 raised in rabbit
BCGO:9000303
A polyclonal antibody raised in rabbit that targets the mouse "Ngn3" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Ngn3 raised in rabbit
BCGO:9000304
A monoclonal antibody raised in mouse that targets the mouse "Ngn3" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Ngn3 raised in mouse
BCGO:9000305
A monoclonal antibody raised in mouse that targets the mouse "Ngn3" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Ngn3 raised in mouse
BCGO:9000307
A monoclonal antibody raised in mouse that targets the rat "Nkx6.1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Nkx6.1 raised in mouse
BCGO:9000308
A monoclonal antibody raised in mouse that targets the rat "Nkx6.1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Nkx6.1 raised in mouse
BCGO:9000309
A monoclonal antibody raised in mouse that targets the rat "Nkx6.1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Nkx6.1 raised in mouse
BCGO:9000310
A monoclonal antibody raised in mouse that targets the rat "Nkx6.1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Nkx6.1 raised in mouse
BCGO:9000311
A polyclonal antibody raised in rabbit that targets the human "HNF6" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human HNF6 raised in rabbit
BCGO:9000312
A polyclonal antibody raised in goat that targets the mouse "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse PDX1 raised in goat
BCGO:9000313
A polyclonal antibody raised in guinea pig that targets the mouse "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse PDX1 raised in guinea pig
BCGO:9000314
A polyclonal antibody raised in rabbit that targets the human "ghrelin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human ghrelin raised in rabbit
BCGO:9000315
A polyclonal antibody raised in rabbit that targets the human "ghrelin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human ghrelin raised in rabbit
BCGO:9000316
A monoclonal antibody raised in mouse that targets the rat "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat PDX1 raised in mouse
BCGO:9000317
A monoclonal antibody raised in mouse that targets the rat "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat PDX1 raised in mouse
BCGO:9000318
A monoclonal antibody raised in mouse that targets the rat "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat PDX1 raised in mouse
BCGO:9000321
A polyclonal antibody raised in rabbit that targets the human "Sox2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Sox2 raised in rabbit
BCGO:9000322
A polyclonal antibody raised in goat that targets the mouse "FoxA2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse FoxA2 raised in goat
BCGO:9000323
A monoclonal antibody raised in mouse that targets the human "E-cadherin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human E-cadherin raised in mouse
BCGO:9000324
A polyclonal antibody raised in rabbit that targets the human "Sox17" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Sox17 raised in rabbit
BCGO:9000325
A polyclonal antibody raised in rabbit that targets the human "Sox17" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Sox17 raised in rabbit
BCGO:9000326
A monoclonal antibody raised in mouse that targets the human "Pancreatic endocrine cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic endocrine cells raised in mouse
BCGO:9000327
A monoclonal antibody raised in mouse that targets the human "Pancreatic endocrine cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic endocrine cells raised in mouse
BCGO:9000328
A monoclonal antibody raised in mouse that targets the human "Pancreatic endocrine cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic endocrine cells raised in mouse
BCGO:9000329
A monoclonal antibody raised in mouse that targets the human "Pancreatic endocrine cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic endocrine cells raised in mouse
BCGO:9000330
A monoclonal antibody raised in mouse that targets the human "Pancreatic endocrine cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic endocrine cells raised in mouse
BCGO:9000331
A polyclonal antibody raised in goat that targets the human "Sox17" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Sox17 raised in goat
BCGO:9000332
A polyclonal antibody raised in goat that targets the mouse "Shh" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Shh raised in goat
BCGO:9000333
A polyclonal antibody raised in chicken that targets the e. coli "beta Galactosidase" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal e. coli beta Galactosidase raised in chicken
BCGO:9000334
A monoclonal antibody raised in mouse that targets the aequorea victoria "Green Fluorescent Protein" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal aequorea victoria Green Fluorescent Protein raised in mouse
BCGO:9000335
A polyclonal antibody raised in rabbit that targets the mouse "Ptf1a" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Ptf1a raised in rabbit
BCGO:9000336
A polyclonal antibody raised in rabbit that targets the mouse "IA1 (Insm-1)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse IA1 (Insm-1) raised in rabbit
BCGO:9000337
A monoclonal antibody raised in mouse that targets the human "Pancreatic duct cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic duct cells raised in mouse
BCGO:9000338
A monoclonal antibody raised in mouse that targets the human "Pancreatic duct cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic duct cells raised in mouse
BCGO:9000339
A monoclonal antibody raised in mouse that targets the human "Pancreatic exocrine cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic exocrine cells raised in mouse
BCGO:9000340
A monoclonal antibody raised in mouse that targets the human "Pancreatic exocrine cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic exocrine cells raised in mouse
BCGO:9000341
A monoclonal antibody raised in mouse that targets the human "Pancreatic endocrine cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic endocrine cells raised in mouse
BCGO:9000342
A monoclonal antibody raised in mouse that targets the human "Alpha cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Alpha cells raised in mouse
BCGO:9000343
A monoclonal antibody raised in mouse that targets the human "Alpha cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Alpha cells raised in mouse
BCGO:9000344
A monoclonal antibody raised in rat that targets the mouse "Mo ES-Derived Definitive Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Mo ES-Derived Definitive Endoderm raised in rat
BCGO:9000345
A monoclonal antibody raised in rat that targets the mouse "Mo ES-Derived Definitive Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Mo ES-Derived Definitive Endoderm raised in rat
BCGO:9000346
A polyclonal antibody raised in goat that targets the human "T (Brachyury)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human T (Brachyury) raised in goat
BCGO:9000347
A polyclonal antibody raised in rabbit that targets the mouse "Laminin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Laminin raised in rabbit
BCGO:9000348
A monoclonal antibody raised in mouse that targets the chicken "Pax6" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal chicken Pax6 raised in mouse
BCGO:9000602
A mouse ESC line in which part or all of the targeted gene, SRY-box containing gene 17 (NCBI Gene ID: 20671) is replaced to create Sox17{Cre-GFP} using the Loxed Cassette Acceptor allele Sox17{tm1(LCA)}). Using an RMCE strategy, we inserted a Cre-GFP (Green fluorescent protein) fusion protein into a Sox17[LCA] allele thereby replacing Sox17 coding sequences. The Sox17-CreGFP ESCs may be used to track Sox17-expressing cells and their progeny, or to conditionally inactivate genes in Sox17-expressing cells. Mark the expression of Sox17 with both Cre and GFP. Cre will enable lineage tracing using reporter alleles that are activated by cre recombination. GFP will enable direct visualization of Sox17 gene expression.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Sox17{GFPCre} mouse ESC line
BCGO:9000661
A mouse strain in which part or all of the targeted gene, insulinoma-associated 1 (NCBI Gene ID: 53626) is replaced to create Insm1{tm1.1(GFP-Cre)} using the Loxed Cassette Acceptor allele Insm1{tm1(LCA)}). <p>Insm1{GFPCre} mice contain a GFP-Cre fusion protein which replaces the Insm1 coding sequence. These mice express green fluorescent protein (GFP) under control of theInsm1gene locus. Insm1 is expressed in pancreatic primordium starting at E9.5. Insm1 is also expressed in neural precursor cells and tumors of may be used for lineage tracing of Insm1-positive cells in both wild-type and Insm1-null mice.</p>
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Insm1{tm1.1Mgn}
Vanderbilt University Medical Center
Insm1{tm1.1Mgn} mouse strain
BCGO:9000721
A mouse ESC line in which the targeted gene, Ghrelin (NCBI Gene ID: 58991), has been modified (allele type: Cassette Acceptor) to targeted mutation (MGI ID: Ghrl{LCA}). ES cells were modified by homologous recombination to replace a 6.912 kb region of the Ghrelin (GHRL) gene from 2.7 kb upstream of exon 1 to 0.5 kb downstream of exon 5 with tandemly oriented lox71 and lox2272 sites as well as both positive and negative selectable markers. The gene was replaced by tandemly oriented lox71 and lox2272 sitesas well as both positive and negative selectable markers.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ghrl{LCA} mouse ESC line
BCGO:9000761
A mouse ESC line in which part or all of the targeted gene, Ghrelin (NCBI Gene ID: 58991) is replaced to create Ghrl{Cre-eGFP} using the Loxed Cassette Acceptor allele Ghrl{LCA}). Recombinase mediated cassette exchange (RMCE) was used to insert the Cre-eGFP fusion protein into the ghrelin locus using ES cells containing the Ghrl{LCA} allele. The Cre-eGFP protein uses the endogenous AUG start codon and polyadenylation sequence.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ghrl{Cre-eGFP} mouse ESC line
BCGO:9000821
A monoclonal antibody raised in mouse that targets the mouse "BetaTC6" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse BetaTC6 raised in mouse
BCGO:9000842
A mouse strain containing a transgene in which GCK (transgene) is driven by the ROSA26 promoter (NCBI Gene ID: 14910). Glucokinase containing the Y214C activating mutation, causing severe persistent hyperinsulinemic hypoglycemia (Diabetes 53:2164-2168, 2004) was targeted to the ROSA26 locus, preceded by a lox-stop-lox sequence and followed by IRES-EGFP.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Gt(ROSA)26Sor{tm1(GCK*)Ydor}
Vanderbilt University Medical Center
Gt(ROSA)26Sor{tm1(GCK*)Ydor} mouse strain
BCGO:9000861
A polyclonal antibody raised in rabbit that targets the rat "CART" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat CART raised in rabbit
BCGO:9000901
A monoclonal antibody raised in rat that targets the mouse "Mo ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Mo ES-Derived Early Endoderm raised in rat
BCGO:9000903
A monoclonal antibody raised in rat that targets the mouse "Mo ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Mo ES-Derived Early Endoderm raised in rat
BCGO:9000904
A monoclonal antibody raised in rat that targets the mouse "Mo ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Mo ES-Derived Early Endoderm raised in rat
BCGO:9000905
A monoclonal antibody raised in rat that targets the mouse "Mo ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Mo ES-Derived Early Endoderm raised in rat
BCGO:9000906
A monoclonal antibody raised in rat that targets the mouse "Mo ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Mo ES-Derived Early Endoderm raised in rat
BCGO:9000907
A monoclonal antibody raised in rat that targets the mouse "Mo ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Mo ES-Derived Early Endoderm raised in rat
BCGO:9000908
A monoclonal antibody raised in rat that targets the mouse "Mo ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Mo ES-Derived Early Endoderm raised in rat
BCGO:9000921
A monoclonal antibody raised in mouse that targets the human "Hu ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Hu ES-Derived Early Endoderm raised in mouse
BCGO:9000922
A monoclonal antibody raised in mouse that targets the human "Hu ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Hu ES-Derived Early Endoderm raised in mouse
BCGO:9000941
A monoclonal antibody raised in mouse that targets the human "Hu ES-Derived Early Endoderm" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Hu ES-Derived Early Endoderm raised in mouse
BCGO:9000942
A monoclonal antibody raised in rat that targets the mouse "Pancreatic duct cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Pancreatic duct cells raised in rat
BCGO:9000943
A monoclonal antibody raised in rat that targets the mouse "Pancreatic duct and acinar cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Pancreatic duct and acinar cells raised in rat
BCGO:9000945
A monoclonal antibody raised in rat that targets the mouse "Endothelial cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Endothelial cells raised in rat
BCGO:9000961
A monoclonal antibody raised in mouse that targets the mouse "BetaTC6" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse BetaTC6 raised in mouse
BCGO:9000962
A monoclonal antibody raised in mouse that targets the mouse "BetaTC6" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse BetaTC6 raised in mouse
BCGO:9000964
A monoclonal antibody raised in mouse that targets the human "Disp2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Disp2 raised in mouse
BCGO:9000965
A monoclonal antibody raised in mouse that targets the human "Disp2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Disp2 raised in mouse
BCGO:9000966
A polyclonal antibody raised in rabbit that targets the mouse "Lrp11" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Lrp11 raised in rabbit
BCGO:9000967
A polyclonal antibody raised in rabbit that targets the mouse "Sez6l2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Sez6l2 raised in rabbit
BCGO:9000968
A polyclonal antibody raised in rabbit that targets the mouse "Sez6l2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Sez6l2 raised in rabbit
BCGO:9000969
A polyclonal antibody raised in goat that targets the human "DDR1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human DDR1 raised in goat
BCGO:9000970
A monoclonal antibody raised in mouse that targets the human "DDR1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human DDR1 raised in mouse
BCGO:9000971
A polyclonal antibody raised in rabbit that targets the mouse "Gpr39-1a" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Gpr39-1a raised in rabbit
BCGO:9000972
A polyclonal antibody raised in rabbit that targets the rat "CART" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat CART raised in rabbit
BCGO:9000974
A monoclonal antibody raised in mouse that targets the rat "CART" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat CART raised in mouse
BCGO:9000981
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{R26-60-DR5-TA-Cerulean} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). In these cells Rosa26 gene sequences from -60 to +81 were replaced by a retinoic acid response element (DR5) fused to a TATA-Cerulean (CFP) reporter. These ESCs may be useful for assess retinoic acid responsiveness.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{R26-60-DR5-TA-Cerulean} mouse ESC line
BCGO:9000982
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Roas26{R26-228-DR5-TA-Cerulean} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). In these cells Rosa26 gene sequences from -228 to +81 were replaced by a retinoic acid response element (DR5) fused to a TATA-Cerulean (CFP) reporter. These ESCs may be useful for assess retinoic acid responsiveness.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{R26-228-DR5-TA-Cerulean} mouse ESC line
BCGO:9001001
A mouse strain in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create Ptf1a{tm3Macd} using the Loxed Cassette Acceptor allele Ptf1a{tm1(LCA)}). Modified allele of Ptf1a with a biotinylation Tag sequence attached to the amino terminus of Ptf1a.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ptf1a{tm3Macd}
Vanderbilt University Medical Center
Ptf1a{tm3Macd} mouse strain
BCGO:9001101
A mouse strain in which part or all of the targeted gene, SRY-box containing gene 17 (NCBI Gene ID: 20671) is replaced to create Sox17{CreERT2} using the Loxed Cassette Acceptor allele Sox17{tm1(LCA)}). Sox17{CreERT2} mice may be used either to track Sox17-expressing cells or their progeny or to conditionally inactivate genes in Sox17-expressing cells at specific time points by tamoxifen injection. This line is complementary to Sox17-CreGFP and may avoid possible interferences of expression in the extra-embryonic visceral endoderm. We plan to analyze the effects of a direct activation/deletion of the Wnt pathway in the endoderm by crossing the Sox17-CreERT2 with the gain- and loss-of-function of beta-catenin.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Sox17{tm1.2Mgn}
Vanderbilt University Medical Center
Sox17{tm1.2Mgn} mouse strain
BCGO:9001161
A polyclonal antibody raised in goat that targets the mouse "Carboxypeptidase A1 (CPA1)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Carboxypeptidase A1 (CPA1) raised in goat
BCGO:9001162
A polyclonal antibody raised in rabbit that targets the human "Muc1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Muc1 raised in rabbit
BCGO:9001163
A polyclonal antibody raised in rabbit that targets the human "Cleaved Notch1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Cleaved Notch1 raised in rabbit
BCGO:9001164
A polyclonal antibody raised in goat that targets the human "Jagged1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Jagged1 raised in goat
BCGO:9001181
A mouse ESC line in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1{CFP} using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). This ES cell line contains cyan fluorescent protein (CFP, Cerulean variant) inserted into a Pdx1{LCA} allele by recombinase mediated cassette exchange. These cells may be useful for identifying pancreatic progenitor cells in cultures that have been stimulated to differentiate towards endodermal and pancreatic fates.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Pdx1{CFP} mouse ESC line
BCGO:9001221
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{(Ccnd1T286A)} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This strain expresses both mutant cyclin D1{T286A} and a cherry reporter under the regulation of a tetracycline-responsive bi-directional minimal CMV promoter (TRE-Tight; tetO). The cyclin D1-T286A mutant cannot be phosphorylated by GSK-3beta and is resistant to polyubiquitination. Therefore, cyclin D1-T286A remains nuclear throughout the cell cycle and has an extended half-life relative to wild-type cyclin D1. This strain represents an effective tool for generating inducible tissue-specific cyclin D1{T286A} mutants with a cherry reporter.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Gt(ROSA)26Sor{tm1(Ccnd1T286A)Stang}
Vanderbilt University Medical Center
Gt(ROSA)26Sor{tm1(Ccnd1T286A)Stang} mouse strain
BCGO:9001241
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{tm1.1(R26-DR5-TA-Cerulean)} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). These mice were generated using RMCE to insert an exchange vector containing a modified Rosa26 promoter linked to a Cerulean fluorescent protein (CFP) reporter gene into mESCs containing a Loxed Cassette Acceptor (LCA) allele within the Rosa26 gene locus. The Rosa26 promoter in this mouse was altered by replacing DNA sequences from -60 to +81 with a multimerized retinoic acid response element (DR5) fused to a TATA box. This mouse will facilitate studies of retinoic acid signaling in an intact animal.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{tm1.1(R26-60-DR5-TA-Cerulean)Mgn}
Vanderbilt University Medical Center
Rosa26{tm1.1(R26-60-DR5-TA-Cerulean)Mgn} mouse strain
BCGO:9001261
A mouse strain in which the targeted gene, recombination activating gene 1 (NCBI Gene ID: 19373), has been modified (allele type: Global Null) to (MGI ID: Rag1{tm1Mom}). Backcrossing of the Rag1 null allele onto the NOD/Lt strain background (NOD-Rag1{null} mice) provided a radio-resistant and longer-lived model for human-cell engraftment. Mutations in X-chromosome-linked Il2rg gene cause X-linked severe combined immunodeficiency (XSCID). Immunodeficient NOD-Rag1{null} IL2rg nullmice tolerated much higher levels of irradiation conditioning than did NOD-Prkdcscid IL2rg{null} mice. This immunodeficient mouse also develops spontaneous hyperglycemia based on the Ins2{Akita} mutation.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Rag1{tm1Mom}Ins2{Akita}Il2rg{tm1Wjl}/Sz
Vanderbilt University Medical Center
NOD.Cg-Rag1{tm1Mom}Ins2{Akita}Il2rg{tm1Wjl}/Sz mouse strain
BCGO:9001262
A mouse strain in which the targeted gene, interleukin 2 receptor, gamma chain (NCBI Gene ID: 16186), has been modified (allele type: Global Null) to targeted mutation 1 (MGI ID: Il2rg{tm1Wjl}). NOD-scid IL2rg{null} mice are deficient in mature lymphocytes and NK cells, survive beyond 16-month of age, and even after sublethal irradiation resist lymphoma development. Moreover, cytokine-mobilized human peripheral blood stem cells engraft at high levels in NOD-scid IL2rg{null} mice and develop into human CD3+CD4+ and CD3+CD8+ T cells, Ig+B cells, myeloid cells, NK cells and plasmacytoid dentritic cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Prkdc{scid}Il2rg{tm1Wjl}/Sz
Vanderbilt University Medical Center
NOD.Cg-Prkdc{scid}Il2rg{tm1Wjl}/Sz mouse strain
BCGO:9001281
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{tm1.2((R26-228-DR5-Cerulean) using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). These mice were generated using RMCE to insert an exchange vector containing a modified Rosa26 promoter linked to a Cerulean fluorescent protein (CFP) reporter gene into mESCs containing a Loxed Cassette Acceptor (LCA) allele within the Rosa26 gene locus. The Rosa26 promoter in this mouse was altered by replacing DNA sequences from -228 to +81 with a multimerized retinoic acid response element (DR5) fused to a TATA box. This mouse will facilitate studies of retinoic acid signaling in an intact animal.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{tm1.2(R26-228-DR5-TA-Cerulean)Mgn}
Vanderbilt University Medical Center
Rosa26{tm1.2(R26-228-DR5-TA-Cerulean)Mgn} mouse strain
BCGO:9001321
A mouse strain in which the targeted gene, Nkx2.2 (NCBI Gene ID: 18088), has been modified (allele type: Global Null) to Null (MGI ID: Nkx2.2{tm5(null)}). These mice contain a deletion of the Nkx2.2 coding region to create a null allele.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx2-2{tm5(null)Suss}
Vanderbilt University Medical Center
Nkx2-2{tm5(null)Suss} mouse strain
BCGO:9001342
A mouse strain in which the targeted gene, Nk6 Homeobox 1 (NCBI Gene ID: 18096), has been modified (allele type: Conditional Null) to targeted mutation 1.1 (MGI ID: Nkx6.1{tm1.1Msan}). A conditional allele for nkx6.1 is necessary to study the function of Nkx6.1 in adult mice. A homozygous nkx6.1 null allele results in neonatal lethality due to a paralytic state, which is a direct result of Nkx6.1 function in the development of motor neurons. Conditional loss of Nkx6.1 is achieved through Cre mediated recombination of a floxed exon II of nkx6.1. Our use for a conditional nkx6.1 allele is to study its function in beta cells of the adult pancreas.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx6-1{tm2(flox)Msan}
Vanderbilt University Medical Center
Nkx6-1{tm2(flox)Msan} mouse strain
BCGO:9001421
A mouse strain in which the targeted gene, Perforin 1 (Pore forming protein) (NCBI Gene ID: 18646), has been modified (allele type: Global Null) to (MGI ID: ). Mice that are homozygous for both targeted mutations are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities when housed under specific pathogen free conditions. These double homozygote mutant mice have no mature T or B lymphocytes, no detectable NK cell cytotoxic activity, and lack serum immunoglobulin. The number of nucleated spleen cells is significantly reduced in double mutant mice, when compared to the single homozygote, NOD.129S7(B6)-Rag1tm1Mom/J (Stock No. 003729). Although an increased number of DX5+CD122+ NK cells are found in the spleens of double mutants, these NK cells have impaired cytotoxic activity. The disruption of Prf1 ablates NK cell cytotoxic activity resulting in increased engraftment levels over that observed with Stock No. 003729. All mutant mice develop thymic lymphomas. This double mutant mouse strain may be useful in studies involving engraftment of human hematolymphoid cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Rag1{tm1Mom}Prf1{tm1Sdz}/SzJ
Vanderbilt University Medical Center
NOD.Cg-Rag1{tm1Mom}Prf1{tm1Sdz}/SzJ mouse strain
BCGO:9001701
A mouse strain in which part or all of the targeted gene, forkhead box O1 (NCBI Gene ID: 56458) is replaced to create Foxo1{DBD} using the Loxed Cassette Acceptor allele Foxo1{tm1(LCA)}). <p>This line contains a DNA binding-deficient mutant of Foxo1. The mutation may be useful for assessing the contribution of DNA co-activation in the function of Foxo1.</p>
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Foxo1{tm1(DBD)Dac}
Vanderbilt University Medical Center
Foxo1{tm1(DBD)Dac} mouse strain
BCGO:9001961
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{Ccnd1} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). ES cells express mutant cyclin D1-T286A and a cherry reporter under the regulation of a tetracycline-responsive bi-directional minimal CMV promoter (TRE-Tight; tetO) targeted to the ROSA26 locus.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{tm1(Ccnd1)} mouse ESC line
BCGO:9002001
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{R26-60-IBRE4-TA-Cerulean} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). In these cells Rosa26 gene sequences from -60 to +81 were replaced by a BMP response element (IBRE4) fused to a TATA-Cerulean (CFP) reporter.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{R26-60-IBRE4-TA-Cerulean} mouse ESC line
BCGO:9002002
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{R26-228-IBRE4-TA-Cerulean} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). In these cells Rosa26 gene sequences from -228 to +81 were replaced by a BMP response element (IBRE4) fused to a TATA-Cerulean (CFP) reporter. These ESCs may be useful for assess BMP responsiveness.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{R26-228-IBRE4-TA-Cerulean} mouse ESC line
BCGO:9002061
A mouse strain in which part or all of the targeted gene, forkhead box O1 (NCBI Gene ID: 56458) is replaced to create Foxo1{GFP} using the Loxed Cassette Acceptor allele Foxo1{tm1(LCA)}). A GFP cDNA has been knocked into the Foxo1 locus at the 3' end of the endogenous Foxo1 cDNA to generate a Foxo1-gfp fusion protein that can be used to study Foxo1 translocation in vivo.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Foxo1{tm1(GFP)Dac}
Vanderbilt University Medical Center
Foxo1{tm1(GFP)Dac} mouse strain
BCGO:9002201
A polyclonal antibody raised in goat that targets the mouse "DNER" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse DNER raised in goat
BCGO:9002222
A monoclonal antibody raised in mouse that targets the rat "Shh" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Shh raised in mouse
BCGO:9002223
A monoclonal antibody raised in mouse that targets the chicken "Chick HNF3Beta" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal chicken Chick HNF3Beta raised in mouse
BCGO:9002241
A mouse ESC line in which the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609), has been modified (allele type: Cassette Acceptor) to targeted mutation 1 (MGI ID: Pdx1{tm1(LCA)}). This mouse ES cell line contains a loxed cassette acceptor (LCA) allele that may be utilized for the exchange of DNAs of interest into the Pdx1 gene locus by recombinase mediated cassette exchange (RMCE). An 8.62 kb region of the gene was replaced by tandemly oriented Lox66 and Lox2272 sites flanking both positive (puromycin) and negative (HSV-TK)selectable markers.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Pdx1{LCA} mouse ESC line
BCGO:9002263
A polyclonal antibody raised in guinea pig that targets the mouse "Pax4" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Pax4 raised in guinea pig
BCGO:9002281
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{EN-Cherry-Neo} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line expresses mCherry, a red fluorescent protein, under control of the endogenous Rosa26gene. A cassette containing mCherry and other sequences to assure efficient expression were inserted into the Rosa26[LCA] allele by recombinase mediated cassette exchange. These cells will be used to identify an optimal combination of regulatory elements for fluorescent protein expression from a single gene copy and as a reference cell line for fluorescent cell sorting.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{EN-Cherry-Neo} mouse ESC line
BCGO:9002301
A mouse strain in which the targeted gene, Neurogenin 3 (NCBI Gene ID: 11925), has been modified (allele type: Gene Replacement) to Ngn3{nCre} (MGI ID: Neurog3{nCre}). A nCre-iRES (n-terminal half of Cre followed by internal ribosomal entry site) was inserted after Ngn3ATG. This allele is confirmed to express both nCre and Ngn3 (no visible phenotype in homozygous animals).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Neurog3{tm1.1(nCre)Ggu}
Vanderbilt University Medical Center
Neurog3{tm1.1(nCre)Ggu} mouse strain
BCGO:9002401
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{LCA} using the Loxed Cassette Acceptor allele Rosa26{tm1.8(Non-EN-CFP)}). This ES cell line contains CFP (Cerulean) inserted into a Rosa26{LCA} allele by recombinase mediated cassette exchange. These cells were used to identifythe optimal arrangement of regulatory elements for fluorescent protein expression from a single genomic copy.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{Non-EN-CFP-Neo} mouse ESC line
BCGO:9002482
A polyclonal antibody raised in goat that targets the mouse "Ngn3" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Ngn3 raised in goat
BCGO:9002502
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{EN.CFP} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line contains CFP (Cerulean) inserted into a Rosa26 LCA allele by recombinase mediated cassette exchange. These cells were used to identify the optimal arrangement of regulatory elements for fluorescent protein expression from a single genomic copy.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{EN-CFP-Neo} mouse ESC line
BCGO:9002522
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{CFP.SV40} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line contains CFP (Cerulean) inserted into a Rosa26 LCA allele by recombinase mediated cassette exchange. These cells were used to identify the optimal arrangement of regulatory elements for fluorescent protein expression from a single genomic copy.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{EN.CFP.SV40.Neo} mouse ESC line
BCGO:9002542
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{EN.GFP} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line contains eGFP inserted into the Rosa26 gene locus. These cells were used to identify an optimal combination of regulatory elements for fluorescent protein expression from a single genomic copy and can serve as a reference cell line for fluorescent cell sorting.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{EN-GFP-Neo} mouse ESC line
BCGO:9002562
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{CFP} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line contains CFP (Cerulean) inserted into a Rosa26{LCA} allele by recombinase mediated cassette exchange. These cells were used to identify an optimal combination of regulatory elements for fluorescent protein expression from single a genomic copy.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{EN-CFP-bGpA-Neo} mouse ESC line
BCGO:9002582
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{Ngn3-CFP} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse contains a bidirectional TetO-regulated fusion gene that has been inserted into a disabled Rosa26 locus. In one direction the tetO/CMV promoter drives expression of CFP (Cerulean). In the other direction it drives Ngn3. Mice containing this allelecan be used to drive the expression of Ngn3 under control of both doxycycline and either an rtTA or tTA transgene.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(Ngn3.CFP)Mgn}
Vanderbilt University Medical Center
Rosa26{(Ngn3.CFP)Mgn} mouse strain
BCGO:9002702
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{MafA-Cherry} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse contains a bidirectional Tet0-regulated fusion gene that has been inserted into adisabled Rosa26 loxed cassette acceptor allele by RMCE. In one direction the tetO/CMV promoter drives expression of a red fluorescent protein (Cherry) while in the other direction it drives MafA expression.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{tm1.4(MafA-Cherry)Mgn}
Vanderbilt University Medical Center
Rosa26{tm1.4(MafA-Cherry)Mgn} mouse strain
BCGO:9002742
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{(R26-60-CNotch-TA-Cerulean)} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). The Rosa26 gene sequences from -228 to +81 were replaced with a repeat of alternating 32-bp C-elements and 31-bp Rbpj-binding sites (i.e.,C-R-C-R-C-R). The 31 base-pair region is derived from the CBF1/Rbpj binding region of the C-promoter of EBV (cataaattTTTTCCCACGgcgtgtttacacc; uppercase letters are the consensus Rbpj binding sequence within the 31-bp element) (Hsieh, MCB 16:952, 1996). The 32-bp C-element is from the Ela1 enhancer (Kruse et al., MCB 15:4385, 1995).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{R26-60-3XCNotch-TA-Cerulean} mouse ESC line
BCGO:9002762
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{R26-60-AR8-TA-mCherry} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). In these cells Rosa26 gene sequences from -60 to +81 were replaced by an Activin response element (AR8) fused to a TATA-mCherry reporter
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{R26-60-AR8-TA-mCherry} mouse ESC line
BCGO:9002782
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{tm2.2(R26-228-AR8-TA-mCherry)} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). In these cells Rosa26 gene sequences from -228 to +81 were replaced by an Activin response element (AR8) fused to a TATA-mCherry reporter. These ESCs may be usefulto assess Activin, Nodal, and TGFbeta responsiveness.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{R26-228-AR8-TA-mCherry} mouse ESC line
BCGO:9002802
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26(R26-60-6XNotch-TA-Cerulean) using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). The binding site for Rbpj, the transcriptional mediator of Notch signaling was inserted into the Rosa 26 locus replacing nucleotides -60 to -228.The complete insert contains the Rbpj cis element in a series of six repeats. Each repeat includes a 31 base-pair region derived from the CBF1/Rbpj binding region of the C-promoter of EBV (cataaattTTTTCCCACGgcgtgtttacacc). Uppercase letters are the consensus Rbpj binding sequence within the 31-bp element) (Hsieh et al., MCB 16:952, 1996).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{R26-60-6XNotch-TA-Cerulean} mouse ESC line
BCGO:9002822
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26(R26-228-3XCNotch-TA-Cerulean) using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). The Rosa26 gene sequences from -60 to -228 were replaced with a repeat of alternating 32-bp C-elements and 31-bp Rbpj-binding sites (i.e.,C-R-C-R-C-R). The 31 base-pair region is derived from the CBF1/Rbpj binding region of the C-promoter of EBV (cataaattTTTTCCCACGgcgtgtttacacc; uppercase letters are the consensus Rbpj binding sequence within the 31-bp element) (Hsieh, MCB 16:952, 1996). The 32-bp C-element is from the Ela1 enhancer (Kruse et al., MCB 15:4385, 1995).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{-228.3XCNotch.TA.Cerulean} mouse ESC line
BCGO:9002842
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26(Rbpj(R26-228-6XNotch-TA-Cerulean)) using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). The binding site for Rbpj, the transcriptional mediator of Notch signaling was inserted into the Rosa 26 locus replacing nucleotides -60 to -228.The complete insert contains the Rbpj cis element in a series of six repeats. Each repeat includes a 31 base-pair region derived from the CBF1/Rbpj binding region of the C-promoter of EBV (cataaattTTTTCCCACGgcgtgtttacacc). Uppercase letters are the consensus Rbpj binding sequence within the 31-bp element) (Hsieh et al., MCB 16:952, 1996).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{-228.6XNotch.TA.Cerulean} mouse ESC line
BCGO:9003022
A polyclonal antibody raised in rabbit that targets the mouse "Irx2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Irx2 raised in rabbit
BCGO:9003023
A polyclonal antibody raised in rabbit that targets the mouse "Arx" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Arx raised in rabbit
BCGO:9003042
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{Nkx2.2/CFP} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). In this strain both CFP and myc-tagged Nkx2.2 were inserted into a ROSA26 LCA allele under control of a bidirectional tetO/CMV promoter element. The mouse line will allow us to explore the contribution of Nkx2.2 to progenitor cell population competency by allowing for the manipulation of Nkx2.2 gene expression within the developing pancreas.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
ROSA26{(Nkx2.2.CFP)Suss}
Vanderbilt University Medical Center
ROSA26{(Nkx2.2.CFP)Suss} mouse strain
BCGO:9003102
A polyclonal antibody raised in guinea pig that targets the mouse "mArx" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse mArx raised in guinea pig
BCGO:9003185
A monoclonal antibody raised in rat that targets the human "C-peptide" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human C-peptide raised in rat
BCGO:9004012
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{tm2.1(R26-60-IBRE4-TA-Cerulean)} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse contains aBMP reporter element withina modified ROSA26 promoter followed by a CFP reporter. This mouse is identical to the -228 variant except for the amount of ROSA26 DNA.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(-60.IBRE4.TACerulean)Hri}
Vanderbilt University Medical Center
Rosa26{(-60.IBRE4.TACerulean)Hri} mouse strain
BCGO:9004015
A mouse ESC line in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create Ptf1a{rtTA} using the Loxed Cassette Acceptor allele Ptf1a{tm1(LCA)}). These mESCs contain the reverse tetracycline transactivator (rtTA) under control of the Ptf1a regulatory sequences. rtTA is a transcriptional activator, which can inducibly (in the presence of the tetracycline analog doxycycline) activate the genes under Tet-O activator/promoter element. The rtTA sequences were introduced in to Ptf1a[LCA] by Recombinase-Mediated Cassette Exchange using standard methods.These cells were made in order togenerate a mouse line that express rtTA under control of the Ptf1a gene locus.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ptf1a{rtTA} mouse ESC line
BCGO:9004016
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Nepn-Cherry using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line was generated by RMCE usingthe Rosa26.LCA allele. To create a Nepn reporter allele, a 9kb promoter region of the Nepn gene is inserted upstream of the red fluorescent protein mCherry-pA sequence. Since Nepn is expressed during endoderm development, this cell line can be used for visualisation and sorting of endodermal cell populations.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{Nepn.Cherry} mouse ESC line
BCGO:9004017
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{YFP} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). These mESCs contain yellow fluorescent protein (YFP, Citrine) under control of the ROSA26 gene locus. They were made as part of a study to quantify variables that affect fluorescent protein expression levels in mESCs. TheYFP sequences are flanked by a translational enhancer and beta-globin splice/polyA sequences. The cassette containing the YFP was inserted intoa ROSA26 LCA allel using Recombinase-Mediated Cassette Exchange.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{EN.YFP.bGsplicepA.Neo} mouse ESC line
BCGO:9004018
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{EN.Apple.bGspliceA.neo} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). To better quantify protein expression levels via confocal microscopy, flow sorting and western blot analysis this cell line contains a 4kb R26 promoter element, Apple (a red fluorescent protein) with an upstream enhancer element, a splicing beta-globin polyA tail and the neomycin gene as a selection agent. Through Recombinase-Mediated Cassette Exchange this construct was inserted into the Rosa26 locus.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{Apple.bGsplicepA.Neo} mouse ESC line
BCGO:9004019
A mouse ESC line in which part or all of the targeted gene, Gt(ROSA)26Sor gene trap ROSA 26, Philippe Soriano [ Mus musculus ] (NCBI Gene ID: 14910) is replaced to create Rosa26 LCA using the Loxed Cassette Acceptor allele ). Recombinase mediated cassette exchange was performed to introduce a bidirectional tetO-regulated cassette containing coding sequences for transcription factors MafA and Ngn3 into Rosa26 LCA mESCs. ThismESC line can be used to generate mice that will simultaneously overexpress MafA and Ngn3 using tet-inducible activation with rtTA.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{Ngn3.Mafa} mouse ESC line
BCGO:9004020
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{EN-Cherry-Neo} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line expresses mCherry, a red fluorescent protein, under control of the endogenous ROSA26 gene locus. This mouse was generated as part of a study to identify the optimal combination of regulatory elements for fluorescent protein expression from a single gene copy.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{tm2Mgn}
Vanderbilt University Medical Center
Rosa26{tm2Mgn} mouse strain
BCGO:9004021
A mouse strain in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create Ptf1a{tm1.2(rtTA)Mgn} using the Loxed Cassette Acceptor allele Ptf1a{tm1(LCA)}). This mouse line expresses the reverse tetracycline transactivator (rtTA) under control of the Ptf1a regulatory sequences. This mouseisuseful for activating expression of various TetO-regulated genes in sites where Ptf1a is normally expressed.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ptf1a{tm2(rtTA)Mgn}
Vanderbilt University Medical Center
Ptf1a{tm2(rtTA)Mgn} mouse strain
BCGO:9004022
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26[Nepn.Cherry] using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). Nephrocan (Nepn) has been shown to be expressed specifically during early endoderm development. A Nepn promoter driven reporter (Cherry) has been inserted in the Rosa26LCA locus by recombinase mediated cassette exchange. This mouse line will be useful in visualizing whether Nepn can be used as a specific DE marker for beta-cell development.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(Nepn.Cherry)Mgn}
Vanderbilt University Medical Center
Rosa26{(Nepn.Cherry)Mgn} mouse strain
BCGO:9004023
A mouse ESC line in which part or all of the targeted gene, Gt(ROSA)26Sor gene trap ROSA 26, Philippe Soriano [ Mus musculus ] (NCBI Gene ID: 14910) is replaced to create Rosa26 LCA using the Loxed Cassette Acceptor allele Rosa26{tm1.1(mlre1.WT.Cherry)FerozPapa}). This mESC line contains a bidirectional Tet0-regulated fusion gene that has been inserted into a disabled Rosa26 loxed cassette acceptor allele by RMCE. In one direction the tetO/CMV promoter drives expression of a red fluorescent protein (Cherry) while in the other direction it drives the wild type form of mlre1. mlre1 is an endoplasmic reticulum (ER) membrane kinase response to unfolded protein response (UPR). Activated mlre1 endonucleases leads to the splicing of XBP-1 (a transcription factor which is upregulated in times of ER stress) which transcriptionally increases the expression of ER chaperones and alleviates UPR. This cell line should be useful for studying the role of mlre1 in the response to ER stress. By generating mice with this allele
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{mIre1.WT.Cherry} mouse ESC line
BCGO:9004024
A mouse ESC line in which part or all of the targeted gene, Gt(ROSA)26Sor gene trap ROSA 26, Philippe Soriano [ Mus musculus ] (NCBI Gene ID: 14910) is replaced to create Rosa26 LCA using the Loxed Cassette Acceptor allele Rosa26{tm1.1(mlre1.IG.Cherry)FerozPapa}). This mESC line contains a bidirectional Tet0-regulated fusion gene that has been inserted into a disabled Rosa26 loxed cassette acceptor allele by RMCE. In one direction the tetO/CMV promoter drives expression of a red fluorescent protein (Cherry) while in the other direction it drives a mutant version of mlre1. mlre1 is an endoplasmic reticulum (ER) membrane kinase response to unfolded protein response (UPR). Activated mlre1 endonucleases leads to the splicing of XBP-1 (a transcription factor which is upregulated in times of ER stress) which transcriptionally increases the expression of ER chaperones and alleviates UPR. This cell line should be useful for studying the role of mlre1 in the response to ER stress. By generating mice with this allele t
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{mIre1.IG.Cherry} mouse ESC line
BCGO:9004025
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{mlre1.WT-Cherry} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line contains a bidirectional Tet0-regulated fusion gene that has been inserted into a disabled Rosa26 loxed cassette acceptor allele by RMCE. In one direction the tetO/CMV promoter drives expression of a red fluorescent protein (Cherry) while in the other direction it drives a wild type mlre1. mlre1 is an endoplasmic reticulum (ER) membrane kinase response to unfolded protein response (UPR). Activated mlre1 endonucleases leads to the splicing of XBP-1 (a transcription factor which is upregulated in times of ER stress) which transcriptionally increases the expression of ER chaperones and alleviates UPR. These mice may be useful for studying the role of mlre1 in the response to ER stress in the setting of diet induced obesity and insulin resistance.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(mlre1.WT.Cherry)Fpa}
Vanderbilt University Medical Center
Rosa26{(mlre1.WT.Cherry)Fpa} mouse strain
BCGO:9004026
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{mlre1.IG-Cherry} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line contains a bidirectional Tet0-regulated fusion gene that has been inserted into a disabled Rosa26 loxed cassette acceptor allele by RMCE. In one direction the tetO/CMV promoter drives expression of a red fluorescent protein (Cherry) while in the other direction it drives a mutant mlre1. mlre1 is an endoplasmic reticulum (ER) membrane kinase response to unfolded protein response (UPR). Activated mlre1 endonucleases leads to the splicing of XBP-1 (a transcription factor which is upregulated in times of ER stress) which transcriptionally increases the expression of ER chaperones and alleviates UPR. These mice may be usefulfor studying the role of mlre1 in the response to ER stress in the setting of diet induced obesity and insulin resistance.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(mlre1.IG.Cherry)Fpa}
Vanderbilt University Medical Center
Rosa26{(mlre1.IG.Cherry)Fpa} mouse strain
BCGO:9004027
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{R26-228-IBRE4-TA-Cerulean} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). These mice were generated by performing recombinase mediated cassette exchange on the Rosa26 LCA. The sequence from -228 to +81 of the Rosa26 gene was replaced with a BMP responsive element (IBRE4) fused to a TATA-Cerulean (CFP) reporter. These mice may be useful in visualizing BMP responsiveness.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(R26-228-IBRE4-TA-Cerulean)Hri}
Vanderbilt University Medical Center
Rosa26{(R26-228-IBRE4-TA-Cerulean)Hri} mouse strain
BCGO:9004029
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Sox9/mCherry using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES line contains bidirectional TetO-regulated genes inserted into the Rosa26.LCA allele by RMCE. In one direction the TetO/CMV promoter drives the expression of transcription factor Sox9. In the other direction it drives the expression of red fluorescent protein mCherry. This ES cell line can be used to simultaneously over-express Sox9 and mCherry upon administration of doxycyline when the effector protein rtTA is expressed.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{Sox9.Cherry} mouse ESC line
BCGO:9004030
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Sox9 using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line contains bidirectional TetO-regulated genes inserted into the Rosa26{LCA} allele by RMCE. In one direction, the TetO/CMV promoter drives the expression of the transcription factor Sox9. In the other direction, it drives the expression of the red fluorescent protein mCherry. In this mouse line, when the effector protein rtTA is expressed, Sox9 and mCherry will be over-expressed simultaneously upon administration of doxycyline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(TetO.Sox9)Msan}
Vanderbilt University Medical Center
Rosa26{(TetO.Sox9)Msan} mouse strain
BCGO:9004031
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create NRSF using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This cell line contains bidirectional TetO-regulated genes inserted into the Rosa26{LCA} allele by RMCE. In one direction, the TetO/CMV promoter drives expression of the transcription factor NRSF/REST. In the other direction, it drives the expression of the red fluorescent protein mCherry. In this cell line, when the effector protein rtTA is expressed, NRSF and mCherry are simultaneously over-expressed upon administration of doxycyline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{TetO.NRSF} mouse ESC line
BCGO:9004032
A mouse ESC line in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create Ptf1a{td.TOM} using the Loxed Cassette Acceptor allele Ptf1a{tm1(LCA)}). Recombinase mediated cassette exchange was performed using the Ptf1aLCA. This cell line expresses both tdTOM (a red fluorescent protein) and an N-terminal epitope tagged Strep/Flag (NSF) fusion of ptf1a in the adult pancreas. These cells will be useful in a variety of applications such as FACS sorting of ptf1a expressing cells, chromatin immunoprecipitation and proteomic analyses.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ptf1a{tdTOM} mouse ESC line
BCGO:9004040
A polyclonal antibody raised in rabbit that targets the human "TSPAN7" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human TSPAN7 raised in rabbit
BCGO:9004041
A monoclonal antibody raised in mouse that targets the human "FXYD2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human FXYD2 raised in mouse
BCGO:9004047
A polyclonal antibody raised in rabbit that targets the mouse "Sez6l2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Sez6l2 raised in rabbit
BCGO:9004048
A polyclonal antibody raised in rabbit that targets the human "Lrp11" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Lrp11 raised in rabbit
BCGO:9004052
A polyclonal antibody raised in guinea pig that targets the mouse "Onecut1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Onecut1 raised in guinea pig
BCGO:9004054
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create CFP using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line was made by RMCE in the Rosa26[LCA] allele and has a cyan fluorescent protein (CFP, Cerulean) expressed under the control of the ROSA26 promoter. The CFP sequence is preceded by a translational enhancer and followed by intron-containing rabbit beta-globin polyA sequences. This mouse has ubiquitously expressed CFP protein and can be used for transplantation and other experiments where tracing of source cells is required.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{tm3Mgn}
Vanderbilt University Medical Center
Rosa26{tm3Mgn} mouse strain
BCGO:9004055
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create YFP using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line was made by RMCE in the Rosa26[LCA] allele and has yellow fluorescent protein (YFP, Citrine) expressed under control of the ROSA26 promoter. The YFP sequence is preceded by a translational enhancer and followed by intron-containing rabbit beta-globin polyA sequences. This mouse has ubiquitously expressed YFP protein and can be used for transplantation and other experiments where tracing of source cells is required.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{tm4Mgn}
Vanderbilt University Medical Center
Rosa26{tm4Mgn} mouse strain
BCGO:9004056
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Setd5/GFP using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line was generated by RMCE in the Rosa26{LCA} allele. A coding sequence for green fluorescent protein (GFP) was inserted into the first exon of the Setd5 gene. This exon is located upstream of the Rosa26 transcribed sequence and is transcribed in an opposite orientation. The GFP-polyA cassette, transcribed from the Setd5 promoter, knocks out Setd5 transcription and provides a reporter for Setd5 gene expression. The purpose of this cell line is to study the molecular function of the Setd5 gene.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{Setd5.GFP} mouse ESC line
BCGO:9004058
A mouse strain in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1{H2B.Apple} using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). This mouse contains a coding sequence for the mApple-H2B fusion protein in order to tag cells expressing Pdx1 with a red fluorescent protein. The generation of a Pdx-1 red fluorescent marker will enable the isolation of pancreatic lineage progenitors by FACS. The presence of the H2B sequences may also be useful in allowing the plane of cell division to be analyzed.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pdx1{(H2B.Apple)Mgn}
Vanderbilt University Medical Center
Pdx1{(H2B.Apple)Mgn} mouse strain
BCGO:9004059
A mouse ESC line in which the targeted gene, Neurogenin 3 (NCBI Gene ID: 11925), has been modified (allele type: Cassette Acceptor) to (MGI ID: ). This ES cell line was made by gene targeting and designed to express an HA-tagged version of the transcription factor Ngn3. The Lox71 and Lox2272 sites were inserted flanking the Ngn3 coding sequence. Within the flanked region an HA-tag was placed at the N-terminus of the Ngn3 protein. This allele can be used to study chromatin and protein-protein interactions of Ngn3. Additionally, the Lox71 and Lox2272 sites allow for manipulations of the flanked region by RMCE.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ngn3{HA.LCA} mouse ESC line
BCGO:9004060
A mouse ESC line in which the targeted gene, Forkhead box M1 (NCBI Gene ID: 14235), has been modified (allele type: Gene Replacement) to (MGI ID: ). This ES cell line was made by gene targeting and is designed to serve as a cassette acceptor allele at the Foxm1 locus. The portion of genomic DNA containing exons 2-4 of Foxm1 was flanked with Lox71 and Lox2272 sites and replaced with a selection marker. This line allows for modification of the flanked sequences through RMCE.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Foxm1{LCA} mouse ESC line
BCGO:9004061
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Pdx1/YFP using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line contains bidirectional TetO-regulated genes inserted into the Rosa26{LCA} allele by RMCE. In one direction, the tetO/CMV promoter will drive expression of Pdx1. In the other direction, it will drive the expression of yellow fluorescent protein (YFP). In this cell line, when the effector protein rtTA is expressed, Pdx1 and YFP will be over-expressed simultaneously upon administration of doxycyline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{Pdx1.YFP} mouse ESC line
BCGO:9004062
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Pdx1/YFP using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line contains bidirectional TetO-regulated genes inserted into the Rosa26[LCA] allele by RMCE. In one direction, the TetO/CMV promoter will drive expression of Pdx1. In the other direction, it will drive the expression of yellow fluorescent protein (YFP). In this mouse line, when the effector protein rtTA is expressed, Pdx1 and YFP will be over-expressed simultaneously upon administration of doxycyline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(Pdx1.YFP)Mgn}
Vanderbilt University Medical Center
Rosa26{(Pdx1.YFP)Mgn} mouse strain
BCGO:9004072
A mouse ESC line in which part or all of the targeted gene, insulinoma-associated 1 (NCBI Gene ID: 53626) is replaced to create Pdx1/YFP using the Loxed Cassette Acceptor allele Insm1{tm1(LCA)}). This ES cell line contains bidirectional TetO-regulated genes inserted into the Insm1{LCA} allele by RMCE. In one direction, the TetO/CMV promoter drives the expression of the transcription factor Pdx1. In the other direction, it drives the expression of yellow fluorescent protein (YFP). In this cell line, when the effector protein rtTA is expressed, Pdx1 and YFP will be over-expressed simultaneously upon administration of doxycyline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Insm1{Pdx1.YFP} mouse ESC line
BCGO:9004074
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create mCherry/MafA/Pdx1/Ngn3 using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line contains bidirectional TetO-regulated genes inserted into the Rosa26{LCA} allele by RMCE. In one direction, the TetO/CMV promoter drives the expression of a polycistronic mRNA with transcription factors MafA, Pdx1, and Ngn3 linked by 2A peptide cleavage sequences. In the other direction, it drives the expression of the red fluorescent protein mCherry. In this cell line, when the effector protein rtTA is expressed, all three transcription factors and mCherry will be over-expressed simultaneously upon administration of doxycyline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{3TF.Cherry} mouse ESC line
BCGO:9004075
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create mCherry/MafA/Pdx1/Ngn3 using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line contains bidirectional TetO-regulated genes inserted into the Rosa26[LCA] by RMCE. In one direction, the TetO/CMV promoter drives expression of a polycistronic mRNA with transcription factors MafA, Pdx1, and Ngn3 linked by 2A peptide cleavage sequences. In the other direction, it drives the expression of red fluorescent protein mCherry. In this mouse line, when the effector protein rtTA is expressed, all three transcription factors and mCherry will be over-expressed simultaneously upon administration of doxycyline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(3TF.Cherry)Mgn}
Vanderbilt University Medical Center
Rosa26{(3TF.Cherry)Mgn} mouse strain
BCGO:9004076
A mouse ESC line in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1{aIVd} using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). In this ES cell line, Area IV of the Pdx1 enhancer (-2168/-1913 relative to the primary transcription start site) was deleted using RMCE in the Pdx1{LCA} allele. This cell line allows for assessment of the role of these DNA sequences in the regulation and function of Pdx1.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Pdx1{AIVd} mouse ESC line
BCGO:9004077
A mouse strain in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1{area IV deletion} using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). In this mouse line, Area IV of the Pdx1 enhancer (-2168/-1913 relative to the primary transcription start site) was deleted using RMCE in the Pdx1[LCA] allele. This mouse line allows for assessment of the role of these DNA sequences in the regulation and function of Pdx1.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pdx1{(AIVd)Rwst}
Vanderbilt University Medical Center
Pdx1{(AIVd)Rwst} mouse strain
BCGO:9004078
A mouse ESC line in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2{Cre} using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). In this ES cell line, the sequence for one of the two bi-partite Cre molecules (cCre) and the IRES sequence were knocked into a site directly upstream of the Nkx2.2 start codon using RMCE in the Nkx2.2{LCA} allele. The presence of the IRES sequence allows for the transcription of cCre and Nkx2.2 from the native Nkx2.2 locus at the same time. This results in the labeling of pancreatic epithelium cells that co-express high levels of Ngn3 and Nkx2.2 during mouse embryonic development.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Nkx2.2{cCre-Knock-in} mouse ESC line
BCGO:9004079
A mouse strain in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2{Cre-knock-in)} using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). In this mouse line, one of the two bi-partite Cre molecules, cCre, together with the IRES sequence was knocked into the site directly upstream of the Nkx2.2 start codon using RMCE in the Nkx2.2[LCA] allele. The presence of the IRES sequence allows for transcription of cCre and Nkx2.2 from the native Nkx2.2 locus at the same time. This mouse line allows the labeling of pancreatic epithelium cells that co-express high levels of Ngn3 and Nkx2.2 during mouse embryonic development.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx2.2{(Cre-Knock-in)}
Vanderbilt University Medical Center
Nkx2.2{(Cre-Knock-in)} mouse strain
BCGO:9004080
A mouse ESC line in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2{3XHA-Nkx2.2} using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). In this cell line RMCE in the Nkx2.2.LCA allele was used to introduce a triple HA tag in frame at the N-terminus of the transcription factor Nkx2.2. This allows for efficient immunoprecipitation of HA-tagged Nkx2.2 protein from mouse tissues to perform ChIP and protein-protein interaction studies.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Nkx2.2{3XHA.Nkx2.2} mouse ESC line
BCGO:9004086
A mouse strain in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2{3XHA-Nkx2.2} using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). In this mouse line, RMCE in the Nkx2.2{LCA} allele was used to introduce a triple HA tag in frame at the N-terminus of the transcription factor Nkx2.2. This allows for efficient immunoprecipitation of HA-tagged Nkx2.2 protein from mouse tissues to perform ChIP and protein-protein interaction studies.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx2.2{(3XHA.Nkx2.2)Suss}
Vanderbilt University Medical Center
Nkx2.2{(3XHA.Nkx2.2)Suss} mouse strain
BCGO:9004087
A mouse ESC line in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2{Cre-EGFP} using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). In this ES cell line, a coding portion of the transcription factor Nkx2.2 was replaced with a Cre-EGFP cassette, in frame to the Nkx2.2 ATG. This allows for sites of Nkx2.2 gene expression to be identified in mice using direct immunofluorescence, FACS purification of Nkx2.2 expressing cells, and lineage tracing using Nkx2.2 driven Cre expression.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Nkx2.2{Cre.EGFP} mouse ESC line
BCGO:9004088
A mouse strain in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1/cre-ER using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). In this mouse line, the first exon of the transcription factor Pdx1 was replaced with the coding sequence for a Cre-ER fusion protein using RMCE in the Pdx1[LCA] allele. Pdx1-promoter driven Cre-ER expressing mice enable tamoxifen-inducible Cre-LoxP manipulation of pancreatic lineage cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pdx1{(Cre-ER)}
Vanderbilt University Medical Center
Pdx1{(Cre-ER)} mouse strain
BCGO:9004093
A mouse ESC line in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Cherry using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). In this ES cell, 1.956 kb of the native Nkx2.2 gene, containing a portion of exon 1 (all but the first 214 bp) and all of exon 2, was replaced by the mCherry cassette in frame to the Nkx2.2 ATG. This allows for sites of Nkx2.2 gene expression in the mouse to be identified using direct immunofluorescence and FACS purification of Nkx2.2 expressing cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Nkx2.2{Cherry} mouse ESC line
BCGO:9004113
A polyclonal antibody raised in guinea pig that targets the enterobacteria phage p1 "Cre" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal enterobacteria phage p1 Cre raised in guinea pig
BCGO:9004123
A mouse ESC line in which the targeted gene, paired box 4 (NCBI Gene ID: 18506), has been modified (allele type: Cassette Acceptor) to targeted mutation 1 (MGI ID: Pax4{tm1(LCA)Ggu}). This ES cell line is made by gene targeting and is designed to express an HA-tagged version of the transcription factor Pax4. Lox71 and Lox2272 sites are inserted, flanking the last coding exon of the Pax4 gene. In the flanked region, an HA-tag was placed at the C-terminus of the PAX4 protein. This allele can be used to study chromatin and protein-protein interactions of PAX4. Additionally, the Lox71 and Lox2272 sites allow for future manipulations of the flanked region by RMCE.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Pax4{HA.LCA} mouse ESC line
BCGO:9004125
A polyclonal antibody raised in goat that targets the human "CDCP1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human CDCP1 raised in goat
BCGO:9004126
A polyclonal antibody raised in goat that targets the human "CD-200" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human CD-200 raised in goat
BCGO:9004127
A polyclonal antibody raised in goat that targets the human "Coagulation factor 3(rhF3)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Coagulation factor 3(rhF3) raised in goat
BCGO:9004129
A polyclonal antibody raised in sheep that targets the human "Ngn3" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Ngn3 raised in sheep
BCGO:9004130
A monoclonal antibody raised in mouse that targets the mouse "Pax4" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Pax4 raised in mouse
BCGO:9004131
A monoclonal antibody raised in mouse that targets the mouse "Pax4" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Pax4 raised in mouse
BCGO:9004132
A monoclonal antibody raised in mouse that targets the mouse "Pax4" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal mouse Pax4 raised in mouse
BCGO:9004133
A monoclonal antibody raised in mouse that targets the human "CD142" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human CD142 raised in mouse
BCGO:9004134
A monoclonal antibody raised in rat that targets the rat "Beta cell, IC2" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Beta cell, IC2 raised in rat
BCGO:9004135
A polyclonal antibody raised in goat that targets the human "CD-200" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human CD-200 raised in goat
BCGO:9004142
A mouse strain in which the targeted gene, protein kinase, DNA activated, catalytic polypeptide (NCBI Gene ID: 19090), has been modified (allele type: Other) to severe combined immunodeficiency (MGI ID: Prkdc{scid}). The NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice, commonly known as NOD scid gamma (NSG), do not express the Prkdc gene nor the X-linked Il2rg gene. NSG mice are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. Histological examination of lymphoid tissues reveals absence of lymphoid cells and some cystic structures in the thymus, an absence of follicles in the spleen and markedly diminished celluarity of lymph nodes. NSG mice are deficient in mature lymphocytes, serum Ig is not detectable and natural killer (NK) cell cytotoxic activity is extremely low. These mice are resistant to lymphoma development even after sublethal irradiation treatment. These mutant mice have been shown to readily support engraftment of human CD34+ hematopoietic stem cells and represent a superior, long-lived model suitable for studies employing xenotransplantation strategies. Please note that the NSG carries the true null interleukin-2 receptor gamma chain mutation and should not be confused with other strains that express a truncated interleukin-2 receptor gamma chain as described in: "Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain".
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl}/SzJ
Vanderbilt University Medical Center
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl}/SzJ mouse strain
BCGO:9004143
A mouse strain in which the targeted gene, insulin II (NCBI Gene ID: 16334), has been modified (allele type: Other) to Akita (MGI ID: Ins2{Akita}). NRG-Akita mice, which are homozygous for the Rag1tm1Mom and the Il2rgtm1Wjl alleles (males are hemizygous for the X-linked Il2rgtm1Wjl allele) and heterozygous for the Ins2Akita allele, develop spontaneous hyperglycermia. No mature T, B or NK cells are detected in flow cytometric analysis of splenocytes from NRG-Akita mutant mice. Granulocyte and macrophage populations are similar to those seen in NRG mice. NRG-Akita mice develop hyperglycemia between 3 and 5 weeks of age. Histological examination at 3 weeks of age reveals normal pancreas morphology, and routine insulin and glucagon staining. By approximately 32 weeks of age, NRG-Akita mice display disorganized, condensed pancreatic islet architecture, with loss of insulin-positive cells. Euglycemia is restored by subrenal transplantation of mouse or human islets or intrapancreatic transplantation of dissociated mouse islet cells. NRG-Akita mice engrafted with human hematopoietic stem cells (HSC) develop humanized immune systems. Approximately 60% of the human HSC engrafted NRG-Akita mice reject human islet allografts.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Rag1{tm1Mom}Ins2{Akita}Il2rg{tm1Wjl}/SzJ
Vanderbilt University Medical Center
NOD.Cg-Rag1{tm1Mom}Ins2{Akita}Il2rg{tm1Wjl}/SzJ mouse strain
BCGO:9004144
A mouse ESC line in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1/cre-ER using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). In this cell line, the first exon of the transcription factor Pdx1 was replaced with the coding sequence for a Cre-ER fusion protein using RMCE in the Pdx1{LCA} allele. Pdx1-promoter driven Cre-ER expressing mice enable tamoxifen-inducible Cre-LoxP manipulation of pancreatic lineage cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Pdx1{Cre.ER} mouse ESC line
BCGO:9004145
A mouse strain in which the targeted gene, Neurogenin 3 (NCBI Gene ID: 11925), has been modified (allele type: Cassette Acceptor) to (MGI ID: ). This mouse line was made by gene targeting and designed to express an HA-tagged version of the transcription factor Ngn3. The Lox71 and Lox2272 sites were inserted flanking the Ngn3 coding sequence. Within the flanked region an HA-tag was placed at the N-terminus of the Ngn3 protein. This allele can be used to study chromatin and protein-protein interactions of Ngn3. Additionally, the Lox71 and Lox2272 sites allow for manipulations of the flanked region by RMCE.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ngn3{(HA.LCA)}
Vanderbilt University Medical Center
Ngn3{(HA.LCA)} mouse strain
BCGO:9004146
A mouse strain in which the targeted gene, paired box 4 (NCBI Gene ID: 18506), has been modified (allele type: Cassette Acceptor) to targeted mutation 1 (MGI ID: Pax4{tm1(LCA)Ggu}). This mouse line was made by gene targeting and designed to express an HA-tagged version of the transcription factor Pax4. The Lox71 and Lox2272 sites were inserted flanking the last coding exon of the Pax4 gene. Within the flanked region an HA-tag was placed at the C-terminus of the PAX4 protein. This allele can be used to study chromatin and protein-protein interactions of PAX4. Additionally, the Lox71 and Lox2272 sites allow for manipulations of the flanked region by RMCE in the future.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pax4{(HA.LCA)Ggu}
Vanderbilt University Medical Center
Pax4{(HA.LCA)Ggu} mouse strain
BCGO:9004147
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Setd5/GFP using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line was generated by RMCE in the Rosa26[LCA] allele. A coding sequence for green fluorescent protein (GFP) was inserted into the first exon of the Setd5 gene. This exon is located upstream of the Rosa26 transcribed sequence and is transcribed in an opposite orientation. The GFP-polyA cassette, transcribed from the Setd5 promoter, knocks out Setd5 transcription and provides a reporter for Setd5 gene expression. The purpose of this mouse line is to study the molecular function of the Setd5 gene.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(Setd5.GFP)Mgn}
Vanderbilt University Medical Center
Rosa26{(Setd5.GFP)Mgn} mouse strain
BCGO:9004148
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create 7xTcf/Lef binding site using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES cell line was generated by RMCE in the Rosa26{LCA} allele. The Rosa26 gene sequence (from -228 to +81) was replaced by a Wnt response element (7xTcf/Lef binding site) fused to a TATA-Cerulean (CFP) reporter. This ES cell line may be useful for assessing canonical Wnt responsiveness.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{228.TOP.CFP} mouse ESC line
BCGO:9004149
A mouse strain in which part or all of the targeted gene, pancreas specific transcription factor, 1a (NCBI Gene ID: 19213) is replaced to create Ptf1a{td.TOM} using the Loxed Cassette Acceptor allele Ptf1a{tm1(LCA)}). This mouse cell line was generated by RMCE in the Ptf1a[LCA] allele. Pancreata of this mouse line express both td.Tomato (a red fluorescent protein) and an N-terminal epitope tagged Strep/Flag (NSF) fusion of the transcription factor Ptf1a. This line may be used in a variety of applications such as FACS sorting of Ptf1a expressing cells, chromatin immunoprecipitation, and proteomic analyses.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ptf1a{(tdTomato)}
Vanderbilt University Medical Center
Ptf1a{(tdTomato)} mouse strain
BCGO:9004150
A mouse strain in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2{Cre-EGFP} using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). In this mouse, a coding portion of the transcription factor Nkx2.2 was replaced with a Cre-EGFP cassette, in frame to the Nkx2.2 ATG. This allows for sites of Nkx2.2 gene expression to be identified in mice using direct immunofluorescence, FACS purification of Nkx2.2 expressing cells, and lineage tracing using Nkx2.2 driven Cre expression.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx2.2{(Cre.EGFP)Suss}
Vanderbilt University Medical Center
Nkx2.2{(Cre.EGFP)Suss} mouse strain
BCGO:9004152
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create NRSF using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line contains bidirectional TetO-regulated genes inserted into the Rosa26[LCA] allele by RMCE. In one direction, the TetO/CMV promoter drives the expression of the transcription factor NRSF/REST. In the other direction, it drives the expression of red fluorescent protein mCherry. In this mouse line, when the effector protein rtTA is expressed, NRSF and mCherry will be simultaneously over-expressed upon administration of doxycyline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{(TetO.NRSF)Msan}
Vanderbilt University Medical Center
Rosa26{(TetO.NRSF)Msan} mouse strain
BCGO:9004153
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{(R26-228-AR8-TA-mCherry)} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse line was generated by RMCE in the Rosa26[LCA] allele. In this mouse line, the Rosa26 gene sequence (-228 to +81) was replaced by the Foxh1/Smad2-dependent, Mix2-derived Activin response element (AR8) fused to a TATA-mCherry reporter. These mice may be useful to assess Activin, Nodal, and TGFbeta responsiveness.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Gt(ROSA)26Sor{tm2.1(mix1b-mCherry)Mgn}
Vanderbilt University Medical Center
Gt(ROSA)26Sor{tm2.1(mix1b-mCherry)Mgn} mouse strain
BCGO:9004154
A mouse ESC line in which the targeted gene, Nephrocan (NCBI Gene ID: 66650), has been modified (allele type: Global Null) to (MGI ID: Neph(mCherry)). This ES cell line was made by gene targeting and was designed to express red fluorescent protein (mCherry) from the Nepn promoter thereby disrupting the expression of Nepn. The FP coding sequence was inserted dowstream of the Nepn start codon, in front of the Nepn first exon. This cell line is used to study the function and expression of Nepn.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Nepn{Cherry} mouse ESC line
BCGO:9004156
A mouse ESC line in which the targeted gene, Insulin 2 (NCBI Gene ID: 20671), has been modified (allele type: Cassette Acceptor) to (MGI ID: Ins2{(apple.LCA)}). This ES cell line was made by gene targeting and designed to express a H2B-Apple fusion protein (nuclear red fluorescent protein) from the Ins2 promoter. The FP coding sequence is downsteam of the Ins2 start codon (replacing exon 2 of Ins2) and is flanked by Lox66/Lox2272 sites to allow for future manipulations of the flanked region by RMCE.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ins2{Apple.LCA} mouse ESC line
BCGO:9004157
A mouse ESC line in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1{rTTA} using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). In this cell line, thefirst exon of Pdx1 was replaced with the coding sequence for rTTA protein, using RMCE in the Pdx1{LCA} allele. Generation of Pdx1-promoter driven rTTA expressing mice will enable tetracycline-inducible manipulation of pancreatic lineage cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Pdx1{rTTA} mouse ESC line
BCGO:9004158
A mouse ESC line in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1/cre using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). In this cell line, thefirst exon of Pdx1 was replaced with the coding sequence for Cre-recombinase using RMCE in the Pdx1{LCA} allele. Generation of Pdx1-promoter driven Cre-expressing cells will enable Cre-LoxP manipulation of pancreatic lineage cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Pdx1{Cre} mouse ESC line
BCGO:9004159
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create 3TF.GFP-Cre using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This cell line contains TetO-regulated genes inserted into the Rosa26{LCA} allele by RMCE. The TetO/miniCMV promoter was placed (at -228) upstream of the putative ROSA26 transcription start site and drives the expression of a polycistronic mRNA with transcription factors MafA, Pdx1, and Ngn3 together with a GFP-Cre fusion protein. The sequences are linked by 2A peptide cleavage sequences. In this cell line, when the effector protein rtTA is expressed, all three transcription factors and GFP-Cre will be over-expressed simultaneously upon administration of doxycyline.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{228.3TF.GFP.Cre} mouse ESC line
BCGO:9004160
A mouse ESC line in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{mIre1.N906A.Cherry} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This ES line contains bidirectional TetO-regulated genes inserted into the Rosa26{LCA} allele by RMCE. In one direction the TetO/CMV promoter drives the expression of point mutant(N906A) of IRE1, an ER transmenbrane kinase response to unfolded protein response (UPR). In the other direction it drives the expression of red fluorescent protein mCherry. This ES cell line can be used to simultaneously over-express Ire1(N906A) and mCherry upon administration of doxycyline when the effector protein rtTA is expressed. This line can be used to study the roles of IRE1 in the response to ER stress, diet induced obesity and insulin resistance.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Rosa26{mIre1.N906A.Cherry} mouse ESC line
BCGO:9004256
A polyclonal antibody raised in rabbit that targets the human "HIP-14 ZDHHC17" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human HIP-14 ZDHHC17 raised in rabbit
BCGO:9004278
A mouse strain in which part or all of the targeted gene, Ghrelin (NCBI Gene ID: 58991) is replaced to create Ghrl Cre-eGFP CEV using the Loxed Cassette Acceptor allele Ghrl{LCA}). Ghrl{Cre-eGGP} mice contain a Cre-eGFP fusion protein which replaces the Ghrelin coding sequence. These mice expressc Cre-eGFP phusion protein under control of the Ghrelin gene locus. The Ghrl{Cre-eGGP} mice may be used to track ghrelin-expressing cells progeny,or to conditionally inactivate genes in ghrelin-expressing cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ghrl{tm1(Cre-eGFP)Suss}
Vanderbilt University Medical Center
Ghrl{tm1(Cre-eGFP)Suss} mouse strain
BCGO:9004305
A monoclonal antibody raised in mouse that targets the human "Cd31 (PECAM1)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Cd31 (PECAM1) raised in mouse
BCGO:9004306
A polyclonal antibody raised in rabbit that targets the cow "GFAP" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal cow GFAP raised in rabbit
BCGO:9004307
A polyclonal antibody raised in rabbit that targets the human "Glucagon (GCG)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Glucagon (GCG) raised in rabbit
BCGO:9004308
A polyclonal antibody raised in guinea pig that targets the human "Glucagon (GCG)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Glucagon (GCG) raised in guinea pig
BCGO:9004309
A polyclonal antibody raised in guinea pig that targets the pig "Insulin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal pig Insulin raised in guinea pig
BCGO:9004310
A polyclonal antibody raised in rabbit that targets the human "Ki67" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Ki67 raised in rabbit
BCGO:9004311
A polyclonal antibody raised in rabbit that targets the human "MafA" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human MafA raised in rabbit
BCGO:9004312
A polyclonal antibody raised in rabbit that targets the human "MafB" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human MafB raised in rabbit
BCGO:9004313
A polyclonal antibody raised in rabbit that targets the human "Pancreatic Polypeptide (PPY)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Pancreatic Polypeptide (PPY) raised in rabbit
BCGO:9004315
A polyclonal antibody raised in sheep that targets the human "Somatostatin (Sst)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Somatostatin (Sst) raised in sheep
BCGO:9004316
A monoclonal antibody raised in rabbit that targets the rat "Tuj1 (TUBB3)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal rat Tuj1 (TUBB3) raised in rabbit
BCGO:9004317
A polyclonal antibody raised in goat that targets the rat "VEGFA" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat VEGFA raised in goat
BCGO:9004318
A polyclonal antibody raised in goat that targets the mouse "Foxa2 (HNF3b)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Foxa2 (HNF3b) raised in goat
BCGO:9004319
A monoclonal antibody raised in hamster (armenian) that targets the human "Muc1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Muc1 raised in hamster (armenian)
BCGO:9004320
A polyclonal antibody raised in goat that targets the human "HNF-1β" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human HNF-1β raised in goat
BCGO:9004321
A polyclonal antibody raised in rabbit that targets the human "Sox9" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Sox9 raised in rabbit
BCGO:9004322
A polyclonal antibody raised in goat that targets the human "CDCP1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human CDCP1 raised in goat
BCGO:9004323
A polyclonal antibody raised in rabbit that targets the human "α-Amylase (AMY2A)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human α-Amylase (AMY2A) raised in rabbit
BCGO:9004324
A polyclonal antibody raised in guinea pig that targets the cow "Insulin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal cow Insulin raised in guinea pig
BCGO:9004325
A polyclonal antibody raised in guinea pig that targets the human "Insulin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Insulin raised in guinea pig
BCGO:9004326
A polyclonal antibody raised in goat that targets the human "Insulin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Insulin raised in goat
BCGO:9004327
A polyclonal antibody raised in rabbit that targets the human "Glucagon" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Glucagon raised in rabbit
BCGO:9004328
A polyclonal antibody raised in goat that targets the human "Somatostatin (Sst)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal human Somatostatin (Sst) raised in goat
BCGO:9004329
A polyclonal antibody raised in rabbit that targets the rat "Synaptophysin (SYP)" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal rat Synaptophysin (SYP) raised in rabbit
BCGO:9004489
A mouse ESC line in which part or all of the targeted gene, Neurogenin 3 (NCBI Gene ID: 11925) is replaced to create Ngn3{T2A.nCre} using the Loxed Cassette Acceptor allele ). In this mouse ES cell line, one of the two bi-partite Cre molecules, nCre, was knocked in upstream of Ngn3 coding sequence by RMCE in Ngn3.HA.LCA ES cell line. nCre sequence is expressed from policistronic mRNA linked by 2a peptide to Ngn3 coding sequence allowing for simultanious expression of both proteins from Ngn3 promoter. This mouse line, in combination with Nkx2.2-cCre mouse line, allows to label pancreatic epithelium cells that co-express high levels of Ngn3 and Nkx2.2 during mouse embryonic development.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Ngn3{T2A.nCre} mouse ESC line
BCGO:9004527
A mouse ESC line in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2{T2A.cCre} using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). In this line, one of the two bi-partite Cre molecules, cCre, is inserted downstream of Nkx2.2 coding sequence fused with 2a peptide using RMCE in the Nkx2.2{LCA}allele. The presence of the T2A sequence allows for transcription of Nkx2.2 and cCre from the native Nkx2.2 locus at the same time. Mouse lines obtained from these ES cells allow the labeling of pancreatic epithelium cells that co-express high levels of Ngn3 and Nkx2.2 during mouse embryonic development.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Nkx2.2{T2A.cCre} mouse ESC line
BCGO:9004529
A mouse ESC line containing a transgene in which Cre (transgene) is driven by the Neurog3 promoter (NCBI Gene ID: 11925). This line has a single copy of Neurog3.Cre-ER.LCA BAC transgene inserted in a genome. The transgene is designed to express Cre-ER under control of Neurog 3 promoter and will allow inducible tracking or gene inactivation in the Ngn3-LOW and Ngn3-HIGH populations of pre-endocrine cells. Additionally, the lox66 and lox2272 sites will allow the BAC transgene to serve as a loxed cassette acceptor (LCA) in ES cells for future recombinase-mediated cassette exchange (RMCE).
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Neurog3{Cre-ER.BAC} mouse ESC line
BCGO:9004533
A mouse strain in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1{Cre} using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). In this mouse strain, the first exon of Pdx1 is replaced with coding sequence for Cre recombinase using RMCE in the Pdx1{LCA} allele. Generation of Pdx-promoter driven Cre expressing mice will enable Cre-LoxP manipulation of pancreatic lineage cells.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Pdx1{CreMgn}
Vanderbilt University Medical Center
Pdx1{CreMgn} mouse strain
BCGO:9004534
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26{228.TOP.CFP} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). In this mouse strain the Rosa26 gene sequence from -228 to +81 was replaced by a Wnt response element (7xTcf/Lef binding site) fused to a TATA-Cerulean (CFP) reporter. These mice may be useful in assessing Canonical Wnt responsiveness.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{228.TOP.CFPHri}
Vanderbilt University Medical Center
Rosa26{228.TOP.CFPHri} mouse strain
BCGO:9004536
A mouse ESC line containing a transgene in which RG (transgene) is driven by the Neurog3 promoter (NCBI Gene ID: 11925). This line has a single copy of Neurog3.RG.LCA BAC transgene inserted in the genome. The transgene is designed to express an H2B-mCherry fusion protein in the nucleus and a membrane anchored EGFP (via GPI), both under the control of the Neurog3 promoter. This will allow for live-cell imaging of mitotic nuclear/chromosome dynamics and membrane protrusive behavior in endocrine progenitors. Additionally, Lox71 and Lox2272 sites flanking the transgene will allow for manipulations by RMCE in the future.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Neurog3{RG.BAC} mouse ESC line
BCGO:9004537
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create ROSA26{228.3TF.GFP-Cre} using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse strain contains TetO-regulated genes inserted into the Rosa 26{LCA} allele by RMCE. TetO/miniCMV promoter is placed at -228 position upstream of putative ROSA26 transcription start site and drives the expression of a polycistronic mRNA with transcription factors MafA, Pdx1, and Ngn3 together with GFP-Cre fusion protein linked by 2A peptide cleavage sequences. These mice will be able to simultaneously over-express all three transcription factors and GFP-Cre upon administration of doxycyline when the effector protein rtTA is expressed.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{228.3TF.GFP-CreMgn}
Vanderbilt University Medical Center
Rosa26{228.3TF.GFP-CreMgn} mouse strain
BCGO:9004538
A mouse strain in which part or all of the targeted gene, Neurogenin 3 (NCBI Gene ID: 11925) is replaced to create Ngn3{T2A.nCre} using the Loxed Cassette Acceptor allele ). In this mouse line, one of the two bi-partite Cre molecules, nCre, was knocked in upstream of Ngn3 coding sequence by RMCE in Ngn3{HA.LCA} ES cell line. nCre sequence is expressed from policistronic mRNA linked by 2a peptide to Ngn3 coding sequence allowing for simultanious expression of both proteins from the Ngn3 promoter. This mouse line, in combination with Nkx2.2{cCre} mouse line, allows for the labeling of pancreatic epithelium cells that co-express high levels of Ngn3 and Nkx2.2 during mouse embryonic development.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Ngn3{T2A.nCreGgu}
Vanderbilt University Medical Center
Ngn3{T2A.nCreGgu} mouse strain
BCGO:9004539
A mouse ESC line in which part or all of the targeted gene, pancreatic and duodenal homeobox 1 (NCBI Gene ID: 18609) is replaced to create Pdx1{H2B.Neptune} using the Loxed Cassette Acceptor allele Pdx1{tm1(LCA)}). In this line, the first exon of Pdx1 is replaced with coding sequence for mNeptune (a far red fluorescent protein) using RMCE in the Pdx1 LCA allele. Generation of a Pdx-promoter driven mNeptune fluorescent allele will enable the isolation of pancreatic lineage cells by FACS and broaden the possibilities for combinatorial sorting with other fluorescent alleles.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Pdx1{H2B.Neptune} mouse ESC line
BCGO:9004545
A mouse ESC line in which the targeted gene, Somatostatin (NCBI Gene ID: 20604), has been modified (allele type: Cassette Acceptor) to Sst.rTTA loxed cassette acceptor (MGI ID: Sst.rTTA{LCA}). This allelle is designed to express a tet-inducible reverse-transactivator under control of the somatostatin promoter. Lox66 and Lox2272 sites are inserted flanking 500bp of Sst promoter region, Sst exons I and II and Sst poly A site. The rTTA-beta-globin poly A cassete replaces Sst coding exons (I and II). The allele can be used to drive tet-inducible expression in somatostatin expressing cells (Delta-cells). Additionally, the Lox66 and Lox2272 sites allow for manipulations of the flanked region by RMCE in the future.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Sst.rTTA.LCA mouse ESC line
BCGO:9004547
A mouse ESC line in which the targeted gene, forkhead box A2 (NCBI Gene ID: 15376), has been modified (allele type: Cassette Acceptor) to Forkhead box A2 loxed cassette acceptor (MGI ID: Foxa2{LCA}). This ES cell line contains a loxed cassette acceptor (LCA) allele that may be utilized for the exchange of DNAs of interest into the Foxa2 locus by recombinase mediated cassette exchange (RMCE). This LCA uses a Lox66/71 and Lox2272 strategy for RMCE and allows for manipulation of a 4.7 kb region of the gene (contains a promoter and all exons: exon 1, 2 and 3). This leads to a variety of experiments that can be performed using a wide range of cassette designs.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Foxa2{LCA} mouse ESC line
BCGO:9004548
A polyclonal antibody raised in chicken that targets the mouse "Ngn3" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Ngn3 raised in chicken
BCGO:9004549
A polyclonal antibody raised in chicken that targets the mouse "Ngn3" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Ngn3 raised in chicken
BCGO:9004550
A polyclonal antibody raised in chicken that targets the mouse "Nkx6.1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Nkx6.1 raised in chicken
BCGO:9004551
A polyclonal antibody raised in chicken that targets the mouse "Nkx6.1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Nkx6.1 raised in chicken
BCGO:9004552
A polyclonal antibody raised in chicken that targets the mouse "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse PDX1 raised in chicken
BCGO:9004553
A polyclonal antibody raised in chicken that targets the mouse "PDX1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse PDX1 raised in chicken
BCGO:9004554
A polyclonal antibody raised in chicken that targets the mouse "Prox1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Prox1 raised in chicken
BCGO:9004555
A polyclonal antibody raised in chicken that targets the mouse "Prox1" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Polyclonal mouse Prox1 raised in chicken
BCGO:9004556
A mouse strain in which part or all of the targeted gene, NK2 transcription factor related, locus 2 (NCBI Gene ID: 18088) is replaced to create Nkx2.2{T2A.cCre} using the Loxed Cassette Acceptor allele Nkx2.2{tm1(LCA)}). In this line, one of the two bi-partite Cre molecules, cCre, is placed downstream of Nkx2.2 coding sequence fused with 2a peptide using RMCE in the Nkx2.2[LCA] allele. The presence of the T2A sequence allows for transcription of Nkx2.2 and cCre from the native Nkx2.2 locus at the same time. This mouse line allows the labeling of pancreatic epithelium cells that co-express high levels of Ngn3 and Nkx2.2 during mouse embryonic development.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Nkx2.2{T2A.cCreGgu}
Vanderbilt University Medical Center
Nkx2.2{T2A.cCreGgu} mouse strain
BCGO:9004560
A mouse strain in which part or all of the targeted gene, gene trap ROSA 26, Philippe Soriano (NCBI Gene ID: 14910) is replaced to create Rosa26.mIre1.N906A.Cherry using the Loxed Cassette Acceptor allele Rosa26{tm1(LCA)}). This mouse contains bidirectional TetO-regulated genes inserted into the Rosa26.LCA allele by RMCE. In one direction the TetO/CMV promoter drives the expression of point mutant (N906A) of IRE1, an ER transmembrane kinase response to unfolded protein response (UPR). In the other direction it drives the expression of red fluorescent protein mCherry. This mouse can be used to simultaneously over-express Ire1 (N906A) and mCherry upon administration of doxycyline when the effector protein rtTA is expressed. This line can be used to study the roles of IRE1 in the response to ER stress, diet induced obesity and insulin resistance.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Rosa26{mIre1.N906A.CherryMgn}
Vanderbilt University Medical Center
Rosa26{mIre1.N906A.CherryMgn} mouse strain
BCGO:9004561
A mouse strain in which the targeted gene, Somatostatin (NCBI Gene ID: 20604), has been modified (allele type: Gene Replacement) to (MGI ID: Sst{rTTA.LCA}). TheSst.rTTA.LCA mice are designed to express a tet-inducible reverse-transactivator under control of somatostatin promoter. Lox66 and Lox2272 sites are inserted flanking 500bp of Sst promoter region, Sst exons I and II and Sst poly A site. The rTTA-beta-globin poly A cassete is put in place of Sst coding exons (I and II). The mice can be used to drive tet-inducible expression in somatostatin expressing cells (Delta-cells). Additionally, the Lox66 and Lox2272 sites allow for manipulations of the flanked region by RMCE in the future.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Sst{rTTA.LCA.Mgn}
Vanderbilt University Medical Center
Sst{rTTA.LCA.Mgn} mouse strain
BCGO:9004563
A monoclonal antibody raised in mouse that targets the human "ghrelin" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human ghrelin raised in mouse
BCGO:9004573
A monoclonal antibody raised in mouse that targets the human "Gallbladder mucosal epithelium" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Gallbladder mucosal epithelium raised in mouse
BCGO:9004574
A monoclonal antibody raised in mouse that targets the human "Gallbladder mucosal epithelium" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Gallbladder mucosal epithelium raised in mouse
BCGO:9004575
A monoclonal antibody raised in mouse that targets the human "Gallbladder mucosal epithelium" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Gallbladder mucosal epithelium raised in mouse
BCGO:9004576
A monoclonal antibody raised in mouse that targets the human "Gallbladder mucosal epithelium" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Gallbladder mucosal epithelium raised in mouse
BCGO:9004597
A monoclonal antibody raised in mouse that targets the human "Alpha cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Alpha cells raised in mouse
BCGO:9004598
A monoclonal antibody raised in mouse that targets the human "Pancreatic duct cells" antigen.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
Vanderbilt University Medical Center
Monoclonal human Pancreatic duct cells raised in mouse
BCGO:9004611
A mouse strain that is immunodeficient and express human HLA class 1 heavy and light chains. This strain may be useful as a human hematopoietic engraftment host that supports the maturation of human T cells with transplantation http://jaxmice.jax.org/strain/014570.html.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl} Tg(HLA-A/H2-D/B2M)1Dvs/SzJ
Vanderbilt University Medical Center
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl} Tg(HLA-A/H2-D/B2M)1Dvs/SzJ mouse strain
BCGO:9004612
A mouse strain that lacks expression of the murine Prkdc gene, the X-linked Il2rg gene, and MHC class II, but express the human leukocyte antigen DR4 gene. These mice may be useful for targeting human CD4{+} T cells in transplantation studies in the absence of xeno-GVHD.More details are available at http://jaxmice.jax.org/strain/017637.html.
Person: Mark A. Magnuson, Jill Lindner, Jean-Philippe Cartailler
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl} H2-Ab1{tm1Gru} Tg(HLA-DRB1)31Dmz/SzJ
Vanderbilt University Medical Center
NOD.Cg-Prkdc{scid} Il2rg{tm1Wjl} H2-Ab1{tm1Gru} Tg(HLA-DRB1)31Dmz/SzJ mouse strain
BFO:0000001
entity
Entity
Julius Caesar
Verdi’s Requiem
the Second World War
your body mass index
BFO 2 Reference: In all areas of empirical inquiry we encounter general terms of two sorts. First are general terms which refer to universals or types:animaltuberculosissurgical procedurediseaseSecond, are general terms used to refer to groups of entities which instantiate a given universal but do not correspond to the extension of any subuniversal of that universal because there is nothing intrinsic to the entities in question by virtue of which they – and only they – are counted as belonging to the given group. Examples are: animal purchased by the Emperortuberculosis diagnosed on a Wednesdaysurgical procedure performed on a patient from Stockholmperson identified as candidate for clinical trial #2056-555person who is signatory of Form 656-PPVpainting by Leonardo da VinciSuch terms, which represent what are called ‘specializations’ in [81
Entity doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example Werner Ceusters 'portions of reality' include 4 sorts, entities (as BFO construes them), universals, configurations, and relations. It is an open question as to whether entities as construed in BFO will at some point also include these other portions of reality. See, for example, 'How to track absolutely everything' at http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf
An entity is anything that exists or has existed or will exist. (axiom label in BFO2 Reference: [001-001])
entity
Entity doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example Werner Ceusters 'portions of reality' include 4 sorts, entities (as BFO construes them), universals, configurations, and relations. It is an open question as to whether entities as construed in BFO will at some point also include these other portions of reality. See, for example, 'How to track absolutely everything' at http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf
per discussion with Barry Smith
An entity is anything that exists or has existed or will exist. (axiom label in BFO2 Reference: [001-001])
BFO:0000002
continuant
Continuant
An entity that exists in full at any time in which it exists at all, persists through time while maintaining its identity and has no temporal parts.
BFO 2 Reference: Continuant entities are entities which can be sliced to yield parts only along the spatial dimension, yielding for example the parts of your table which we call its legs, its top, its nails. ‘My desk stretches from the window to the door. It has spatial parts, and can be sliced (in space) in two. With respect to time, however, a thing is a continuant.’ [60, p. 240
Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants
A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002])
if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001])
if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002])
if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002])
(forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002]
(forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001]
(forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002]
(forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002]
continuant
Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants
A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002])
if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001])
if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002])
if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002])
(forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002]
(forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001]
(forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002]
(forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002]
BFO:0000003
occurrent
Occurrent
An entity that has temporal parts and that happens, unfolds or develops through time.
BFO 2 Reference: every occurrent that is not a temporal or spatiotemporal region is s-dependent on some independent continuant that is not a spatial region
BFO 2 Reference: s-dependence obtains between every process and its participants in the sense that, as a matter of necessity, this process could not have existed unless these or those participants existed also. A process may have a succession of participants at different phases of its unfolding. Thus there may be different players on the field at different times during the course of a football game; but the process which is the entire game s-depends_on all of these players nonetheless. Some temporal parts of this process will s-depend_on on only some of the players.
Occurrent doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the sum of a process and the process boundary of another process.
Simons uses different terminology for relations of occurrents to regions: Denote the spatio-temporal location of a given occurrent e by 'spn[e]' and call this region its span. We may say an occurrent is at its span, in any larger region, and covers any smaller region. Now suppose we have fixed a frame of reference so that we can speak not merely of spatio-temporal but also of spatial regions (places) and temporal regions (times). The spread of an occurrent, (relative to a frame of reference) is the space it exactly occupies, and its spell is likewise the time it exactly occupies. We write 'spr[e]' and `spl[e]' respectively for the spread and spell of e, omitting mention of the frame.
An occurrent is an entity that unfolds itself in time or it is the instantaneous boundary of such an entity (for example a beginning or an ending) or it is a temporal or spatiotemporal region which such an entity occupies_temporal_region or occupies_spatiotemporal_region. (axiom label in BFO2 Reference: [077-002])
Every occurrent occupies_spatiotemporal_region some spatiotemporal region. (axiom label in BFO2 Reference: [108-001])
b is an occurrent entity iff b is an entity that has temporal parts. (axiom label in BFO2 Reference: [079-001])
(forall (x) (if (Occurrent x) (exists (r) (and (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion x r))))) // axiom label in BFO2 CLIF: [108-001]
(forall (x) (iff (Occurrent x) (and (Entity x) (exists (y) (temporalPartOf y x))))) // axiom label in BFO2 CLIF: [079-001]
occurrent
Occurrent doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the sum of a process and the process boundary of another process.
per discussion with Barry Smith
Simons uses different terminology for relations of occurrents to regions: Denote the spatio-temporal location of a given occurrent e by 'spn[e]' and call this region its span. We may say an occurrent is at its span, in any larger region, and covers any smaller region. Now suppose we have fixed a frame of reference so that we can speak not merely of spatio-temporal but also of spatial regions (places) and temporal regions (times). The spread of an occurrent, (relative to a frame of reference) is the space it exactly occupies, and its spell is likewise the time it exactly occupies. We write 'spr[e]' and `spl[e]' respectively for the spread and spell of e, omitting mention of the frame.
An occurrent is an entity that unfolds itself in time or it is the instantaneous boundary of such an entity (for example a beginning or an ending) or it is a temporal or spatiotemporal region which such an entity occupies_temporal_region or occupies_spatiotemporal_region. (axiom label in BFO2 Reference: [077-002])
Every occurrent occupies_spatiotemporal_region some spatiotemporal region. (axiom label in BFO2 Reference: [108-001])
b is an occurrent entity iff b is an entity that has temporal parts. (axiom label in BFO2 Reference: [079-001])
(forall (x) (if (Occurrent x) (exists (r) (and (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion x r))))) // axiom label in BFO2 CLIF: [108-001]
(forall (x) (iff (Occurrent x) (and (Entity x) (exists (y) (temporalPartOf y x))))) // axiom label in BFO2 CLIF: [079-001]
BFO:0000004
ic
IndependentContinuant
a chair
a heart
a leg
a molecule
a spatial region
an atom
an orchestra.
an organism
the bottom right portion of a human torso
the interior of your mouth
A continuant that is a bearer of quality and realizable entity entities, in which other entities inhere and which itself cannot inhere in anything.
b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002])
For any independent continuant b and any time t there is some spatial region r such that b is located_in r at t. (axiom label in BFO2 Reference: [134-001])
For every independent continuant b and time t during the region of time spanned by its life, there are entities which s-depends_on b during t. (axiom label in BFO2 Reference: [018-002])
(forall (x t) (if (IndependentContinuant x) (exists (r) (and (SpatialRegion r) (locatedInAt x r t))))) // axiom label in BFO2 CLIF: [134-001]
(forall (x t) (if (and (IndependentContinuant x) (existsAt x t)) (exists (y) (and (Entity y) (specificallyDependsOnAt y x t))))) // axiom label in BFO2 CLIF: [018-002]
(iff (IndependentContinuant a) (and (Continuant a) (not (exists (b t) (specificallyDependsOnAt a b t))))) // axiom label in BFO2 CLIF: [017-002]
independent continuant
b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002])
For any independent continuant b and any time t there is some spatial region r such that b is located_in r at t. (axiom label in BFO2 Reference: [134-001])
For every independent continuant b and time t during the region of time spanned by its life, there are entities which s-depends_on b during t. (axiom label in BFO2 Reference: [018-002])
(forall (x t) (if (IndependentContinuant x) (exists (r) (and (SpatialRegion r) (locatedInAt x r t))))) // axiom label in BFO2 CLIF: [134-001]
(forall (x t) (if (and (IndependentContinuant x) (existsAt x t)) (exists (y) (and (Entity y) (specificallyDependsOnAt y x t))))) // axiom label in BFO2 CLIF: [018-002]
(iff (IndependentContinuant a) (and (Continuant a) (not (exists (b t) (specificallyDependsOnAt a b t))))) // axiom label in BFO2 CLIF: [017-002]
BFO:0000005
A continuant that is either dependent on one or other independent continuant bearers or inheres in or is borne by other entities.
obsolete dependent continuant
true
BFO:0000006
s-region
SpatialRegion
BFO 2 Reference: Spatial regions do not participate in processes.
Spatial region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the union of a spatial point and a spatial line that doesn't overlap the point, or two spatial lines that intersect at a single point. In both cases the resultant spatial region is neither 0-dimensional, 1-dimensional, 2-dimensional, or 3-dimensional.
A spatial region is a continuant entity that is a continuant_part_of spaceR as defined relative to some frame R. (axiom label in BFO2 Reference: [035-001])
All continuant parts of spatial regions are spatial regions. (axiom label in BFO2 Reference: [036-001])
(forall (x y t) (if (and (SpatialRegion x) (continuantPartOfAt y x t)) (SpatialRegion y))) // axiom label in BFO2 CLIF: [036-001]
(forall (x) (if (SpatialRegion x) (Continuant x))) // axiom label in BFO2 CLIF: [035-001]
spatial region
Spatial region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the union of a spatial point and a spatial line that doesn't overlap the point, or two spatial lines that intersect at a single point. In both cases the resultant spatial region is neither 0-dimensional, 1-dimensional, 2-dimensional, or 3-dimensional.
per discussion with Barry Smith
A spatial region is a continuant entity that is a continuant_part_of spaceR as defined relative to some frame R. (axiom label in BFO2 Reference: [035-001])
All continuant parts of spatial regions are spatial regions. (axiom label in BFO2 Reference: [036-001])
(forall (x y t) (if (and (SpatialRegion x) (continuantPartOfAt y x t)) (SpatialRegion y))) // axiom label in BFO2 CLIF: [036-001]
(forall (x) (if (SpatialRegion x) (Continuant x))) // axiom label in BFO2 CLIF: [035-001]
BFO:0000008
t-region
TemporalRegion
Temporal region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the mereological sum of a temporal instant and a temporal interval that doesn't overlap the instant. In this case the resultant temporal region is neither 0-dimensional nor 1-dimensional
A temporal region is an occurrent entity that is part of time as defined relative to some reference frame. (axiom label in BFO2 Reference: [100-001])
All parts of temporal regions are temporal regions. (axiom label in BFO2 Reference: [101-001])
Every temporal region t is such that t occupies_temporal_region t. (axiom label in BFO2 Reference: [119-002])
(forall (r) (if (TemporalRegion r) (occupiesTemporalRegion r r))) // axiom label in BFO2 CLIF: [119-002]
(forall (x y) (if (and (TemporalRegion x) (occurrentPartOf y x)) (TemporalRegion y))) // axiom label in BFO2 CLIF: [101-001]
(forall (x) (if (TemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [100-001]
temporal region
Temporal region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the mereological sum of a temporal instant and a temporal interval that doesn't overlap the instant. In this case the resultant temporal region is neither 0-dimensional nor 1-dimensional
per discussion with Barry Smith
A temporal region is an occurrent entity that is part of time as defined relative to some reference frame. (axiom label in BFO2 Reference: [100-001])
All parts of temporal regions are temporal regions. (axiom label in BFO2 Reference: [101-001])
Every temporal region t is such that t occupies_temporal_region t. (axiom label in BFO2 Reference: [119-002])
(forall (r) (if (TemporalRegion r) (occupiesTemporalRegion r r))) // axiom label in BFO2 CLIF: [119-002]
(forall (x y) (if (and (TemporalRegion x) (occurrentPartOf y x)) (TemporalRegion y))) // axiom label in BFO2 CLIF: [101-001]
(forall (x) (if (TemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [100-001]
BFO:0000009
2d-s-region
TwoDimensionalSpatialRegion
an infinitely thin plane in space.
the surface of a sphere-shaped part of space
A two-dimensional spatial region is a spatial region that is of two dimensions. (axiom label in BFO2 Reference: [039-001])
(forall (x) (if (TwoDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [039-001]
two-dimensional spatial region
A two-dimensional spatial region is a spatial region that is of two dimensions. (axiom label in BFO2 Reference: [039-001])
(forall (x) (if (TwoDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [039-001]
BFO:0000011
st-region
SpatiotemporalRegion
the spatiotemporal region occupied by a human life
the spatiotemporal region occupied by a process of cellular meiosis.
the spatiotemporal region occupied by the development of a cancer tumor
A spatiotemporal region is an occurrent entity that is part of spacetime. (axiom label in BFO2 Reference: [095-001])
All parts of spatiotemporal regions are spatiotemporal regions. (axiom label in BFO2 Reference: [096-001])
Each spatiotemporal region at any time t projects_onto some spatial region at t. (axiom label in BFO2 Reference: [099-001])
Each spatiotemporal region projects_onto some temporal region. (axiom label in BFO2 Reference: [098-001])
Every spatiotemporal region occupies_spatiotemporal_region itself.
Every spatiotemporal region s is such that s occupies_spatiotemporal_region s. (axiom label in BFO2 Reference: [107-002])
(forall (r) (if (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion r r))) // axiom label in BFO2 CLIF: [107-002]
(forall (x t) (if (SpatioTemporalRegion x) (exists (y) (and (SpatialRegion y) (spatiallyProjectsOntoAt x y t))))) // axiom label in BFO2 CLIF: [099-001]
(forall (x y) (if (and (SpatioTemporalRegion x) (occurrentPartOf y x)) (SpatioTemporalRegion y))) // axiom label in BFO2 CLIF: [096-001]
(forall (x) (if (SpatioTemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [095-001]
(forall (x) (if (SpatioTemporalRegion x) (exists (y) (and (TemporalRegion y) (temporallyProjectsOnto x y))))) // axiom label in BFO2 CLIF: [098-001]
spatiotemporal region
A spatiotemporal region is an occurrent entity that is part of spacetime. (axiom label in BFO2 Reference: [095-001])
All parts of spatiotemporal regions are spatiotemporal regions. (axiom label in BFO2 Reference: [096-001])
Each spatiotemporal region at any time t projects_onto some spatial region at t. (axiom label in BFO2 Reference: [099-001])
Each spatiotemporal region projects_onto some temporal region. (axiom label in BFO2 Reference: [098-001])
Every spatiotemporal region s is such that s occupies_spatiotemporal_region s. (axiom label in BFO2 Reference: [107-002])
(forall (r) (if (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion r r))) // axiom label in BFO2 CLIF: [107-002]
(forall (x t) (if (SpatioTemporalRegion x) (exists (y) (and (SpatialRegion y) (spatiallyProjectsOntoAt x y t))))) // axiom label in BFO2 CLIF: [099-001]
(forall (x y) (if (and (SpatioTemporalRegion x) (occurrentPartOf y x)) (SpatioTemporalRegion y))) // axiom label in BFO2 CLIF: [096-001]
(forall (x) (if (SpatioTemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [095-001]
(forall (x) (if (SpatioTemporalRegion x) (exists (y) (and (TemporalRegion y) (temporallyProjectsOnto x y))))) // axiom label in BFO2 CLIF: [098-001]
BFO:0000015
process
Process
a process of cell-division, \ a beating of the heart
a process of meiosis
a process of sleeping
the course of a disease
the flight of a bird
the life of an organism
your process of aging.
An occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t.
p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])
BFO 2 Reference: The realm of occurrents is less pervasively marked by the presence of natural units than is the case in the realm of independent continuants. Thus there is here no counterpart of ‘object’. In BFO 1.0 ‘process’ served as such a counterpart. In BFO 2.0 ‘process’ is, rather, the occurrent counterpart of ‘material entity’. Those natural – as contrasted with engineered, which here means: deliberately executed – units which do exist in the realm of occurrents are typically either parasitic on the existence of natural units on the continuant side, or they are fiat in nature. Thus we can count lives; we can count football games; we can count chemical reactions performed in experiments or in chemical manufacturing. We cannot count the processes taking place, for instance, in an episode of insect mating behavior.Even where natural units are identifiable, for example cycles in a cyclical process such as the beating of a heart or an organism’s sleep/wake cycle, the processes in question form a sequence with no discontinuities (temporal gaps) of the sort that we find for instance where billiard balls or zebrafish or planets are separated by clear spatial gaps. Lives of organisms are process units, but they too unfold in a continuous series from other, prior processes such as fertilization, and they unfold in turn in continuous series of post-life processes such as post-mortem decay. Clear examples of boundaries of processes are almost always of the fiat sort (midnight, a time of death as declared in an operating theater or on a death certificate, the initiation of a state of war)
(iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003]
process
p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])
(iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003]
BFO:0000016
disposition
Disposition
an atom of element X has the disposition to decay to an atom of element Y
certain people have a predisposition to colon cancer
children are innately disposed to categorize objects in certain ways.
the cell wall is disposed to filter chemicals in endocytosis and exocytosis
BFO 2 Reference: Dispositions exist along a strength continuum. Weaker forms of disposition are realized in only a fraction of triggering cases. These forms occur in a significant number of cases of a similar type.
b is a disposition means: b is a realizable entity & b’s bearer is some material entity & b is such that if it ceases to exist, then its bearer is physically changed, & b’s realization occurs when and because this bearer is in some special physical circumstances, & this realization occurs in virtue of the bearer’s physical make-up. (axiom label in BFO2 Reference: [062-002])
If b is a realizable entity then for all t at which b exists, b s-depends_on some material entity at t. (axiom label in BFO2 Reference: [063-002])
(forall (x t) (if (and (RealizableEntity x) (existsAt x t)) (exists (y) (and (MaterialEntity y) (specificallyDepends x y t))))) // axiom label in BFO2 CLIF: [063-002]
(forall (x) (if (Disposition x) (and (RealizableEntity x) (exists (y) (and (MaterialEntity y) (bearerOfAt x y t)))))) // axiom label in BFO2 CLIF: [062-002]
disposition
b is a disposition means: b is a realizable entity & b’s bearer is some material entity & b is such that if it ceases to exist, then its bearer is physically changed, & b’s realization occurs when and because this bearer is in some special physical circumstances, & this realization occurs in virtue of the bearer’s physical make-up. (axiom label in BFO2 Reference: [062-002])
If b is a realizable entity then for all t at which b exists, b s-depends_on some material entity at t. (axiom label in BFO2 Reference: [063-002])
(forall (x t) (if (and (RealizableEntity x) (existsAt x t)) (exists (y) (and (MaterialEntity y) (specificallyDepends x y t))))) // axiom label in BFO2 CLIF: [063-002]
(forall (x) (if (Disposition x) (and (RealizableEntity x) (exists (y) (and (MaterialEntity y) (bearerOfAt x y t)))))) // axiom label in BFO2 CLIF: [062-002]
BFO:0000017
realizable
RealizableEntity
the disposition of this piece of metal to conduct electricity.
the disposition of your blood to coagulate
the function of your reproductive organs
the role of being a doctor
the role of this boundary to delineate where Utah and Colorado meet
A specifically dependent continuant that inheres in continuant entities and are not exhibited in full at every time in which it inheres in an entity or group of entities. The exhibition or actualization of a realizable entity is a particular manifestation, functioning or process that occurs under certain circumstances.
To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002])
All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002])
(forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002]
(forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002]
realizable entity
To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002])
All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002])
(forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002]
(forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002]
BFO:0000018
0d-s-region
ZeroDimensionalSpatialRegion
A zero-dimensional spatial region is a point in space. (axiom label in BFO2 Reference: [037-001])
(forall (x) (if (ZeroDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [037-001]
zero-dimensional spatial region
A zero-dimensional spatial region is a point in space. (axiom label in BFO2 Reference: [037-001])
(forall (x) (if (ZeroDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [037-001]
BFO:0000019
quality
Quality
the ambient temperature of this portion of air
the color of a tomato
the length of the circumference of your waist
the mass of this piece of gold.
the shape of your nose
the shape of your nostril
a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001])
If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001])
(forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001]
(forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001]
quality
a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001])
If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001])
(forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001]
(forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001]
BFO:0000020
sdc
SpecificallyDependentContinuant
Reciprocal specifically dependent continuants: the function of this key to open this lock and the mutually dependent disposition of this lock: to be opened by this key
of one-sided specifically dependent continuants: the mass of this tomato
of relational dependent continuants (multiple bearers): John’s love for Mary, the ownership relation between John and this statue, the relation of authority between John and his subordinates.
the disposition of this fish to decay
the function of this heart: to pump blood
the mutual dependence of proton donors and acceptors in chemical reactions [79
the mutual dependence of the role predator and the role prey as played by two organisms in a given interaction
the pink color of a medium rare piece of grilled filet mignon at its center
the role of being a doctor
the shape of this hole.
the smell of this portion of mozzarella
A continuant that inheres in or is borne by other entities. Every instance of A requires some specific instance of B which must always be the same.
b is a relational specifically dependent continuant = Def. b is a specifically dependent continuant and there are n > 1 independent continuants c1, … cn which are not spatial regions are such that for all 1 i < j n, ci and cj share no common parts, are such that for each 1 i n, b s-depends_on ci at every time t during the course of b’s existence (axiom label in BFO2 Reference: [131-004])
b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003])
Specifically dependent continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. We're not sure what else will develop here, but for example there are questions such as what are promises, obligation, etc.
(iff (RelationalSpecificallyDependentContinuant a) (and (SpecificallyDependentContinuant a) (forall (t) (exists (b c) (and (not (SpatialRegion b)) (not (SpatialRegion c)) (not (= b c)) (not (exists (d) (and (continuantPartOfAt d b t) (continuantPartOfAt d c t)))) (specificallyDependsOnAt a b t) (specificallyDependsOnAt a c t)))))) // axiom label in BFO2 CLIF: [131-004]
(iff (SpecificallyDependentContinuant a) (and (Continuant a) (forall (t) (if (existsAt a t) (exists (b) (and (IndependentContinuant b) (not (SpatialRegion b)) (specificallyDependsOnAt a b t))))))) // axiom label in BFO2 CLIF: [050-003]
specifically dependent continuant
b is a relational specifically dependent continuant = Def. b is a specifically dependent continuant and there are n > 1 independent continuants c1, … cn which are not spatial regions are such that for all 1 i < j n, ci and cj share no common parts, are such that for each 1 i n, b s-depends_on ci at every time t during the course of b’s existence (axiom label in BFO2 Reference: [131-004])
b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003])
Specifically dependent continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. We're not sure what else will develop here, but for example there are questions such as what are promises, obligation, etc.
per discussion with Barry Smith
(iff (RelationalSpecificallyDependentContinuant a) (and (SpecificallyDependentContinuant a) (forall (t) (exists (b c) (and (not (SpatialRegion b)) (not (SpatialRegion c)) (not (= b c)) (not (exists (d) (and (continuantPartOfAt d b t) (continuantPartOfAt d c t)))) (specificallyDependsOnAt a b t) (specificallyDependsOnAt a c t)))))) // axiom label in BFO2 CLIF: [131-004]
(iff (SpecificallyDependentContinuant a) (and (Continuant a) (forall (t) (if (existsAt a t) (exists (b) (and (IndependentContinuant b) (not (SpatialRegion b)) (specificallyDependsOnAt a b t))))))) // axiom label in BFO2 CLIF: [050-003]
BFO:0000023
role
Role
John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married.
the priest role
the role of a boundary to demarcate two neighboring administrative territories
the role of a building in serving as a military target
the role of a stone in marking a property boundary
the role of subject in a clinical trial
the student role
A realizable entity the manifestation of which brings about some result or end that is not essential to a continuant in virtue of the kind of thing that it is but that can be served or participated in by that kind of continuant in some kinds of natural, social or institutional contexts.
BFO 2 Reference: One major family of examples of non-rigid universals involves roles, and ontologies developed for corresponding administrative purposes may consist entirely of representatives of entities of this sort. Thus ‘professor’, defined as follows,b instance_of professor at t =Def. there is some c, c instance_of professor role & c inheres_in b at t.denotes a non-rigid universal and so also do ‘nurse’, ‘student’, ‘colonel’, ‘taxpayer’, and so forth. (These terms are all, in the jargon of philosophy, phase sortals.) By using role terms in definitions, we can create a BFO conformant treatment of such entities drawing on the fact that, while an instance of professor may be simultaneously an instance of trade union member, no instance of the type professor role is also (at any time) an instance of the type trade union member role (any more than any instance of the type color is at any time an instance of the type length).If an ontology of employment positions should be defined in terms of roles following the above pattern, this enables the ontology to do justice to the fact that individuals instantiate the corresponding universals – professor, sergeant, nurse – only during certain phases in their lives.
b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001])
(forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001]
role
b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001])
(forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001]
BFO:0000024
fiat-object
FiatObjectPart
or with divisions drawn by cognitive subjects for practical reasons, such as the division of a cake (before slicing) into (what will become) slices (and thus member parts of an object aggregate). However, this does not mean that fiat object parts are dependent for their existence on divisions or delineations effected by cognitive subjects. If, for example, it is correct to conceive geological layers of the Earth as fiat object parts of the Earth, then even though these layers were first delineated in recent times, still existed long before such delineation and what holds of these layers (for example that the oldest layers are also the lowest layers) did not begin to hold because of our acts of delineation.Treatment of material entity in BFOExamples viewed by some as problematic cases for the trichotomy of fiat object part, object, and object aggregate include: a mussel on (and attached to) a rock, a slime mold, a pizza, a cloud, a galaxy, a railway train with engine and multiple carriages, a clonal stand of quaking aspen, a bacterial community (biofilm), a broken femur. Note that, as Aristotle already clearly recognized, such problematic cases – which lie at or near the penumbra of instances defined by the categories in question – need not invalidate these categories. The existence of grey objects does not prove that there are not objects which are black and objects which are white; the existence of mules does not prove that there are not objects which are donkeys and objects which are horses. It does, however, show that the examples in question need to be addressed carefully in order to show how they can be fitted into the proposed scheme, for example by recognizing additional subdivisions [29
the FMA:regional parts of an intact human body.
the Western hemisphere of the Earth
the division of the brain into regions
the division of the planet into hemispheres
the dorsal and ventral surfaces of the body
the upper and lower lobes of the left lung
BFO 2 Reference: Most examples of fiat object parts are associated with theoretically drawn divisions
b is a fiat object part = Def. b is a material entity which is such that for all times t, if b exists at t then there is some object c such that b proper continuant_part of c at t and c is demarcated from the remainder of c by a two-dimensional continuant fiat boundary. (axiom label in BFO2 Reference: [027-004])
(forall (x) (if (FiatObjectPart x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y) (and (Object y) (properContinuantPartOfAt x y t)))))))) // axiom label in BFO2 CLIF: [027-004]
fiat object
b is a fiat object part = Def. b is a material entity which is such that for all times t, if b exists at t then there is some object c such that b proper continuant_part of c at t and c is demarcated from the remainder of c by a two-dimensional continuant fiat boundary. (axiom label in BFO2 Reference: [027-004])
(forall (x) (if (FiatObjectPart x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y) (and (Object y) (properContinuantPartOfAt x y t)))))))) // axiom label in BFO2 CLIF: [027-004]
BFO:0000026
1d-s-region
OneDimensionalSpatialRegion
an edge of a cube-shaped portion of space.
A one-dimensional spatial region is a line or aggregate of lines stretching from one point in space to another. (axiom label in BFO2 Reference: [038-001])
(forall (x) (if (OneDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [038-001]
one-dimensional spatial region
A one-dimensional spatial region is a line or aggregate of lines stretching from one point in space to another. (axiom label in BFO2 Reference: [038-001])
(forall (x) (if (OneDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [038-001]
BFO:0000027
object-aggregate
ObjectAggregate
a collection of cells in a blood biobank.
a swarm of bees is an aggregate of members who are linked together through natural bonds
a symphony orchestra
an organization is an aggregate whose member parts have roles of specific types (for example in a jazz band, a chess club, a football team)
defined by fiat: the aggregate of members of an organization
defined through physical attachment: the aggregate of atoms in a lump of granite
defined through physical containment: the aggregate of molecules of carbon dioxide in a sealed container
defined via attributive delimitations such as: the patients in this hospital
the aggregate of bearings in a constant velocity axle joint
the aggregate of blood cells in your body
the nitrogen atoms in the atmosphere
the restaurants in Palo Alto
your collection of Meissen ceramic plates.
An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects
BFO 2 Reference: object aggregates may gain and lose parts while remaining numerically identical (one and the same individual) over time. This holds both for aggregates whose membership is determined naturally (the aggregate of cells in your body) and aggregates determined by fiat (a baseball team, a congressional committee).
ISBN:978-3-938793-98-5pp124-158#Thomas Bittner and Barry Smith, 'A Theory of Granular Partitions', in K. Munn and B. Smith (eds.), Applied Ontology: An Introduction, Frankfurt/Lancaster: ontos, 2008, 125-158.
b is an object aggregate means: b is a material entity consisting exactly of a plurality of objects as member_parts at all times at which b exists. (axiom label in BFO2 Reference: [025-004])
(forall (x) (if (ObjectAggregate x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y z) (and (Object y) (Object z) (memberPartOfAt y x t) (memberPartOfAt z x t) (not (= y z)))))) (not (exists (w t_1) (and (memberPartOfAt w x t_1) (not (Object w)))))))) // axiom label in BFO2 CLIF: [025-004]
object aggregate
An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects
An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects
ISBN:978-3-938793-98-5pp124-158#Thomas Bittner and Barry Smith, 'A Theory of Granular Partitions', in K. Munn and B. Smith (eds.), Applied Ontology: An Introduction, Frankfurt/Lancaster: ontos, 2008, 125-158.
b is an object aggregate means: b is a material entity consisting exactly of a plurality of objects as member_parts at all times at which b exists. (axiom label in BFO2 Reference: [025-004])
(forall (x) (if (ObjectAggregate x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y z) (and (Object y) (Object z) (memberPartOfAt y x t) (memberPartOfAt z x t) (not (= y z)))))) (not (exists (w t_1) (and (memberPartOfAt w x t_1) (not (Object w)))))))) // axiom label in BFO2 CLIF: [025-004]
BFO:0000028
3d-s-region
ThreeDimensionalSpatialRegion
a cube-shaped region of space
a sphere-shaped region of space,
A three-dimensional spatial region is a spatial region that is of three dimensions. (axiom label in BFO2 Reference: [040-001])
(forall (x) (if (ThreeDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [040-001]
three-dimensional spatial region
A three-dimensional spatial region is a spatial region that is of three dimensions. (axiom label in BFO2 Reference: [040-001])
(forall (x) (if (ThreeDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [040-001]
BFO:0000029
site
Site
Manhattan Canyon)
a hole in the interior of a portion of cheese
a rabbit hole
an air traffic control region defined in the airspace above an airport
the Grand Canyon
the Piazza San Marco
the cockpit of an aircraft
the hold of a ship
the interior of a kangaroo pouch
the interior of the trunk of your car
the interior of your bedroom
the interior of your office
the interior of your refrigerator
the lumen of your gut
your left nostril (a fiat part – the opening – of your left nasal cavity)
b is a site means: b is a three-dimensional immaterial entity that is (partially or wholly) bounded by a material entity or it is a three-dimensional immaterial part thereof. (axiom label in BFO2 Reference: [034-002])
(forall (x) (if (Site x) (ImmaterialEntity x))) // axiom label in BFO2 CLIF: [034-002]
site
b is a site means: b is a three-dimensional immaterial entity that is (partially or wholly) bounded by a material entity or it is a three-dimensional immaterial part thereof. (axiom label in BFO2 Reference: [034-002])
(forall (x) (if (Site x) (ImmaterialEntity x))) // axiom label in BFO2 CLIF: [034-002]
BFO:0000030
object
Object
atom
cell
cells and organisms
engineered artifacts
grain of sand
molecule
organelle
organism
planet
solid portions of matter
star
BFO 2 Reference: BFO rests on the presupposition that at multiple micro-, meso- and macroscopic scales reality exhibits certain stable, spatially separated or separable material units, combined or combinable into aggregates of various sorts (for example organisms into what are called ‘populations’). Such units play a central role in almost all domains of natural science from particle physics to cosmology. Many scientific laws govern the units in question, employing general terms (such as ‘molecule’ or ‘planet’) referring to the types and subtypes of units, and also to the types and subtypes of the processes through which such units develop and interact. The division of reality into such natural units is at the heart of biological science, as also is the fact that these units may form higher-level units (as cells form multicellular organisms) and that they may also form aggregates of units, for example as cells form portions of tissue and organs form families, herds, breeds, species, and so on. At the same time, the division of certain portions of reality into engineered units (manufactured artifacts) is the basis of modern industrial technology, which rests on the distributed mass production of engineered parts through division of labor and on their assembly into larger, compound units such as cars and laptops. The division of portions of reality into units is one starting point for the phenomenon of counting.
BFO 2 Reference: Each object is such that there are entities of which we can assert unproblematically that they lie in its interior, and other entities of which we can assert unproblematically that they lie in its exterior. This may not be so for entities lying at or near the boundary between the interior and exterior. This means that two objects – for example the two cells depicted in Figure 3 – may be such that there are material entities crossing their boundaries which belong determinately to neither cell. Something similar obtains in certain cases of conjoined twins (see below).
BFO 2 Reference: To say that b is causally unified means: b is a material entity which is such that its material parts are tied together in such a way that, in environments typical for entities of the type in question,if c, a continuant part of b that is in the interior of b at t, is larger than a certain threshold size (which will be determined differently from case to case, depending on factors such as porosity of external cover) and is moved in space to be at t at a location on the exterior of the spatial region that had been occupied by b at t, then either b’s other parts will be moved in coordinated fashion or b will be damaged (be affected, for example, by breakage or tearing) in the interval between t and t.causal changes in one part of b can have consequences for other parts of b without the mediation of any entity that lies on the exterior of b. Material entities with no proper material parts would satisfy these conditions trivially. Candidate examples of types of causal unity for material entities of more complex sorts are as follows (this is not intended to be an exhaustive list):CU1: Causal unity via physical coveringHere the parts in the interior of the unified entity are combined together causally through a common membrane or other physical covering\. The latter points outwards toward and may serve a protective function in relation to what lies on the exterior of the entity [13, 47
BFO 2 Reference: an object is a maximal causally unified material entity
BFO 2 Reference: ‘objects’ are sometimes referred to as ‘grains’ [74
b is an object means: b is a material entity which manifests causal unity of one or other of the types CUn listed above & is of a type (a material universal) instances of which are maximal relative to this criterion of causal unity. (axiom label in BFO2 Reference: [024-001])
object
b is an object means: b is a material entity which manifests causal unity of one or other of the types CUn listed above & is of a type (a material universal) instances of which are maximal relative to this criterion of causal unity. (axiom label in BFO2 Reference: [024-001])
BFO:0000031
gdc
GenericallyDependentContinuant
The entries in your database are patterns instantiated as quality instances in your hard drive. The database itself is an aggregate of such patterns. When you create the database you create a particular instance of the generically dependent continuant type database. Each entry in the database is an instance of the generically dependent continuant type IAO: information content entity.
the pdf file on your laptop, the pdf file that is a copy thereof on my laptop
the sequence of this protein molecule; the sequence that is a copy thereof in that protein molecule.
A continuant that is dependent on one or other independent continuant bearers. For every instance of A requires some instance of (an independent continuant type) B but which instance of B serves can change from time to time.
b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001])
(iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001]
generically dependent continuant
b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001])
(iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001]
BFO:0000034
function
Function
the function of a hammer to drive in nails
the function of a heart pacemaker to regulate the beating of a heart through electricity
the function of amylase in saliva to break down starch into sugar
BFO 2 Reference: In the past, we have distinguished two varieties of function, artifactual function and biological function. These are not asserted subtypes of BFO:function however, since the same function – for example: to pump, to transport – can exist both in artifacts and in biological entities. The asserted subtypes of function that would be needed in order to yield a separate monoheirarchy are not artifactual function, biological function, etc., but rather transporting function, pumping function, etc.
A function is a disposition that exists in virtue of the bearer’s physical make-up and this physical make-up is something the bearer possesses because it came into being, either through evolution (in the case of natural biological entities) or through intentional design (in the case of artifacts), in order to realize processes of a certain sort. (axiom label in BFO2 Reference: [064-001])
(forall (x) (if (Function x) (Disposition x))) // axiom label in BFO2 CLIF: [064-001]
function
A function is a disposition that exists in virtue of the bearer’s physical make-up and this physical make-up is something the bearer possesses because it came into being, either through evolution (in the case of natural biological entities) or through intentional design (in the case of artifacts), in order to realize processes of a certain sort. (axiom label in BFO2 Reference: [064-001])
(forall (x) (if (Function x) (Disposition x))) // axiom label in BFO2 CLIF: [064-001]
BFO:0000035
p-boundary
ProcessBoundary
the boundary between the 2nd and 3rd year of your life.
p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001])
Every process boundary occupies_temporal_region a zero-dimensional temporal region. (axiom label in BFO2 Reference: [085-002])
(forall (x) (if (ProcessBoundary x) (exists (y) (and (ZeroDimensionalTemporalRegion y) (occupiesTemporalRegion x y))))) // axiom label in BFO2 CLIF: [085-002]
(iff (ProcessBoundary a) (exists (p) (and (Process p) (temporalPartOf a p) (not (exists (b) (properTemporalPartOf b a)))))) // axiom label in BFO2 CLIF: [084-001]
process boundary
p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001])
Every process boundary occupies_temporal_region a zero-dimensional temporal region. (axiom label in BFO2 Reference: [085-002])
(forall (x) (if (ProcessBoundary x) (exists (y) (and (ZeroDimensionalTemporalRegion y) (occupiesTemporalRegion x y))))) // axiom label in BFO2 CLIF: [085-002]
(iff (ProcessBoundary a) (exists (p) (and (Process p) (temporalPartOf a p) (not (exists (b) (properTemporalPartOf b a)))))) // axiom label in BFO2 CLIF: [084-001]
BFO:0000038
1d-t-region
OneDimensionalTemporalRegion
the temporal region during which a process occurs.
BFO 2 Reference: A temporal interval is a special kind of one-dimensional temporal region, namely one that is self-connected (is without gaps or breaks).
A one-dimensional temporal region is a temporal region that is extended. (axiom label in BFO2 Reference: [103-001])
(forall (x) (if (OneDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [103-001]
one-dimensional temporal region
A one-dimensional temporal region is a temporal region that is extended. (axiom label in BFO2 Reference: [103-001])
(forall (x) (if (OneDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [103-001]
BFO:0000040
material
MaterialEntity
a flame
a forest fire
a human being
a hurricane
a photon
a puff of smoke
a sea wave
a tornado
an aggregate of human beings.
an energy wave
an epidemic
the undetached arm of a human being
An independent continuant that is spatially extended whose identity is independent of that of other entities and can be maintained through time.
BFO 2 Reference: Material entities (continuants) can preserve their identity even while gaining and losing material parts. Continuants are contrasted with occurrents, which unfold themselves in successive temporal parts or phases [60
BFO 2 Reference: Object, Fiat Object Part and Object Aggregate are not intended to be exhaustive of Material Entity. Users are invited to propose new subcategories of Material Entity.
BFO 2 Reference: ‘Matter’ is intended to encompass both mass and energy (we will address the ontological treatment of portions of energy in a later version of BFO). A portion of matter is anything that includes elementary particles among its proper or improper parts: quarks and leptons, including electrons, as the smallest particles thus far discovered; baryons (including protons and neutrons) at a higher level of granularity; atoms and molecules at still higher levels, forming the cells, organs, organisms and other material entities studied by biologists, the portions of rock studied by geologists, the fossils studied by paleontologists, and so on.Material entities are three-dimensional entities (entities extended in three spatial dimensions), as contrasted with the processes in which they participate, which are four-dimensional entities (entities extended also along the dimension of time).According to the FMA, material entities may have immaterial entities as parts – including the entities identified below as sites; for example the interior (or ‘lumen’) of your small intestine is a part of your body. BFO 2.0 embodies a decision to follow the FMA here.
A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002])
Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002])
every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002])
(forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002]
(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002]
(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002]
material entity
A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002])
Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002])
every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002])
(forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002]
(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002]
(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002]
BFO:0000140
cf-boundary
ContinuantFiatBoundary
b is a continuant fiat boundary = Def. b is an immaterial entity that is of zero, one or two dimensions and does not include a spatial region as part. (axiom label in BFO2 Reference: [029-001])
BFO 2 Reference: In BFO 1.1 the assumption was made that the external surface of a material entity such as a cell could be treated as if it were a boundary in the mathematical sense. The new document propounds the view that when we talk about external surfaces of material objects in this way then we are talking about something fiat. To be dealt with in a future version: fiat boundaries at different levels of granularity.More generally, the focus in discussion of boundaries in BFO 2.0 is now on fiat boundaries, which means: boundaries for which there is no assumption that they coincide with physical discontinuities. The ontology of boundaries becomes more closely allied with the ontology of regions.
BFO 2 Reference: a continuant fiat boundary is a boundary of some material entity (for example: the plane separating the Northern and Southern hemispheres; the North Pole), or it is a boundary of some immaterial entity (for example of some portion of airspace). Three basic kinds of continuant fiat boundary can be distinguished (together with various combination kinds [29
Continuant fiat boundary doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the mereological sum of two-dimensional continuant fiat boundary and a one dimensional continuant fiat boundary that doesn't overlap it. The situation is analogous to temporal and spatial regions.
Every continuant fiat boundary is located at some spatial region at every time at which it exists
(iff (ContinuantFiatBoundary a) (and (ImmaterialEntity a) (exists (b) (and (or (ZeroDimensionalSpatialRegion b) (OneDimensionalSpatialRegion b) (TwoDimensionalSpatialRegion b)) (forall (t) (locatedInAt a b t)))) (not (exists (c t) (and (SpatialRegion c) (continuantPartOfAt c a t)))))) // axiom label in BFO2 CLIF: [029-001]
continuant fiat boundary
b is a continuant fiat boundary = Def. b is an immaterial entity that is of zero, one or two dimensions and does not include a spatial region as part. (axiom label in BFO2 Reference: [029-001])
Continuant fiat boundary doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the mereological sum of two-dimensional continuant fiat boundary and a one dimensional continuant fiat boundary that doesn't overlap it. The situation is analogous to temporal and spatial regions.
(iff (ContinuantFiatBoundary a) (and (ImmaterialEntity a) (exists (b) (and (or (ZeroDimensionalSpatialRegion b) (OneDimensionalSpatialRegion b) (TwoDimensionalSpatialRegion b)) (forall (t) (locatedInAt a b t)))) (not (exists (c t) (and (SpatialRegion c) (continuantPartOfAt c a t)))))) // axiom label in BFO2 CLIF: [029-001]
BFO:0000141
immaterial
ImmaterialEntity
BFO 2 Reference: Immaterial entities are divided into two subgroups:boundaries and sites, which bound, or are demarcated in relation, to material entities, and which can thus change location, shape and size and as their material hosts move or change shape or size (for example: your nasal passage; the hold of a ship; the boundary of Wales (which moves with the rotation of the Earth) [38, 7, 10
immaterial entity
BFO:0000142
1d-cf-boundary
OneDimensionalContinuantFiatBoundary
The Equator
all geopolitical boundaries
all lines of latitude and longitude
the line separating the outer surface of the mucosa of the lower lip from the outer surface of the skin of the chin.
the median sulcus of your tongue
a one-dimensional continuant fiat boundary is a continuous fiat line whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [032-001])
(iff (OneDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (OneDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [032-001]
one-dimensional continuant fiat boundary
a one-dimensional continuant fiat boundary is a continuous fiat line whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [032-001])
(iff (OneDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (OneDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [032-001]
BFO:0000144
process-profile
ProcessProfile
On a somewhat higher level of complexity are what we shall call rate process profiles, which are the targets of selective abstraction focused not on determinate quality magnitudes plotted over time, but rather on certain ratios between these magnitudes and elapsed times. A speed process profile, for example, is represented by a graph plotting against time the ratio of distance covered per unit of time. Since rates may change, and since such changes, too, may have rates of change, we have to deal here with a hierarchy of process profile universals at successive levels
One important sub-family of rate process profiles is illustrated by the beat or frequency profiles of cyclical processes, illustrated by the 60 beats per minute beating process of John’s heart, or the 120 beats per minute drumming process involved in one of John’s performances in a rock band, and so on. Each such process includes what we shall call a beat process profile instance as part, a subtype of rate process profile in which the salient ratio is not distance covered but rather number of beat cycles per unit of time. Each beat process profile instance instantiates the determinable universal beat process profile. But it also instantiates multiple more specialized universals at lower levels of generality, selected from rate process profilebeat process profileregular beat process profile3 bpm beat process profile4 bpm beat process profileirregular beat process profileincreasing beat process profileand so on.In the case of a regular beat process profile, a rate can be assigned in the simplest possible fashion by dividing the number of cycles by the length of the temporal region occupied by the beating process profile as a whole. Irregular process profiles of this sort, for example as identified in the clinic, or in the readings on an aircraft instrument panel, are often of diagnostic significance.
The simplest type of process profiles are what we shall call ‘quality process profiles’, which are the process profiles which serve as the foci of the sort of selective abstraction that is involved when measurements are made of changes in single qualities, as illustrated, for example, by process profiles of mass, temperature, aortic pressure, and so on.
b is a process_profile =Def. there is some process c such that b process_profile_of c (axiom label in BFO2 Reference: [093-002])
b process_profile_of c holds when b proper_occurrent_part_of c& there is some proper_occurrent_part d of c which has no parts in common with b & is mutually dependent on b& is such that b, c and d occupy the same temporal region (axiom label in BFO2 Reference: [094-005])
(forall (x y) (if (processProfileOf x y) (and (properContinuantPartOf x y) (exists (z t) (and (properOccurrentPartOf z y) (TemporalRegion t) (occupiesSpatioTemporalRegion x t) (occupiesSpatioTemporalRegion y t) (occupiesSpatioTemporalRegion z t) (not (exists (w) (and (occurrentPartOf w x) (occurrentPartOf w z))))))))) // axiom label in BFO2 CLIF: [094-005]
(iff (ProcessProfile a) (exists (b) (and (Process b) (processProfileOf a b)))) // axiom label in BFO2 CLIF: [093-002]
process profile
b is a process_profile =Def. there is some process c such that b process_profile_of c (axiom label in BFO2 Reference: [093-002])
b process_profile_of c holds when b proper_occurrent_part_of c& there is some proper_occurrent_part d of c which has no parts in common with b & is mutually dependent on b& is such that b, c and d occupy the same temporal region (axiom label in BFO2 Reference: [094-005])
(forall (x y) (if (processProfileOf x y) (and (properContinuantPartOf x y) (exists (z t) (and (properOccurrentPartOf z y) (TemporalRegion t) (occupiesSpatioTemporalRegion x t) (occupiesSpatioTemporalRegion y t) (occupiesSpatioTemporalRegion z t) (not (exists (w) (and (occurrentPartOf w x) (occurrentPartOf w z))))))))) // axiom label in BFO2 CLIF: [094-005]
(iff (ProcessProfile a) (exists (b) (and (Process b) (processProfileOf a b)))) // axiom label in BFO2 CLIF: [093-002]
BFO:0000145
r-quality
RelationalQuality
John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married.
a marriage bond, an instance of love, an obligation between one person and another.
b is a relational quality = Def. for some independent continuants c, d and for some time t: b quality_of c at t & b quality_of d at t. (axiom label in BFO2 Reference: [057-001])
(iff (RelationalQuality a) (exists (b c t) (and (IndependentContinuant b) (IndependentContinuant c) (qualityOfAt a b t) (qualityOfAt a c t)))) // axiom label in BFO2 CLIF: [057-001]
relational quality
b is a relational quality = Def. for some independent continuants c, d and for some time t: b quality_of c at t & b quality_of d at t. (axiom label in BFO2 Reference: [057-001])
(iff (RelationalQuality a) (exists (b c t) (and (IndependentContinuant b) (IndependentContinuant c) (qualityOfAt a b t) (qualityOfAt a c t)))) // axiom label in BFO2 CLIF: [057-001]
BFO:0000146
2d-cf-boundary
TwoDimensionalContinuantFiatBoundary
a two-dimensional continuant fiat boundary (surface) is a self-connected fiat surface whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [033-001])
(iff (TwoDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (TwoDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [033-001]
two-dimensional continuant fiat boundary
a two-dimensional continuant fiat boundary (surface) is a self-connected fiat surface whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [033-001])
(iff (TwoDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (TwoDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [033-001]
BFO:0000147
0d-cf-boundary
ZeroDimensionalContinuantFiatBoundary
the geographic North Pole
the point of origin of some spatial coordinate system.
the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet
zero dimension continuant fiat boundaries are not spatial points. Considering the example 'the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet' : There are many frames in which that point is zooming through many points in space. Whereas, no matter what the frame, the quadripoint is always in the same relation to the boundaries of Colorado, Utah, New Mexico, and Arizona.
a zero-dimensional continuant fiat boundary is a fiat point whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [031-001])
(iff (ZeroDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (ZeroDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [031-001]
zero-dimensional continuant fiat boundary
zero dimension continuant fiat boundaries are not spatial points. Considering the example 'the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet' : There are many frames in which that point is zooming through many points in space. Whereas, no matter what the frame, the quadripoint is always in the same relation to the boundaries of Colorado, Utah, New Mexico, and Arizona.
requested by Melanie Courtot
a zero-dimensional continuant fiat boundary is a fiat point whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [031-001])
(iff (ZeroDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (ZeroDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [031-001]
BFO:0000148
0d-t-region
ZeroDimensionalTemporalRegion
a temporal region that is occupied by a process boundary
right now
the moment at which a child is born
the moment at which a finger is detached in an industrial accident
the moment of death.
temporal instant.
A zero-dimensional temporal region is a temporal region that is without extent. (axiom label in BFO2 Reference: [102-001])
(forall (x) (if (ZeroDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [102-001]
zero-dimensional temporal region
A zero-dimensional temporal region is a temporal region that is without extent. (axiom label in BFO2 Reference: [102-001])
(forall (x) (if (ZeroDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [102-001]
BFO:0000182
history
History
A history is a process that is the sum of the totality of processes taking place in the spatiotemporal region occupied by a material entity or site, including processes on the surface of the entity or within the cavities to which it serves as host. (axiom label in BFO2 Reference: [138-001])
history
A history is a process that is the sum of the totality of processes taking place in the spatiotemporal region occupied by a material entity or site, including processes on the surface of the entity or within the cavities to which it serves as host. (axiom label in BFO2 Reference: [138-001])
BTO:0000632
A cell of a usually benign tumor of the insulin-secreting cells of the pancreas.
insulinoma cell
BTO:0000773
Human cell line from tissue infected with Epstein-Barr virus, resembling a lymphoblast.
lymphoblastoid cell line
BTO:0001581
embryonic stem cell line
BTO:0003081
pancreatic ductal adenocarcinoma cell
BTO:0003560
CCE is a mouse embryonic stem cell line derived from 129/Sv mouse strain and has been provided for research use only.
CCE cell
CARO:0001008
gross anatomical part
Anatomical structure that is part of a multicellular organism and is at the gross anatomical level, e.g. above the level of a cell. Included are portions of organism substances such as blood, multi-cell-part structures such as axon tracts, acellular anatomical structures such as hair, and organism subdivisions such as head. Excluded is the whole organism and more granular parts of the organism, such as atoms, molecules, macromolecular complexes and cells.
gross anatomical part
CHEBI:15956
biotin
An organic heterobicyclic compound that consists of 2-oxohexahydro-1H-thieno[3,4-d]imidazole having a valeric acid substituent attached to the tetrahydrothiophene ring. The parent of the class of biotins.
biotin
CHEBI:15986
polynucleotide
A nucleobase-containing molecular entity with a polymeric structure comprised of a linear sequence of 13 or more nucleotide residues.
polynucleotide
CHEBI:16670
peptide
Amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc.
peptide
CHEBI:16991
deoxyribonucleic acid
High molecular weight, linear polymers, composed of nucleotides containing deoxyribose and linked by phosphodiester bonds; DNA contain the genetic information of organisms.
deoxyribonucleic acid
CHEBI:17137
hydrogensulfite
A sulfur oxoanion that has formula HO3S.
hydrogensulfite
CHEBI:18154
polysaccharide
A biomacromolecule consisting of large numbers of monosaccharide residues linked glycosidically. This term is commonly used only for those containing more than ten monosaccharide residues.
polysaccharide
CHEBI:18274
2'-deoxyribonucleoside
2'-deoxyribonucleoside
CHEBI:19255
pyrimidine 2'-deoxyribonucleoside
pyrimidine 2'-deoxyribonucleoside
CHEBI:21731
N-glycosyl compound
A glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to a nitrogen atom, thus creating a C-N bond.
N-glycosyl compound
CHEBI:22728
benzopyrrole
benzopyrrole
CHEBI:23367
molecular entity
Any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity.
molecular entity
CHEBI:23636
deoxyribonucleoside
deoxyribonucleoside
CHEBI:24431
chemical entity
A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances.
chemical entity
CHEBI:24532
organic heterocyclic compound
A cyclic compound having as ring members atoms of carbon and at least of one other element.
organic heterocyclic compound
CHEBI:24651
hydroxides
Hydroxides are chemical compounds containing a hydroxy group or salts containing hydroxide (OH(-)).
hydroxides
CHEBI:24828
indoles
Any compound containing an indole skeleton.
indoles
CHEBI:24870
ion
A molecular entity having a net electric charge.
ion
CHEBI:2511
agarose
agarose
CHEBI:25367
molecule
Any polyatomic entity that is an electrically neutral entity consisting of more than one atom.
molecule
CHEBI:25693
organic heteromonocyclic compound
organic heteromonocyclic compound
CHEBI:25741
oxide
An oxide is a chemical compound of oxygen with other chemical elements.
oxide
CHEBI:25806
oxygen molecular entity
oxygen molecular entity
CHEBI:26440
pyrimidine nucleoside
pyrimidine nucleoside
CHEBI:26835
sulfur molecular entity
sulfur molecular entity
CHEBI:26912
oxolanes
Any oxacycle having an oxolane (tetrahydrofuran) skeleton.
oxolanes
CHEBI:27171
organic heterobicyclic compound
organic heterobicyclic compound
CHEBI:28659
phosphorus atom
A pnictogen that has formula P.
phosphorus atom
CHEBI:33250
atom
A chemical entity constituting the smallest component of an element having the chemical properties of the element.
atom
CHEBI:33256
primary amide
A derivative of an oxoacid RkE(=O)l(OH)m (l =/= 0) in which an acidic hydroxy group has been replaced by an amino or substituted amino group.
primary amide
CHEBI:33261
organosulfur compound
An organosulfur compound is a compound containing at least one carbon-sulfur bond.
organosulfur compound
CHEBI:33273
polyatomic anion
An anion consisting of more than one atom.
polyatomic anion
CHEBI:33285
heteroorganic entity
A heteroorganic entity is an organic molecular entity in which carbon atoms or organic groups are bonded directly to one or more heteroatoms.
heteroorganic entity
CHEBI:33304
chalcogen molecular entity
Any p-block molecular entity containing a chalcogen.
chalcogen molecular entity
CHEBI:33318
main group element atom
An atom belonging to one of the main groups (found in the s- and p- blocks) of the periodic table.
main group element atom
CHEBI:33424
sulfur oxoacid derivative
sulfur oxoacid derivative
CHEBI:33482
sulfur oxoanion
sulfur oxoanion
CHEBI:33551
organosulfonic acid
An organic derivative of sulfonic acid in which the sulfo group is linked directly to carbon.
organosulfonic acid
CHEBI:33575
carboxylic acid
A carbon oxoacid acid carrying at least one -C(=O)OH group and having the structure RC(=O)OH, where R is any any monovalent functional group. Carboxylic acids are the most common type of organic acid.
carboxylic acid
CHEBI:33579
main group molecular entity
A molecular entity containing one or more atoms from any of groups 1, 2, 13, 14, 15, 16, 17, and 18 of the periodic table.
main group molecular entity
CHEBI:33595
cyclic compound
Any molecule that consists of a series of atoms joined together to form a ring.
cyclic compound
CHEBI:33659
organic aromatic compound
organic aromatic compound
CHEBI:33670
heteromonocyclic compound
heteromonocyclic compound
CHEBI:33671
heteropolycyclic compound
heteropolycyclic compound
CHEBI:33672
heterobicyclic compound
A bicyclic compound in which at least one of the rings contains at least one skeletal heteroatom.
heterobicyclic compound
CHEBI:33675
p-block molecular entity
A p-block molecular entity is a molecular entity containing one or more atoms of a p-block element.
p-block molecular entity
CHEBI:33694
biomacromolecule
A macromolecule formed by a living organism.
biomacromolecule
CHEBI:33696
nucleic acid
A macromolecule made up of nucleotide units and hydrolysable into certain pyrimidine or purine bases (usually adenine, cytosine, guanine, thymine, uracil), D-ribose or 2-deoxy-D-ribose and phosphoric acid.
nucleic acid
CHEBI:33697
ribonucleic acid
High molecular weight, linear polymers, composed of nucleotides containing ribose and linked by phosphodiester bonds; RNA is central to the synthesis of proteins.
ribonucleic acid
CHEBI:33832
organic cyclic compound
Any organic molecule that consists of atoms connected in the form of a ring.
organic cyclic compound
CHEBI:33833
heteroarene
A heterocyclic compound formally derived from an arene by replacement of one or more methine (-C=) and/or vinylene (-CH=CH-) groups by trivalent or divalent heteroatoms, respectively, in such a way as to maintain the continuous pi-electron system characteristic of aromatic systems and a number of out-of-plane pi-electrons corresponding to the Hueckel rule (4n+2).
heteroarene
CHEBI:33838
nucleoside
An N-glycosyl compound that has both a nucleobase, normally adenine, guanine, xanthine, thymine, cytosine or uracil, and either a ribose or deoxyribose as functional parents.
nucleoside
CHEBI:35352
organonitrogen compound
Any heteroorganic entity containing at least one carbon-nitrogen bond.
organonitrogen compound
CHEBI:35406
oxoanion
An oxoanion is an anion derived from an oxoacid by loss of hydron(s) bound to oxygen.
oxoanion
CHEBI:35605
carbon oxoacid
carbon oxoacid
CHEBI:36357
polyatomic entity
Any molecular entity consisting of more than one atom.
polyatomic entity
CHEBI:36358
polyatomic ion
An ion consisting of more than one atom.
polyatomic ion
CHEBI:36586
carbonyl compound
Any compound containing the carbonyl group, C=O. The term is commonly used in the restricted sense of aldehydes and ketones, although it actually includes carboxylic acids and derivatives.
carbonyl compound
CHEBI:36962
organochalcogen compound
An organochalcogen compound is a compound containing at least one carbon-chalcogen bond.
organochalcogen compound
CHEBI:36963
organooxygen compound
An organochalcogen compound containing at least one carbon-oxygen bond.
organooxygen compound
CHEBI:37577
heteroatomic molecular entity
A molecular entity consisting of two or more chemical elements.
heteroatomic molecular entity
CHEBI:37622
carboxamide
An amide of a carboxylic acid, having the structure RC(=O)NR2. The term is used as a suffix in systematic name formation to denote the -C(=O)NH2 group including its carbon atom.
carboxamide
CHEBI:37960
cyanine dye
Cyanine dyes are synthetic dyes with the general formula R2N[CH=CH]nCH=N(+)R2 <-> R2N(+)=CH[CH=CH]nNR2 (n is a small number) in which the nitrogen and part of the conjugated chain usually form part of a heterocyclic system, such as imidazole, pyridine, pyrrole, quinoline and thiazole.
cyanine dye
CHEBI:37972
phosphorus-32 atom
The radioactive isotope of phosphorus with relative atomic mass 31.973907 and half-life of 14.26 days.
phosphorus-32 atom
CHEBI:37973
phosphorus-33 atom
The radioactive isotope of phosphorus with relative atomic mass 32.971725, half-life of 25.34 days and nuclear spin (1)/2.
phosphorus-33 atom
CHEBI:37987
Cy3 dye
Cy3 dye
CHEBI:37989
Cy5 dye
Cy5 dye
CHEBI:38101
organonitrogen heterocyclic compound
Any organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms.
organonitrogen heterocyclic compound
CHEBI:38104
oxacycle
Any organic heterocyclic compound containing at least one ring oxygen atom.
oxacycle
CHEBI:38106
organosulfur heterocyclic compound
organosulfur heterocyclic compound
CHEBI:38164
organic heteropentacyclic compound
organic heteropentacyclic compound
CHEBI:38166
organic heteropolycyclic compound
organic heteropolycyclic compound
CHEBI:38295
azabicycloalkane
azabicycloalkane
CHEBI:38297
thiabicycloalkane
thiabicycloalkane
CHEBI:38313
diazines
Any organic heterocyclic compound containing a benzene ring in which two of the C-H fragments have been replaced by isolobal nitrogens (the diazine parent structure).
diazines
CHEBI:4705
double-stranded DNA
double-stranded DNA
CHEBI:472552
5-bromo-2'-deoxyuridine
A pyrimidine 2'-deoxyribonucleoside compound having 5-bromouracil as the nucleobase.
5-bromo-2'-deoxyuridine
CHEBI:50860
organic molecular entity
Any molecular entity that contains carbon.
organic molecular entity
CHEBI:51143
nitrogen molecular entity
nitrogen molecular entity
CHEBI:51570
biotins
Compounds containing a biotin (5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid) skeleton.
biotins
CHEBI:51756
Alexa Fluor 532
An organosulfonic acid that has formula C34H33N3O11S2.
Alexa Fluor 532
CHEBI:51760
Alexa Fluor 546
An organic heteropentacyclic compound that has formula C44H46Cl3N4NaO14S3.
Alexa Fluor 546
CHEBI:5686
heterocyclic compound
A cyclic compound having as ring members atoms of at least two different elements.
heterocyclic compound
CHEBI:61120
nucleobase-containing molecular entity
Any compound that has a nucleobase as a part.
nucleobase-containing molecular entity
CHEBI:68472
pyrimidine deoxyribonucleoside
A deoxyribonucleoside containing a pyrimidine base.
pyrimidine deoxyribonucleoside
CHEBI:72695
organic molecule
Any molecule that consists of at least one carbon atom as part of the electrically neutral entity.
organic molecule
CHEBI:78616
carbohydrates and carbohydrate derivatives
Any organooxygen compound that is a polyhydroxy-aldehyde or -ketone, or a compound derived from one. Carbohydrates contain only carbon, hydrogen and oxygen and usually have an empirical formula Cm(H2O)n; carbohydrate derivatives may contain other elements by substitution or condensation.
carbohydrates and carbohydrate derivatives
CLO:0000001
A cultured cell that is part of a cell line - a stable and homogeneous population of cells with a common biological origin and propagation history in culture
cell line cell
CLO:0000019
A cell line cell that is expected to be capable of an unlimited number of divisions, and is thus able to support indefinite propagation in vitro as part of an immortal cell line.
immortal cell line cell
CLO:0000031
A cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (i.e. has been successively passaged together in culture).
cell line
CLO:0000044
a cell line that is derived from stem cell
immortal stem cell line cell
CLO:0000081
a immortal electrically responsive cell line cell that is derived from neuron
immortal neuron cell line cell
CLO:0000128
a immortal eukaryotic cell line that is derived from animal cell
immortal animal cell line cell
CLO:0000147
a immortal animal cell line that is derived from hematopoietic cell
immortal hematopoietic cell line cell
CLO:0000156
a immortal animal cell line that is derived from neural cell
immortal neural cell line cell
CLO:0000166
a cell line that is derived from somatic cell
immortal somatic cell line cell
CLO:0000503
An immortal embryo-derived cell line cell that derives from mouse.
immortal mouse embryo-derived cell line cell
CLO:0001352
3T3-L1 cell
CLO:0001690
Ainv15 cell
CLO:0001932
BETA-TC-3 cell
CLO:0002405
CGR8 cell
CLO:0002708
Daudi cell
CLO:0003612
H9 cell
CLO:0007043
JURKAT cell
CLO:0007050
K 562 cell
CLO:0008734
Raji cell
CLO:0009218
SW480 cell
CLO:0009828
A cell line that is expected to be capable of indefinite propagation in an vitro culture.
immortal cell line
CL:0000000
A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.
CALOHA:TS-2035
FMA:68646
GO:0005623
KUPO:0000002
VHOG:0001533
WBbt:0004017
XAO:0003012
cell
The definition of cell is intended to represent all cells, and thus a cell is defined as a material entity and not an anatomical structure, which implies that it is part of an organism (or the entirety of one).
cell
CL:0000001
A cultured cell that is freshly isolated from a organismal source, or derives in culture from such a cell prior to the culture being passaged.
BTO:0002290
primary cell culture cell
unpassaged cultured cell
cell
primary cell line cell
Covers cells actively being cultured or stored in a quiescent state for future use.
primary cultured cell
CL:0000003
A cell that is found in a natural setting, which includes multicellular organism cells 'in vivo' (i.e. part of an organism), and unicellular organisms 'in environment' (i.e. part of a natural environment).
CARO:0000013
cell in vivo
cell
To accommodate unicellular organisms better, 'cell in vivo' has been re-labeled 'native cell' to better represent its intended meaning - that is, that it is a cell in the context of a multicellular organism or in a natural environment. 'Native' is intended to contrast with 'in vitro', which refers to cells or other biological entities that have been intentionally placed in a controlled, non-natural setting for the purpose of study or manipulation. (MAH 1.12.12).
native cell
CL:0000010
A cell in vitro that is or has been maintained or propagated as part of a cell culture.
cell
Note that this class was re-labeled to 'cultured cell' instead of 'cell line cell', as it intent was clarified to cover any cultured cells of multicellular and unicellular organisms. This includes cells actively being cultured, or cells that have been cultured but are stored in a quiescent state for future use. In having been cultured, cells must establish homeostasis and often replicate in a foreign environment. Accomodation of this stress initiates a selection of cells fit for such challenges, wherein necessary adaptive biochemical and.or genetic changes can occur. These changes can set them apart from the in vivo cells from which they derive, and such changes will typically accumulate and change over increasing time in culture.
cultured cell
CL:0000021
Female germ cell is a germ cell that supports female gamete production.
MA:0000388
VHOG:0001530
ncithesaurus:Egg
cell
female germ cell
CL:0000023
A female germ cell that has entered meiosis.
BTO:0000964
CALOHA:TS-0711
FBbt:00004886
FMA:18644
WBbt:0006797
cell
oogonium
oocyte
CL:0000034
A relatively undifferentiated cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
CALOHA:TS-2086
FMA:63368
cell
stem cell
CL:0000037
A stem cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system. Hematopoietic stem cells lack cell markers of effector cells (lin-negative). Lin-negative is defined by lacking one or more of the following cell surface markers: CD2, CD3 epsilon, CD4, CD5 ,CD8 alpha chain, CD11b, CD14, CD19, CD20, CD56, ly6G, ter119.
BTO:0000725
CALOHA:TS-0448
FMA:70337
FMA:86475
VHOG:0001485
HSC
blood forming stem cell
hemopoietic stem cell
cell
colony forming unit hematopoietic
Markers differ between species, and two sets of markers have been described for mice. HSCs are reportedly CD34-positive, CD45-positive, CD48-negative, CD150-positive, CD133-positive, and CD244-negative.
hematopoietic stem cell
CL:0000038
A progenitor cell committed to the erythroid lineage.
BTO:0004911
cell
BFU-E
CFU-E
blast forming unit erythroid
burst forming unit erythroid
colony forming unit erythroid
erythroid stem cell
erythroid progenitor cell
CL:0000039
A cell that is within the developmental lineage of gametes and is able to pass along its genetic material to offspring.
cell
Originally this term had some plant germ line cell children.
germ line cell
CL:0000040
A myeloid progenitor cell committed to the monocyte lineage. This cell is CD11b-positive, has basophilic cytoplasm, euchromatin, and the presence of a nucleolus.
CALOHA:TS-1195
FMA:83553
cell
CFU-M
colony forming unit macrophage
colony forming unit monocyte
monocyte stem cell
Morphology: mononuclear cell, diameter 12-20 _M, non-granular, N/C ratio 3/1 - 4/1; markers: CD11b (shared with many other myeloid cells); location: Adult: bone marrow; fetal: liver, Yolk Sac; role or process: hematopoiesis, monocyte development; lineage: hematopoietic, myeloid.
monoblast
CL:0000048
A stem cell that can give rise to multiple lineages of cells.
FMA:84789
multi-fate stem cell
multifate stem cell
multipotent cell
multipotent stem cell
cell
multi fate stem cell
CL:0000049
A progenitor cell committed to myeloid lineage, including the megakaryocyte and erythroid lineages.
BTO:0004730
CMP
common myeloid precursor
cell
CFU-GEMM
CFU-S
colony forming unit granulocyte, erythrocyte, macrophage, and megakaryocyte
multipotential myeloid stem cell
myeloid stem cell
pluripotent stem cell (bone marrow)
This cell type is intended to be compatible with any vertebrate common myeloid progenitor. For mammalian CMP known to be CD34-positive, please use the term 'common myeloid progenitor, CD34-positive' (CL_0001059).
common myeloid progenitor
CL:0000050
A progenitor cell committed to the megakaryocyte and erythroid lineages.
CFU-EM
CFU-MegE
MEP
Meg/E progenitor
colony forming unit erythroid megakaryocyte
megakaryocyte/erythrocyte progenitor
megakaryocyte/erythroid progenitor cell
cell
MEPs are reportedly CD19-negative, CD34-negative, CD45RA-negative, CD110-positive, CD117-positive, and SCA1-negative and reportedly express the transcription factors GATA-1 and NF-E2.
megakaryocyte-erythroid progenitor cell
CL:0000051
A oligopotent progenitor cell committed to the lymphoid lineage.
CL:0000044
CLP
common lymphocyte precursor
common lymphocyte progenitor
common lymphoid precursor
cell
ELP
committed lymphopoietic stem cell
early lymphocyte progenitor
lymphoid stem cell
lymphopoietic stem cell
CLP are CD7-positive, CD10-positive, CD19-negative, CD34-positive, CD45RA-positive, CD79a-negative, CD127-positive, AA4.1-positive, RAG-negative, Sca-1-low, sIgM-negative, sIgD-negative, TdT-negative, Vpre-B-negative, and pre-BCR-negative. Expression of transcription factors include E2A-positive, EBF-positive, Ikaros-negative, PU.1-negative, and Pax5-negative.
common lymphoid progenitor
CL:0000055
A precursor cell with a limited number of potential fates.
BTO:0000125
FMA:84782
blast cell
cell
define using PATO mulit-potent or oligopotent?
non-terminally differentiated cell
CL:0000056
A cell that is commited to differentiating into a muscle cell. Embryonic myoblasts develop from the mesoderm. They undergo proliferation, migrate to their various sites, and then differentiate into the appropriate form of myocytes. Myoblasts also occur as transient populations of cells in muscles undergoing repair.
BTO:0000222
CALOHA:TS-0650
FBbt:00005083
FMA:70335
VHOG:0001529
cell
myoblast
CL:0000057
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.
BTO:0000452
CALOHA:TS-0362
FMA:63877
VHOG:0001482
cell
These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
fibroblast
CL:0000066
A cell that is usually found in a two-dimensional sheet with a free surface. The cell has a cytoskeleton that allows for tight cell to cell contact and for cell polarity where apical part is directed towards the lumen and the basal part to the basal lamina.
BTO:0000414
CALOHA:TS-2026
CARO:0000077
FBbt:00000124
FMA:66768
WBbt:0003672
epitheliocyte
cell
epithelial cell
CL:0000068
cell
duct epithelial cell
CL:0000069
cell
branched duct epithelial cell
CL:0000071
An endothelial cell that lines the vasculature.
cuboidal endothelial cell of vascular tree
cell
blood vessel endothelial cell
CL:0000076
CALOHA:TS-1249
cell
squamous epithelial cell
CL:0000081
A cell found predominately in the blood.
FMA:62844
cell
blood cell
CL:0000083
An epithelial cell of the pancreas.
BTO:0000028
pancreas epithelial cell
pancreatic epithelial cell
cell
epithelial cell of pancreas
CL:0000084
A type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.
CL:0000804
CL:0000812
BTO:0000782
CALOHA:TS-1001
FMA:62870
VHOG:0001479
T lymphocyte
T-cell
T-lymphocyte
cell
immature T cell
mature T cell
T cell
CL:0000094
A leukocyte with abundant granules in the cytoplasm.
BTO:0000539
BTO:0001026
CALOHA:TS-0422
FMA:62854
granular leucocyte
granular leukocyte
polymorphonuclear leukocyte
cell
granulocyte
CL:0000115
An endothelial cell comprises the outermost layer or lining of anatomical structures and can be squamous or cuboidal. In mammals, endothelial cell has vimentin filaments and is derived from the mesoderm.
BTO:0001176
CALOHA:TS-0278
FMA:66772
endotheliocyte
cell
From FMA: 9.07.2001: Endothelial cell has always been classified as a kind of epithelial cell, specifically a squamous cell but that is not true. First, endothelial cell can either be squamous or cuboidal (e.g. high-endothelial cell) and secondly, it has different embryological derivation (mesodermal) than a true epithelial cell (ectodermal and endodermal). The basis for present classification is the fact that it comprises the outermost layer or lining of anatomical structures (location-based) but a better structural basis for the differentia is the cytoskeleton of the cell. Endothelial cell has vimentin filaments while an epithelial cell has keratin filaments. [Onard].
endothelial cell
CL:0000133
Ectoderm destined to be nervous tissue.
neurectoderm cell
cell
neurectodermal cell
CL:0000134
A connective tissue cell that normally gives rise to other cells that are organized as three-dimensional masses. This cell type is CD73-positive, CD90-positive, CD105-positive, CD45-negative, CD34-negative, and MHCII-negative. They may further differentiate into osteoblasts, adipocytes, myocytes, neurons, or chondroblasts in vitro. Originally described as residing in the bone marrow, this cell type is now known to reside in many, if not all, adult organs.
CL:0002452
BTO:0002625
BTO:0003298
FMA:70546
BMSC
bone marrow stromal cells
colony-forming unit-fibroblast
marrow stromal cells
cell
CFU-F
MSC
mesenchymal precursor cell
mesenchymal progenitor cells
mesenchymal stem cell
mesenchymal stromal cell
mesenchymal stromal cells
stem cells, mesenchymal
Many but not all mesenchymal cells derive from the mesoderm. MSCs are reportedly CD3-negative, CD4-negative, CD5-negative, CD8-negative, CD11a-negative, CD11b-negative, CD14-negative, CD19-negative, CD29-positive, CD31-negative, CD34-negative, CD38-negative, CD40-negative, CD44-positive, CD45-negative, CD49-positive, CD54-positive, CD66b-negative, CD79a-negative, CD80-negative, CD102-positive, CD106-positive, CD117-positive, CD121a-positive, CD121b-positive, CD123-positive, CD124-positive, CD133-negative, CD146-positive, CD166-positive, CD271-positive, B220-negative, Gr1-negative, MHCI-positive, MHCII-negative, SSEA4-negative, sca1-positive, Ter119-negative, and glycophorin A-negative. Cultured MSCs are capable of producing stem cell factor, IL7, IL8, IL11, TGF-beta, cofilin, galectin-1, laminin-receptor 1, cyclophilin A, and MMP-2.
mesenchymal stem cell
CL:0000136
A fat-storing cell found mostly in the abdominal cavity and subcutaneous tissue of mammals. Fat is usually stored in the form of triglycerides.
CL:0000450
BTO:0000443
CALOHA:TS-0012
FMA:63880
adipocyte
adipose cell
cell
fat cell
CL:0000147
A pigment cell is a cell that contains pigment granules.
VHOG:0001678
chromatocyte
chromatophore
cell
pigment cell
CL:0000148
A pigment cell derived from the neural crest. Contains melanin-filled pigment granules, which gives a brown to black appearance.
CL:0000572
BTO:0000847
CALOHA:TS-0613
FMA:70545
VHOG:0001679
melanophore
cell
melanocyte
CL:0000150
A specialized epithelial cell that is capable of synthesizing and secreting certain biomolecules.
CALOHA:TS-2085
FMA:86494
cell
glandular epithelial cell
CL:0000151
A cell that specializes in controlled release of one or more substances.
BTO:0003659
FMA:86916
cell
secretory cell
CL:0000152
A cell of an exocrine gland; i.e. a gland that discharges its secretion via a duct.
FMA:16014
cell
exocrine cell
CL:0000154
cell
protein secreting cell
CL:0000163
A cell of an endocrine gland, ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions.
FMA:83809
endocrinocyte
cell
endocrine cell
CL:0000164
An endocrine cell that is located in the epithelium of the gastrointestinal tract or in the pancreas.
BTO:0003865
FMA:62930
cell
enteroendocrine cell
CL:0000167
cell
peptide hormone secreting cell
CL:0000168
BTO:0000783
cell
insulin secreting cell
CL:0000169
A cell that secretes insulin and is located towards the center of the islets of Langerhans.
beta cell
BTO:0000783
EV:0200009
FMA:70586
MA:0002419
ncithesaurus:Beta_Cell
B-cell of pancreatic islet
beta cell of pancreatic islet
insulin-secreting cell
pancreatic B cell
pancreatic B-cell
pancreatic beta cell
pancreatic islet core
type B enteroendocrine cell
cell
beta cell islet
Pancreatic beta cells are also reportedly CD284-positive. Upon activation, they upregulate their CD14 expression.
type B pancreatic cell
CL:0000170
A cell that secretes glucagon.
FMA:84045
glucagon-secreting cell
cell
glucagon secreting cell
CL:0000171
A type of enteocrine cell found in the periphery of the islets of Langerhans that secretes glucagon.
BTO:0000990
FMA:70585
alpha cell of iselt of Langerhans
pancreatic alpha cell
cell
pancreatic A cell
CL:0000172
cell
somatostatin secreting cell
CL:0000173
A D cell located in the pancreas. Peripherally placed within the islets like type A cells; contains somatostatin.
BTO:0000803
FMA:70587
D-cell of pancreatic islet
delta cell of islet
delta cell of pancreatic islet
pancreatic D-cell
pancreatic delta cell
somatostatin-secreting pancreatic cell
cell
pancreatic D cell
CL:0000181
A cell whose primary function is intermediary metabolism.
cell
metabolising cell
CL:0000182
The main structural component of the liver. They are specialized epithelial cells that are organized into interconnected plates called lobules. Majority of cell population of liver, polygonal in shape, arranged in plates or trabeculae between sinusoids; may have single nucleus or binucleated.
BTO:0000575
CALOHA:TS-0454
FMA:14515
cell
Hepatocytes are reportedly MHC Class I-positive and MHC Class II-positive.
hepatocyte
CL:0000183
A cell whose primary function is to shorten.
cell
contractile cell
CL:0000187
A mature contractile cell, commonly known as a myocyte. This cell has as part of its cytoplasm myofibrils organized in various patterns.
BTO:0000888
BTO:0000902
CALOHA:TS-2032
FBbt:00005074
FMA:67328
WBbt:0003675
muscle fiber
myocyte
cell
muscle cell
CL:0000211
A cell whose function is determined by the generation or the reception of an electric signal.
cell
electrically active cell
CL:0000213
A cell within an epithelial cell sheet whose main function is to act as an internal or external covering for a tissue or an organism.
boundary cell
cell
lining cell
CL:0000215
A cell whose primary function is to prevent the transport of stuff across compartments.
cell
barrier cell
CL:0000219
A cell that moves by its own activities.
cell
motile cell
CL:0000221
A cell of the outer of the three germ layers of the embryo.
FMA:72549
ectoderm cell
cell
ectodermal cell
CL:0000222
A cell of the middle germ layer of the embryo.
FMA:72554
mesoblast
mesoderm cell
cell
mesodermal cell
CL:0000223
A cell of the inner of the three germ layers of the embryo.
FMA:72555
endoderm cell
cell
endodermal cell
CL:0000225
A cell that lacks a nucleus.
FMA:68647
non-nucleated cell
cell
anucleate cell
CL:0000226
A cell with a single nucleus.
cell
single nucleate cell
CL:0000232
A red blood cell. In mammals, mature erythrocytes are biconcave disks containing hemoglobin whose function is to transport oxygen.
BTO:0000424
CALOHA:TS-0290
FMA:81100
RBC
red blood cell
cell
erythrocyte
CL:0000233
A non-nucleated disk-shaped cell formed by extrusion from megakaryocytes, found in the blood of all mammals, and mainly involved in blood coagulation.
BTO:0000132
CALOHA:TS-0803
FMA:62851
anucleate thrombocyte
blood platelet
enucleate thrombocyte
cell
Platelets are reportedly CCR1-positive, CCR2-negative, CCR3-positive, CCR4-positive, CCR5-negative, CCR6-negative, CCR7-negative, CCR8-negative, CCR9-negative, CCR10-negative, CD16-positive, CD23-positive, CD32-positive, CD40-positive, CD41-positive CD42-positive, CD61-positive, CD62P-positive, CD64-positive, CD89-positive, CD102-positive, CD147-positive (activated platelets), CD154-positive (activated platelets), CD162-positive, CD209, CD282-positive, CD284-positive, CD289-positive, CD181-negative, CD182-negative, CD183-negative, CD184-positive, CLEC2-positive, GPVI-positive, JAMC-positive, PAR1-positive, PAR2-negative, PAR3-positive, PAR4-positive, TSP1-positive, and TXA2R-positive. Platelets can reportedly produce CCL2, CCL3, CCL5, CCL7, CCL17, CD40L, CXCL1, CXCL4, CXCL4L1, CXCL5, CXCL7, CXCL8, CXCL12, EGF, factor V, factor VII, factor XI, factor XIII, bFGF, histamine, IGF-1, IL-1beta, PAI-1, PDGF, plasminogen, protein S, serotonin, TGF-beta, TFPI, VEGF, and vWF.
platelet
CL:0000236
A lymphocyte of B lineage with the phenotype CD19-positive, CD20-positive, and capable of B cell mediated immunity.
BTO:0000776
CALOHA:TS-0068
FMA:62869
VHOG:0001480
B lymphocyte
B-cell
B-lymphocyte
cell
B cell
CL:0000255
cell
eukaryotic cell
CL:0000325
A cell that is specialised to accumulate a particular substance(s).
cell
stuff accumulating cell
CL:0000329
cell
oxygen accumulating cell
CL:0000333
A cell derived from the specialized ectoderm flanking each side of the embryonic neural plate, which after the closure of the neural tube, forms masses of cells that migrate out from the dorsal aspect of the neural tube to spread throughout the body.
FMA:86667
cell
migratory neural crest cell
CL:0000393
A cell whose function is determined by its response to an electric signal.
cell
electrically responsive cell
CL:0000412
A cell whose nucleus, or nuclei, each contain more than two haploid genomes.
cell
polyploid cell
CL:0000417
cell
endopolyploid cell
CL:0000448
Fat cells with light coloration and few mitochondria. They contain a scant ring of cytoplasm surrounding a single large lipid droplet or vacuole.
CALOHA:TS-1119
FMA:83434
white adipose cell
white fat cell
cell
white adipocyte
white fat cell
CL:0000451
A cell of hematopoietic origin, typically resident in particular tissues, specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. These cells are lineage negative (CD3-negative, CD19-negative, CD34-negative, and CD56-negative).
BTO:0002042
CALOHA:TS-0194
FMA:83036
cell
interdigitating cell
veiled cell
dendritic cell
CL:0000457
cell
biogenic amine secreting cell
CL:0000458
A cell type that secretes 5-Hydroxytryptamine (serotonin).
5-HT secreting cell
5-Hydroxytryptamine secreting cell
cell
serotonin secreting cell
CL:0000502
A cell found throughout the gastrointestinal tract and in the pancreas. They secrete somatostatin in both an endocrine and paracrine manner. Somatostatin inhibits gastrin, cholecystokinin, insulin, glucagon, pancreatic enzymes, and gastric hydrochloric acid. A variety of substances which inhibit gastric acid secretion (vasoactive intestinal peptide, calcitonin gene-related peptide, cholecystokinin, beta-adrenergic agonists, and gastric inhibitory peptide) are thought to act by releasing somatostatin.
FMA:62935
D cell
cell
type D enteroendocrine cell
CL:0000513
A precursor cell destined to differentiate into cardiac muscle cell.
CL:0000714
FMA:84797
cell
cardiac muscle myoblast
CL:0000541
A cell that originates from the neural crest and differentiates into a pigment cell.
BTO:0003217
FMA:83377
cell
Derived from UBERON:0002342 neural crest.
melanoblast
CL:0000542
A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.
BTO:0000775
CALOHA:TS-0583
FMA:62863
VHOG:0001535
cell
Editors note: consider adding taxon constraint to vertebrata (PMID:18025161)
lymphocyte
CL:0000547
An immature, nucleated erythrocyte occupying the stage of erythropoeisis that follows formation of erythroid progenitor cells. This cell is CD71-positive, has both a nucleus and a nucleolus, and lacks hematopoeitic lineage markers.
FMA:83518
rubriblast
cell
pronormoblast
proerythroblast
CL:0000548
cell
animal cell
CL:0000549
A nucleated immature erythrocyte, having cytoplasm generally similar to that of the earlier proerythroblast but sometimes even more basophilic, and usually regular in outline. The nucleus is still relatively large, but the chromatin strands are thicker and more deeply staining, giving a coarser appearance; the nucleoli have disappeared. This cell is CD71-positive and lacks hematopoeitic lineage markers.
FMA:83505
basophilic normoblast
early erythroblast
early normoblast
prorubricyte
cell
basophilic erythroblast
CL:0000550
A nucleated, immature erythrocyte in which the nucleus occupies a relatively smaller part of the cell than in its precursor, the basophilic erythroblast. The cytoplasm is beginning to acquire hemoglobin and thus is no longer a purely basophilic, but takes on acidophilic aspects, which becomes progressively more marked as the cell matures. The chromatin of the nucleus is arranged in coarse, deeply staining clumps. This cell is CD71-positive and lacks hematopoeitic lineage markers.
FMA:83506
intermediate erythroblast
intermediate normoblast
polychromatic erythroblast
polychromatic normoblast
polychromatophilic normoblast
rubricyte
cell
polychromatophilic erythroblast
CL:0000552
The final stage of the nucleated, immature erythrocyte, before nuclear loss. Typically the cytoplasm is described as acidophilic, but it still shows a faint polychromatic tint. The nucleus is small and initially may still have coarse, clumped chromatin, as in its precursor, the polychromatophilic erythroblast, but ultimately it becomes pyknotic, and appears as a deeply staining, blue-black, homogeneous structureless mass. The nucleus is often eccentric and sometimes lobulated.
FMA:84646
acidophilic erythroblast
eosinophilic erythroblast
late erythoblast
orthochromatic normoblast
pyknotic eto enrythroblast
cell
orthochromatic erythroblast
CL:0000553
The earliest cytologically identifiable precursor in the thrombocytic series. This cell is capable of endomitosis and lacks expression of hematopoieitic lineage markers (lin-negative).
BTO:0001164
CALOHA:TS-0610
FMA:84235
CFU-Meg
Meg-CFC
MkP
colony-forming unit-megakaryocyte
megacaryoblast
megacaryocyte progenitor cell
megakaryoblast
megakaryocytic progenitor cell
cell
promegacaryocyte
promegakaryocyte
Lineage negative is described here as CD2-negative, CD3-negative, CD4-negative, CD5-negative, CD8a-negative, CD14-negative, CD19-negative, CD20-negative, CD56-negative, Ly6g-negative, and Ter119-negative.
megakaryocyte progenitor cell
CL:0000556
A giant cell 50 to 100 micron in diameter, with a greatly lobulated nucleus, found in the bone marrow; mature blood platelets are released from its cytoplasm.
BTO:0000843
CALOHA:TS-0611
FMA:83555
megacaryocyte
megalocaryocyte
megalokaryocyte
cell
Megakaryocytes are reportedly CD181-positive and CD182-positive.
megakaryocyte
CL:0000557
A hematopoietic progenitor cell that is committed to the granulocyte and monocyte lineages. These cells are CD123-positive, and do not express Gata1 or Gata2 but do express C/EBPa, and Pu.1.
CFU-C , Colony forming unit in culture
CFU-GM
GMP
colony forming unit granulocyte macrophage
granulocyte-macrophage progenitor
granulocyte/monocyte precursor
granulocyte/monocyte progenitor
cell
Originally described in the dendritic cell ontology (DC_CL:0000042)(PMID:19243617). GMPs are reportedly CD16-positive, CD32-positive, CD34-positive, CD38-positive, CD45RA-positive, CD110-negative, CD117-positive, CD123-positive, and SCA1-negative.
granulocyte monocyte progenitor cell
CL:0000558
An immature erythrocyte that changes the protein composition of its plasma membrane by exosome formation and extrusion. The types of protein removed differ between species though removal of the transferrin receptor is apparent in mammals and birds.
BTO:0001173
CALOHA:TS-0864
cell
reticulocyte
CL:0000559
A precursor in the monocytic series, being a cell intermediate in development between the monoblast and monocyte. This cell is CD11b-positive and has fine azurophil granules.
BTO:0004657
FMA:83551
cell
Morphology: Mononuclear cell, diameter 14-18 _M, fine azurophilic granules; markers: CD11b (shared with many other myeloid cells); location: Adult: bone marrow; Fetal: Liver, Yolk Sac; role or process: hematopoiesis, monocyte development; lineage: hematopoietic, myeloid.
promonocyte
CL:0000566
A mesenchymal stem cell capable of developing into blood vessel endothelium.
angioblast
chondroplast
cell
These cells are reportedly CD31-positive, CD34-positive, CD144-positive, CD309-positive, and TAL1-positive.
angioblastic mesenchymal cell
CL:0000576
Myeloid mononuclear recirculating leukocyte that can act as a precursor of tissue macrophages, osteoclasts and some populations of tissue dendritic cells.
BTO:0000876
CALOHA:TS-0638
FMA:62864
cell
Morphology: Mononuclear cell, diameter, 14 to 20 _M, N/C ratio 2:1-1:1. Nucleus may appear in variety of shapes: round, kidney, lobulated, or convoluted. Fine azurophilic granules present; markers: CD11b (shared with other myeloid cells), human: CD14, mouse: F4/80-mid,GR1-low; location: Blood, but can be recruited into tissues; role or process: immune & tissue remodelling; lineage: hematopoietic, myeloid.
monocyte
CL:0000578
A cell in vitro that has undergone physical changes as a consequence of a deliberate and specific experimental procedure.
cell
This class has been re-labeled to imply reference only to in vitro experimentally modified cells, similarly, the definition has been slightly updated to reflect this. 'experimentally modified cell' refers only to cells in vitro, and not modified in vivo/in environment cells. There is currently no class representing unmodified in vitro cells (other than the parent 'cell in vitro'), or a class representing modified native cells. More granular subclassing of experimentally modified cell can be found in ReO. MHB 1.12.12
experimentally modified cell in vitro
CL:0000586
The reproductive cell in multicellular organisms.
BTO:0000535
VHOG:0001534
WBbt:0006796
cell
germ cell
CL:0000622
A secretory cell that is grouped together with other cells of the same type to form grape shaped clusters known as acini (singular acinus).
FMA:83625
acinic cell
acinous cell
cell
acinar cell
CL:0000623
A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.
large granular lymphocyte
null cell
BTO:0000914
BTO:0004716
CALOHA:TS-0664
FMA:63147
FMA:83601
VHOG:0001697
NK cell
cell
natural killer cell
CL:0000680
cell
muscle precursor cell
CL:0000696
A cell that stores and secretes pancreatic polypeptide hormone.
FMA:62938
FMA:83409
type F enteroendocrine cell
cell
PP cell
CL:0000723
A stem cell that can give rise to cell types of the body other than those of the germ-line.
CALOHA:TS-2086
FMA:63368
cell
somatic stem cell
CL:0000737
Muscle cell which has as its direct parts myofilaments organized into sarcomeres.
BTO:0002916
CALOHA:TS-2157
FMA:86936
cell
striated muscle cell
CL:0000738
An achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.
BTO:0000751
CALOHA:TS-0549
FMA:62852
immune cell
leucocyte
white blood cell
cell
leukocyte
CL:0000746
Cardiac muscle cells are striated muscle cells that are responsible for heart contraction. In mammals, the contractile fiber resembles those of skeletal muscle but are only one third as large in diameter, are richer in sarcoplasm, and contain centrally located instead of peripheral nuclei.
FMA:83808
cardiocyte
BTO:0001539
CALOHA:TS-0115
FMA:14067
cardiac muscle fiber
cardiac myocyte
cardiomyocyte
heart muscle cell
cell
This class encompasses the muscle cells responsible for heart* contraction in both vertebrates and arthropods. The ultrastucture of a wide range of arthropod heart cells has been examined including spiders, horseshoe crabs, crustaceans (see Sherman, 1973 and refs therein) and insects (see Lehmacher et al (2012) and refs therein). According to these refs, the cells participating in heart contraction in all cases are transversely striated. Insects hearts additionally contain ostial cells, also transversely striated muscle cells, but which do not participate in heart contraction.
cardiac muscle cell
CL:0000763
A cell of the monocyte, granulocyte, mast cell, megakaryocyte, or erythroid lineage.
BTO:0001441
CALOHA:TS-0647
cell
myeloid cell
CL:0000764
A immature or mature cell in the lineage leading to and including erythrocytes.
CL:0002156
CALOHA:TS-0290
FMA:62845
FMA:83516
erythropoietic cell
cell
Note that in FMA erythropoietic cells are types of nucleated erythrocytes and thus don't include erythrocytes.
erythroid lineage cell
CL:0000765
A nucleated precursor of an erythrocyte that lacks hematopoietic lineage markers.
BTO:0001571
CALOHA:TS-0289
FMA:83504
normoblast
cell
erythroblast
CL:0000766
A cell of the monocyte, granulocyte, or mast cell lineage.
cell
myeloid leukocyte
CL:0000767
Any of the immature or mature forms of a granular leukocyte that in its mature form has an irregularly shaped, pale-staining nucleus that is partially constricted into two lobes, and with cytoplasm that contains coarse, bluish-black granules of variable size. Basophils contain vasoactive amines such as histamine and serotonin, which are released on appropriate stimulation. A basophil is CD123-positive, CD193-positive, CD203c-positive, and FceRIa-positive.
polymorphonuclear leucocyte
polymorphonuclear leukocyte
BTO:0000129
CALOHA:TS-0073
FMA:62862
basophilic leucocyte
basophilic leukocyte
cell
Matures in the bone marrow and account for <1% of leukocytes in the peripheral blood, spleen, and bone marrow. Basophils are described as being CD11a-positive, CD11b-positive, CD13-positive, CD15-positive, CD18-positive, CD21-positive, CD25-positive, CD29-positive, CD35-positive, CD40-positive, CD40L-positive, CD44-positive, CD45R-negative, CD46-positive, CD49a-positive, CD49b-positive, CD49d-positive, CD55-positive, CD59-positive, CD62L-positive, CD63-positive, CD69-positive, CD90-negative, CD116-positive, CD117-negative, CD124-positive, CD125-positive, CD131-positive, CD161-positive, CD184-positive, CD191-positive, CD192-positive, CD197-positive, CD200R3-positive, CD218-positive, CD282-positive, CD284-positive, CD289-positive, CD290-positive, CD294-positive, natural killer cell receptor 2B4-positive, smad1-positive, CD3-negative, CD4-negative, CD7-negative, CD8-negative, CD14-negative, CD15-negative, CD16-negative, CD19-negative, CD20-negative, CD34-negative, CD36-negative, CD45R-negative, CD56-negative, CD57-negative, CD235a-negative, and GR1-negative. Transcription factors- GATA1-positive, PU.1-positive.
basophil
CL:0000771
Any of the immature or mature forms of a granular leukocyte with a nucleus that usually has two lobes connected by one or more slender threads of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and which can be stained by the dye eosin. Eosinophils are CD9-positive, CD191-positive, and CD193-positive.
polymorphonuclear leucocyte
polymorphonuclear leukocyte
BTO:0000399
CALOHA:TS-0279
FMA:62861
eosinocyte
eosinophilic granulocyte
eosinophilic leucocyte
eosinophilic leukocyte
cell
Eosinophils are also CD14-negative, CD32-positive, CD44-positive, CD48-positive, CD69-positive, CD192-negative, MBP1-positive, MBP2-positive, TLR2-negative, TLR4-negative, and lineage-negative (B220, CD2, CD14, CD19, CD56, CD71, CD117, CD123, CD235a (glycophorin A), and TER119). The cytokines IL-3, IL-5, and GM-CSF are involved in their development and differentiation. Usually considered CD16-negative, CD16 is observed on eosinophilic metamyelocyte.
eosinophil
CL:0000775
Any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.
PMN
poly
polymorphonuclear leucocyte
polymorphonuclear leukocyte
polymorphonuclear neutrophil
polynuclear neutrophilic leucocyte
polynuclear neutrophilic leukocyte
BTO:0000130
CALOHA:TS-0688
FMA:62860
neutrocyte
neutrophil leucocyte
neutrophil leukocyte
neutrophilic leucocyte
neutrophilic leukocyte
cell
neutrophil
CL:0000825
A lymphoid progenitor cell that is committed to the natural killer cell lineage, expressing CD122 (IL-15) receptor, but lacking many of the phenotypic characteristics of later stages of natural killer cell development such as expression of NK activating and inhibitory molecules. In human this cell has the phenotype CD34-positive, CD45RA-positive, CD10-positive, CD117-negative, and CD161 negative.
NKP
natural killer cell progenitor
pro-natural killer cell
cell
null cell
preNK cell
Most markers only described for human pro NK cells.
pro-NK cell
CL:0000826
A progenitor cell of the B cell lineage, with some lineage specific activity such as early stages of recombination of B cell receptor genes, but not yet fully committed to the B cell lineage until the expression of PAX5 occurs.
pre-pro B cell
BTO:0003104
pro-B lymphocyte
pro-B-cell
pro-B-lymphocyte
progenitor B cell
progenitor B lymphocyte
progenitor B-cell
progenitor B-lymphocyte
cell
pre-B cell (Philadelphia nomenclature)
Human pro-B cells are reportedly CD10-positive, CD22-positive, CD34-positive, CD38-positive, CD45-low, CD48-positive, CD79a-positive, CD127-positive, CD184-positive, RAG-positive, TdT-positive, Vpre-B-positive, pre-BCR-negative, IgD-negative, and IgM-negative. Transcription factors expressed: Pax5-positive, EBF-positive, E2A-negative, Ikaros-negative, and PU.1-negative.
pro-B cell
CL:0000827
A lymphoid progenitor cell of the T cell lineage, with some lineage specific marker expression, but not yet fully committed to the T cell lineage.
pro-T lymphocyte
progenitor T cell
DN1 cell
DN1 thymocyte
TN1 cell
cell
pro-T cell
CL:0000835
The most primitive precursor in the granulocytic series, having fine, evenly distributed chromatin, several nucleoli, a high nuclear-to-cytoplasmic ration (5:1-7:1), and a nongranular basophilic cytoplasm. They reside in the bone marrow.
BTO:0000187
FMA:83524
cell
myeloblast
CL:0000836
A precursor in the granulocytic series, being a cell intermediate in development between a myeloblast and myelocyte, that has distinct nucleoli, a nuclear-to-cytoplasmic ratio of 5:1 to 3:1, and containing a few primary cytoplasmic granules. Markers for this cell are fucosyltransferase FUT4-positive, CD33-positive, integrin alpha-M-negative, low affinity immunoglobulin gamma Fc region receptor III-negative, and CD24-negative.
CALOHA:TS-0825
FMA:83530
cell
promyelocyte
CL:0000837
A hematopoietic multipotent progenitor cell is multipotent, but not capable of long-term self-renewal. These cells are characterized as lacking lineage cell surface markers and being CD34-positive in both mice and humans.
BTO:0000725
CALOHA:TS-0448
MPP
hemopoietic progenitor cell
cell
Markers differ between mouse and human.
hematopoietic multipotent progenitor cell
CL:0000838
A progenitor cell restricted to the lymphoid lineage.
lymphoid progenitor cell
BTO:0004731
CALOHA:TS-2025
FMA:70338
cell
Note that this is a class of cell types, not an identified single cell type.
lymphoid lineage restricted progenitor cell
CL:0000839
A progenitor cell restricted to the myeloid lineage.
myeloid progenitor cell
BTO:0004730
CALOHA:TS-2099
FMA:70339
cell
Note that this is a class of cell types, not an identified single cell type.
myeloid lineage restricted progenitor cell
CL:0000842
A leukocyte with a single non-segmented nucleus in the mature form.
BTO:0000878
CALOHA:TS-0768
FMA:86713
peripheral blood mononuclear cell
cell
mononuclear cell
CL:0000945
A lymphocyte of B lineage is a lymphocyte that expresses CD19 on the cell surface. An additional defining characteristic is the commitment to express an immunoglobulin complex.
cell
Types of B lineage lymphocytes include B cells and antibody secreting cells (plasmablasts and plasma cells). Lymphocytes of B cell lineage can be distinguished from those of T cell lineage by their lack of CD3e (as part of the T cell receptor complex).
lymphocyte of B lineage
CL:0000988
A cell of a hematopoietic lineage.
BTO:0000574
CALOHA:TS-2017
FMA:70366
FMA:83598
haematopoietic cell
haemopoietic cell
hemopoietic cell
cell
hematopoietic cell
CL:0000995
CD71-positive common myeloid precursor OR CD7-negative lymphoid precursor OR CD7-positive lymphoid
cell
Originally described in the dendritic cell ontology (DC_CL:1100000)(PMID:19243617).
CD34-positive, CD38-positive common myeloid progenitor OR CD34-positive, CD38-positive common lymphoid progenitor
CL:0001012
cell
Originally described in the dendritic cell ontology (DC_CL:1110000)(PMID:19243617).
CD7-negative lymphoid progenitor OR granulocyte monocyte progenitor
CL:0001021
A common lymphoid progenitor that is CD10-positive, CD45RA-positive, CD34-positive and CD38-positive.
CD10-positive common lymphocyte precursor
CD10-positive common lymphocyte progenitor
CD10-positive common lymphoid precursor
cell
These markers are associated with human common lymphoid progenitors. Originally described in the dendritic cell ontology (DC_CL:0000032)(PMID:19243617).
CD34-positive, CD38-positive common lymphoid progenitor
CL:0001024
CD133-positive hematopoietic stem cell is a hematopoietic stem cell that is CD34-positive, CD90-positive, and CD133-positive.
CALOHA:TS-0448
FMA:86475
CD133-positive hematopoietic stem cell
cell
Cell markers are associated with human hematopoietic stem cells. Originally described in the dendritic cell ontology (DC_CL:0000035)(PMID:19243617).
CD34-positive, CD38-negative hematopoietic stem cell
CL:0001026
A common myeloid progenitor that is CD34-positive, CD38-positive, IL3ra-low, CD10-negative, CD7-negative, CD45RA-negative, and IL-5Ralpha-negative.
CD71-positive common myeloid precursor
cell
Markers are associated with human cell type. Originally described in the dendritic cell ontology (DC_CL:0000038)(PMID:19243617).
CD34-positive, CD38-positive common myeloid progenitor
CL:0001027
CD7-negative lymphoid progenitor cell is a lymphoid progenitor cell that is CD34-positive, CD7-negative and CD45RA-negative.
CD7-negative lymphoid precursor
cell
These markers are associated with human cells. Originally described in the dendritic cell ontology (DC_CL:0000039)(PMID:19243617).
CD7-negative lymphoid progenitor cell
CL:0001034
A cell that is maintained or propagated in a controlled artificial environment for use in an investigation.
haendel
2012-01-12T09:58:38Z
cell
'In vitro', translating literally to 'in glass', typically refers to a controlled, often sterile, laboratory setting where cells or other specimens are placed by some agent for the purpose of studying or manipulating them as part of some research investigation. 'In vitro' is intended to contrast with 'native',which refers to cells or other biological entities that are found in a natural setting. It describes unicellular organisms removed from a natural environement and multicellular organism cells removed from an organism, or cells derived in culture from such displaced cells.
cell in vitro
CL:0001035
A connective tissue cell found in bone.
adiehl
2011-11-16T04:28:16Z
cell
bone cell
CL:0001059
A progenitor cell committed to myeloid lineage, including the megakaryocyte and erythroid lineages. These cells are CD34-positive, and express Gata1, Gata2, C/EBPa, and Pu.1.
CMP
common myeloid precursor, CD34-positive
cell
CFU-GEMM
CFU-S
colony forming unit granulocyte, erythrocyte, macrophage, and megakaryocyte
multipotential myeloid stem cell
myeloid stem cell
pluripotent stem cell (bone marrow)
CMP are reportedly CD16-positive, CD32-positive, CD38-positive, CD45RA-negative, CD110-negative, CD117-positive, CD123-positive, and SCA1-negative.
common myeloid progenitor, CD34-positive
CL:0001060
A hematopoietic oligopotent progenitor cell that has the ability to differentiate into limited cell types but lacks lineage cell markers and self renewal capabilities. Cell lacks hematopoeitic lineage markers.
tmeehan
2010-01-06T03:43:27Z
cell
hematopoietic oligopotent progenitor cell, lineage-negative
CL:0002009
A progenitor cell that can give rise to plasmacytoid and myeloid dendritic cells, and to monocytes and macrophages.
tmeehan
2010-01-19T02:51:58Z
MDP
cell
macrophage dendritic cell progenitor
CL:0002031
A hematopoietic progenitor cell that is capable of developing into only one lineage of hematopoietic cells.
tmeehan
2010-01-06T03:43:20Z
cell
hematopoietic lineage restricted progenitor cell
CL:0002032
A hematopoietic oligopotent progenitor cell that has the ability to differentiate into limited cell types but lacks lineage cell markers and self renewal capabilities. Cell lacks hematopoeitic lineage markers.
tmeehan
2010-01-06T03:43:27Z
cell
This cell type is intended to be compatible with any vertebrate hematopoietic oligopotent progenitor cell. For mammalian hematopoietic oligopotent progenitor cells known to be lineage-negative, please use the term 'hematopoietic oligopotent progenitor cell' (CL_0001060).
hematopoietic oligopotent progenitor cell
CL:0002043
A hematopoietic multipotent progenitor cell that is CD34-positive, CD38-negative, CD45RA-negative, and CD90-negative.
tmeehan
2010-01-12T11:14:15Z
cell
Cell markers are associated with human hematopoietic multipotent progenitor cells.
CD34-positive, CD38-negative multipotent progenitor cell
CL:0002064
A secretory cell found in pancreatic acini that secretes digestive enzymes and mucins. This cell is a typical zymogenic cell, have a basal nucleus and basophilic cytoplasm consisting of regular arrays of granular endoplasmic reticulum with mitochondria and dense secretory granules.
tmeehan
2010-06-24T03:16:29Z
BTO:0000028
CALOHA:TS-0737
FMA:63032
acinar cell of pancreas
cell
pancreatic acinar cell
CL:0002067
An enterocrine cell that produces glucagon.
tmeehan
2010-09-10T10:48:54Z
FMA:62939
cell
type A enterocrine cell
CL:0002076
An epithelial cell derived from endoderm.
tmeehan
2010-06-29T03:38:14Z
FMA:69075
cell
endo-epithelial cell
CL:0002078
Epithelial cell derived from mesoderm or mesenchyme.
tmeehan
2010-06-29T03:49:14Z
FMA:69076
epithelial mesenchymal cell
cell
meso-epithelial cell
CL:0002079
Epithelial cell found in the ducts of the pancreas. This cell type contributes to the high luminal pH.
tmeehan
2010-06-30T08:49:43Z
FMA:63099
cell
pancreatic ductal cell
CL:0002087
A leukocyte that lacks granules.
tmeehan
2010-07-22T11:30:33Z
FMA:62855
agranular leukocyte
cell
nongranular leukocyte
CL:0002092
A cell found in the bone marrow. This can include fibroblasts, macrophages, adipocytes, osteoblasts, osteoclasts, endothelial cells and hematopoietic cells.
tmeehan
2010-07-22T04:48:15Z
BTO:0004850
FMA:83621
cell
MH consider whether bone marrow cells are bone cells in the structural sense vs. being part of bone organ sense.
bone marrow cell
CL:0002139
An endothelial cell of the vascular tree, which includes blood vessels and lymphatic vessels.
tmeehan
2010-08-24T02:06:40Z
BTO:0001854
CALOHA:TS-1106
FMA:67755
vascular endothelial cell
cubodial endothelial cell of vascular tree
cell
These cells are reportedly CD31-positive, CD34-positive, CD144-positive, TAL1-positive.
endothelial cell of vascular tree
CL:0002191
A cell involved in the formation of a granulocyte.
tmeehan
2010-08-30T12:54:27Z
FMA:83519
cell
granulocytopoietic cell
CL:0002193
A cell type that is the first of the maturation stages of the granulocytic leukocytes normally found in the bone marrow. Granules are seen in the cytoplasm. The nuclear material of the myelocyte is denser than that of the myeloblast but lacks a definable membrane. The cell is flat and contains increasing numbers of granules as maturation progresses.
tmeehan
2010-08-30T01:08:19Z
BTO:0000734
FMA:83525
cell
myelocyte
CL:0002194
A cell involved in the formation of a monocyte (monopoiesis).
tmeehan
2010-08-30T01:27:48Z
FMA:83552
cell
monopoietic cell
CL:0002202
An epithelial cell of the tracheobronchial tree.
tmeehan
2010-09-02T02:09:14Z
CL:1000407
FMA:66816
cell
epithelial cell of tracheobronchial tree
CL:0002242
A cell containing at least one nucleus.
tmeehan
2010-09-07T03:32:33Z
FMA:67513
cell
nucleate cell
CL:0002275
A PP cell located in the islets of the pancreas.
tmeehan
2010-09-10T03:30:31Z
BTO:0000805
FMA:70588
PP cell of pancreatic islet
PP-cell of pancreatic islet
pancreatic polypeptide-secreting cell
cell
The term PP cell of pancreatic acinus was obsoleted due to a lack of evidence, making PP cell of pancreatic islets synonymous with pancreatic PP cell.
pancreatic PP cell
CL:0002293
An epithelial cell of the thymus. Epithelial reticular cells are pleomorphic, stellate, non-phagocytic cells which seem to be supportive in function and are held together by desmosomes. They replace the fibroblastoid reticular cells found in other lymphoid organs. Other epithelial cells in the medulla have the ultrastructure of secretory cells. Although different epithelial cells throughout the thymus appear alike by light microscopy their ultrastructure and function varies.
tmeehan
2010-09-13T02:34:22Z
CL:1000459
CALOHA:TS-1040
FMA:72208
epithelial cell of thymus gland
epithelial reticular cell
epithelial reticular cell of thymus
thymic epithelial cell
cell
epithelial cell of thymus
CL:0002320
A cell of the supporting or framework tissue of the body, arising chiefly from the embryonic mesoderm and including adipose tissue, cartilage, and bone.
tmeehan
2010-09-15T03:01:54Z
CL:1000406
CALOHA:TS-2096
FMA:63875
cell
connective tissue cell
CL:0002321
A cell of the embryo.
tmeehan
2010-09-15T03:39:21Z
CALOHA:TS-0263
FMA:82840
FMA:82841
WBbt:0007028
cell
embryonic cell
CL:0002322
A stem cell of embryonic origin.
tmeehan
2010-09-15T03:44:35Z
BTO:0001086
CALOHA:TS-0263
FMA:82841
ESC
cell
This is an in vitro cell type and may be removed in future releases. These cells are reportedly SSEA-4-positive, CD73-negative, and CD324-positive.
embryonic stem cell
CL:0002328
An epithelial cell of the bronchus.
tmeehan
2010-09-20T02:00:00Z
BTO:0002922
cell
bronchial epithelial cell
CL:0002334
An undifferentiated fibroblast that can be stimulated to form a fat cell.
tmeehan
2010-09-20T02:31:53Z
BTO:0001107
cell
preadipocyte
CL:0002351
A multi-fate stem cell that is able to differentiate into the pancreas alpha, beta and delta endocrine cells. This cell type expresses neurogenin-3 and Isl-1.
tmeehan
2010-09-21T04:41:06Z
pancreatic endocrine progenitor
pancreatic islet progenitor cell
cell
progenitor cell of endocrine pancreas
CL:0002365
An epithelial cell of the medullary thymus. This cell type expresses a diverse range of tissue-specific antigens. This promiscuous gene expression is a cell-autonomous property of medullary epithelial cells and is maintained during the entire period of thymic T cell output.
tmeehan
2010-09-23T03:17:14Z
BTO:0004563
mTEC
cell
medullary thymic epithelial cell
CL:0002368
An endo-epithelial cell of the respiratory tract.
tmeehan
2010-09-23T04:38:49Z
BTO:0004533
airway epithelial cell
cell
respiratory epithelial cell
CL:0002371
A cell of an organism that does not pass on its genetic material to the organism's offspring (i.e. a non-germ line cell).
tmeehan
2010-09-24T09:44:42Z
BTO:0001268
FMA:72300
WBbt:0008378
cell
somatic cell
CL:0002494
A cell located in the heart, including both muscle and non muscle cells.
tmeehan
2010-12-07T09:37:22Z
BTO:0001539
CALOHA:TS-0115
FMA:83808
FMA:84791
heart cell
cell
From Onard of the FMA: Cardiac muscle cell or cardiac myocyte is a striated muscle cell. Cardiocyte on the other hand is any cell in the heart which includes cells other than muscle cells (e.g. endothelial cell of endocardium). Unless there is a consensus among anatomists that cardiocytes refer only to muscle cells, we will treat them as a general class of cells in the heart.
cardiocyte
CL:0002544
An arterial endothelial cell that is part of the aorta endothelium.
tmeehan
2011-02-28T03:54:42Z
BTO:0003245
CALOHA:TS-0047
cell
aortic endothelial cell
CL:0002546
An endothelial progenitor cell that participates in angiogenesis during development.
tmeehan
2011-02-28T04:20:39Z
cell
See CL:0002619.
embryonic blood vessel endothelial progenitor cell
CL:0002632
tmeehan
2011-06-21T12:29:31Z
cell
epithelial cell of lower respiratory tract
CL:0005018
A cell that secretes ghrelin, the peptide hormone that stimulates hunger.
cell
ghrelin secreting cell
CL:0005019
Ghrelin secreting cells found in the found in the exocrine pancreas.
pancreatic E cell
cell
In mammals the endocrine pancreas is called the Islets of Langerhans.
pancreatic epsilon cell
CL:0005026
Multi fate stem cell that gives rise to to both hepatocytes and cholangiocytes as descendants.
hepatoblast
CL:0007004
Cell that is part of the neural crest region of the neuroepithelium, prior to migration. Note that not all premigratory neural crest cells may become migratory neural crest cells.
haendel
2012-06-27T08:27:35Z
cell
premigratory neural crest cell
CL:0008001
Any hematopoietic cell that is a precursor of some other hematopoietic cell type.
hematopoietic precursor cell
CL:0008024
An endocrine cell that is part of the pancreas.
cell
pancreatic endocrine cell
CL:0010021
cardiac myoblast
CL:0011115
A cell that, by division or terminal differentiation, can give rise to other cell types.
Work is needed on GO 'cell differentiation' before it is clear whether the equivalent class definition 'native cell' that capable_of some 'cell differentiation' works. Also, may want to consider merging this with non-terminally differentiated cell.
precursor cell
CL:1000413
A blood vessel endothelial cell that is part of an arterial endothelium.
CL:0002542
BTO:0004758
FMA:67761
KUPO:0001095
arterial endothelial cell
cell
endothelial cell of artery
CL:1000415
An epithelial cell that is part of the gallbladder.
FMA:67780
cell
epithelial cell of gall bladder
CL:1000488
An epithelial cell that is part of the bile duct. Cholangiocytes contribute to bile secretion via net release of bicarbonate and water. They are cuboidal epithelium in the small interlobular bile ducts, but become columnar and mucus secreting in larger bile ducts approaching the porta hepatis and the extrahepatic ducts.
FMA:86481
epithelial cell of bile duct
cell
cholangiocyte
CL:1001433
An epithelial cell of the exocrine pancreas.
FMA:70986
exocrine pancreas cell
cell
epithelial cell of exocrine pancreas
CL:1001599
Glandular cell of exocrine pancreas epithelium. Example: pancreatic acinar cell, glandular cells in pancreatic canaliculi, glandular cells in pancreatic ducts.
BTO:0000028
CALOHA:TS-1242
exocrine pancreas glandular cell
pancreas exocrine glandular cells
pancreas exocrine glandular cell
CL:1001610
Hematopoietic cells resident in the bone marrow. Include: hematopoietic stem cells (lymphoid stem cells and myeloid stem cells) and the precursor cells for thrombocytes, erythrocytes, basophils, neutrophils, eosinophils, monocytes and lymphocytes.
CALOHA:TS-2109
bone marrow hematopoietic cells
bone marrow poietic cells
bone marrow hematopoietic cell
CP:0000000
Cytoplasm that exhibits molecular interaction for acidic dyes under specific pH conditions.
tmeehan
2010-05-25T01:36:34Z
cell
neutrophillic cytoplasm
CP:0000027
Cytoplasm that exhibits molecular interaction for acidic dyes under specific pH conditions.
tmeehan
2009-12-22T04:23:25Z
eosinophilic
cell
acidophilic cytoplasm
CP:0000028
Cytoplasm that exhibits molecular interaction for basic dyes under specific pH conditions.
tmeehan
2009-12-22T04:24:54Z
cell
basophilic cytoplasm
CP:0000035
Cytoplasm that exhibits affinity for both basic and acid stains under specific pH conditions.
tmeehan
2009-12-28T04:25:23Z
cell
polychromatophilic cytoplasm
CP:0000037
A nucleus size quality which is relatively high compared to the amount of cytoplasm present in the same cell.
tmeehan
2009-12-23T10:53:24Z
cell
increased nucleus size
ENVO:00001998
Any material within 2 m from the Earth's surface that is in contact with the atmosphere, with the exclusion of living organisms, areas with continuous ice not covered by other material, and water bodies deeper than 2 m.
soil
ENVO:00010483
A portion of environmental material is a fiat object which forms the medium or part of the medium of an environmental system.
environmental material
ERO:0000378
A material processing technique that uses operative manual and instrumental techniques on a patient to investigate and/or treat a pathological condition such as disease or injury or to help improve bodily function or appearance.
surgery
ERO:0001211
A DNA sequencing by ligation technique that involves a bead-based method that uses a complex approach of adapter ligation followed by adapter decoding, reading the sequence in increments of four nucleotides; this method made it susceptible to sequence-specific bias or loss of specific sequences.
massively parallel signature sequencing
ERO:0001334
Specimen creation of a sample of tissue from a living body for diagnostic purposes.
biopsy
ERO:0001400
A cell line that is derived from a stem cell.
stem cell derived cell line
ERO:0001716
A database is an organized collection of data, today typically in digital form.
database
FMA:63919
Fetal structure, which is a developmental form of a vertebrate animal at any given time point from 8 weeks of gestation to birth (or hatching). Examples: There is only one fetus.
Fetus
GAZ:00000448
A reference to a place on the Earth, by its name or by its geographical location.
geographical location
GO:0000785
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
chromatin
GO:0000791
A dispersed and relatively uncompacted form of chromatin.
euchromatin
GO:0000792
A compact and highly condensed form of chromatin.
heterochromatin
GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
osteoblast differentiation
GO:0001667
Cell migration that is accomplished by extension and retraction of a pseudopodium.
ameboidal-type cell migration
GO:0001816
The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
cytokine production
GO:0001820
The regulated release of serotonin by a cell. Serotonin (5-hydroxytryptamine, or 5-HT) is a monoamine synthesised in serotonergic neurons in the central nervous system, enterochromaffin cells in the gastrointestinal tract and some immune system cells.
serotonin secretion
GO:0002200
The somatic process allowing for the production of immune receptors whose specificity is not encoded in the germline genomic sequences.
somatic diversification of immune receptors
GO:0002228
The promotion of an immune response by natural killer cells through direct recognition of target cells or through the release of cytokines.
natural killer cell mediated immunity
GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
hematopoietic progenitor cell differentiation
GO:0002376
Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
immune system process
GO:0002449
Any process involved in the carrying out of an immune response by a lymphocyte.
lymphocyte mediated immunity
GO:0002456
Any process involved in the carrying out of an immune response by a T cell.
T cell mediated immunity
GO:0002460
An immune response based on directed amplification of specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains, and allowing for enhanced responses upon subsequent exposures to the same antigen (immunological memory). Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies). An example of this is the adaptive immune response found in Mus musculus.
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
GO:0002521
The process in which a relatively unspecialized hemopoietic precursor cell acquires the specialized features of a leukocyte. A leukocyte is an achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.
leukocyte differentiation
GO:0002562
The process in which immune receptor genes are diversified through recombination of the germline genetic elements within a single genetic locus.
somatic diversification of immune receptors via germline recombination within a single locus
GO:0002573
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte lineage.
myeloid leukocyte differentiation
GO:0002682
Any process that modulates the frequency, rate, or extent of an immune system process.
regulation of immune system process
GO:0002694
Any process that modulates the frequency, rate, or extent of leukocyte activation.
regulation of leukocyte activation
GO:0002790
The controlled release of a peptide from a cell or a tissue.
peptide secretion
GO:0003006
A developmental process in which a progressive change in the state of some part of an organism specifically contributes to its ability to form offspring.
developmental process involved in reproduction
GO:0003013
A organ system process carried out by any of the organs or tissues of the circulatory system. The circulatory system is an organ system that moves extracellular fluids to and from tissue within a multicellular organism.
circulatory system process
GO:0003674
Elemental activities, such as catalysis or binding, describing the actions of a gene product at the molecular level. A given gene product may exhibit one or more molecular functions.
molecular_function
GO:0003824
Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
catalytic activity
GO:0003964
Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes RNA-template-directed extension of the 3'- end of a DNA strand by one deoxynucleotide at a time.
RNA-directed DNA polymerase activity
GO:0005575
The part of a cell or its extracellular environment in which a gene product is located. A gene product may be located in one or more parts of a cell and its location may be as specific as a particular macromolecular complex, that is, a stable, persistent association of macromolecules that function together.
cellular_component
GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
nucleus
GO:0005730
A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleolus
GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoplasm
GO:0005773
A closed structure, found only in eukaryotic cells, that is completely surrounded by unit membrane and contains liquid material. Cells contain one or several vacuoles, that may have different functions from each other. Vacuoles have a diverse array of functions. They can act as a storage organelle for nutrients or waste products, as a degradative compartment, as a cost-effective way of increasing cell size, and as a homeostatic regulator controlling both turgor pressure and pH of the cytosol.
vacuole
GO:0005840
An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.
ribosome
GO:0006139
Any cellular metabolic process involving nucleobases, nucleosides, nucleotides and nucleic acids.
nucleobase-containing compound metabolic process
GO:0006259
Any cellular metabolic process involving deoxyribonucleic acid. This is one of the two main types of nucleic acid, consisting of a long, unbranched macromolecule formed from one, or more commonly, two, strands of linked deoxyribonucleotides.
DNA metabolic process
GO:0006260
The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA.
DNA replication
GO:0006304
The covalent alteration of one or more nucleotide sites in DNA, resulting in a change in its properties.
DNA modification
GO:0006306
The covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine.
DNA methylation
GO:0006323
Any process in which DNA and associated proteins are formed into a compact, orderly structure.
DNA packaging
GO:0006338
Dynamic structural changes to eukaryotic chromatin occurring throughout the cell division cycle. These changes range from the local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation.
chromatin remodeling
GO:0006464
The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications) occurring at the level of an individual cell. Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).
cellular protein modification process
GO:0006725
The chemical reactions and pathways involving aromatic compounds, any organic compound characterized by one or more planar rings, each of which contains conjugated double bonds and delocalized pi electrons, as carried out by individual cells.
cellular aromatic compound metabolic process
GO:0006810
The directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.
transport
GO:0006811
The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
ion transport
GO:0006812
The directed movement of cations, atoms or small molecules with a net positive charge, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
cation transport
GO:0006837
The directed movement of serotonin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Serotonin (5-hydroxytryptamine) is a monoamine neurotransmitter occurring in the peripheral and central nervous systems.
serotonin transport
GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
apoptotic process
GO:0006950
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
response to stress
GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
immune response
GO:0006996
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an organelle within a cell. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.
organelle organization
GO:0007049
The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.
cell cycle
GO:0007113
A mitotic cell cycle in which chromosomes are replicated and sister chromatids separate, but spindle formation, nuclear membrane breakdown and nuclear division do not occur, resulting in an increased number of chromosomes in the cell.
endomitotic cell cycle
GO:0007143
A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the female germline.
female meiotic division
GO:0007159
The attachment of a leukocyte to another cell via adhesion molecules.
leukocyte cell-cell adhesion
GO:0007276
The generation and maintenance of gametes in a multicellular organism. A gamete is a haploid reproductive cell.
gamete generation
GO:0007281
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
germ cell development
GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
female pregnancy
GO:0007596
The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
blood coagulation
GO:0008015
The flow of blood through the body of an animal, enabling the transport of nutrients to the tissues and the removal of waste products.
blood circulation
GO:0008150
Any process specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end.
biological_process
GO:0008152
The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
metabolic process
GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as "apoptotic bodies"); and/or (3) its corpse (or its fragments) have been engulfed by an adjacent cell in vivo.
cell death
GO:0009058
The chemical reactions and pathways resulting in the formation of substances; typically the energy-requiring part of metabolism in which simpler substances are transformed into more complex ones.
biosynthetic process
GO:0009059
The chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
macromolecule biosynthetic process
GO:0009306
The controlled release of proteins from a cell.
protein secretion
GO:0009730
The series of events in which a carbohydrate stimulus is received by a cell and converted into a molecular signal.
detection of carbohydrate stimulus
GO:0009732
The series of events in which a stimulus from a hexose is received and converted into a molecular signal.
detection of hexose stimulus
GO:0009743
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbohydrate stimulus.
response to carbohydrate
GO:0009746
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hexose stimulus.
response to hexose
GO:0009914
The directed movement of hormones into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
hormone transport
GO:0009987
Any process that is carried out at the cellular level, but not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.
cellular process
GO:0010467
The process in which a gene's sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.
gene expression
GO:0010817
Any process that modulates the levels of hormone within an organism or a tissue. A hormone is any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action.
regulation of hormone levels
GO:0015031
The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
protein transport
GO:0015106
Catalysis of the transfer of bicarbonate from one side of a membrane to the other. Bicarbonate is the hydrogencarbonate ion, HCO3-.
bicarbonate transmembrane transporter activity
GO:0015671
The directed movement of oxygen (O2) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
oxygen transport
GO:0015696
The directed movement of ammonium into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Ammonium is the cation NH4+ which is formed from N2 by root-nodule bacteria in leguminous plants and is an excretory product in ammonotelic animals.
ammonium transport
GO:0015833
The directed movement of peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
peptide transport
GO:0015844
The directed movement of monoamines, organic compounds that contain one amino group that is connected to an aromatic ring by an ethylene group (-CH2-CH2-), into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
monoamine transport
GO:0015850
The directed movement of an organic hydroxy compound (organic alcohol) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. An organic hydroxy compound is an organic compound having at least one hydroxy group attached to a carbon atom.
organic hydroxy compound transport
GO:0016023
A membrane-bounded vesicle found in the cytoplasm of the cell.
cytoplasmic membrane-bounded vesicle
GO:0016043
A process that results in the assembly, arrangement of constituent parts, or disassembly of a cellular component.
cellular component organization
GO:0016337
The attachment of one cell to another cell via adhesion molecules, where both cells are part of the same organism.
single organismal cell-cell adhesion
GO:0016447
The process in which immunoglobulin genes are formed through recombination of the germline genetic elements, as known as immunoglobulin gene segments, within a single locus.
somatic recombination of immunoglobulin gene segments
GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
cell migration
GO:0016568
The alteration of DNA, protein, or sometimes RNA, in chromatin, which may result in changing the chromatin structure.
chromatin modification
GO:0016570
The covalent alteration of one or more amino acid residues within a histone protein.
histone modification
GO:0017145
The self-renewing division of a stem cell. A stem cell is an undifferentiated cell, in the embryo or adult, that can undergo unlimited division and give rise to one or several different cell types.
stem cell division
GO:0019219
Any cellular process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nucleobases, nucleosides, nucleotides and nucleic acids.
regulation of nucleobase-containing compound metabolic process
GO:0019222
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism.
regulation of metabolic process
GO:0019538
The chemical reactions and pathways involving a specific protein, rather than of proteins in general. Includes protein modification.
protein metabolic process
GO:0019724
Any process involved with the carrying out of an immune response by a B cell, through, for instance, the production of antibodies or cytokines, or antigen presentation to T cells.
B cell mediated immunity
GO:0019814
A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.
immunoglobulin complex
GO:0019815
An immunoglobulin complex that is present in the plasma membrane of B cells and that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains and a signaling subunit, a heterodimer of the Ig-alpha and Ig-beta proteins.
B cell receptor complex
GO:0019882
The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
antigen processing and presentation
GO:0022407
Any process that modulates the frequency, rate or extent of attachment of a cell to another cell.
regulation of cell-cell adhesion
GO:0022414
A biological process that directly contributes to the process of producing new individuals by one or two organisms. The new individuals inherit some proportion of their genetic material from the parent or parents.
reproductive process
GO:0022610
The attachment of a cell or organism to a substrate or other organism.
biological adhesion
GO:0023061
The process in which a signal is secreted or discharged into the extracellular medium from a cellular source.
signal release
GO:0030017
The repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs.
sarcomere
GO:0030072
The regulated release of a peptide hormone from a cell.
peptide hormone secretion
GO:0030073
The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin.
insulin secretion
GO:0030098
The process in which a relatively unspecialized precursor cell acquires specialized features of a lymphocyte. A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.
lymphocyte differentiation
GO:0030099
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages.
myeloid cell differentiation
GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
secretory granule
GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
cell differentiation
GO:0030182
The process in which a relatively unspecialized cell acquires specialized features of a neuron.
neuron differentiation
GO:0030217
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
T cell differentiation
GO:0030218
The process in which a myeloid precursor cell acquires specializes features of an erythrocyte.
erythrocyte differentiation
GO:0030219
The process in which a myeloid precursor cell acquires specializes features of a megakaryocyte.
megakaryocyte differentiation
GO:0030224
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
monocyte differentiation
GO:0030225
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
macrophage differentiation
GO:0030261
The progressive compaction of dispersed interphase chromatin into threadlike chromosomes prior to mitotic or meiotic nuclear division, or during apoptosis, in eukaryotic cells.
chromosome condensation
GO:0030263
The compaction of chromatin during apoptosis.
apoptotic chromosome condensation
GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
osteoclast differentiation
GO:0030529
A macromolecular complex containing both protein and RNA molecules.
ribonucleoprotein complex
GO:0030659
The lipid bilayer surrounding a cytoplasmic vesicle.
cytoplasmic vesicle membrane
GO:0030667
The lipid bilayer surrounding a secretory granule.
secretory granule membrane
GO:0030851
The process in which a myeloid precursor cell acquires the specialized features of a granulocyte. Granulocytes are a class of leukocytes characterized by the presence of granules in their cytoplasm. These cells are active in allergic immune reactions such as arthritic inflammation and rashes. This class includes basophils, eosinophils and neutrophils.
granulocyte differentiation
GO:0030855
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
epithelial cell differentiation
GO:0031016
The process whose specific outcome is the progression of the pancreas over time, from its formation to the mature structure. The pancreas is an endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes.
pancreas development
GO:0031018
The process whose specific outcome is the progression of the endocrine pancreas over time, from its formation to the mature structure. The endocrine pancreas is made up of islet cells that produce insulin, glucagon and somatostatin.
endocrine pancreas development
GO:0031090
A membrane that is one of the two lipid bilayers of an organelle envelope or the outermost membrane of single membrane bound organelle.
organelle membrane
GO:0031323
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances.
regulation of cellular metabolic process
GO:0031410
A vesicle formed of membrane or protein, found in the cytoplasm of a cell.
cytoplasmic vesicle
GO:0031982
Any small, fluid-filled, spherical organelle enclosed by membrane or protein.
vesicle
GO:0031988
Any small, fluid-filled, spherical organelle enclosed by a lipid bilayer.
membrane-bounded vesicle
GO:0032501
Any biological process, occurring at the level of a multicellular organism, pertinent to its function.
multicellular organismal process
GO:0032502
A biological process whose specific outcome is the progression of an integrated living unit: an anatomical structure (which may be a subcellular structure, cell, tissue, or organ), or organism over time from an initial condition to a later condition.
developmental process
GO:0032940
The controlled release of a substance by a cell.
secretion by cell
GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which the constituent parts function together.
macromolecular complex
GO:0033152
The process in which immunoglobulin gene segments are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS). For immunoglobulin heavy chains V, D, and J gene segments are joined, and for immunoglobulin light chains V and J gene segments are joined.
immunoglobulin V(D)J recombination
GO:0034109
The attachment of a cell to a second cell of the identical type via adhesion molecules.
homotypic cell-cell adhesion
GO:0034284
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a monosaccharide stimulus.
response to monosaccharide
GO:0034287
The series of events in which a stimulus from a monosaccharide is received and converted into a molecular signal.
detection of monosaccharide stimulus
GO:0034641
The chemical reactions and pathways involving various organic and inorganic nitrogenous compounds, as carried out by individual cells.
cellular nitrogen compound metabolic process
GO:0034645
The chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass, carried out by individual cells.
cellular macromolecule biosynthetic process
GO:0036211
The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications). Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).
protein modification process
GO:0036321
The regulated release of ghrelin from a cell. Ghrelin is a 28 amino acid hunger-stimulating peptide hormone.
ghrelin secretion
GO:0040030
Any heritable epigenetic process that modulates the frequency, rate or extent of protein function by self-perpetuating conformational conversions of normal proteins in healthy cells. This is distinct from, though mechanistically analogous to, disease states associated with prion propagation and amyloidogenesis. A single protein, if it carries a glutamine/asparagine-rich ('prion') domain, can sometimes stably exist in at least two distinct physical states, each associated with a different phenotype; propagation of one of these traits is achieved by a self-perpetuating change in the protein from one form to the other, mediated by conformational changes in the glutamine/asparagine-rich domain. Prion domains are both modular and transferable to other proteins, on which they can confer a heritable epigenetic alteration of function; existing bioinformatics data indicate that they are rare in non-eukarya, but common in eukarya.
regulation of molecular function, epigenetic
GO:0042101
A protein complex that contains a disulfide-linked heterodimer of T cell receptor (TCR) chains, which are members of the immunoglobulin superfamily, and mediates antigen recognition, ultimately resulting in T cell activation. The TCR heterodimer is associated with the CD3 complex, which consists of the nonpolymorphic polypeptides gamma, delta, epsilon, zeta, and, in some cases, eta (an RNA splice variant of zeta) or Fc epsilon chains.
T cell receptor complex
GO:0042110
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
T cell activation
GO:0042470
A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells.
melanosome
GO:0042571
An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component.
immunoglobulin complex, circulating
GO:0042575
A protein complex that possesses DNA polymerase activity and is involved in template directed synthesis of DNA.
DNA polymerase complex
GO:0042582
Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.
azurophil granule
GO:0042589
The lipid bilayer surrounding a zymogen granule.
zymogen granule membrane
GO:0042611
A transmembrane protein complex composed of an MHC alpha chain and, in most cases, either an MHC class II beta chain or an invariant beta2-microglobin chain, and with or without a bound peptide, lipid, or polysaccharide antigen.
MHC protein complex
GO:0042613
A transmembrane protein complex composed of an MHC class II alpha and MHC class II beta chain, and with or without a bound peptide or polysaccharide antigen.
MHC class II protein complex
GO:0042886
The directed movement of an amide, any compound containing one, two, or three acyl groups attached to a nitrogen atom, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
amide transport
GO:0043011
The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
myeloid dendritic cell differentiation
GO:0043170
The chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
macromolecule metabolic process
GO:0043226
Organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, and prokaryotic structures such as anammoxosomes and pirellulosomes. Excludes the plasma membrane.
organelle
GO:0043227
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
membrane-bounded organelle
GO:0043229
Organized structure of distinctive morphology and function, occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.
intracellular organelle
GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
intracellular membrane-bounded organelle
GO:0043232
Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane and occurring within the cell. Includes ribosomes, the cytoskeleton and chromosomes.
intracellular non-membrane-bounded organelle
GO:0043234
Any macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.
protein complex
GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
receptor complex
GO:0043412
The covalent alteration of one or more monomeric units in a polypeptide, polynucleotide, polysaccharide, or other biological macromolecule, resulting in a change in its properties.
macromolecule modification
GO:0043414
The covalent attachment of a methyl residue to one or more monomeric units in a polypeptide, polynucleotide, polysaccharide, or other biological macromolecule.
macromolecule methylation
GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
sequence-specific DNA binding
GO:0044030
Any process that modulates the frequency, rate or extent of the covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine.
regulation of DNA methylation
GO:0044237
The chemical reactions and pathways by which individual cells transform chemical substances.
cellular metabolic process
GO:0044238
The chemical reactions and pathways involving those compounds which are formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism.
primary metabolic process
GO:0044249
The chemical reactions and pathways resulting in the formation of substances, carried out by individual cells.
cellular biosynthetic process
GO:0044260
The chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass, as carried out by individual cells.
cellular macromolecule metabolic process
GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
cellular protein metabolic process
GO:0044342
The multiplication or reproduction of pancreatic B cells, resulting in the expansion of an pancreatic B cell population. Pancreatic B cell are cells of the pancreas that secrete insulin.
type B pancreatic cell proliferation
GO:0044422
Any constituent part of an organelle, an organized structure of distinctive morphology and function. Includes constituent parts of the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, but excludes the plasma membrane.
organelle part
GO:0044424
Any constituent part of the living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
intracellular part
GO:0044425
Any constituent part of a membrane, a double layer of lipid molecules that encloses all cells, and, in eukaryotes, many organelles; may be a single or double lipid bilayer; also includes associated proteins.
membrane part
GO:0044433
Any constituent part of cytoplasmic vesicle, a vesicle formed of membrane or protein, found in the cytoplasm of a cell.
cytoplasmic vesicle part
GO:0044444
Any constituent part of the cytoplasm, all of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoplasmic part
GO:0044446
A constituent part of an intracellular organelle, an organized structure of distinctive morphology and function, occurring within the cell. Includes constituent parts of the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton but excludes the plasma membrane.
intracellular organelle part
GO:0044449
Any constituent part of a contractile fiber, a fiber composed of actin, myosin, and associated proteins, found in cells of smooth or striated muscle.
contractile fiber part
GO:0044459
Any constituent part of the plasma membrane, the membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
plasma membrane part
GO:0044464
Any constituent part of a cell, the basic structural and functional unit of all organisms.
cell part
GO:0044699
A biological process that involves only one organism.
single-organism process
GO:0044702
A biological process that directly contributes to the process of producing new individuals, involving a single organism.
single organism reproductive process
GO:0044703
A biological process that directly contributes to the process of producing new individuals, involving another organism.
multi-organism reproductive process
GO:0044706
A multicellular organism process which involves another multicellular organism of the same or different species.
multi-multicellular organism process
GO:0044707
A biological process occurring within a single, multicellular organism.
single-multicellular organism process
GO:0044710
A metabolic process - chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances - which involves a single organism.
single-organism metabolic process
GO:0044763
Any process that is carried out at the cellular level, occurring within a single organism.
single-organism cellular process
GO:0044765
The directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore, involving a single organism.
single-organism transport
GO:0044767
A biological process whose specific outcome is the progression of an integrated living unit: an anatomical structure (which may be a subcellular structure, cell, tissue, or organ), or organism over time from an initial condition to a later condition, involving only one organism.
single-organism developmental process
GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
innate immune response
GO:0045321
A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor.
leukocyte activation
GO:0045444
The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.
fat cell differentiation
GO:0045580
Any process that modulates the frequency, rate or extent of T cell differentiation.
regulation of T cell differentiation
GO:0045595
Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
regulation of cell differentiation
GO:0045619
Any process that modulates the frequency, rate or extent of lymphocyte differentiation.
regulation of lymphocyte differentiation
GO:0046483
The chemical reactions and pathways involving heterocyclic compounds, those with a cyclic molecular structure and at least two different atoms in the ring (or rings).
heterocycle metabolic process
GO:0046649
A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor.
lymphocyte activation
GO:0046879
The regulated release of hormones, substances with a specific regulatory effect on a particular organ or group of cells.
hormone secretion
GO:0046903
The controlled release of a substance by a cell or a tissue.
secretion
GO:0048103
The self-renewing division of a somatic stem cell, a stem cell that can give rise to cell types of the body other than those of the germ-line.
somatic stem cell division
GO:0048468
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
cell development
GO:0048477
The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster.
oogenesis
GO:0048609
The process, occurring above the cellular level, that is pertinent to the reproductive function of a multicellular organism. This includes the integrated processes at the level of tissues and organs.
multicellular organismal reproductive process
GO:0048856
The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
anatomical structure development
GO:0048863
The process in which a relatively unspecialized cell acquires specialized features of a stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
stem cell differentiation
GO:0048869
A biological process whose specific outcome is the progression of a cell over time from an initial condition to a later condition.
cellular developmental process
GO:0048870
Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another.
cell motility
GO:0050432
The regulated release of catecholamines by a cell. The catecholamines are a group of physiologically important biogenic amines that possess a catechol (3,4-dihydroxyphenyl) nucleus and are derivatives of 3,4-dihydroxyphenylethylamine.
catecholamine secretion
GO:0050776
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
regulation of immune response
GO:0050789
Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.
regulation of biological process
GO:0050793
Any process that modulates the frequency, rate or extent of development, the biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
regulation of developmental process
GO:0050794
Any process that modulates the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.
regulation of cellular process
GO:0050863
Any process that modulates the frequency, rate or extent of T cell activation.
regulation of T cell activation
GO:0050878
Any process that modulates the levels of body fluids.
regulation of body fluid levels
GO:0050879
Any physiological process involved in changing the position of a multicellular organism or an anatomical part of a multicellular organism.
multicellular organismal movement
GO:0050896
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism.
response to stimulus
GO:0051052
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving DNA.
regulation of DNA metabolic process
GO:0051171
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds.
regulation of nitrogen compound metabolic process
GO:0051179
Any process in which a cell, a substance, or a cellular entity, such as a protein complex or organelle, is transported to or maintained in a specific location.
localization
GO:0051234
The directed movement of a cell, substance or cellular entity, such as a protein complex or organelle, to a specific location.
establishment of localization
GO:0051249
Any process that modulates the frequency, rate or extent of lymphocyte activation.
regulation of lymphocyte activation
GO:0051276
A process that is carried out at the cellular level that results in the assembly, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information. This term covers covalent modifications at the molecular level as well as spatial relationships among the major components of a chromosome.
chromosome organization
GO:0051594
The series of events in which a glucose stimulus is received by a cell and converted into a molecular signal.
detection of glucose
GO:0051704
A biological process which involves another organism of the same or different species.
multi-organism process
GO:0051937
The directed movement of catecholamines, a group of physiologically important biogenic amines that possess a catechol (3,4-dihydroxyphenyl) nucleus and are derivatives of 3,4-dihydroxyphenylethylamine.
catecholamine transport
GO:0055007
The process in which a cardiac muscle precursor cell acquires specialized features of a cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
cardiac muscle cell differentiation
GO:0060047
The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
heart contraction
GO:0060255
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
regulation of macromolecule metabolic process
GO:0060290
The conversion of a differentiated cell of one fate into a differentiated cell of another fate without first undergoing cell division or reversion to a more primitive or stem cell-like fate.
transdifferentiation
GO:0060591
The process in which a mesenchymal cell, acquires specialized structural and/or functional features of a chondroblast. Differentiation includes the processes involved in commitment of a cell to a chondroblast fate. A chondroblast is a precursor cell to chondrocytes.
chondroblast differentiation
GO:0060986
The regulated release of a hormone into the circulatory system.
endocrine hormone secretion
GO:0065007
Any process that modulates a measurable attribute of any biological process, quality or function.
biological regulation
GO:0065008
Any process that modulates a qualitative or quantitative trait of a biological quality. A biological quality is a measurable attribute of an organism or part of an organism, such as size, mass, shape, color, etc.
regulation of biological quality
GO:0070091
The regulated release of glucagon from secretory granules in the A (alpha) cells of the pancreas (islets of Langerhans).
glucagon secretion
GO:0070253
The regulated release of somatostatin from secretory granules in the D cells of the pancreas.
somatostatin secretion
GO:0070486
The adhesion of one leukocyte to one or more other leukocytes via adhesion molecules.
leukocyte aggregation
GO:0070925
The aggregation, arrangement and bonding together of a set of components to form an organelle. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.
organelle assembly
GO:0071702
The directed movement of organic substances into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore. An organic substance is a molecular entity that contains carbon.
organic substance transport
GO:0071704
The chemical reactions and pathways involving an organic substance, any molecular entity containing carbon.
organic substance metabolic process
GO:0071705
The directed movement of nitrogen-containing compounds into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
nitrogen compound transport
GO:0071971
The aggregation, arrangement and bonding together of a set of components to form an extracellular vesicular exosome, a membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane.
extracellular exosome assembly
GO:0080090
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism involving those compounds formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism.
regulation of primary metabolic process
GO:0090304
Any cellular metabolic process involving nucleic acids.
nucleic acid metabolic process
GO:0098602
The attachment, via cell adhesion molecules, of a cell to either another cell of the same organism, or to an underlying substrate of the same organism such as the extracellular matrix.
single organism cell adhesion
GO:1901360
The chemical reactions and pathways involving organic cyclic compound.
organic cyclic compound metabolic process
GO:1901576
The chemical reactions and pathways resulting in the formation of an organic substance, any molecular entity containing carbon.
organic substance biosynthetic process
GO:1902105
Any process that modulates the frequency, rate or extent of leukocyte differentiation.
regulation of leukocyte differentiation
GO:1902494
A protein complex which is capable of catalytic activity.
catalytic complex
GO:1902578
A localization which involves only one organism.
single-organism localization
GO:1902589
An organelle organization which involves only one organism.
single-organism organelle organization
GO:1903706
Any process that modulates the frequency, rate or extent of hemopoiesis.
regulation of hemopoiesis
GO:2000026
Any process that modulates the frequency, rate or extent of multicellular organismal development.
regulation of multicellular organismal development
IAO:0000003
measurement unit label
Examples of measurement unit labels are liters, inches, weight per volume.
A measurement unit label is as a label that is part of a scalar measurement datum and denotes a unit of measure.
2009-03-16: provenance: a term measurement unit was
proposed for OBI (OBI_0000176) , edited by Chris Stoeckert and
Cristian Cocos, and subsequently moved to IAO where the objective for
which the original term was defined was satisfied with the definition
of this, different, term.
2009-03-16: review of this term done during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI.
PERSON: Alan Ruttenberg
PERSON: Melanie Courtot
measurement unit label
IAO:0000005
objective specification
In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction.
a directive information entity that describes an intended process endpoint. When part of a plan specification the concretization is realized in a planned process in which the bearer tries to effect the world so that the process endpoint is achieved.
2009-03-16: original definition when imported from OBI read: "objective is an non realizable information entity which can serve as that proper part of a plan towards which the realization of the plan is directed."
2014-03-31: In the example of usage ("In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction") there is a protocol which is the ChIP assay protocol. In addition to being concretized on paper, the protocol can be concretized as a realizable entity, such as a plan that inheres in a person. The objective specification is the part that says that some protein and DNA interactions are identified. This is a specification of a process endpoint: the boundary in the process before which they are not identified and after which they are. During the realization of the plan, the goal is to get to the point of having the interactions, and participants in the realization of the plan try to do that.
Answers the question, why did you do this experiment?
PERSON: Alan Ruttenberg
PERSON: Barry Smith
PERSON: Bjoern Peters
PERSON: Jennifer Fostel
goal specification
OBI Plan and Planned Process/Roles Branch
OBI_0000217
objective specification
IAO:0000007
action specification
Pour the contents of flask 1 into flask 2
a directive information entity that describes an action the bearer will take
Alan Ruttenberg
OBI Plan and Planned Process branch
action specification
IAO:0000009
datum label
A label is a symbol that is part of some other datum and is used to either partially define the denotation of that datum or to provide a means for identifying the datum as a member of the set of data with the same label
http://www.golovchenko.org/cgi-bin/wnsearch?q=label#4n
GROUP: IAO
9/22/11 BP: changed the rdfs:label for this class from 'label' to 'datum label' to convey that this class is not intended to cover all kinds of labels (stickers, radiolabels, etc.), and not even all kind of textual labels, but rather the kind of labels occuring in a datum.
datum label
IAO:0000010
software
Software is a plan specification composed of a series of instructions that can be
interpreted by or directly executed by a processing unit.
see sourceforge tracker discussion at http://sourceforge.net/tracker/index.php?func=detail&aid=1958818&group_id=177891&atid=886178
PERSON: Alan Ruttenberg
PERSON: Bjoern Peters
PERSON: Chris Stoeckert
PERSON: Melanie Courtot
GROUP: OBI
software
IAO:0000027
data item
Data items include counts of things, analyte concentrations, and statistical summaries.
a data item is an information content entity that is intended to be a truthful statement about something (modulo, e.g., measurement precision or other systematic errors) and is constructed/acquired by a method which reliably tends to produce (approximately) truthful statements.
2/2/2009 Alan and Bjoern discussing FACS run output data. This is a data item because it is about the cell population. Each element records an event and is typically further composed a set of measurment data items that record the fluorescent intensity stimulated by one of the lasers.
2009-03-16: data item deliberatly ambiguous: we merged data set and datum to be one entity, not knowing how to define singular versus plural. So data item is more general than datum.
2009-03-16: removed datum as alternative term as datum specifically refers to singular form, and is thus not an exact synonym.
2014-03-31: See discussion at http://odontomachus.wordpress.com/2014/03/30/aboutness-objects-propositions/
JAR: datum -- well, this will be very tricky to define, but maybe some
information-like stuff that might be put into a computer and that is
meant, by someone, to denote and/or to be interpreted by some
process... I would include lists, tables, sentences... I think I might
defer to Barry, or to Brian Cantwell Smith
JAR: A data item is an approximately justified approximately true approximate belief
PERSON: Alan Ruttenberg
PERSON: Chris Stoeckert
PERSON: Jonathan Rees
data
data item
IAO:0000028
symbol
a serial number such as "12324X"
a stop sign
a written proper name such as "OBI"
An information content entity that is a mark(s) or character(s) used as a conventional representation of another entity.
20091104, MC: this needs work and will most probably change
2014-03-31: We would like to have a deeper analysis of 'mark' and 'sign' in the future (see https://code.google.com/p/information-artifact-ontology/issues/detail?id=154).
PERSON: James A. Overton
PERSON: Jonathan Rees
based on Oxford English Dictionary
symbol
IAO:0000030
information content entity
Examples of information content entites include journal articles, data, graphical layouts, and graphs.
A generically dependent continuant that is about some thing.
2014-03-10: The use of "thing" is intended to be general enough to include universals and configurations (see https://groups.google.com/d/msg/information-ontology/GBxvYZCk1oc/-L6B5fSBBTQJ).
information_content_entity 'is_encoded_in' some digital_entity in obi before split (040907). information_content_entity 'is_encoded_in' some physical_document in obi before split (040907).
Previous. An information content entity is a non-realizable information entity that 'is encoded in' some digital or physical entity.
PERSON: Chris Stoeckert
OBI_0000142
information content entity
1
1
IAO:0000032
scalar measurement datum
10 feet. 3 ml.
a scalar measurement datum is a measurement datum that is composed of two parts, numerals and a unit label.
2009-03-16: we decided to keep datum singular in scalar measurement datum, as in
this case we explicitly refer to the singular form
Would write this as: has_part some 'measurement unit label' and has_part some numeral and has_part exactly 2, except for the fact that this won't let us take advantage of OWL reasoning over the numbers. Instead use has measurment value property to represent the same. Use has measurement unit label (subproperty of has_part) so we can easily say that there is only one of them.
PERSON: Alan Ruttenberg
PERSON: Melanie Courtot
scalar measurement datum
IAO:0000033
directive information entity
An information content entity whose concretizations indicate to their bearer how to realize them in a process.
2009-03-16: provenance: a term realizable information entity was proposed for OBI (OBI_0000337) , edited by the PlanAndPlannedProcess branch. Original definition was "is the specification of a process that can be concretized and realized by an actor" with alternative term "instruction".It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term.
2013-05-30 Alan Ruttenberg: What differentiates a directive information entity from an information concretization is that it can have concretizations that are either qualities or realizable entities. The concretizations that are realizable entities are created when an individual chooses to take up the direction, i.e. has the intention to (try to) realize it.
8/6/2009 Alan Ruttenberg: Changed label from "information entity about a realizable" after discussions at ICBO
Werner pushed back on calling it realizable information entity as it isn't realizable. However this name isn't right either. An example would be a recipe. The realizable entity would be a plan, but the information entity isn't about the plan, it, once concretized, *is* the plan. -Alan
PERSON: Alan Ruttenberg
PERSON: Bjoern Peters
directive information entity
IAO:0000064
algorithm
PMID: 18378114.Genomics. 2008 Mar 28. LINKGEN: A new algorithm to process data in genetic linkage studies.
A plan specification which describes the inputs and output of mathematical functions as well as workflow of execution for achieving an predefined objective. Algorithms are realized usually by means of implementation as computer programs for execution by automata.
Philippe Rocca-Serra
PlanAndPlannedProcess Branch
OBI_0000270
adapted from discussion on OBI list (Matthew Pocock, Christian Cocos, Alan Ruttenberg)
algorithm
IAO:0000078
curation status specification
The curation status of the term. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value.
Better to represent curation as a process with parts and then relate labels to that process (in IAO meeting)
PERSON:Bill Bug
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
OBI_0000266
curation status specification
IAO:0000100
data set
Intensity values in a CEL file or from multiple CEL files comprise a data set (as opposed to the CEL files themselves).
A data item that is an aggregate of other data items of the same type that have something in common. Averages and distributions can be determined for data sets.
2009/10/23 Alan Ruttenberg. The intention is that this term represent collections of like data. So this isn't for, e.g. the whole contents of a cel file, which includes parameters, metadata etc. This is more like java arrays of a certain rather specific type
2014-05-05: Data sets are aggregates and thus must include two or more data items. We have chosen not to add logical axioms to make this restriction.
person:Allyson Lister
person:Chris Stoeckert
OBI_0000042
group:OBI
data set
IAO:0000101
image
An image is an affine projection to a two dimensional surface, of measurements of some quality of an entity or entities repeated at regular intervals across a spatial range, where the measurements are represented as color and luminosity on the projected on surface.
person:Alan Ruttenberg
person:Allyson
person:Chris Stoeckert
OBI_0000030
group:OBI
image
IAO:0000102
data about an ontology part
data about an ontology part is a data item about a part of an ontology, for example a term
Person:Alan Ruttenberg
data about an ontology part
IAO:0000104
plan specification
PMID: 18323827.Nat Med. 2008 Mar;14(3):226.New plan proposed to help resolve conflicting medical advice.
A directive information entity with action specifications and objective specifications as parts that, when concretized, is realized in a process in which the bearer tries to achieve the objectives by taking the actions specified.
2009-03-16: provenance: a term a plan was proposed for OBI (OBI_0000344) , edited by the PlanAndPlannedProcess branch. Original definition was " a plan is a specification of a process that is realized by an actor to achieve the objective specified as part of the plan". It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term.
2014-03-31: A plan specification can have other parts, such as conditional specifications.
Alternative previous definition: a plan is a set of instructions that specify how an objective should be achieved
Alan Ruttenberg
OBI Plan and Planned Process branch
OBI_0000344
2/3/2009 Comment from OBI review.
Action specification not well enough specified.
Conditional specification not well enough specified.
Question whether all plan specifications have objective specifications.
Request that IAO either clarify these or change definitions not to use them
plan specification
IAO:0000109
measurement datum
Examples of measurement data are the recoding of the weight of a mouse as {40,mass,"grams"}, the recording of an observation of the behavior of the mouse {,process,"agitated"}, the recording of the expression level of a gene as measured through the process of microarray experiment {3.4,luminosity,}.
A measurement datum is an information content entity that is a recording of the output of a measurement such as produced by a device.
2/2/2009 is_specified_output of some assay?
person:Chris Stoeckert
OBI_0000305
group:OBI
measurement datum
IAO:0000225
obsolescence reason specification
The reason for which a term has been deprecated. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value.
The creation of this class has been inspired in part by Werner Ceusters' paper, Applying evolutionary terminology auditing to the Gene Ontology.
PERSON: Alan Ruttenberg
PERSON: Melanie Courtot
obsolescence reason specification
IAO:0000300
textual entity
Words, sentences, paragraphs, and the written (non-figure) parts of publications are all textual entities
A textual entity is a part of a manifestation (FRBR sense), a generically dependent continuant whose concretizations are patterns of glyphs intended to be interpreted as words, formulas, etc.
AR, (IAO call 2009-09-01): a document as a whole is not typically a textual entity, because it has pictures in it - rather there are parts of it that are textual entities. Examples: The title, paragraph 2 sentence 7, etc.
MC, 2009-09-14 (following IAO call 2009-09-01): textual entities live at the FRBR (http://en.wikipedia.org/wiki/Functional_Requirements_for_Bibliographic_Records) manifestation level. Everything is significant: line break, pdf and html versions of same document are different textual entities.
PERSON: Lawrence Hunter
text
textual entity
IAO:0000308
figure
Any picture, diagram or table
An information content entity consisting of a two dimensional arrangement of information content entities such that the arrangement itself is about something.
PERSON: Lawrence Hunter
figure
IAO:0000310
document
A journal article, patent application, laboratory notebook, or a book
A collection of information content entities intended to be understood together as a whole
PERSON: Lawrence Hunter
document
IAO:0000311
publication
A journal article or book
A document that has been accepted by a publisher
PERSON: Lawrence Hunter
publication
IAO:0000312
publication about an investigation
Most scientific journal articles
A publication that is about an investigation
PERSON: Lawrence Hunter
scientific publication
publication about an investigation
IAO:0000416
time measurement datum
A scalar measurement datum that is the result of measuring a temporal interval
2009/09/28 Alan Ruttenberg. Fucoidan-use-case
Person:Alan Ruttenberg
time measurement datum
IAO:0000429
email address
Alan Ruttenberg 1/3/2012 - Provisional id, see issue at http://code.google.com/p/information-artifact-ontology/issues/detail?id=130&thanks=130&ts=1325636583
Person:Alan Ruttenberg
Person:Chris Stoeckart
email address
IAO:0000572
documenting
Recording the current temperature in a laboratory notebook. Writing a journal article. Updating a patient record in a database.
a planned process in which a document is created or added to by including the specified input in it.
6/11/9: Edited at OBI workshop. We need to be able identify a child form of information artifact which corresponds to something enduring (not brain like). This used to be restricted to physical document or digital entity as the output, but that excludes e.g. an audio cassette tape
Bjoern Peters
wikipedia http://en.wikipedia.org/wiki/Documenting
documenting
IAO:0000577
centrally registered identifier symbol
The sentence "The article has Pubmed ID 12345." contains a CRID that has two parts: one part is the CRID symbol, which is '12345'; the other part denotes the CRID registry, which is Pubmed.
A symbol that is part of a CRID and that is sufficient to look up a record from the CRID's registry.
PERSON: Alan Ruttenberg
PERSON: Bill Hogan
PERSON: Bjoern Peters
PERSON: Melanie Courtot
CRID symbol
Original proposal from Bjoern, discussions at IAO calls
centrally registered identifier symbol
IAO:0000578
centrally registered identifier
The sentence "The article has Pubmed ID 12345." contains a CRID that has two parts: one part is the CRID symbol, which is '12345'; the other part denotes the CRID registry, which is Pubmed.
An information content entity that consists of a CRID symbol and additional information about the CRID registry to which it belongs.
2014-05-05: In defining this term we take no position on what the CRID denotes. In particular do not assume it denotes a *record* in the CRID registry (since the registry might not have 'records').
Alan, IAO call 20101124: potentially the CRID denotes the instance it was associated with during creation.
Note, IAO call 20101124: URIs are not always CRID, as not centrally registered. We acknowledge that CRID is a subset of a larger identifier class, but this subset fulfills our current needs. OBI PURLs are CRID as they are registered with OCLC. UPCs (Universal Product Codes from AC Nielsen)are not CRID as they are not centrally registered.
PERSON: Alan Ruttenberg
PERSON: Bill Hogan
PERSON: Bjoern Peters
PERSON: Melanie Courtot
CRID
Original proposal from Bjoern, discussions at IAO calls
centrally registered identifier
IAO:0000579
centrally registered identifier registry
PubMed is a CRID registry. It has a dataset of PubMed identifiers associated with journal articles.
A CRID registry is a dataset of CRID records, each consisting of a CRID symbol and additional information which was recorded in the dataset through a assigning a centrally registered identifier process.
PERSON: Alan Ruttenberg
PERSON: Bill Hogan
PERSON: Bjoern Peters
PERSON: Melanie Courtot
CRID registry
Original proposal from Bjoern, discussions at IAO calls
centrally registered identifier registry
IAO:0000590
written name
"Bill Clinton"
"The Eiffel Tower"
"United States of America"
A textual entity that denotes a particular in reality.
PERSON: Bill Hogan
http://code.google.com/p/information-artifact-ontology/issues/detail?id=114
The qualifier "written" is to set it apart from spoken names. Also, note the restrictions to particulars. We are not naming universals. We could however, be naming, attributive collections which are particulars, so "All people located in the boundaries of the city of Little Rock, AR on June 18, 2011 at 9:50a CDT" would be a name.
written name
MP:0001261
a status with body weight that is grossly above the average, acceptable or desirable weight, usually due to accumulation of excess fat tissue in the body
obese
NBO:0000073
"The process of biting and mashing food with the teeth prior to swallowing." [NBO:GVG]
chewing
NCBITaxon:10090
Mus musculus
Mus musculus
NCBITaxon:10114
Rattus
Rattus
NCBITaxon:10116
Rattus norvegicus
Rattus norvegicus
NCBITaxon:10239
Viruses
Viruses
NCBITaxon:117571
Euteleostomi
Euteleostomi
NCBITaxon:2
Bacteria
Bacteria
NCBITaxon:2157
Archaea
Archaea
NCBITaxon:2759
Eukaryota
Eukaryota
NCBITaxon:314146
Euarchontoglires
Euarchontoglires
NCBITaxon:32443
Teleostei
Teleostei
NCBITaxon:32524
Amniota
Amniota
NCBITaxon:32561
Sauria
Sauria
NCBITaxon:39107
Murinae
Murinae
NCBITaxon:7742
Vertebrata <Metazoa>
Vertebrata <Metazoa>
NCBITaxon:7776
Gnathostomata <vertebrate>
Gnathostomata <vertebrate>
NCBITaxon:7955
Danio rerio
Danio rerio
NCBITaxon:8570
Serpentes
Serpentes
NCBITaxon:8782
Aves
Aves
NCBITaxon:9606
Homo sapiens
Homo sapiens
OBCS:0000164
A software that is used for the differential gene expression significance analysis of DNA microarray experiments for both standard and time course experiments. The outputs consist of bothe p-values and q-values.
Elisabetta Manduchi
EDGE
Storey J.D. (2007) The optimal discovery procedure: A new approach to simultaneous significance testing, Journal of the Royal Statistical Society, Series B, 69: 347-368.
Storey J.D., Dai J.Y., and Leek J.T. (2007) The optimal discovery procedure for large-scale significance testing, with applications to comparative microarray experiments, Biostatistics, 8: 414-432.
Leek J.T,. Monsen E.C., Dabney A.R., and Storey J.D. (2006) EDGE: Extraction and analysis of differential gene expression, Bioinformatics, 22: 507-508.
Storey J.D., Xiao W., Leek J.T., Tompkins R.G., and Davis R.W. (2005) Significance analysis of time course microarray experiments, Proceedings of the National Academy of Sciences, 102: 12837-12842.
Beta Cell Biology Consortium
Extraction of Differential Gene Expression software
OBCS:0000165
A software that can be used to produce lists of differentially expressed genes with confidence measures attached. These lists are generated via a False Discovery Rate (FDR) method of controlling the false positives. Patterns from Gene Expression (PaGE) is more than a differential expression analysis tool. PaGE is a tool to attach descriptive, dependable, and easily interpretable expression patterns to genes across multiple conditions, each represented by a set of replicated array experiments.
The input consists of (replicated) intensities from a collection of array experiments from two or more conditions (or from a collection of direct comparisons on 2-channel arrays). The output consists of patterns, one for each row identifier in the data file. One condition is used as a reference to which the other types are compared. The length of a pattern equals the number of non-reference sample types. The symbols in the patterns are integers, where positive integers represent up-regulation as compared to the reference sample type and negative integers represent down-regulation. The patterns are based on the false discovery rates for each position in the pattern, so that the number of positive and negative symbols that appear in each position of the pattern is as descriptive as the data variability allows. The patterns generated are easily interpretable in that integers are used to represent different levels of up- or down-regulation as compared to the reference sample type.
Elisabetta Manduchi
PaGE
PMID:15797908
Grant G.R., Liu J., Stoeckert C.J.Jr. (2005) A practical false discovery rate approach to identifying patterns of differential expression in microarray data, Bioinformatics, 21(11): 2684-2690.
Beta Cell Biology Consortium
Patterns from Gene Expression software
OBCS:0000166
A software that is used to identify transcription factor binding sites in a genome that have been enriched with aligned reads generated from ChIP-Seq technology.
Elisabetta Manduchi, Jie Zheng
GLITR
PMID:19553195
Tuteja G., White P., Schug J., Kaestner K.H. (2009) Extracting transcription factor targets from ChIP-Seq data. Nucleic Acids Res., 37(17): e113. doi: 10.1093/nar/gkp536.
Beta Cell Biology Consortium
GLobal Identifier of Target Regions software
OBCS:0000167
A data transformation to identify protein-binding regions in a genome sequence from the data generated from a ChIP-sequencing or ChIP-chip experiment. When the protein is a transcription factor, the region is a transcription factor binding site (TFBS).
Jie Zheng
http://en.wikipedia.org/wiki/Peak_calling
peak calling
OBI:0000011
planned process
Injecting mice with a vaccine in order to test its efficacy
A processual entity that realizes a plan which is the concretization of a plan specification.
'Plan' includes a future direction sense. That can be problematic if plans are changed during their execution. There are however implicit contingencies for protocols that an agent has in his mind that can be considered part of the plan, even if the agent didn't have them in mind before. Therefore, a planned process can diverge from what the agent would have said the plan was before executing it, by adjusting to problems encountered during execution (e.g. choosing another reagent with equivalent properties, if the originally planned one has run out.)
We are only considering successfully completed planned processes. A plan may be modified, and details added during execution. For a given planned process, the associated realized plan specification is the one encompassing all changes made during execution. This means that all processes in which an agent acts towards achieving some
objectives is a planned process.
Bjoern Peters
branch derived
6/11/9: Edited at workshop. Used to include: is initiated by an agent
This class merges the previously separated objective driven process and planned process, as they the separation proved hard to maintain. (1/22/09, branch call)
planned process
OBI:0000015
biological feature identification objective
Biological_feature_identification_objective is an objective role carried out by the proposition defining the aim of a study designed to examine or characterize a particular biological feature.
Jennifer Fostel
biological feature identification objective
OBI:0000018
material supplier role
Jackson Labs is an organization which provide mice as experimental material
a role realized through the process of supplying materials such as animal subjects, reagents or other materials used in an investigation.
Supplier role is a special kind of service, e.g. biobank
PERSON:Jennifer Fostel
material provider role
supplier
material supplier role
OBI:0000025
reference substance role
Calibration standard, positive control substance, vehicle Good Laboratory Practices: Questions and Answers - Test Control and Reference Substance Characterization http://www.epa.gov/enforcement/monitoring/programs/fifra/glpqanda-character.html
a role inhering in a material entity that is realized when characteristics or responses elicited by the substance are used for comparison or reference.
Person:Jennifer Fostel
reference substance
OBI
reference substance role
OBI:0000045
waiting
not actively doing anything to a material for a duration of time.
PERSON:Alan Ruttenberg
OBI branch derived
BP: I have doubts about the utility of this.
We need a better handling/modeling of time (January 2008)
waiting
OBI:0000047
processed material
Examples include gel matrices, filter paper, parafilm and buffer solutions, mass spectrometer, tissue samples
Is a material entity that is created or changed during material processing.
PERSON: Alan Ruttenberg
processed material
OBI:0000049
mass spectrometer
LCQ Fleet Ion Trap MSn manufactured by thermo fisher scientific
A mass spectrometer is an instrument which is used to measure the mass to charge ratio of ions. All mass spectrometers consist of three basic parts: an ion source, a mass analyzer, and a detector system. The stages within the mass spectrometer are: 1. Production of ions from the sample 2. Separation of ions with different masses 3. Detection of the number of ions of each mass produced 4.Collection of data to generate the mass spectrum
Frank Gibson
http://en.wikipedia.org/wiki/Mass_spectrometry
mass spectrometer
OBI:0000052
microarray platform
A microarray platform is a platform that contains the instruments, software and reagents needed to perform a microarray protocol. definition_source: OBI.
OBI Instrument branch
OBI Instrument branch
microarray platform
OBI:0000055
software optimization objective
Software_optimization is a software_testing_objective role describing a study designed to identify the best software or parameters of the software.
Jennifer Fostel
software optimization objective
OBI:0000066
investigation
Lung cancer investigation using expression profiling, a stem cell transplant investigation, biobanking is not an investigation, though it may be part of an investigation
a planned process that consists of parts: planning, study design execution, documentation and which produce conclusion(s).
Bjoern Peters
OBI branch derived
Could add specific objective specification
Following OBI call November 2012,26th: it was decided there was no need for adding "achieves objective of drawing conclusion" as existing relations were providing equivalent ability. this note closes the issue and validates the class definition to be part of the OBI core
editor = PRS
study
investigation
OBI:0000067
evaluant role
When a specimen of blood is assayed for glucose concentration, the blood has the evaluant role. When measuring the mass of a mouse, the evaluant is the mouse. When measuring the time of DNA replication, the evaluant is the DNA. When measuring the intensity of light on a surface, the evaluant is the light source.
a role that inheres in a material entity that is realized in an assay in which data is generated about the bearer of the evaluant role
Role call - 17nov-08: JF and MC think an evaluant role is always specified input of a process. Even in the case where we have an assay taking blood as evaluant and outputting blood, the blood is not the specified output at the end of the assay (the concentration of glucose in the blood is)
examples of features that could be described in an evaluant: quality.... e.g. "contains 10 pg/ml IL2", or "no glucose detected")
GROUP: Role Branch
OBI
Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
evaluant role
OBI:0000068
reporting party role
Person who prepares microarray data in MAGE-TAB format and submits to a database, such as ArrayExpress.
The first section has been pre-designated as the 'Reporting Party' section and should be filled with the Reporting Party's personal information. http://www.mercedsheriff.com/SelfReporting.htm
a study personnel role played by a party who reports the outcome of a study component
MO:submitter mapped to this term. So, alternative term 'submitter' was added.
Jennifer Fostel
reporting party
submitter
OBI
reporting party role
OBI:0000070
assay
Assay the wavelength of light emitted by excited Neon atoms. Count of geese flying over a house.
A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies.
12/3/12: BP: the reference to the 'physical examination' is included to point out that a prediction is not an assay, as that does not require physical examiniation.
PlanAndPlannedProcess Branch
measuring
scientific observation
OBI branch derived
study assay
any method
assay
OBI:0000075
diagnosis textual entity
diagnosis is an assessment of a disease or injury, its likely prognosis and treatment.
Jennifer Fostel
diagnosis textual entity
OBI:0000079
culture medium
A growth medium or culture medium is a substance in which microorganisms or cells can grow. Wikipedia, growth medium, Feb 29, 2008
a processed material that provides the needed nourishment for microorganisms or cells grown in vitro.
changed from a role to a processed material based on on Aug 22, 2011 dev call. Details see the tracker item: http://sourceforge.net/tracker/?func=detail&aid=3325270&group_id=177891&atid=886178
Modification made by JZ.
Person: Jennifer Fostel, Jie Zheng
OBI
culture medium
OBI:0000086
reagent role
Buffer, dye, a catalyst, a solvating agent.
A role inhering in a biological or chemical entity that is intended to be applied in a scientific technique to participate (or have molecular components that participate) in a chemical reaction that facilitates the generation of data about some entity distinct from the bearer, or the generation of some specified material output distinct from the bearer.
PERSON:Matthew Brush
reagent
PERSON:Matthew Brush
Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
May 28 2013. Updated definition taken from ReO based on discussions initiated in Philly 2011 workshop. Former defnition described a narrower view of reagents in chemistry that restricts bearers of the role to be chemical entities ("a role played by a molecular entity used to produce a chemical reaction to detect, measure, or produce other substances"). Updated definition allows for broader view of reagents in the domain of biomedical research to include larger materials that have parts that participate chemically in a molecular reaction or interaction.
(copied from ReO)
Reagents are distinguished from instruments or devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in or have parts that participate in some chemical interaction or reaction during their intended participation in some technique. By contrast, instruments do not participate in a chemical reaction/interaction during the technique.
Reagents are distinguished from study subjects/evaluants in that study subjects and evaluants are that about which conclusions are drawn and knowledge is sought in an investigation - while reagents, by definition, are not. It should be noted, however, that reagent and study subject/evaluant roles can be borne by instances of the same type of material entity - but a given instance will realize only one of these roles in the execution of a given assay or technique. For example, taq polymerase can bear a reagent role or an evaluant role. In a DNA sequencing assay aimed at generating sequence data about some plasmid, the reagent role of the taq polymerase is realized. In an assay to evaluate the quality of the taq polymerase itself, the evaluant/study subject role of the taq is realized, but not the reagent role since the taq is the subject about which data is generated.
In regard to the statement that reagents are 'distinct' from the specified outputs of a technique, note that a reagent may be incorporated into a material output of a technique, as long as the IDENTITY of this output is distinct from that of the bearer of the reagent role. For example, dNTPs input into a PCR are reagents that become part of the material output of this technique, but this output has a new identity (ie that of a 'nucleic acid molecule') that is distinct from the identity of the dNTPs that comprise it. Similarly, a biotin molecule input into a cell labeling technique are reagents that become part of the specified output, but the identity of the output is that of some modified cell specimen which shares identity with the input unmodified cell specimen, and not with the biotin label. Thus, we see that an important criteria of 'reagent-ness' is that it is a facilitator, and not the primary focus of an investigation or material processing technique (ie not the specified subject/evaluant about which knowledge is sought, or the specified output material of the technique).
reagent role
OBI:0000094
material processing
A cell lysis, production of a cloning vector, creating a buffer.
A planned process which results in physical changes in a specified input material
PERSON: Bjoern Peters
PERSON: Frank Gibson
PERSON: Jennifer Fostel
PERSON: Melanie Courtot
PERSON: Philippe Rocca Serra
material transformation
OBI branch derived
material processing
OBI:0000096
protocol testing objective
Protocol_testing_objective is a methodology_testing_objective role describing a study designed to examine the effects of using different protocols.
Jennifer Fostel
protocol testing objective
OBI:0000097
participant under investigation role
Human subjects in a clinical trial, rats in a toxicogenomics study, tissue cutlures subjected to drug tests, fish observed in an ecotoxicology study.
Parasite example: people are infected with a parasite which is then extracted; the particpant under investigation could be the parasite, the people, or a population of which the people are members, depending on the nature of the study.
Lake example: a lake could realize this role in an investigation that assays pollution levels in samples of water taken from the lake.
A role that is realized through the execution of a study design in which the bearer of the role participates and in which data about that bearer is collected.
A participant can realize both "specimen role" and "participant under investigation role" at the same time. However "participant under investigation role" is distinct from "specimen role", since a specimen could somehow be involved in an investigation without being the thing that is under investigation.
GROUP: Role Branch
OBI
Following OBI call November 2012,26th:
1. it was decided there was no need for moving the children class and making them siblings of study subject role.
2. it also settles the disambiguation about 'study subject'. This is about the individual participating in the investigation/study, Not the 'topic' (as in 'toxicity study') of the investigation/study
This note closes the issue and validates the class definition to be part of the OBI core
editor = PRS
participant under investigation role
OBI:0000101
measured expression level
Examples are quantified data from an expression microarray experiment, PCR measurements, etc.
A measurement datum that is the outcome of the quantification of an assay for the activity of a gene, or the number of RNA transcripts.
person:Chris Stoeckert
OBI Data Transformation branch
measured expression level
OBI:0000109
biological vector role
1983 Sci. Amer. Jan. 58/2 Plasmids are routinely used as vectors for introducing foreign DNA into bacteria.
Some epidemiological aspects and vector role of tick infestation on layers in the Faisalabad district (Pakistan). http://journals.cambridge.org/action/displayAbstract;jsessionid=0373164489D00868AEEF2C556EB4FD29.tomcat1?fromPage=online&aid=624280
a biological vector role is a material to be added role that is realized by the process of transmitting material to the organism that is the target of the transmission.
Feb 20, 2009. The material transmitted can be genetic information (as in cloning vector) or a pathogen (as in a disease vector)
GROUP: Role Branch
OBI and Wikipedia
6/12/2009 Alan made this a material to be added role, because it was, and because this speeded up reasoning
biological vector role
OBI:0000112
specimen role
liver section; a portion of a culture of cells; a nemotode or other animal once no longer a subject (generally killed); portion of blood from a patient.
a role borne by a material entity that is gained during a specimen collection process and that can be realized by use of the specimen in an investigation
22Jun09. The definition includes whole organisms, and can include a human. The link between specimen role and study subject role has been removed. A specimen taken as part of a case study is not considered to be a population representative, while a specimen taken as representing a population, e.g. person taken from a cohort, blood specimen taken from an animal) would be considered a population representative and would also bear material sample role.
Note: definition is in specimen creation objective which is defined as an objective to obtain and store a material entity for potential use as an input during an investigation.
blood taken from animal: animal continues in study, whereas blood has role specimen.
something taken from study subject, leaves the study and becomes the specimen.
parasite example
- when parasite in people we study people, people are subjects and parasites are specimen
- when parasite extracted, they become subject in the following study
specimen can later be subject.
GROUP: Role Branch
OBI
specimen role
OBI:0000113
sequence feature identification objective
Sequence_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize molecular features exhibited at the level of a macromolecular sequence, e.g. nucleic acid, protein, polysaccharide.
Jennifer Fostel
sequence feature identification objective
OBI:0000115
intervention design
PMID: 18208636.Br J Nutr. 2008 Jan 22;:1-11.Effect of vitamin D supplementation on bone and vitamin D status among Pakistani immigrants in Denmark: a randomised double-blinded placebo-controlled intervention study.
An intervention design is a study design in which a controlled process applied to the subjects (the intervention) serves as the independent variable manipulated by the experimentalist. The treatment (perturbation or intervention) defined can be defined as a combination of values taken by independent variable manipulated by the experimentalists are applied to the recruited subjects assigned (possibly by applying specific methods) to treatment groups. The specificity of intervention design is the fact that independent variables are being manipulated and a response of the biological system is evaluated via response variables as monitored by possibly a series of assays.
Philppe Rocca-Serra
OBI branch derived
intervention design
OBI:0000116
worker role
Public sector workers in states that run their own OSHA programs are covered by those states. http://www.osha.gov/as/opa/worker/index.html
a personnel role played by a party who executes a component of the study plan; this can occur before, during, after or outside the study timeline
"executes the study plan" includes the suppliers and manufacturers of reagents and other materials used in the study
Person:Jennifer Fostel
worker
OBI
worker role
OBI:0000118
gene list
Gene lists may arise from analysis to determine differentially expressed genes, may be collected from the literature for involvement in a particular process or pathway (e.g., inflammation), or may be the input for gene set enrichment analysis.
A data set of the names or identifiers of genes that are the outcome of an analysis or have been put together for the purpose of an analysis.
person:Chris Stoeckert
group:OBI
kind of report. (alan) need to be careful to distinguish from output of a data transformation or calculation. A gene list is a report when it is published as such? Relates to question of whether report is a whole, or whether it can be a part of some other narrative object.
gene list
OBI:0000131
molecular feature identification objective
Molecular_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize molecular features of a biological system, e.g. expression profiling, copy number of molecular components, epigenetic modifications.
Jennifer Fostel
molecular feature identification objective
OBI:0000134
hardware testing objective
Hardware_testing_objective is a methodology_testing_objective role describing a study designed to examine the effects of using different hardware, e.g. scanner.
Jennifer Fostel
hardware testing objective
OBI:0000162
complete nutrient role
Rat chow; RPMI medium + serum; use example: CNS17 (Complete Nutrient System) Grow 3-2-4, http://www.kalyx.com/store/proddetail.cfm/ItemID/552307/CategoryID/12000/SubCatID/2755/file.htm
A nutrient role that inheres in a material entity and is realized in the use of that material entity by an organism to provide all needed nourishment.
Person: Jennifer Fostel
complete nutrient
complete nutrient role
OBI:0000164
cDNA library
PMID:6110205. collection of cDNA derived from mouse splenocytes.
Mixed population of cDNAs (complementaryDNA) made from mRNA from a defined source, usually a specific cell type. This term should be associated only to nucleic acid interactors not to their proteins product. For instance in 2h screening use living cells (MI:0349) as sample process.
ALT DEF (PRS):: a cDNA library is a collection of host cells, typically E.Coli cells but not exclusively. modified by transfer of plasmid DNA molecule used as vector containing a fragment or totality of cDNA molecule (the insert) . cDNA library may have an array of role and applications.
PERSON: Luisa Montecchi
PERSON: Philippe Rocca-Serra
GROUP: PSI
PRS: 22022008. class moved under population,
modification of definition and replacement of biomaterials in previous definition with 'material'
addition of has_role restriction
cDNA library
OBI:0000181
population
PMID12564891. Environ Sci Technol. 2003 Jan 15;37(2):223-8. Effects of historic PCB exposures on the reproductive success of the Hudson River striped bass population.
a population is a collection of individuals from the same taxonomic class living, counted or sampled at a particular site or in a particular area
1/28/2013, BP, on the call it was raised that we may want to switch to an external ontology for all populatin terms:
http://code.google.com/p/popcomm-ontology/
PERSON: Philippe Rocca-Serra
adapted from Oxford English Dictionnary
rem1: collection somehow always involve a selection process
population
OBI:0000185
imaging assay
An imaging assay is an assay to produce a picture of an entity. definition_source: OBI.
PlanAndPlannedProcess Branch
OBI branch derived
imaging assay
OBI:0000186
protocol optimization objective
Protocol_optimization is a protocol_testing_objective role describing a study designed to identify the best protocol. This may be carried out by comparing different protocols or by modifying the parameters used within a single protocol.
Jennifer Fostel
protocol optimization objective
OBI:0000198
biological replicate role
A member of a dose-time group; a patient in a given arm of a trial
a reference participant role realized by equivalent treatment of participants
Person:Jennifer Fostel
biological replicate
OBI
biological replicate role
OBI:0000202
investigation agent role
The person perform microarray experiments and submit microarray results (including raw data, processed data) with experiment description to ArrayExpress.
A role borne by an entity and that is realized in a process that is part of an investigation in which an objective is achieved. These processes include, among others: planning, overseeing, funding, reviewing.
Implementing a study means carrying out or performing the study and providing reagents or other materials used in the study and other tasks without which the study would not happen.
Philly2013: Historically, this role would have been borne only by humans or organizations. However, we now also want to enable representing investigations run by robot scientists such as ADAM (King et al, Science, 2009)
GROUP: Role Branch
investigator
OBI
Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
study person role
Philly2013: Historically, this role would have been borne only by humans or organizations. However, we now also want to enable investigations run by robot scientists such as ADAM (King et al, Science, 2009)
investigation agent role
OBI:0000204
nutrient role
Luria broth; vitamin A; A nutrient is a substance used in an organism's metabolism which must be taken in from the environment. Wikipedia.
a role that inheres in a material entity and is realized in the use of that material entity by an organism when it is used in that organism's metabolism and provides nourishment.
GROUP: Role branch
nutrient
Wikipedia, feb 29, 2008
19 Feb 2009; old def: A nutrient role is a role played by a substance used in an organism's metabolism which is taken in from the environment and provides nourishment.
nutrient role
OBI:0000208
methodology testing objective
Methodology_testing_objective is an objective role carried out by a proposition defining the aim of the study is to examine the effect of using different methodologies.
Jennifer Fostel
methodology testing objective
OBI:0000219
cellular feature identification objective
Cellular_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize a biological feature monitored at the cellular level, e.g. stage of cell cycle, stage of differentiation.
Jennifer Fostel
cellular feature identification objective
OBI:0000220
reference subject role
Saline treated rat; one of three identically-treated subjects
a reference subject role which inheres in an organism or entity of organismal origin so that the characteristics or responses of the participant playing the reference participant role are used for comparison or reference
Jennifer Fostel
reference participant
OBI
reference subject role
OBI:0000231
enzymatic cleavage
Polymorphism R62W results in resistance of CD23 to enzymatic cleavage in cultured cells. Genes Immun. 2007 Apr;8(3):215-23. Epub 2007 Feb 15. PMID: 17301828
enzymatic cleavage is a protocol application to digest the fraction of input material that is susceptible to that enzyme
PlanAndPlannedProcess Branch
OBI branch derived
enzymatic cleavage
OBI:0000232
hardware optimization objective
Hardware_optimization is a hardware_testing_objective describing a study designed to identify the best hardware.
Jennifer Fostel
hardware optimization objective
OBI:0000242
software testing objective
Software_testing_objective is a hardware_optimization role describing a study designed to examine the effects of using different software or software parameters, e.g. data processing software.
Jennifer Fostel
software testing objective
OBI:0000245
organization
PMID: 16353909.AAPS J. 2005 Sep 22;7(2):E274-80. Review. The joint food and agriculture organization of the United Nations/World Health Organization Expert Committee on Food Additives and its role in the evaluation of the safety of veterinary drug residues in foods.
An entity that can bear roles, has members, and has a set of organization rules. Members of organizations are either organizations themselves or individual people. Members can bear specific organization member roles that are determined in the organization rules. The organization rules also determine how decisions are made on behalf of the organization by the organization members.
BP: The definition summarizes long email discussions on the OBI developer, roles, biomaterial and denrie branches. It leaves open if an organization is a material entity or a dependent continuant, as no consensus was reached on that. The current placement as material is therefore temporary, in order to move forward with development. Here is the entire email summary, on which the definition is based:
1) there are organization_member_roles (president, treasurer, branch
editor), with individual persons as bearers
2) there are organization_roles (employer, owner, vendor, patent holder)
3) an organization has a charter / rules / bylaws, which specify what roles
there are, how they should be realized, and how to modify the
charter/rules/bylaws themselves.
It is debatable what the organization itself is (some kind of dependent
continuant or an aggregate of people). This also determines who/what the
bearer of organization_roles' are. My personal favorite is still to define
organization as a kind of 'legal entity', but thinking it through leads to
all kinds of questions that are clearly outside the scope of OBI.
Interestingly enough, it does not seem to matter much where we place
organization itself, as long as we can subclass it (University, Corporation,
Government Agency, Hospital), instantiate it (Affymetrix, NCBI, NIH, ISO,
W3C, University of Oklahoma), and have it play roles.
This leads to my proposal: We define organization through the statements 1 -
3 above, but without an 'is a' statement for now. We can leave it in its
current place in the is_a hierarchy (material entity) or move it up to
'continuant'. We leave further clarifications to BFO, and close this issue
for now.
PERSON: Alan Ruttenberg
PERSON: Bjoern Peters
PERSON: Philippe Rocca-Serra
PERSON: Susanna Sansone
GROUP: OBI
organization
OBI:0000248
feed role
Purina rat chow; cited use: Control; F = feed (rat chow); W = water; F. g. = feed-ginger concentrate. www.academicjournals.org/AJB/PDF/pdf2007/19Sep/Egwurugwu%20et%20al.pdf - Feb 29, 2008
a role that inheres in a material entity and is realized in the use of that material entity by lab animal to provide all needed nourishment.
Person: Jennifer Fostel
feed
OBI
feed role
OBI:0000249
technical replicate role
Aliquots of a tissue subjected to parallel assays
technical replicate role is realized when two portions from one evaluant are used in replicate runs of an assay
Person: Jennifer Fostel
technical replicate
technical replicate role
OBI:0000257
DNA extraction
A DNA extraction is a nucleic acid extraction where the desired output material is DNA.
PlanAndPlannedProcess Branch
OBI branch derived
DNA extraction
OBI:0000268
organism feature identification objective
Organism_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize a biological feature monitored at the level of the organism, e.g. height, weight, stage of development, stage of life cycle.
Jennifer Fostel
organism feature identification objective
OBI:0000272
protocol
PCR protocol, has objective specification, amplify DNA fragment of interest, and has action specification describes the amounts of experimental reagents used (e..g. buffers, dNTPS, enzyme), and the temperature and cycle time settings for running the PCR.
A plan specification which has sufficient level of detail and quantitative information to communicate it between investigation agents, so that different investigation agents will reliably be able to independently reproduce the process.
PlanAndPlannedProcess Branch
OBI branch derived + wikipedia (http://en.wikipedia.org/wiki/Protocol_%28natural_sciences%29)
study protocol
protocol
OBI:0000274
adding a material entity into a target
Injecting a drug into a mouse. Adding IL-2 to a cell culture. Adding NaCl into water.
is a process with the objective to place a material entity bearing the 'material to be added role' into a material bearing the 'target of material addition role'.
Class was renamed from 'administering substance', as this is commonly used only for additions into organisms.
BP
branch derived
adding a material entity into a target
OBI:0000275
analyte role
Glucose in blood (measured in an assay to determine the concentration of glucose).
A role borne by a molecular entity or an atom and realized in an analyte assay which achieves the objective to measure the magnitude/concentration/amount of the analyte in the entity bearing evaluant role
interestingly, an analyte is still an analyte even if it is not detected. for this reason it does not bear a specified input role
pH (technically the inverse log of [H+]) may be considered a quality; this remains to be tested.
qualities such as weight, color are not assayed but measured, so they do not fall into this category.
GROUP: Role Branch
OBI
Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
analyte role
OBI:0000278
disease stage
Stage II breast cancer, The timepoint of recovery from a disease
a part of an occurrence of a disease process which is associated with position in the normal progression of the disease
PERSON: Bjoern peters
disease stage
OBI:0000281
intraperitoneal injection
is the injection of a material entity (bearing the administered substance role) into the peritoneum (bearing the target role) of an organism using a syringe
BP
intraperitoneal injection
OBI:0000291
transcription factor binding site identification
Transcription factor binding site identification in yeast: a comparison of high-density oligonucleotide and PCR-based microarray platforms.
Funct Integr Genomics. 2007 Oct;7(4):335-45. Epub 2007 Jul 19. PMID: 17638031
a planned process with objective to find DNA region specifically recognized by proteins that function as transcription factors
JZ:
add equivalent axiom for classification
add alternative term 'TF binding' which was used in BCBC database
Philippe Rocca-Serra
TF binding
OBI
transcription factor binding site identification
OBI:0000319
material to be added role
drug added to a buffer contained in a tube; substance injected into an animal;
material to be added role is a protocol participant role realized by a material which is added into a material bearing the target of material addition role in a material addition process
Role Branch
OBI
9 March 09 from discussion with PA branch
material to be added role
OBI:0000338
drawing a conclusion based on data
Concluding that a gene is upregulated in a tissue sample based on the band intensity in a western blot. Concluding that a patient has a infection based on measurement of an elevated body temperature and reported headache. Concluding that there were problems in an investigation because data from PCR and microarray are conflicting. Concluding that 'defects in gene XYZ cause cancer due to improper DNA repair' based on data from experiments in that study that gene XYZ is involved in DNA repair, and the conclusion of a previous study that cancer patients have an increased number of mutations in this gene.
A planned process in which data gathered in an investigation is evaluated in the context of existing knowledge with the objective to generate more general conclusions or to conclude that the data does not allow one to draw general conclusion
PERSON: Bjoern Peters
PERSON: Jennifer Fostel
Bjoern Peters
drawing a conclusion based on data
OBI:0000339
planning
The process of a scientist thinking about and deciding what reagents to use as part of a protocol for an experiment. Note that the scientist could be human or a "robot scientist" executing software.
a process of creating or modifying a plan specification
7/18/2011 BP: planning used to itself be a planned process. Barry Smith pointed out that this would lead to an infinite regression, as there would have to be a plan to conduct a planning process, which in itself would be the result of planning etc. Therefore, the restrictions on 'planning' were loosened to allow for informal processes that result in an 'ad hoc plan '. This required changing from 'has_specified_output some plan specifiction' to 'has_participant some plan specification'.
Bjoern Peters
Bjoern Peters
Plans and Planned Processes Branch
planning
OBI:0000341
histological sample preparation
histological sample preparation is the preparation of an input tissue via slicing and labeling to make tissue microstructure of interest visible in a future histology assay
PERSON:Bjoern Peters
OBI branch derived
histological sample preparation
OBI:0000345
mass analyzer
The mass analyzer of the Voyager-DE(tm) STR Biospectrometry Workstation
A Mass analyzer is a device that separates ions according to their mass-to-charge ratio. All mass spectrometers are based on dynamics of charged particles in electric and magnetic fields in vacuum where the two laws of Lorentz force law and Newton's second law of motion apply.
Frank Gibson
PERSON: Daniel Schober
http://en.wikipedia.org/wiki/Mass_spectrometry#Mass_analyzer
mass analyzer
OBI:0000361
ion source
The ion source of a Voyager-DE??? STR Biospectrometry Workstation
An ion source is a device that is part of a mass
spectrometer that ionizes the material under analysis. The ions are
then transported by magnetic or electric fields to the mass analyzer.
Techniques for ionization have been key to determining what types of
samples can be analyzed by mass spectrometry. Electron ionization and
chemical ionization are used for gases and vapors. In chemical
ionization sources, the material is ionized by chemical ion-molecule
reactions during collisions in the source. Two techniques often used
with liquid and solid biological samples include electrospray
ionization (due to John Fenn PMID 2675315.) and matrix-assisted laser
desorption/ionization (MALDI, due to M. Karas and F. Hillenkamp
(Measuring Mass: From Positive Rays to Proteins by Michael A. Grayson
(Editor) (ISBN 0-941901-31-9))).
Frank Gibson
http://en.wikipedia.org/wiki/Mass_spectrometry#Ion_source
ion source
OBI:0000364
ion detector
The ion detector of the Voyager-DE(tm) STR Biospectrometry Workstation
An ion detector is a device that measures and records
the charge induced or current produced when an ion passes by or hits a
surface. In a scanning instrument the signal produced in the detector
during the course of the scan versus where the instrument is in the
scan (at what m/Q) will produce a mass spectrum, a record of ions as a
function of m/Q.
Frank Gibson
http://en.wikipedia.org/wiki/Mass_spectrometry#Detector
ion detector
OBI:0000367
light emission function
A light emission function is an excitation function to excite a material to a specific excitation state that it emits light.
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
light emission function
OBI:0000370
contain function
A syringe, a beaker
A contain function is a function to constrain a material entities location in space
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
contain function
OBI:0000371
heat function
A heat function is a function that increases the internal kinetic energy of a material
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
heat function
OBI:0000372
material separation function
A material separation function is a function that increases the resolution between two or more material entities. The to distinction between the entities is usually based on some associated physical quality.
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
material separation function
OBI:0000374
excitation function
A excitation function is a function to inject energy by bombarding a material with energetic particles (e.g., photons) thereby imbuing internal material components such as electrons with additional energy. These internal, 'excited' particles may lead to the rupturing of covalent chemical bonds or may quickly relax back to there unexcited state with an exponential time course thereby locally emitting energy in the form of photons.
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
excitation function
OBI:0000376
synthesizing function
A synthesizing function is a function to assemble new output materials from distinct input materials. The output materials typically consist of chemically distinct monomeric objects or object aggregate polymers.
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
synthesizing function
OBI:0000377
perturb function
A perturb function is a function that disrupts the normal function of a system induced through either internal or external means. External means of perturbation include: (1) displacement fields in the physical sense - e.g., temperature change, osmotic shock, pressure change; (2) application of small molecules such as drugs or toxins to perturb the function of specific pathways or application of surfactants to perturb the normal function of plasma membrane. Internal means of perturbation include: (1) manipulation of gene function via gene knockout or transcript knockdown via RNAi; (2) directed genetic mutation leading to minimal aa alterations that interfere with peptide function.
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
http://en.wikipedia.org/wiki/Perturbation_biology
perturb function
OBI:0000378
filter function
A filter function is a function to prevent the flow of certain entities based on a quality or qualities of the entity while allowing entities which have different qualities to pass through
Frank Gibson
filter function
OBI:0000379
mechanical function
A mechanical function is a function that is realised via mechanical work (through an certain amount of energy transferred by some force).
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
http://en.wikipedia.org/wiki/Mechanical_work
mechanical function
OBI:0000383
transfer function
A transfer function is a function to displace a material from one location to another.
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
transfer function
OBI:0000385
ionization function
The ion source in amass spectrometer
An ionization function is a function to physically convert an atom or molecule into an ion by adding or removing charged particles such as electrons or other ions.
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
http://en.wikipedia.org/wiki/Ionization
ionization function
OBI:0000387
cool function
A cool function is a function to decrease the internal kinetic energy of a material below the initial kinetic energy of that type of material.
Daniel Schober
Frank Gibson
Melanie Courtot
cool function
OBI:0000392
information processor function
An information processor function is a function that converts information from one form to another, by a lossless process or an extraction process.
Frank Gibson
data processor function
information processor function
OBI:0000397
image acquisition function
An image acquisition function is a function to acquire an image of a material
Frank Gibson
image acquisition function
OBI:0000398
image creation device
An image creation device is a device which captures a digitized image of an object
Frank Gibson
image acquisition device
sep:00096
image creation device
OBI:0000399
solid support function
Taped, glued, pinned, dried or molecularly bonded to a solid support
A solid support function is a function of a device on which an entity is kept in a defined position and prevented in its movement
Daniel Schober
Frank Gibson
Melanie Courtot
solid support function
OBI:0000401
environment control function
An environmental control function is a function that regulates a contained environment within specified parameter ranges. For example the control of light exposure, humidity and temperature.
Bill Bug
Daniel Schober
Frank Gibson
Melanie Courtot
environment control function
OBI:0000403
sort function
A sort function is a function to distinguish material components based on some associated physical quality or entity and to partition the separate components into distinct fractions according to a defined order.
Daniel Schober
Frank Gibson
Melanie Courtot
sort function
OBI:0000406
PCR product
PCR products are the results of amplifcation process. Detection of a PCR products is used to detect DNA and RNA.
is double stranded DNA that is the specified output of a polymerase chain reaction
We are using PCR and not the written out words, as this is the most common used.
GROUP: OBI BIomaterial Branch
GROUP: OBI BIomaterial Branch
PCR product
OBI:0000409
nucleic acid template role
a model or standard for making comparisons; wordnet.princeton.edu/perl/webwn 19 feb 2009
a reference substance role which inheres in nucleic acid material entity and is realized in the process of using the nucleic acid bearing the template role as a reference during synthesis of a reverse copy.
nucleic acid template role
OBI:0000411
cloning vector role
pBluescript plays the role of a cloning vector
a vector role played by a small, self-replicating DNA or RNA molecule - usually a plasmid or chromosome - and realized in a process whereby foreign DNA or RNA is inserted into the vector during the process of cloning.
PERSON: Helen Parkinson
cloning vector role
OBI:0000415
polymerase chain reaction
Opisthorchis viverrini: Detection by polymerase chain reaction (PCR) in human stool samples. Exp Parasitol. 2008 Sep 9. PMID: 18805413
PCR is the process in which a DNA polymerase is used to amplify a piece of DNA by in vitro enzymatic replication. As PCR progresses, the DNA thus generated is itself used as a template for replication. This sets in motion a chain reaction in which the DNA template is exponentially amplified.
OBI Plan
PCR
adapted from wikipedai
polymerase chain reaction
OBI:0000416
cloning insert role
cloning insert role is a role which inheres in DNA or RNA and is realized by the process of being inserted into a cloning vector in a cloning process.
Feb 20, 2009. from Wikipedia: cloning of any DNA fragment essentially involves four steps: DNA fragmentation with restriction endonucleases, ligation of DNA fragments to a vector, transfection, and screening/selection. There are multiple processes involved, it is not just "cloning process"
GROUP: Role branch
OBII and Wikipedia
cloning insert role
OBI:0000419
reverse transcriptase
enzyme and has_function some GO:0003964 (RNA-directed DNA polymerase
activity)
person:Melanie Courtot
group:OBI
reverse transcriptase
OBI:0000422
syringe
Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe.Ann Pharmacother. 2008 Jan;42(1):46-52. Epub 2007 Dec 4. PMID: 18056832
a processed material which is used to introduce or draw fluids from a material entity. A syringe is made of a piston and body. the movement of the piston in the body determines the amount/volume of fluid to inject or draw
Philippe Rocca-Serra
OBI Instrument adapted from Wikipedia
syringe
OBI:0000423
extract
Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G>a polymorphism reveal risk of oral cancer. Cancer Res. 2008 Oct 15;68(20):8489-98. PMID: 18922923
an extract is a material entity which results from an extraction process
PERSON: Philippe Rocca-Serra
extracted material
GROUP: OBI Biomatrial Branch
extract
OBI:0000424
transcription profiling assay
Whole genome transcription profiling of Anaplasma phagocytophilum in human and tick host cells by tiling array analysis. BMC Genomics. 2008 Jul 31;9:364. PMID: 18671858
An assay which aims to provide information about gene expression and transcription activity using ribonucleic acids collected from a material entity using a range of techniques and instrument such as DNA sequencers, DNA microarrays, Northern Blot
Philippe Rocca-Serra
gene expression profiling
OBI
transcription profiling
transcription profiling assay
OBI:0000425
averaging objective
A mean calculation which has averaging objective is a descriptive statistics calculation in which the mean is calculated by taking the sum of all of the observations in a data set divided by the total number of observations. It gives a measure of the 'center of gravity' for the data set. It is also known as the first moment.
An averaging objective is a data transformation objective where the aim is to perform mean calculations on the input of the data transformation.
Elisabetta Manduchi
James Malone
PERSON: Elisabetta Manduchi
averaging objective
OBI:0000426
injection
Multiple Small-Dose Injections Can Reduce the Passage of Sclerosant Foam into Deep Veins During Foam Sclerotherapy for Varicose Veins. Eur J Vasc Endovasc Surg. 2008 Oct 13. PMID: 18922712
injection is process which aims at introducing a compound or a mixture into a material entity (either biological entity or instrument) by relying on devices such as syringe or injector connection, attached or forced into a vascular system (veins of an organism or tubes of a machine) or in a tissue.
Philippe Rocca-Serra
OBI Biomaterial
injection
OBI:0000427
enzyme
(protein or rna) or has_part (protein or rna) and
has_function some GO:0003824 (catalytic activity)
MC: known issue: enzyme doesn't classify under material entity for now as it isn't stated that anything
that has_part some material entity is a material entity. If we add as equivalent classes to material entity has_part some material entity and part_of some material entity (each one in his own necessary and sufficient block) Pellet in P3 doesn't classify any more.
person: Melanie Courtot
GROUP:OBI
enzyme
OBI:0000429
intraperitoneal administration
Rats were injected intraperitoneally with either rrIL-6 (250 ng/0.5 ml) or equal-volume sterile saline twice within an interval of 24 h
The administration of a substance into the peritoneum of an organism
Person:Bjoern Peters
intraperitoneal administration
OBI:0000430
plasmid
plasmid = DNA and has_quality circular and has_function
(is_realized_as some gene expression) GO:0010467
person:Melanie Courtot
group:OBI
plasmid
OBI:0000434
adding material objective
creating a mouse infected with LCM virus
is the specification of an objective to add a material into a target material. The adding is asymmetric in the sense that the target material largely retains its identity
BP
adding material objective
OBI:0000435
genotyping assay
High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry. Clin Chem. 2008 Jan;54(1):86-92. Epub 2007 Nov 2.PMID: 17981923
an assay which generates data about a genotype from a specimen of genomic DNA. A variety of
techniques and instruments can be used to produce information about sequence variation at particular genomic positions.
Philippe Rocca-Serra
genotype profiling, SNP genotyping
OBI Biomaterial
SNP analysis
genotyping assay
OBI:0000437
analyte measurement objective
The objective to measure the concentration of glucose in a blood sample
an assay objective to determine the presence or concentration of an analyte in the evaluant
PERSON: Bjoern Peters
PPPB branch
analyte measurement objective
OBI:0000441
assay objective
the objective to determine the weight of a mouse.
an objective specification to determine a specified type of information about an evaluated entity (the material entity bearing evaluant role)
PPPB branch
PPPB branch
assay objective
OBI:0000443
analyte assay
example of usage: In lab test for blood glucose, the test is the assay, the blood bears evaluant_role and glucose bears the analyte role. The evaluant is considered an input to the assay and the information entity that records the measurement of glucose concentration the output
An assay with the objective to capture information about the presence, concentration, or amount of an analyte in an evaluant.
2013-09-23: simplify equivalent axiom
Note: is_realization of some analyte role isn't always true, for example when there is none of the analyte in the evaluant. For the moment we are writing it this way, but when the information ontology is further worked out this will be replaced with a condition discussing the measurement.
logical def modified to remove expression below, as some analyte assays report below the level of detection, and therefore not a scalar measurement datum, replaced by measurement datum
and
('has measurement unit label' some 'measurement unit label') and
('is quality measurement of' some 'molecular concentration'))
PERSON:Bjoern Peters, Helen Parkinson, Philippe Rocca-Serra, Alan Ruttenberg
PERSON:Bjoern Peters
PERSON:Helen Parkinson
PERSON:Philippe Rocca-Serra
PERSON:Alan Ruttenberg
GROUP:OBI Planned process branch
analyte assay
OBI:0000444
target of material addition role
peritoneum of an animal receiving an interperitoneal injection; solution in a tube receiving additional material; location of absorbed material following a dermal application.
target of material addition role is a role realized by an entity into which a material is added in a material addition process
From Branch discussion with BP, AR, MC -- there is a need for the recipient to interact with the administered material. for example, a tooth receiving a filling was not considered to be a target role.
GROUP: Role Branch
OBI
target of material addition role
OBI:0000451
normalized data set
A data set that is produced as the output of a normalization data transformation.
PERSON: James Malone
PERSON: Melanie Courtot
normalized data set
OBI:0000453
measure function
A glucometer measures blood glucose concentration, the glucometer has a measure function.
Measure function is a function that is borne by a processed material and realized in a process in which information about some entity is expressed relative to some reference.
PERSON: Daniel Schober
PERSON: Helen Parkinson
PERSON: Melanie Courtot
PERSON:Frank Gibson
measure function
OBI:0000455
consume data function
Process data function is a function that is borne by in a material entity by virtue of its structure. When realized the material entity consumes data.
PERSON: Daniel Schober
PERSON: Frank Gibson
PERSON: Melanie Courtot
consume data function
OBI:0000456
material transformation objective
The objective to create a mouse infected with LCM virus. The objective to create a defined solution of PBS.
an objective specifiction that creates an specific output object from input materials.
PERSON: Bjoern Peters
PERSON: Frank Gibson
PERSON: Jennifer Fostel
PERSON: Melanie Courtot
PERSON: Philippe Rocca-Serra
artifact creation objective
GROUP: OBI PlanAndPlannedProcess Branch
material transformation objective
OBI:0000457
manufacturing
Manufacturing is a process with the intent to produce a processed material which will have a function for future use. A person or organization (having manufacturer role) is a participant in this process
Manufacturing implies reproducibility and responsibility AR
This includes a single scientist making a processed material for personal use.
PERSON: Bjoern Peters
PERSON: Frank Gibson
PERSON: Jennifer Fostel
PERSON: Melanie Courtot
PERSON: Philippe Rocca-Serra
GROUP: OBI PlanAndPlannedProcess Branch
manufacturing
OBI:0000458
manufacturing objective
is the objective to manufacture a material of a certain function (device)
PERSON: Bjoern Peters
PERSON: Frank Gibson
PERSON: Jennifer Fostel
PERSON: Melanie Courtot
PERSON: Philippe Rocca-Serra
GROUP: OBI PlanAndPlannedProcess Branch
manufacturing objective
OBI:0000471
study design execution
injecting a mouse with PBS solution, weighing it, and recording the weight according to a study design.
a planned process that realizes the concretization of a study design
removed axiom has_part some (assay or 'data transformation') per discussion on protocol application mailing list to improve reasoner performance. The axiom is still desired.
branch derived
6/11/9: edited at workshop. Used to be: study design execution is a process with the objective to generate data according to a concretized study design. The execution of a study design is part of an investigation, and minimally consists of an assay or data transformation.
study design execution
OBI:0000552
reverse transcribed polymerase chain reaction
Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: an EU-FP6 supported study of members of the EORTC - PathoBiology Group.
Span PN, Sieuwerts AM, Heuvel JJ, Spyratos F, Duffy MJ, Eppenberger-Castori S, Vacher S, O'Brien K, McKiernan E, Pierce A, Vuaroqueaux V, Foekens JA, Sweep FC, Martens JW.
Eur J Cancer. 2009 Jan;45(1):74-81. PMID: 19008094
reverse transcribe pcr is a process which allow amplification of cDNA during a pcr reaction while the cDNA results from a retrotranscription of messenger RNA isolated from a material entity.
3/21/10, BP:Modified definition to clarify that this is not the assay, but the material transformation
Philippe Rocca-Serra
RT-PCR
reverse transcription polymerase chain reaction
reverse transcribed polymerase chain reaction
OBI:0000571
manufacturer role
With respect to The Accuri C6 Flow Cytometer System, the organization Accuri bears the role manufacturer role. With respect to a transformed line of tissue culture cells derived by a specific lab, the lab whose personnel isolated the cll line bears the role manufacturer role. With respect to a specific antibody produced by an individual scientist, the scientist who purifies, characterizes and distributes the anitbody bears the role manufacturer role.
Manufacturer role is a role which inheres in a person or organization and which is realized by a manufacturing process.
GROUP: Role Branch
OBI
manufacturer role
OBI:0000626
DNA sequencing
Genomic deletions of OFD1 account for 23% of oral-facial-digital type 1 syndrome after negative DNA sequencing. Thauvin-Robinet C, Franco B, Saugier-Veber P, Aral B, Gigot N, Donzel A, Van Maldergem L, Bieth E, Layet V, Mathieu M, Teebi A, Lespinasse J, Callier P, Mugneret F, Masurel-Paulet A, Gautier E, Huet F, Teyssier JR, Tosi M, Frébourg T, Faivre L. Hum Mutat. 2008 Nov 19. PMID: 19023858
DNA sequencing is a sequencing process which uses deoxyribonucleic acid as input and results in a the creation of DNA sequence information artifact using a DNA sequencer instrument.
Philippe Rocca-Serra
OBI Branch derived
nucleotide sequencing
DNA sequencing
OBI:0000634
DNA methylation profiling assay
Genome-wide, high-resolution DNA methylation profiling using bisulfite-mediated cytosine conversion. Reinders J, Delucinge Vivier C, Theiler G, Chollet D, Descombes P, Paszkowski J.
Genome Res. 2008 Mar;18(3):469-76. Epub 2008 Jan 24. PMID: 18218979
an assay which aims to provide information about state of methylation of DNA molecules using genomic DNA collected from a material entity using a range of techniques and instrument such as DNA sequencers and often relying on treatment with bisulfites to ensure cytosine conversion.
Philippe Rocca-Serra
OBI branch derived
DNA methylation profiling
DNA methylation profiling assay
OBI:0000639
material separation objective
The objective to obtain multiple aliquots of an enzyme preparation. The objective to obtain cells contained in a sample of blood.
is an objective to transform a material entity into spatially separated components.
PPPB branch
PPPB branch
material separation objective
OBI:0000648
clustered data set
A clustered data set is the output of a K means clustering data transformation
A data set that is produced as the output of a class discovery data transformation and consists of a data set with assigned discovered class labels.
PERSON: James Malone
PERSON: Monnie McGee
data set with assigned discovered class labels
AR thinks could be a data item instead
clustered data set
OBI:0000650
differential expression analysis data transformation
A differential expression analysis data transformation is a data transformation that has objective differential expression analysis and that consists of
James Malone
Melanie Courtot
Monnie McGee
WEB:
differential expression analysis data transformation
OBI:0000651
urine specimen
a portion of urine collected from an organism
4/10/2011BP: It seems to me that the editor notes refer to a previous version, and are no longer relevant.
This could be instead a kind of collection of secreted stuff. Among secreted stuff there is passive, and active. urine is secreted, passiv. lavage is secreted, active
are we happy calling collection of urine a material separation?
urine specimen
OBI:0000652
material combination
Mixing two fluids. Adding salt into water. Injecting a mouse with PBS.
is a material processing with the objective to combine two or more material entities as input into a single material entity as output.
created at workshop as parent class for 'adding material into target', which is asymmetric, while combination encompasses all addition processes.
bp
bp
material combination
OBI:0000654
device setting
Examples, 300V for 4 hours, 200mvolts, 37degrees.A knob set a 300 V is the device setting, the protocol stating to set the instrument to 300V is a device setting specification
a quality inheres_in some device and is concretization of some (device_setting_specification and is_about a quality of the device
PERSON: Frank Gibson
device setting
OBI:0000659
specimen collection process
drawing blood from a patient for analysis, collecting a piece of a plant for depositing in a herbarium, buying meat from a butcher in order to measure its protein content in an investigation
A planned process with the objective of collecting a specimen.
Note: definition is in specimen creation objective which is defined as an objective to obtain and store a material entity for potential use as an input during an investigation.
Philly2013: A specimen collection can have as part a material entity acquisition, such as ordering from a bank. The distinction is that specimen collection necessarily involves the creation of a specimen role. However ordering cell lines cells from ATCC for use in an investigation is NOT a specimen collection, because the cell lines already have a specimen role.
Philly2013: The specimen_role for the specimen is created during the specimen collection process.
label changed to 'specimen collection process' on 10/27/2014, details see tracker:
http://sourceforge.net/p/obi/obi-terms/716/
Bjoern Peters
specimen collection
5/31/2012: This process is not necessarily an acquisition, as specimens may be collected from materials already in posession
6/9/09: used at workshop
specimen collection process
OBI:0000668
error correction data transformation
An error correction data transformation is a data transformation that has the objective of error correction, where the aim is to remove (correct for) erroneous contributions from the input to the data transformation.
James Malone
Monnie McGee
EDITORS
error correction data transformation
OBI:0000671
sample from organism
a material obtained from an organism in order to be a representative of the whole
5/29: This is a helper class for now
we need to work on this: Is taking a urine sample a material separation process? If not, we will need to specify what 'taking a sample from organism' entails. We can argue that the objective to obtain a urine sample from a patient is enough to call it a material separation process, but it could dilute what material separation was supposed to be about.
sample from organism
OBI:0000674
center value
A data item that is produced as the output of a center calculation data transformation and represents the center value of the input data.
PERSON: James Malone
PERSON: Monnie McGee
median
center value
OBI:0000678
portioning objective
The objective to obtain multiple aliquots of an enzyme preparation.
A material separation objective aiming to separate material into multiple portions, each of which contains a similar composition of the input material.
portioning objective
OBI:0000679
average value
A data item that is produced as the output of an averaging data transformation and represents the average value of the input data.
PERSON: James Malone
PERSON: Monnie McGee
arithmetic mean
average value
OBI:0000680
whole organism preparation
putting a mouse in the blender. Not: putting a mouse on a scale
A material entity which is the output of a process in which one or more whole organisms are prepared in a way to make it easier to study them, and in which the great majority of organismal parts are maintained
does this include injecting a dye to a patient to be able to visualize parts of his brain? If not, we should state that the components of the organism are substantially re-arranged.
whole organism preparation
OBI:0000681
separation into different composition objective
The objective to obtain cells contained in a sample of blood.
A material separation objective aiming to separate a material entity that has parts of different types, and end with at least one output that is a material with parts of fewer types (modulo impurities).
We should be using has the grain relations or concentrations to distinguish the portioning and other sub-objectives
separation into different composition objective
OBI:0000684
specimen collection objective
The objective to collect bits of excrement in the rainforest. The objective to obtain a blood sample from a patient.
A objective specification to obtain a material entity for potential use as an input during an investigation.
Bjoern Peters
Bjoern Peters
specimen collection objective
OBI:0000686
material combination objective
is an objective to obtain an output material that contains several input materials.
PPPB branch
bp
material combination objective
OBI:0000689
454 Genome Sequence 20
PMID: 18946007.Pyrosequencing analysis of the oral microflora of healthy adults.
Keijser BJ, Zaura E, Huse SM, van der Vossen JM, Schuren FH, Montijn RC, ten Cate JM, Crielaard W. J Dent Res. 2008 Nov;87(11):1016-20.
is a DNA sequencer which is manufactured by 454 Life Science Corporation and enables pyrosequencing to be performed. It comprises both optics and fluidics subsystems, which are
controlled by a computer subsystem. The fluidics subsystem ensures accurate reagent dispensing. It consists of a reagents cassette (which holds the reagent containers), a sipper manifold, pumps, valves, and debubblers. The fluidics subsystem flows the sequencing reagents across the wells of the PicoTiterPlate device, and moves the spent reagents from the PicoTiterPlate device to the waste receptacle. The optics subsystem consists of a CCD camera and a camera controller. The camera captures the light emitted in the wells of the PicoTiterPlate device during each step of the sequencing cycle, and sends the digital images to the computer subsystem for processing. The computer controls the other Sequencer subsystems, and processes the digital images sent by the camera to extract the DNA sequence information.
Philippe Rocca-Serra
GS 20
454 Genome Sequence 20
OBI:0000690
immunoprecipitation
PMID: 19419533. Arabidopsis RNA immunoprecipitation. Terzi LC, Simpson GG. Plant J. 2009 Jul;59(1):163-8.
is a process which realizes a material separation objective by relying on antibodies to specifically binding to material entity
Philippe Rocca-Serra
OBI plan and planned process branch
immunoprecipitation
OBI:0000691
ABI 377 automated sequencer
is a DNA sequencer which is manufactured by Applied Biosystems corporation (formerly Perkin-Elmer). It allows automated chain termination DNA sequencing. It has part polyacrylamide gel electrophoresis system and a laser -based detection system to detect fluorescence intensity emitted by the dyes attached to the dideoxyterminator nucleotides or to the primers.
Philippe Rocca-Serra
Applied Biosystems
ABI 377 automated sequencer
OBI:0000693
MeDIP-seq assay
PMID: 18612301. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, Gräf S, Johnson N, Herrero J, Tomazou EM, Thorne NP, Bäckdahl L, Herberth M, Howe KL, Jackson DK, Miretti MM, Marioni JC, Birney E, Hubbard TJ, Durbin R, Tavaré S, Beck S. Nat Biotechnol. 2008 Jul;26(7):779-85.
is an assay which aims at identifying methylated sites in genomic DNA and determining methylation pattern that affect gene transcription by relying on immunoprecipitation of methylated genomic DNA, creation of a library of corresponding DNA fragments (either single or paired-end fragments) and subsequent sequencing using parallelized sequencing methods.
Philippe Rocca-Serra
Methylated DNA immunoprecipitation sequencing assay
adapted from wikipedia
MeDIP-seq assay
OBI:0000694
animal feeding
giving crickets to a snake.
animal feeding is a process in which animals are provided with food
In an investigation, this will typically be part of an animal care process
Bjoern Peters
branch derived
animal feeding
OBI:0000695
chain termination sequencing
PMID: 271968. DNA sequencing with chain-terminating inhibitors.
Sanger F, Nicklen S, Coulson AR. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7.
is a DNA sequencing which rely on the use of dideoxynucleotides used in 4 distinct sequencing reaction on the same DNA sample. The dideoxynucleotides, once incorporated in the complementary DNA strand being synthesized by the DNA polymerase prevent any further chain elongation. The newly generated sequences are resolved on a polyacrylamide gel using electrophoresis and labels (either fluorochrome or radioactivity) are used to determine the nucleotide present at a given position
Philippe Rocca-Serra
Sanger sequencing
dye terminator sequencing
adapted from wikipedia
chain termination sequencing
OBI:0000696
AB SOLiD System
PMID: 19336255. RNA-Seq-quantitative measurement of expression through massively parallel RNA-sequencing. Wilhelm BT, Landry JR. Methods. 2009 Jul;48(3):249-57.
is a DNA sequencer which is manufactured by Applied Biosystems and which enable DNA sequencing by ligation
Philippe Rocca-Serra
Applied Biosystems
AB SOLiD System
OBI:0000697
Helicos sequencing
PMID: 18388294. Single-molecule DNA sequencing of a viral genome.
Harris TD, Buzby PR, Babcock H, Beer E, Bowers J, Braslavsky I, Causey M, Colonell J, Dimeo J, Efcavitch JW, Giladi E, Gill J, Healy J, Jarosz M, Lapen D, Moulton K, Quake SR, Steinmann K, Thayer E, Tyurina A, Ward R, Weiss H, Xie Z. Science. 2008 Apr 4;320(5872):106-9.
is a DNA sequencing which allows sequence identification of billions of DNA molecules immobilized to a surface by using DNA polymerase and fluorescently labeled nucleotides added one at a time. The sequencing process does not requires amplification step and is typically able to produce reads of 25 base pair length.
Philippe Rocca-Serra
true single molecule sequencing
adapted from wikipedia
Helicos sequencing
OBI:0000702
454 Genome Sequencer FLX
PMID: 18616967. The Genome Sequencer FLX System--longer reads, more applications, straight forward bioinformatics and more complete data sets. Droege M, Hill B.
J Biotechnol. 2008 Aug 31;136(1-2):3-10.
is a DNA sequencer which is manufactured by 454 Life Science Corporation and enables pyrosequencing to be performed. It comprises both optics and fluidics subsystems, which are
controlled by a computer subsystem. The fluidics subsystem ensures accurate reagent dispensing. It consists of a reagents cassette (which holds the reagent containers), a sipper manifold, pumps, valves, and debubblers. The fluidics subsystem flows the sequencing reagents across the wells of the PicoTiterPlate device, and moves the spent reagents from the PicoTiterPlate device to the waste receptacle. The optics subsystem consists of a CCD camera and a camera controller. The camera captures the light emitted in the wells of the PicoTiterPlate device during each step of the sequencing cycle, and sends the digital images to the computer subsystem for processing. The computer controls the other Sequencer subsystems, and processes the digital images sent by the camera to extract the DNA sequence information.
Philippe Rocca-Serra
454 GS FLX
GS-FLX
adapted from https://www.roche-applied-science.com/servlet/RCProductDisplay?langId=-1&storeId=10202&productId=3.8.8.1.1.3&catalogId=10202&krypto=mgV8a0Sdps6%2BCXU8IoddmzNEyGgjde9j8MOFCiMzRsduELeenAlVZ%2FE1QR%2BxLpzNlqMZPLRHqaI%3D&ddkey=https:RCProductDisplay
454 Genome Sequencer FLX
OBI:0000703
Illumina Genome Analyzer II
PMID: 19336255. RNA-Seq-quantitative measurement of expression through massively parallel RNA-sequencing. Wilhelm BT, Landry JR.Methods. 2009 Jul;48(3):249-57.
is a DNA sequence which is manufactured by Illumina (Solexa) corporation. it support sequencing of single or paired end clone libraries relying on sequencing by synthesis technology
Philippe Rocca-Serra
Illumina Corporation
Illumina Genome Analyzer II
OBI:0000705
Edman degradation
PMID 4773306. Niall HD (1973). "Automated Edman degradation: the protein sequenator". Meth. Enzymol. 27: 942-1010
is a process which produces a sequence from an input peptide or protein. In this process, the amino-terminal (N-terminal) residue is labeled and cleaved from the peptide without disrupting the peptide bonds between other amino acid residues.
adapted from Wikipedia (http://en.wikipedia.org/wiki/Edman_degradation)
Edman degradation
OBI:0000706
SOLiD sequencing
PMID: 19119315. High-resolution analysis of the 5'-end transcriptome using a next generation DNA sequencer. Hashimoto S, Qu W, Ahsan B, Ogoshi K, Sasaki A, Nakatani Y, Lee Y, Ogawa M, Ametani A, Suzuki Y, Sugano S, Lee CC, Nutter RC, Morishita S, Matsushima K. PLoS One. 2009;4(1):e4108.
is a DNA sequencing which allows sequence identification by relying on the following steps:
1. Primers hybridize to the P1 adapter sequence within the library template.
2. A set of four fluorescently labeled di-base probes compete for ligation to the sequencing primer. Specificity of the di-base probe is achieved by interrogating every 1st and 2nd base in each ligation reaction.
3. Multiple cycles of ligation, detection and cleavage are performed with the number of cycles determining the eventual read length.
4. Following a series of ligation cycles, the extension product is removed and the template is reset with a primer complementary to the n-1 position for a second round of ligation cycles
Philippe Rocca-Serra
adapted from Wikipedia and Applied Biosystems web site
SOLiD sequencing
OBI:0000710
Li-Cor 4300 DNA Analysis System
is a DNA sequencer which is manufactured by Li-Cor corporation and enable automated chain termination based DNA sequencing
Philippe Rocca-Serra
OBI and Li-Cor
Li-Cor 4300 DNA Analysis System
OBI:0000711
library preparation
PMID: 19570239. Construction and analysis of cotton (Gossypium arboreum L.) drought-related cDNA library. Zhang L, Li FG, Liu CL, Zhang CJ, Zhang XY. BMC Res Notes. 2009 Jul 2;2:120.
is a process which results in the creation of a library from fragments of DNA using cloning vectors or oligonucleotides with the role of adaptors.
Philippe Rocca-Serra
library construction
library preparation
OBI:0000716
ChIP-seq assay
PMID: 19275939
ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions.
Schmidt D, Wilson MD, Spyrou C, Brown GD, Hadfield J, Odom DT.
Methods. 2009 Jul;48(3):240-8. Epub 2009 Mar 9.
an assay which aims at identifying protein binding sites in genomic DNA and determining how protein may regulate gene transcription by relying on immunoprecipitation of DNA bound protein, creation of a library of corresponding DNA fragments (either single or paired-end fragments) and subsequent sequencing using parallelized sequencing methods.
Philippe Rocca-Serra
chromatin immunoprecipitation sequencing assay
adapted from Wikipedia
made some modification based on the discussion on 2011/4/4 obi dev call, using DNA sequencing instead of union of some specific DNA sequencing processes
ChIP-seq assay
OBI:0000717
HeliScope Single Molecule Sequencer
is a DNA sequencer manufacturer by Helicos Corporation to carry out Single Molecule sequencing using reversible termination chemistry
Philippe Rocca-Serra
HeliScope Single Molecule Sequencer
OBI:0000722
paired-end library
PMID: 19339662. Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. Genome Res. 2009 Apr;19(4):521-32. Fullwood MJ, Wei CL, Liu ET, Ruan Y.
is a collection of short paired tags from the two ends of DNA fragments are extracted and covalently linked as ditag constructs
Philippe Rocca-Serra
mate-paired library
paired-end tag (PET) library
adapted from information provided by Solid web site
paired-end library
OBI:0000723
DNA sequencing by ligation
PMID: 19546169. Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two base encoding.
McKernan KJ, Peckham HE, Costa G, McLaughlin S, Tsung E, Fu Y,
Clouser C, Dunkan C, Ichikawa J, Lee C, Zhang Z, Sheridan A, Fu H, Ranade S, Dimilanta E, Sokolsky T, Zhang L, Hendrickson C, Li B, Kotler L, Stuart J, Malek J, Manning J, Antipova A, Perez D, Moore M, Hayashibara K, Lyons M, Beaudoin R, Coleman B, Laptewicz M, Sanicandro A, Rhodes M, De La Vega F, Gottimukkala RK, Hyland F, Reese M, Yang S, Bafna V, Bashir A, Macbride A, Aklan C, Kidd JM, Eichler EE, Blanchard AP. Genome Res. 2009 Jun 22.
is a DNA sequencing which relies on DNA ligase activity to perform chain extension during the sequencing reaction step.
PERSON: Philippe Rocca-Serra
DNA sequencing by ligation
OBI:0000724
Solexa sequencing
PMID: 18987734
Accurate whole human genome sequencing using reversible terminator chemistry. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, Boutell JM, Bryant J, Carter RJ, Keira Cheetham R, Cox AJ, Ellis DJ, Flatbush MR, Gormley NA, Humphray SJ, Irving LJ, Karbelashvili MS, Kirk SM, Li H, Liu X, Maisinger KS, Murray LJ, Obradovic B, Ost T, Parkinson ML, Pratt MR, Rasolonjatovo IM, Reed MT, Rigatti R, Rodighiero C, Ross MT, Sabot A, Sankar SV, Scally A, Schroth GP, Smith ME, Smith VP, Spiridou A, Torrance PE, Tzonev SS, Vermaas EH, Walter K, Wu X, Zhang L, Alam MD, Anastasi C, Aniebo IC, Bailey DM, Bancarz IR, Banerjee S, Barbour SG, Baybayan PA, Benoit VA, Benson KF, Bevis C, Black PJ, Boodhun A, Brennan JS, Bridgham JA, Brown RC, Brown AA, Buermann DH, Bundu AA, Burrows JC, Carter NP, Castillo N, Chiara E Catenazzi M, Chang S, Neil Cooley R, Crake NR, Dada OO, Diakoumakos KD, Dominguez-Fernandez B, Earnshaw DJ, Egbujor UC, Elmore DW, Etchin SS, Ewan MR, Fedurco M, Fraser LJ, Fuentes Fajardo KV, Scott Furey W, George D, Gietzen KJ, Goddard CP, Golda GS, Granieri PA, Green DE, Gustafson DL, Hansen NF, Harnish K, Haudenschild CD, Heyer NI, Hims MM, Ho JT, Horgan AM, Hoschler K, Hurwitz S, Ivanov DV, Johnson MQ, James T, Huw Jones TA, Kang GD, Kerelska TH, Kersey AD, Khrebtukova I, Kindwall AP, Kingsbury Z, Kokko-Gonzales PI, Kumar A, Laurent MA, Lawley CT, Lee SE, Lee X, Liao AK, Loch JA, Lok M, Luo S, Mammen RM, Martin JW, McCauley PG, McNitt P, Mehta P, Moon KW, Mullens JW, Newington T, Ning Z, Ling Ng B, Novo SM, O'Neill MJ, Osborne MA, Osnowski A, Ostadan O, Paraschos LL, Pickering L, Pike AC, Pike AC, Chris Pinkard D, Pliskin DP, Podhasky J, Quijano VJ, Raczy C, Rae VH, Rawlings SR, Chiva Rodriguez A, Roe PM, Rogers J, Rogert Bacigalupo MC, Romanov N, Romieu A, Roth RK, Rourke NJ, Ruediger ST, Rusman E, Sanches-Kuiper RM, Schenker MR, Seoane JM, Shaw RJ, Shiver MK, Short SW, Sizto NL, Sluis JP, Smith MA, Ernest Sohna Sohna J, Spence EJ, Stevens K, Sutton N, Szajkowski L, Tregidgo CL, Turcatti G, Vandevondele S, Verhovsky Y, Virk SM, Wakelin S, Walcott GC, Wang J, Worsley GJ, Yan J, Yau L, Zuerlein M, Rogers J, Mullikin JC, Hurles ME, McCooke NJ, West JS, Oaks FL, Lundberg PL, Klenerman D, Durbin R, Smith AJ. Nature. 2008 Nov 6;456(7218):53-9.
is a DNA sequencing which allows sequence identification by relying on use of DNA polymerase and reversible terminator. The methods requires immobilization of genomic DNA fragment onto a surface and a specific clonal amplification step known as bridge PCR. Reliance on reversible terminator allow cycles of DNA chain extension by DNA polymerase and imaging without the need of electrophoretic separation of newly synthesized DNA fragment as with Sanger sequencing.
Philippe Rocca-Serra
reversible terminator sequencing
adapted from Wikipedia and Illumina / Solexa web site (SS_DNAsequencing.pdf document available on july 2009)
Solexa sequencing
OBI:0000725
host role
In biology, a host is an organism that harbors a virus or parasite, or a mutual or commensal symbiont, typically providing nourishment and shelter. http://en.wikipedia.org/wiki/Host_(biology) 30 March 09
host role is a role played by an organism and realized by providing nourishment, shelter or a means of reproduction to another organism within the organism playing the host role
30Mar09 virus reproducing inside a cell; bacteria causing a disease, host can be harmed or not. we want to avoid a cat sitting on my lap and an animal care technician; these are not examples or hosts; dental cares = on tooth, but part of outer layer of tooth, so covered by "within" in the definition
GROUP: Role Branch
30 Mar09 submitted by vaccine community
OBI
http://en.wikipedia.org/wiki/Host_(biology)
host role
OBI:0000730
pyrosequencing
Pyrosequencing sheds light on DNA sequencing.
PMID: 1115661. Ronaghi M. Genome Res. 2001 Jan;11(1):3-11. Review.
is a DNA sequencing which allows sequencing of a single strand of DNA by synthesizing the complementary strand along it, one base pair at a time, and detecting which base was actually added at each step. The template DNA is immobilized, and solutions of A, C, G, and T nucleotides are added and removed after the reaction, sequentially. Light is produced only when the nucleotide solution complements the first unpaired base of the template. The sequence of solutions which produce chemiluminescent signals allows the determination of the sequence of the template.
ssDNA template is hybridized to a sequencing primer and incubated with the enzymes DNA polymerase, ATP sulfurylase, luciferase and apyrase, and with the substrates adenosine 5-prime phosphosulfate (APS) and luciferin.
Philippe Rocca-Serra
Wikipedia (http://en.wikipedia.org/wiki/Pyrosequencing) and Roche 454 life science web site
pyrosequencing
OBI:0000731
recombinant vector
A recombinant vector is created by a recombinant vector cloning process, and contains nucleic acids that can be amplified. It retains functions of the original cloning vector.
recombinant vector
OBI:0000734
DNA sequencing by synthesis
PMID: 18263613. A new class of cleavable fluorescent nucleotides: synthesis and optimization as reversible terminators for DNA sequencing by synthesis. Turcatti G, Romieu A, Fedurco M, Tairi AP. Nucleic Acids Res. 2008 Mar;36(4):e25.
is a DNA sequencing which relies on DNA polymerase activity to perform chain extension during the sequencing reaction step.
PERSON: Philippe Rocca-Serra
DNA sequencing by synthesis
OBI:0000736
single fragment library
is a collection of short tags from DNA fragments, are extracted and covalently linked as single tag constructs
Philippe Rocca-Serra
fragment library
single fragment library
OBI:0000737
cloning vector
A cloning vector is an engineered material that is used as an input material for a recombinant vector cloning process to carry inserted nucleic acids. It contains an origin of replication for a specific destination host organism, encodes for a selectable gene product and contains a cloning site.
cloning vector
OBI:0000740
material sample role
a role borne by a portion of blood taken to represent all the blood in an organism; the role borne by a population of humans with HIV enrolled in a study taken to represent patients with HIV in general.
A material sample role is a specimen role borne by a material entity that is the output of a material sampling process.
7/13/09: Note that this is a relational role: between the sample taken and the 'sampled' material of which the sample is thought to be representative off.
material sample role
OBI:0000747
material sample
blood drawn from patient to measure his systemic glucose level. A population of humans with HIV enrolled in a study taken to represent patients with HIV in general.
A material entity that has the material sample role
OBI: workshop
sample population
sample
material sample
OBI:0000748
bisulfite sequencing
PMID: 19581485. High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Hodges E, Smith A, Kendall J, Xuan Z, Ravi K, Rooks M, Zhang M, Ye K, Battacharjee A, Brizuela L, McCombie WR, Wigler M, Hannon GJ, Hicks J.
Genome Res. 2009 Jul 6.
An assay which allows to determine the methylation status of genomic DNA using DNA sequencing techniques preceded by a bisulfite based chemical modification of genomic DNA at CpG island location.
8/19/09: Chris says that there may used to be a way of doing bisulfite sequencing comparing lengths of restriction fragments, which implies that it is possible to do without DNA sequencing.
Philippe Rocca-Serra
adapted from Wikipedia
bisulfite sequencing
OBI:0000750
study design independent variable
In a study in which gene expression is measured in patients between 8 month to 4 years old that have mild or severe malaria and in which the hypothesis is that gene expression in that age group is a function of disease status, disease status is the independent variable.
a directive information entity that is part of a study design. Independent variables are entities whose values are selected to determine its relationship to an observed phenomenon (the dependent variable). In such an experiment, an attempt is made to find evidence that the values of the independent variable determine the values of the dependent variable (that which is being measured). The independent variable can be changed as required, and its values do not represent a problem requiring explanation in an analysis, but are taken simply as given. The dependent variable on the other hand, usually cannot be directly controlled
2/2/2009 Original definition - In the design of experiments, independent variables are those whose values are controlled or selected by the person experimenting (experimenter) to determine its relationship to an observed phenomenon (the dependent variable). In such an experiment, an attempt is made to find evidence that the values of the independent variable determine the values of the dependent variable (that which is being measured). The independent variable can be changed as required, and its values do not represent a problem requiring explanation in an analysis, but are taken simply as given. The dependent variable on the other hand, usually cannot be directly controlled.
In the Philly 2013 workshop the label was chosen to distinguish it from "dependent variable" as used in statistical modelling. See: http://en.wikipedia.org/wiki/Statistical_modeling
PERSON: Alan Ruttenberg
PERSON: Bjoern Peters
PERSON: Chris Stoeckert
experimental factor
independent variable
Web: http://en.wikipedia.org/wiki/Dependent_and_independent_variables
2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify thisdefinition please notify OBI.
study factor
study design independent variable
OBI:0000751
study design dependent variable
In a study in which gene expression is measured in patients between 8 month to 4 years old that have mild or severe malaria and in which the hypothesis is that gene expression in that age group is a function of disease status, the gene expression is the dependent variable.
dependent variable specification is part of a study design. The dependent variable is the event studied and expected to change when the independent variable varies.
2/2/2009 In the design of experiments, independent variables are those whose values are controlled or selected by the person experimenting (experimenter) to determine its relationship to an observed phenomenon (the dependent variable). In such an experiment, an attempt is made to find evidence that the values of the independent variable determine the values of the dependent variable (that which is being measured). The independent variable can be changed as required, and its values do not represent a problem requiring explanation in an analysis, but are taken simply as given. The dependent variable on the other hand, usually cannot be directly controlled.
In the Philly 2013 workshop the label was chosen to distinguish it from "dependent variable" as used in statistical modelling. See: http://en.wikipedia.org/wiki/Statistical_modeling
PERSON: Alan Ruttenberg
PERSON: Bjoern Peters
PERSON: Chris Stoeckert
dependent variable
WEB: http://en.wikipedia.org/wiki/Dependent_and_independent_variables
2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify thisdefinition please notify OBI.
study design dependent variable
OBI:0000785
study design controlled variable
In a study in which gene expression is measured in patients between 8 month to 4 years old that have mild or severe malaria and in which the hypothesis is that gene expression in that age group is a function of disease status, age is a controlled variable.
Controlled variable specification is a part of a study design. They are the entities that could vary, but are kept constant to prevent their influence on the effect of the independent variable on the dependent.
2/2/2009 Original definition: Controlled variables are also important to identify in experiments. They are the variables that are kept constant to prevent their influence on the effect of the independent variable on the dependent. Every experiment has a controlling variable, and it is necessary to not change it, or the results of the experiment won't be valid
In the Philly 2013 workshop the label was chosen to distinguish it from "controlled variable" as used in statistical modelling
PERSON: Alan Ruttenberg
PERSON: Bjoern Peters
PERSON: Chris Stoeckert
controlled variable
WEB: http://en.wikipedia.org/wiki/Control_variable
2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify thisdefinition please notify OBI.
study design controlled variable
OBI:0000791
multiple testing correction objective
Application of the Bonferroni correction
A multiple testing correction objectives is a data transformation objective where the aim is to correct for a set of statistical inferences considered simultaneously
multiple comparison correction objective
http://en.wikipedia.org/wiki/Multiple_Testing_Correction
multiple testing correction objective
OBI:0000794
transcription factor binding site
SO:0000235
PLace_holder for sequence ontology term
transcription factor binding site
OBI:0000796
purification objective
the objective to obtain a pure fraction of a specific peptide when running an HPLC on a crude synthesis of peptides.
The objective to separate a material entity into different compositions of which one or more have are purified fractions that contain higher concentration of a desired component, while others contain impurities and are not of interest
PERSON:Bjoern Peters
isolation objective
BP
10/14/09, BP: This should be linked to the 'purified' 'currently conferred quality
purification objective
OBI:0000800
cross linking
cross linking can be used as a probe to link proteins together, to check protein protein interactions
A process in which bonds are created that link one polymer to another
PERSON: Chris Stoeckert
http://en.wikipedia.org/wiki/Cross-link
cross linking
OBI:0000806
material maintenance objective
An objective specification maintains some or all of the qualities of a material over time.
PERSON: Bjoern Peters
PERSON: Bjoern Peters
material maintenance objective
OBI:0000809
amplified DNA
Amplied DNA created by PCR
DNA that has been produced in an enzymatic amplification process
PERSON: Alan Ruttenberg
Alan Ruttenberg
amplified DNA
OBI:0000811
primary structure of DNA macromolecule
a quality of a DNA molecule that inheres in its bearer due to the order of its DNA nucleotide residues.
placeholder for SO
BP et al
primary structure of DNA macromolecule
OBI:0000831
DNA residue methylation
a quality of a DNA residue that has a methyl group attached to it
DNA residue methylation
OBI:0000832
measurement device
A ruler, a microarray scanner, a Geiger counter.
A device in which a measure function inheres.
GROUP:OBI Philly workshop
OBI
measurement device
OBI:0000834
high molecular weight DNA extract
Extraction of chromosomal DNA from mammalian cells by first isolating nucei
The output of an extraction process in which DNA molecules above a molecular weight cutoff are purified in order to exclude DNA from organellas.
PERSON:Chris Stoeckert
OBI
high molecular weight DNA extract
OBI:0000838
material maintenance
a process with that achieves the objective to maintain some or all of the characteristics of an input material over time
material maintenance
OBI:0000845
primary structure of RNA molecule
The primary structure of an RNA molecule that is completely defined by the set of its nucleic residue parts and the linear order induced by the peptide bonds that hold them together
Person:Bjoern Peters
primary structure of RNA molecule
OBI:0000848
polyA RNA extraction
A RNA extraction process typically involving the use of poly dT oligomers in which the desired output material is polyA RNA.
Person: Chris Stoeckert
Person: Jie Zheng
UPenn Group
polyA RNA extraction
OBI:0000849
organellar RNA extraction
A RNA extraction process in which the desired output material is RNA in the organelle(s).
Person: Chris Stoeckert
Person: Jie Zheng
UPenn Group
organellar RNA extraction
OBI:0000852
record of missing knowledge
A statement in a journal article indicating that the age of a patient at the onset of disease is not known. A statement indicating that the weight of a mouse was not measured.
a information content entity created to indicate that information about something is not available to the person recording it.
This class should probably end up in IAO. It could be further breaken down to indicate different kinds of lack of knowledge, e.g. inability to determine something vs. no attempt made to determine something vs. no informatino available if it was even attempted to determine something. The design pattern should be generalizable. 'unknown sex' is the first example, and needed immediately.
Bjoern Peters
record of missing knowledge
OBI:0000855
total RNA extraction
A RNA extraction process in which total cellular and organelle RNA are extracted.
Person: Chris Stoeckert
Person: Jie Zheng
UPenn Group
total RNA extraction
OBI:0000858
record of unknown sex
A database record indicating that the tissue sample in a microarray experiment came from an organism for which the biological sex is not known to the person who created the record.
a record indicating that the biological sex of an organism is not known.
I think the statement is still about the instance of the biological sex quality of an organism. It is also about information available to the person making the statement.
Bjoern Peters
record of unknown sex
OBI:0000859
cytoplasmic RNA extraction
A RNA extraction process in which the desired output material is RNA in the cytoplasm.
Person: Chris Stoeckert
Person: Jie Zheng
UPenn Group
cytoplasmic RNA extraction
OBI:0000862
nuclear RNA extract
Isolation and purification of nuclear RNA from animal cells using Norgen Bioteck corp. cytoplasmic and nuclear RNA purification kit (http://www.norgenbiotek.com/display-product.php?ID=30)
A RNA extract that is the output of an extraction process in which RNA molecules found in the nucleus, including mRNA precursors (pre-mRNA), are extracted.
PERSON: Chris Stoeckert
PERSON: Jie Zheng
UPenn Group
nuclear RNA extract
OBI:0000869
polyA RNA extract
Preparation of polyA RNA by cellulose-bound oligo-dT (Aviv, H., Leder, P. 1972. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc. Nat. Acad. Sci. USA 69, 1408-1412.)
A RNA extract that is the output of an extraction process in which RNA molecules with poly A tail at its 3' end are purified.
PERSON: Chris Stoeckert
PERSON: Jie Zheng
UPenn Group
polyA RNA extract
OBI:0000873
pre-mortem specimen
material obtained through a liver biopsy from a human patient
a specimen that was taken from a live organism
Bjoern Peters
MO_705 premortem
pre-mortem specimen
OBI:0000876
cytoplasmic RNA extract
Cytoplasmic RNA extraction from mammalian tissues to create cDNA library (Carninci P, Nakamura M, Sato K, Hayashizaki Y, Brownstein MJ. Cytoplasmic RNA extraction from fresh and frozen mammalian tissues. Biotechniques. 2002;33:306–309.)
A RNA extract that is the output of a RNA extraction process in which RNA molecules found in the cytoplasm are extracted.
PERSON: Chris Stoeckert
PERSON: Jie Zheng
UPenn Group
cytoplasmic RNA extract
OBI:0000880
RNA extract
an extract which is the output of an extraction process in which RNA molecules are isolated from a specimen.
PERSON: Chris Stoeckert
PERSON: Jie Zheng
Group: UPenn Group
RNA extract
OBI:0000888
nuclear RNA extraction
A RNA extraction process in which the desired output material is RNA in the nucleus.
Person: Chris Stoeckert
Person: Jie Zheng
UPenn Group
nuclear RNA extraction
OBI:0000893
real time polymerase chain reaction assay
A laboratory technique based on the PCR, which is used to
amplify and simultaneously quantify a specific DNA
molecule based on the use of complementary probes/primers. It enables
both detection and quantification (as absolute number of copies or relative
amount when normalized to DNA input or additional normalizing genes) of one
or more specific sequences in a DNA sample.
person: Bjoern Peters
person: Melanie Courtot
Q-PCR
kinetic polymerase chain reaction
qPCR
quantitative real time polymerase chain reaction
WEB: http://en.wikipedia.org/wiki/Real-time_polymerase_chain_reaction
real time PCR
real time polymerase chain reaction assay
OBI:0000894
protein extract
PMID: 20032479. A bovine whey protein extract stimulates human neutrophils to generate bioactive IL-1Ra through a NF-kappaB- and MAPK-dependent mechanism. Rusu D, Drouin R, Pouliot Y, Gauthier S, Poubelle PE.
J Nutr. 2010 Feb;140(2):382-91. Epub 2009 Dec 23.
a protein extract is the output of an extraction process from tissues or cell cultures resulting in a solution of cellular and/or organellar proteins in buffer solution used to prevent degradation,
Person: Philippe Rocca-Serra
OBI & wikipedia
protein extract
OBI:0000895
total RNA extract
Extraction of total RNA from cells with Qiagen mini RNeasy kit.
A RNA extract that is the output of an extraction process in which total celluar and organelle RNA molecules are isolated from a specimen.
PERSON: Chris Stoeckert
PERSON: Jie Zheng
UPenn Group
total RNA extract
OBI:0000899
organellar RNA extract
Extraction of organellar RNA from plant cells using organellar RNA binding protein.
A RNA extract that is the output of an extraction process in which RNA molecules found in an organelle, e.g., mitochondrion, ER, or chloroplast, excluding the nucleus, are extracted.
PERSON: Chris Stoeckert
PERSON: Jie Zheng
UPenn Group
organellar RNA extract
OBI:0000902
post mortem specimen
the spleen taken from a dead mouse
a specimen that was taken from a dead organism
Bjoern Peters
MO_416 postmortem
post mortem specimen
OBI:0000905
sequence feature annotation
Information about a sequence region
Bjoern Peters
Bjoern Peters
place holder for sequence ontology term
sequence feature annotation
OBI:0000908
labeled DNA extract
a labeled specimen that is the output of a labeling process and has grain labeled DNA to be able to detect DNA in future experiments.
Need to find out if we consider labeled nucleotides still nucleotides. It is after consulting with ChEBI group.
Added duirng Mar 1, 2010 dev call
Group: OBI group
Group: OBI group
labeled DNA extract
OBI:0000915
freezing storage
a fozen pellet used for later assay
A storage process in temperature that maintenance the frozen status of the stored entities.
2010/3/3 Alan Ruttenberg: There is a question of whether we should have a separate objective to "prepare for maintenance"
2014/2/3 OBI dev call: "prepare for maintenance" is a separate process. For example, 'freezing' and 'flash freezing' are defined and can be used to produce frozen material for storage.
Updated both textual and logical definition. Both input and output material of freezing storage have quality frozen.
Person: Alan Ruttenberg, Mathias Brochhausen
MO_481 frozen_storage
OBI
freezing storage
OBI:0000919
animal euthanization
Rats were euthanized with CO2
A process in which is the end of life of animal is brought about in accordance with local regulations on treatment of animal subjects and using a method which causes minimal pain and distress to the animal subject
Helen Parkinson and Melissa Haendel
animal sacrifice
Melissa Haendel
may later be refined with more specific list of organisms
animal euthanization
OBI:0000921
labeled RNA extract
a labeled specimen that is the output of a labeling process and has grain labeled RNA to be able to detect RNA in future experiments.
Need to find out if we consider labeled nucleotides still nucleotides. It is after consulting with ChEBI group.
Added duirng Mar 1, 2010 dev call
Group: OBI group
Group: OBI group
labeled RNA extract
OBI:0000922
frozen specimen
Frozen blood plasma
A specimen that has been frozen in order to store it.
Person:Alan Ruttenberg
MO_610 frozen_sample
frozen specimen
OBI:0000924
labeled specimen
A specimen that has been modified in order to be able to detect it in future experiments
added during call 3/1/2010
OBI group
labeled specimen
OBI:0000927
lyophilization storage
a storage process with input material entity and output freeze dried material for long time storage
PERSON: Chris Stoeckert
PERSON: Jie Zheng
can link to freezing-dying equipment, such as freeze-dryer, rotary evaporator, if needed
lyophilization storage
OBI:0000931
study intervention
the part of the execution of an intervention design study which is varied between two or more subjects in the study
PERSON: Bjoern Peters
GROUP: OBI
study intervention
OBI:0000932
material separation device
flow cytometer
A device with a separation function realized in a planed process
material separation device
OBI:0000934
intramuscular injection
is the injection of a material entity (bearing the administered substance role) into the muscle (bearing the target role) of an organism using a syringe
intramuscular injection
OBI:0000947
service provider role
Jackson Lab provides experimental animals, EBI provides training on databases, a core facility provides access to a DNA sequencer.
is a role which inheres in a person or organization and is realized in in a planned process which provides access to training, materials or execution of protocols for an organization or person
PERSON:Helen Parkinson
service provider role
OBI:0000950
paraffin specimen
liver tissue embedded in paraffin
a specimen that is output of a paraffin storage process in which specimen is embedded in paraffin
PERSON: Chris Stoeckert
PERSON: Jie Zheng
MO_990 paraffin_sample
paraffin specimen
OBI:0000951
compound treatment design
an intervention design in which the treatment is the administration of a compound
This is meant to include all kinds of material administrations, including vaccinations, chemical compounds etc.
PERSON: Bjoern Peters
MO_555 compound_treatment_design
compound treatment design
OBI:0000953
processed specimen
A tissue sample that has been sliced and stained for a histology study.
A blood specimen that has been centrifuged to obtain the white blood cells.
A specimen that has been intentionally physically modified.
Bjoern Peters
Bjoern Peters
A tissue sample that has been sliced and stained for a histology study.
processed specimen
OBI:0000954
subcutaneous injection
is the injection of a material entity (bearing the administered substance role) into the hypodermis (bearing the target role) of an organism using a syringe
PERSON: Melanie Courtot
subcutaneous injection
OBI:0000965
lyophilized specimen
freezing dried DNA
a specimen that is output of a lyophilization storage process in which specimen is lyophilized for storage.
PERSON: Chris Stoeckert
PERSON: Jie Zheng
MO_589 freeze_dried_sample
lyophilized specimen
OBI:0000967
container
A device that can be used to restrict the location of material entities over time
03/21/2010: Added to allow classification of children (similar to what we want to do for 'measurement device'. Lookint at what classifies here, we may want to reconsider a contain function assigned to a part of an entity is necessarily also a function of the whole (e.g. is a centrifuge a container because it has test tubes as parts?)
PERSON: Bjoern Peters
container
OBI:0000968
device
A voltmeter is a measurement device which is intended to perform some measure function.
An autoclave is a device that sterlizes instruments or contaminated waste by applying high temperature and pressure.
A material entity that is designed to perform a function in a scientific investigation, but is not a reagent.
2012-12-17 JAO: In common lab usage, there is a distinction made between devices and reagents that is difficult to model. Therefore we have chosen to specifically exclude reagents from the definition of "device", and are enumerating the types of roles that a reagent can perform.
2013-6-5 MHB: The following clarifications are outcomes of the May 2013 Philly Workshop. Reagents are distinguished from devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in some chemical interaction or reaction during the realization of their experimental role. By contrast, devices do not participate in such chemical reactions/interactions. Note that there are cases where devices use reagent components during their operation, where the reagent-device distinction is less clear. For example:
(1) An HPLC machine is considered a device, but has a column that holds a stationary phase resin as an operational component. This resin qualifies as a device if it participates purely in size exclusion, but bears a reagent role that is realized in the running of a column if it interacts electrostatically or chemically with the evaluant. The container the resin is in (“the column”) considered alone is a device. So the entire column as well as the entire HPLC machine are devices that have a reagent as an operating part.
(2) A pH meter is a device, but its electrode component bears a reagent role in virtue of its interacting directly with the evaluant in execution of an assay.
(3) A gel running box is a device that has a metallic lead as a component that participates in a chemical reaction with the running buffer when a charge is passed through it. This metallic lead is considered to have a reagent role as a component of this device realized in the running of a gel.
In the examples above, a reagent is an operational component of a device, but the device itself does not realize a reagent role (as bearing a reagent role is not transitive across the part_of relation). In this way, the asserted disjointness between a reagent and device holds, as both roles are never realized in the same bearer during execution of an assay.
PERSON: Helen Parkinson
instrument
OBI development call 2012-12-17.
device
OBI:0000969
dose specification
a protocol specifying to administer 1 ml of vaccine to a mouse
a directive information entity that describes the dose that will be administered to a target
dose specification
OBI:0000971
fresh specimen
a liver freshly removed from a rat
a specimen that is output of a specimen creation process used for an investigation without storage.
PERSON: Chris Stoeckert
PERSON: Jie Zheng
MO_730 fresh_sample
fresh specimen
OBI:0000973
sequence data
example of usage: the representation of a nucleotide sequence in FASTA format used for a sequence similarity search.
A measurement datum that representing the primary structure of a macromolecule(it's sequence) sometimes associated with an indicator of confidence of that measurement.
Person:Chris Stoeckert
GROUP: OBI
sequence data
OBI:0000977
paraffin storage
a storage process with input organism or anatomical entity and paraffin and output material embedded in paraffin for long term storage
PERSON: Chris Stoeckert
PERSON: Jie Zheng
UPenn Group
need to specify paraffin or wax is one of specified input of the process
paraffin storage
OBI:0000981
agar stab specimen
a specimen that is output of a process that cell culture inoculated into agar for long term storage.
PERSON: Chris Stoeckert
PERSON: Jie Zheng
MO_971 agar_stab
agar stab specimen
OBI:0000985
growth condition intervention design
A study design in which the independent variable is the environmental condition in which the specimen is growing
PERSON: Bjoern Peters
MO_588 growth_condition_design
growth condition intervention design
OBI:0000989
PCR instrument
A device that is used to amplify a single or few copies of a piece of DNA across several orders of magnitude, generating thousands to millions of copies of a particular DNA sequence.
03/21/2010: Added because it is unclear if the thermal cycler definition is intentionally broader than PCR instrument. Contacted Melanie and Trish about this. Definitions and use of alternative terms need to be made consistent.
PCR instrument
OBI:0000994
intravenous injection
is the injection of a material entity (bearing the administered substance role) into the vein (bearing the target role) of an organism using a syringe
PERSON: Melanie Courtot
intravenous injection
OBI:0000995
administration of material to specimen
Staining cells in a tissue slice with a dye.
The directed combination of a material entity with a specimen.
Bjoern Peters
Bjoern Peters
administration of material to specimen
OBI:0000997
growth environment
The collection of material entities and their qualities that are located near a live organism, tissue or cell and can influence its growth.
Right now this may be incomplete. Should also cover e.g. sound, light as well.
PERSON:Richard Scheuermann, Jie Zheng, Bjoern Peters
OBI group
growth environment
OBI:0001003
agar stab storage
a storage process with input cell culture and agar and output agar stab for long time storage
PERSON: Chris Stoeckert
PERSON: Jie Zheng
UPenn Group
need to specify that agar is one of input for this process
agar stab storage
OBI:0001007
image creation
Taking a polaroid picture of a patients skin lesion; Using a digital camera to take a picture of a gel
A planned process that captures an image of an object.
PERSON: Jie Zheng
image acquisition
image creation
OBI:0001010
nucleic acid extract
An extract that is the output of an extraction process in which nucleic acid molecules are isolated from a specimen.
PERSON: Jie Zheng
UPenn Group
nucleic acid extract
OBI:0001028
feature extraction
A planed process with objective of obtaining quantified values from an image.
PERSON: Jie Zheng
MO_928: feature_extraction
feature extraction
OBI:0001031
array image creation
An image creation process that generate an image from the array.
PERSON: Jie Zheng
array image acquisition
MO_929: image_acquisition
array image creation
OBI:0001032
light emission device
A light source is an optical subsystem that provides light for use in a distant area using a delivery system (e.g., fiber optics)
a device which has a function to emit light.
Person:Helen Parkinson
OBI
light emission device
OBI:0001033
perturbation device
A homogenizer is a perturbation device.
A perturbation device is a device which is designed to perform a perturb function
Helen Parkinson
OBI Vancouver workshop 2010
PERSON: Helen Parkinson
perturbation device
OBI:0001034
environmental control device
A growth chamber is an environmental control device.
An environmental control device is a device which has the function to control some aspect of the environment such as temperature, or humidity.
Helen Parkinson
OBI
environmental control device
OBI:0001051
DNA extract
The output of an extraction process in which DNA molecules are purified in order to exclude DNA from organellas.
Person: Jie Zheng
Group: UPenn group
DNA extract
OBI:0001069
array manufacturer role
a manufacturer role which is played by the person or organization that manufactured the array
PERSON: Chris Stoeckert, Jie Zheng
MO_695 array_manufacturer
array manufacturer role
OBI:0001088
tandem mass spectrometer
A mass spectrometer in which ions are subjected to two or more sequential stages of analysis (which may be separated spatially or temporally) according to the quotient mass/charge.
PERSON: Erik Segerdell
http://goldbook.iupac.org/T06250.html
tandem mass spectrometer
OBI:0001140
spike-in quality control role
a reference substance role that is borne by a material entity with a known amount which is mixed into the evaluant of assays for quality control or data normalization purposes
PERSON: Chris Stoeckert, Jie Zheng, Bjoern Peter
MO_937 spike_quality_control
spike-in quality control role
OBI:0001141
individual organism identifier
a CRID symbol used to distinguish one individual organism from another.
PERSON: Chris Stoeckert, Jie Zheng
MO_169 Individual
individual organism identifier
OBI:0001142
dye swap quality control role
a reference substance role that is borne by a material entity used in a dye swap design experiment for quality control or data normalization purposes
PERSON: Chris Stoeckert, Jie Zheng
MO_524 dye_swap_quality_control
dye swap quality control role
OBI:0001143
labeled nucleic acid extract
a labeled specimen that is the output of a labeling process and has grain labeled nucleic acid for detection of the nucleic acid in future experiments.
Person: Jie Zheng
labeled extract
MO_221 labeledExtract
labeled extract
labeled nucleic acid extract
OBI:0001146
binding assay
Determination of KD value for an antibody binding a protein using a BIACORE assay. Using plate bound antigen in an ELISA to determine if a mixture of serum antibodies bind the antigen.
The following are NOT binding assays, as the desired output is not binding data: RNA microarray experiments to determine levels of gene expression. ChIP experiments to determine where in DNA a transcription factor binds. Using an IL-2 antibody on an ELISA plate to determine presence of IL-2 after stimulating a T cell culture.
An assay with the objective to characterize the disposition of two or more material entities to form a complex.
PERSON:Bjoern Peters, Randi Vita, Jason Greenbaum
binding assay
OBI:0001147
cell culture expansion
a processual entity that results in the increase of cell numbers
including grow of yeast and bacteria
PERSON: Chris Stoeckert, Jie Zheng
MO_758 grow
BP:
add it as subclass of 'cell culturing'
JZ:
No 'cell culturing' in OBI
Has term 'cell co-culturing' and 'maintaining cell culture'. Don't think either of it fit. So leave the term under process.
cell culture expansion
OBI:0001148
gene knock out
a genetic transformation that renders a gene non-functional, e.g. due to a point mutation, or the removal of all, or part of, the gene using recombinant methods.
PERSON: Chris Stoeckert, Jie Zheng
MO_771 gene_knock_out
gene knock out
OBI:0001149
gene knock in
a genetic transformation that involves the insertion of a protein coding cDNA sequence at a particular locus in an organism's chromosome. Typically, this is done in mice since the technology for this process is more refined, and because mouse embryonic stem cells are easily manipulated. The difference between knock-in technology and transgenic technology is that a knock-in involves a gene inserted into a specific locus, and is a "targeted" insertion.
PERSON: Chris Stoeckert, Jie Zheng
MO_437 gene_knock_in
WEB: http://en.wikipedia.org/wiki/Gene_Knock-in
gene knock in
OBI:0001150
chromosomal substitution
A genetic transformation in which all, or part, of a chromosome from a donor replaces that of the recipient. It does not include chromosome recombination. For single gene insertion, use the term 'gene knock in'.
PERSON: Chris Stoeckert, Jie Zheng
MO_995 chromosomal_substitution
chromosomal substitution
OBI:0001151
genetically modified material
a material entity, organism or cell, that is the output of a genetic transformation process.
PERSON: Jie Zheng
GROUP: OBI
term is proposed by BP on Oct 25, 2010 dev call
genetically modified material
OBI:0001152
transfection
a genetic transformation which relies on the use of physical, electrical and chemical phenomena to introduce DNA or RNA into a cell
PERSON: Chris Stoeckert, Jie Zheng
MO_366 transfection
transfection
OBI:0001153
genetic transformation objective
a material transformation objective aims to create genetically modified organism or cell
Person: Jie Zheng
Person: Jie Zheng
suggested to be added by BP and AR during Oct 25, 2010 dev call
genetic transformation objective
OBI:0001154
induced mutation
a genetic transformation that the modification of the genetic material (either coding or non-coding) of an organism is caused by mutagenic compounds or irradiation.
PERSON: Chris Stoeckert, Jie Zheng
MO_564 induced_mutation
induced mutation
OBI:0001156
age since planting measurement datum
An age measurement datum that is the result of the measurement of the age of an organism since planting, the process of placing a plant in media (e.g. soil) to allow it to grow, which excludes sowing.
PERSON:Chris Stoeckert, Jie Zheng
MO_495 planting
Discussed by Jie and Chris, proposed to combine with different kinds of processes as initial time point. Proposed 'age measurement assay' is proceeded by some process. The process can be any kind of process defined in OBI. Think it is more flexible. However, it is hard to model due to lake of temporal predicates on Nov 15, 2010 dev call.
Term proposed by Bjoern on Nov 8, 2010 dev call
Supported by Alan on Nov 15, 2010 dev call
age since planting measurement datum
OBI:0001157
age since hatching measurement datum
An age measurement datum that is the result of the measurement of the age of an organism since hatching, the process of emergence from an egg.
PERSON:Chris Stoeckert, Jie Zheng
MO_745 hatching
age since hatching measurement datum
OBI:0001158
age measurement assay
An assay that measures the duration of temporal interval of a process that is part of the life of the bearer, where the initial time point of the measured process is the beginning of some transitional state of the bearer such as birth or when planted.
This assay measures time not developmental stage. we recognize that development takes different time periods under different conditions such as media / temperature. For example, age measurement assay of fly age, the output likes 28 days but not mid-life of age at room temperature.
PERSON: Alan Ruttenberg
OBI group
age measurement assay
OBI:0001159
age since egg laying measurement datum
An age measurement datum that is the result of the measurement of the age of an organism since egg laying, the process of the production of egg(s) by an organism.
PERSON:Chris Stoeckert, Jie Zheng
MO_767 egg laying
age since egg laying measurement datum
OBI:0001160
assay validation objective
an objective specification to check the accuracy or the quality of the results of an assay by comparison with independent results
PERSON: Chris Stoeckert, Jie Zheng
GROUP: Penn Group
assay validation objective
OBI:0001161
age since germination measurement datum
An age measurement datum that is the result of the measurement of the age of an organism since germination, the process consisting of physiological and developmental changes by a seed, spore, pollen grain (microspore), or zygote that occur after release from dormancy, and encompassing events prior to and including the first visible indications of growth.
Definition of germination comes from GO. However, the term is deprecated from GO now because it is a grouping term without biological significance.
PERSON:Chris Stoeckert, Jie Zheng
MO_590 germination
age since germination measurement datum
OBI:0001162
validation by reverse transcription PCR design
a study design in which checks the accuracy or the quality of the result of an assay by comparing with reverse transcription PCR results
PERSON: Chris Stoeckert, Jie Zheng
MO_986 reverse_transcription_PCR_quality_control
validation by reverse transcription PCR design
OBI:0001163
age since eclosion measurement datum
An age measurement datum that is the result of the measurement of the age of an organism since eclosion, the process of emergence of an adult insect from its pupa or cocoon.
PERSON:Chris Stoeckert, Jie Zheng
MO_876 eclosion
age since eclosion measurement datum
OBI:0001164
age since sowing measurement datum
An age measurement datum that is the result of the measurement of the age of an organism since sowing, the process of placing a seed or spore in some media with the intention to invoke germination.
PERSON:Chris Stoeckert, Jie Zheng
MO_748 sowing
age since sowing measurement datum
OBI:0001165
age since coitus measurement datum
An age measurement datum that is the result of the measurement of the age of an organism since coitus, the process of copulation that occurs during the process of sexual reproduction.
PERSON:Chris Stoeckert, Jie Zheng
MO_783 coitus
age since coitus measurement datum
OBI:0001166
validation by real time PCR design
a study design in which the accuracy or the quality of the result of an assay is checked by comparing with real time PCR results
PERSON: Chris Stoeckert, Jie Zheng
MO_434 real_time_PCR_quality_control
validation by real time PCR design
OBI:0001167
age measurement datum
A time measurement datum that is the result of measurement of age of an organism
note that we are currently defining subtypes of age measurement datum that specify when the age is relative to, e.g. planting, as we don't have adequate temporal predicates yet.
life of bearer doesn't imply organism
this assay measures time not developmental stage. we recognize that development can take different time periods under different conditions such as media / temperature
age as a quality is dubious; we plan to revisit
stages in development are currently handled with controlled vocabulary, such as 2-somite stage
PERSON: Alan Ruttenberg, Chris Stoeckert, Jie Zheng
MO_178 Age
In MageTab file, we use
initialTimePoint (a process) + age (a number expected) + TimeUnit (definied in UO, such as year, hour, day, etc.)
Now we use the term label indicating the start time point of measuring the age, (number + TimeUnit) are expected instances of the class
discussed on Nov 15, dev call
All subtype will be defined by textual definition now.
age measurement datum
OBI:0001168
age since fertilization measurement datum
An age measurement datum that is the result of the measurement of the age of an organism since fertilization, the process of the union of gametes of opposite sexes during the process of sexual reproduction to form a zygote.
Definition of fertilization comes from GO.
PERSON:Chris Stoeckert, Jie Zheng
MO_701 fertilization
age since fertilization measurement datum
OBI:0001169
age since birth measurement datum
An age measurement datum that is the result of the measurement of the age of an organism since birth, the process of emergence and separation of offspring from the mother.
PERSON:Chris Stoeckert, Jie Zheng
MO_710 birth
age since birth measurement datum
OBI:0001170
reverse transcription polymerase chain reaction assay
an assay that evaluates the concentration of RNA in a sample in which an RNA strand is first reverse transcribed into its DNA complement (complementary DNA, or cDNA) using the enzyme reverse transcriptase, and the resulting cDNA is amplified using traditional or real-time PCR.
PERSON: Chris Stoeckert, Jie Zheng
GROUP: Penn Group
reverse transcription polymerase chain reaction assay
OBI:0001175
selective organism creation objective
an objective specification to generate a population or type of organism within species that have some uniform behavioral, morphological, physiological, or genetic characteristics with similarly bred organisms.
PERSON: Chris Stoeckert, Jie Zheng
WEB: wikipedia
http://en.wikipedia.org/wiki/Cultivar
http://en.wikipedia.org/wiki/Ecotype
http://en.wikipedia.org/wiki/Strain_%28biology%29
selective organism creation objective
OBI:0001177
RNA sequencing
RNA sequencing is a sequencing process which uses ribonucleic acid as input and results in a the creation of RNA sequence information artifact
BP 12/21:Created based on a request from Melanie
Bjoern Peters
Bjoern Peters
RNA sequencing
OBI:0001181
binding datum
A data item that states if two or more material entities have the disposition to form a complex, and if so, how strong that disposition is.
Bjoern Peters; Randi Vita
binding datum
OBI:0001185
selectively maintained organism
An organism that is bred to have some uniform behavioral, morphological, physiological, or genetic characteristics with similarly bred organisms
Bjoern Peters, Helen Parkinson, Philippe Rocca-Serra, Jie Zheng, Chris Stoeckert
cultivar
ecotype
strain
MO_9 StrainOrLine, MO_71 Ecotype, MO_124 Cultivar
selectively maintained organism
OBI:0001195
operator variation design
A study design that assesses the operator performance and relation to data consistency and quality.
Person: Chris Stoeckert, Jie Zheng
MO_519 operator_variation_design
operator variation design
OBI:0001197
comparative genome hybridization by array design
A study design that detects genomic copy number variations using microarray technology.
Person: Chris Stoeckert, Jie Zheng
MO_856 comparative_genome_hybridization_design
comparative genome hybridization by array design
OBI:0001199
in vivo design
A study design that is conducted entirely in a living organism, e.g. a compound treatment in a mouse model.
Person: Chris Stoeckert, Jie Zheng
MO_454 in_vivo_design
in vivo design
OBI:0001200
genotyping by high throughput sequencing design
A study design that classifies an individual or group of individuals on the basis of alleles, haplotypes, SNPs using high througput sequencing techniques.
Person: Chris Stoeckert, Jie Zheng
MO_560 genotyping_design
genotyping by high throughput sequencing design
OBI:0001202
innate behavior design
A study design in which the innate behavior of the organism is examined, e.g. path finding in bees.
Person: Chris Stoeckert, Jie Zheng
MO_355 innate_behavior_design
innate behavior design
OBI:0001205
cell component comparison design
A study design that compares samples from different cell components.
Person: Chris Stoeckert, Jie Zheng
MO_1019 cell_component_comparison_design
cell component comparison design
OBI:0001211
ex vivo design
A study design where all or part of an organism is removed and studied in vitro, e.g. part of a mouse is removed and cultured in vitro. A cell culture with an established cell line is an in vitro experiment.
Person: Chris Stoeckert, Jie Zheng
MO_808 ex_vivo_design
ex vivo design
OBI:0001214
normalization testing design
A study design that tests different normalization procedures.
Person: Chris Stoeckert, Jie Zheng
MO_729 normalization_testing_design
normalization testing design
OBI:0001225
genetic population background information
genotype information 'C57BL/6J Hnf1a+/-' in this case, C57BL/6J is the genetic population background information
a genetic characteristics information which is a part of genotype information that identifies the population of organisms
proposed and discussed on San Diego OBI workshop, March 2011
Group: OBI group
Group: OBI group
genetic population background information
OBI:0001226
environmental history design
A study design in which some aspect of the organism's environmental history is studied, such as exposure to teratogen, radiation, climate etc.
Person: Chris Stoeckert, Jie Zheng
MO_698 environmental_history_design
environmental history design
OBI:0001234
epigenetic modification identification objective
A molecular feature identification objective that aims to detect epigenetic modifications, such as DNA methylation, histone modifications.
Chris Stoeckert, Jie Zheng
Person: Chris Stoeckert
epigenetic modification identification objective
OBI:0001235
transcription profiling by tiling array assay
An assay in which the transcriptome of a biological sample is analysed using a tiling path array.
Person: James Malone
EFO_0002769 transcription profiling by tiling array
transcription profiling by tiling array assay
OBI:0001239
transcription profiling by high throughput sequencing design
A study design in which sequencing technology (e.g. Solexa/454) is used to generate RNA sequence, analyse the transcibed regions of the genome, and/or to quantitate transcript abundance
Person: Chris Stoeckert, Jie Zheng
Group: ArrayExpress production team
transcription profiling by high throughput sequencing design
OBI:0001247
genotyping by high throughput sequencing assay
An assay in which high througput sequencer is used to detect polymorphisms in DNA samples
Person: James Malone
EFO_0002771: genotyping by high throughput sequencing
genotyping by high throughput sequencing assay
OBI:0001248
ChIP-chip assay
an assay that aims to investigate the interactions between protein and DNA relying on chromatin immunoprecipitation ('ChIP') combined with microarray technology ('chip'). Specially, it allows the identification of protein binding sites on a genome-wide basis.
Person: James Malone
ChIP-on-chip assay
WEB: http://en.wikipedia.org/wiki/ChIP-on-chip
Philippe Rocca-Serra
ChIP-chip assay
OBI:0001252
array platform variation design
A study design in which the array platform is compared, e.g. Agilent versus Affymetrix.
Person: Chris Stoeckert, Jie Zheng
MO_899 array_platform_variation_design
array platform variation design
OBI:0001258
ChIP-seq design
A study design which aims to identify protein and DNA interactions using a combination of chromatin immunoprecipitation and high throughput sequencing. Massively parallel sequence analyses are used in conjunction with whole-genome sequence databases to analyze the interaction pattern of any protein with DNA, or the pattern of any epigenetic chromatin modifications.
Person: Chris Stoeckert, Jie Zheng
http://en.wikipedia.org/wiki/Chip-Sequencing
ChIP-seq design
OBI:0001259
translational bias design
A study design that characterizes the association of transcripts and translation machinery.
Person: Chris Stoeckert, Jie Zheng
MO_939 translational_bias_design
translational bias design
OBI:0001266
DNA methylation profiling by high throughput sequencing assay
An assay in which the methylation state of DNA is determined and is compared between samples using sequencing based technology
Group: ArrayExpress production team, James Malone, Helen Parkinson
EFO_0002761 methylation profiling by high throughput sequencing
Philippe Rocca-Serra
DNA methylation profiling by high throughput sequencing assay
OBI:0001271
RNA-seq assay
An assay in which sequencing technology (e.g. Solexa/454) is used to generate RNA sequence, analyse the transcibed regions of the genome, and or to quantitate transcript abundance
PERSON: James Malone
transcription profiling by high throughput sequencing
EFO_0002770 transcription profiling by high throughput sequencing
JZ: should be inferred as 'DNA sequencing'. Will check in the future.
an assay that uses high-throughput sequencing technologies to sequence cDNA in order to get information about a sample's RNA content. RNA-Seq provides researchers with efficient ways to measure transcriptome data experimentally, allowing them to get information such as how different alleles of a gene are expressed, detect post-transcriptional mutations or identify gene fusions.
WEB: http://en.wikipedia.org/wiki/RNA-Seq
RNA-seq assay
OBI:0001274
genotyping by array assay
An assay in which an array is used to detect polymorphisms in DNA samples
Group: ArrayExpress production team
EFO_0002767: genotyping by array
genotyping by array assay
OBI:0001278
DNA methylation profiling by array design
A study design in which the methylation state of DNA is determined and is compared between samples using array technology.
Person: Chris Stoeckert, Jie Zheng
GROUP: ArrayExpress production team
DNA methylation profiling by array design
OBI:0001282
translation profiling assay
An assay in which surface-bound, translationally competent ribosome complexes are used to generate a translation profile for mRNA, which mRNA may be a single molecular species, or a combination of species, including complex mixtures such as those found in the set of mRNAs isolated from a cell or tissue. One or more components of the surface-bound ribosome complex may be labeled at specific positions to permit analysis of multiple or single molecules for determination of ribosomal conformational changes and translation kinetics. Translation profiles are used as the basis for comparison of an mRNA or set of mRNA species. The translation profile can be used to determine such characteristics as kinetics of initiation, kinetic of elongation, identity of the polypeptide product, and the like. Analysis of translation profiles may be used to determine differential gene expression, optimization of mRNA sequences for expression, screening drug candidates for an effect on translation.
PERSON: James Malone
EFO_0001033 translation profiling
translation profiling assay
OBI:0001285
in vitro design
A study design that is done in a test tube or a culture dish, e.g. A bacterial invasion assay in an established cell culture.
Person: Chris Stoeckert, Jie Zheng
MO_347 in_vitro_design
in vitro design
OBI:0001286
RNAi profiling by array design
A study design in which experiment double stranded RNA is synthesized with a sequence complementary to a gene(s) of interest and introduced into a cell or organism, where it is recognized as exogenous genetic material and activates the RNAi pathway resulting in knockdown of the transcripts and providing a means to study downstream changes in gene expression.
Person: Chris Stoeckert, Jie Zheng
Group: ArrayExpress production team
RNAi profiling by array design
OBI:0001290
transcription profiling by array design
A study design that identifies forms and abundance of transcripts in the genome using microarray technology.
Person: Chris Stoeckert, Jie Zheng
MO_533 transcript_identification_design
transcription profiling by array design
OBI:0001293
disease state design
A study design in which the pathological condition of a part, organ, or system of an organism is studied. The etiology may be from infection, genetic defect, or environmental stress.
Person: Chris Stoeckert, Jie Zheng
MO_902 disease_state_design
disease state design
OBI:0001294
wild type organism genotype information
C57BL/6J wild type
a genotype information about an organism and includes information that there are no known modifications to the genetic background. Generally it is the genotype information of a representative individual from a class of organisms.
proposed and discussed on San Diego OBI workshop, March 2011
Group: OBI group
Group: OBI group
wild type organism genotype information
OBI:0001304
RNAi profiling by array assay
An assay in which double stranded RNA is synthesized with a sequence complementary to a gene(s) of interest and introduced into a cell or organism, where it is recognized as exogenous genetic material and activates the RNAi pathway resulting in knockdown of the transcripts and providing a means to study downstream changes in gene expression.
PERSON: James Malone
EFO_0001030 RNAi profiling by array
RNAi profiling by array assay
OBI:0001305
genotype information
Genotype information can be: Mus musculus wild type (in this case the genetic population background information is Mus musculus), C57BL/6J Hnf1a+/- (in this case, C57BL/6J is the genetic population background information and Hnf1a+/- is the allele information
a genetic characteristics information that is about the genetic material of an organism and minimally includes information about the genetic background and can in addition contain information about specific alleles, genetic modifications, etc.
discussed on San Diego OBI workshop, March 2011
Group: OBI group
Group: OBI group
genotype information
OBI:0001306
RNA stability design
A study design that examines the stability and/or decay of RNA transcripts.
Person: Chris Stoeckert, Jie Zheng
MO_553 RNA_stability_design
RNA stability design
OBI:0001307
tiling microarray
a DNA microarray which has short fragments of nucleic acid immobilized on a substrate. These are designed to cover the whole genome of the target species. Tiling arrays are used to determine genome binding in ChIP assays or to identify transcribed regions.
Person: Helen Parkinson
genome tiling array
EFO_0002704: tiling array
tiling microarray
OBI:0001310
species comparison design
A study design that assays differences between distinct species.
Person: Chris Stoeckert, Jie Zheng
MO_675 species_design
species comparison design
OBI:0001313
transcription profiling by RT-PCR design
A study design which aims to examine the transcriptome of a biological sample by reverse transcription PCR (RT-PCR).
Person: Chris Stoeckert, Jie Zheng
Group: ArrayExpress production team
transcription profiling by RT-PCR design
OBI:0001318
proteomic profiling by array assay
An assay that proteins in a sample are detected, quantified or otherwise analysed, e.g. antibody profiling using an array based technology
Person: James Malone
EFO_0002765 proteomic profiling by array
proteomic profiling by array assay
OBI:0001323
microRNA profiling by array design
A study design in which a microRNA array is used to analyse the microRNA component of the transcriptome.
Person: Chris Stoeckert, Jie Zheng
Group: ArrayExpress production team
microRNA profiling by array design
OBI:0001328
organism development design
A study design that assays events associated with development. Development applies to organism(s) acquiring a mature state.
Person: Chris Stoeckert, Jie Zheng
MO_892 development_or_differentiation_design
organism development design
OBI:0001329
family history design
A study design in which the family history such as traits, characteristics, susceptibility to disease is studied.
Person: Chris Stoeckert, Jie Zheng
MO_544 family_history_design
family history design
OBI:0001331
transcription profiling identification objective
A molecular feature identification objective that aims to characterize the abundance of transcripts
Person: Chris Stoeckert, Jie Zheng
Group: Penn Group
transcription profiling identification objective
OBI:0001332
DNA methylation profiling by array assay
An assay in which the methylation state of DNA is determined and is compared between samples using array technology
Person: James Malone
EFO_0002759 methylation profiling by array
Philippe Rocca-Serra
DNA methylation profiling by array assay
OBI:0001335
microRNA profiling by array assay
An assay in which a microRNA array is used to analyse the microRNA component of the transcriptome.
PERSON: James Malone
EFO_0000753 microRNA profiling by array
microRNA profiling by array assay
OBI:0001336
quality control testing design
A study design in which some aspects of the experiment is quality controlled for the purposes of quality assurance.
Person: Chris Stoeckert, Jie Zheng
MO_981 quality_control_testing_design
quality control testing design
OBI:0001337
clinical history design
A study design that the organism's clinical history of diagnosis, treatments, e.g. vaccinations, surgery etc. is studied.
Person: Chris Stoeckert, Jie Zheng
MO_832 clinical_history_design
clinical history design
OBI:0001352
allele information
genotype information 'C57BL/6J Hnf1a+/-' in this case, Hnf1a+/- is the allele information
a genetic alteration information that about one of two or more alternative forms of a gene or marker sequence and differing from other alleles at one or more mutational sites based on sequence. Polymorphisms are included in this definition.
discussed on San Diego OBI workshop, March 2011
Person: Chris Stoeckert, Jie Zheng
MO_58 Allele
allele information
OBI:0001358
post-transcriptional modification design
A study design in which a modification of the transcriptome, proteome (not genome) is made, for example RNAi, antibody targeting.
Person: Chris Stoeckert, Jie Zheng
MO_392 cellular_modification_design
post transcription modification design?
or more clear RNAi design / antibody targeting design?
need to check the use cases
post-transcriptional modification design
OBI:0001361
transcription profiling by RT-PCR assay
An assay in which the transcriptome of a biological sample is analysed by reverse transcription PCR (RT-PCR)
Person: Anna Farne
EFO_0002943: transcription profiling by RT-PCR
transcription profiling by RT-PCR assay
OBI:0001364
genetic alteration information
a genetic characteristics information that is about known changes or the lack thereof from the genetic background, including allele information, duplication, insertion, deletion, etc.
proposed and discussed on San Diego OBI workshop, March 2011
Group: OBI group
Group: OBI group
genetic alteration information
OBI:0001365
cellular process design
A study design that aims to study the processes that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.
Person: Chris Stoeckert, Jie Zheng
MO_810 cellular_process_design
cellular process design
OBI:0001369
wild type allele information
an allele information that is about the allele found most frequently in natural populations, or in standard laboratory stocks for a given organism.
discussed on San Diego OBI workshop, March 2011
Person: Chris Stoeckert, Jie Zheng
MO_605 genotype
wild type allele information
OBI:0001374
injury design
A study design in which the response of an organism(s) to injury or damage is studied.
Person: Chris Stoeckert, Jie Zheng
MO_726 injury_design
injury design
OBI:0001377
organism status comparison design
A study design that compares samples from live and dead organisms.
Person: Chris Stoeckert, Jie Zheng
MO_841 organism_status_design
organism status comparison design
OBI:0001387
genotyping by array design
A study design that classifies an individual or group of individuals on the basis of alleles, haplotypes, SNPs using microarray technology.
Person: Chris Stoeckert, Jie Zheng
MO_560 genotyping_design
genotyping by array design
OBI:0001393
comparative genomic hybridization by array assay
An assay in which changes in DNA sequence copy number are analysed using a microarray. For example the analysis of LOH in tumor cells vs a non diseased sample or the comparison of clinical isolated of disease causing bacteria.
Person: James Malone
array CGH
EFO_0000749: comparative genomic hybridization by array
Philippe Rocca-Serra
comparative genomic hybridization by array assay
OBI:0001396
stimulus or stress design
A study design in which the response of an organism(s) to the stress or stimulus is studied, e.g. osmotic stress, heat shock, radiation exposure, behavioral treatment etc.
Person: Chris Stoeckert, Jie Zheng
MO_568 stimulus_or_stress_design
stimulus or stress design
OBI:0001398
protein and DNA interaction identification objective
A sequence feature identification objective that aims to characterize the interactions between protein and DNA which includes identification of transcription factor binding sites.
Person: Chris Stoeckert, Jie Zheng
MO_933 binding_site_identification_design
protein and DNA interaction identification objective
OBI:0001401
protocol optimization design
A study design where different protocols or protocol parameters are compared aims to find an optimized protocol
Person: Chris Stoeckert, Jie Zheng
MO_934 optimization_design
protocol optimization design
OBI:0001403
ChIP-chip design
A study design which aims to identify protein binding sites in genomic DNA by a combination of chromatin immunoprecipitation and DNA microarray (chip) assays.
Person: Chris Stoeckert, Jie Zheng
ChIP-on-chip design
MO_933 binding_site_identification_design
ChIP-chip design
OBI:0001404
genetic characteristics information
a data item that is about genetic material including polymorphisms, disease alleles, and haplotypes.
Person: Chris Stoeckert, Jie Zheng
MO_66 IndividualGeneticCharacteristics
MO definition:
The genotype of the individual organism from which the biomaterial was derived. Individual genetic characteristics include polymorphisms, disease alleles, and haplotypes.
examples in ArrayExpress
wild_type
MutaMouse (CD2F1 mice with lambda-gt10LacZ integration)
AlfpCre; SNF5 flox/knockout
p53 knock out
C57Bl/6 gp130lox/lox MLC2vCRE/+
fer-15; fem-1
df/df
pat1-114/pat1-114 ade6-M210/ade6-M216 h+/h+ (cells are diploid)
genetic characteristics information
OBI:0001408
imprinting design
A study design where differences in genetic imprinting of maternally- and paternally-inherited chromosomes (e.g., due to in vivo differences in chemical modification and/or chromatin structure) are compared.
Person: Chris Stoeckert, Jie Zheng
MO_914 imprinting_design
imprinting design
OBI:0001409
cell cycle design
A study design that assays events that occur in relation to the cell cycle, which is the period between the formation of a cell, by division of its mother cell and the time when the cell itself divides to form two daughter cells.
Person: Chris Stoeckert, Jie Zheng
MO_822 cell_cycle_design
cell cycle design
OBI:0001410
translation profiling design
A study design in which surface-bound, translationally competent ribosome complexes are used to generate a translation profile for mRNA, where mRNA may be a single molecular species, or a combination of species, including complex mixtures such as those found in the set of mRNAs isolated from a cell or tissue. One or more components of the surface-bound ribosome complex may be labeled at specific positions to permit analysis of multiple or single molecules for determination of ribosomal conformational changes and translation kinetics. Translation profiles are used as the basis for comparison of an mRNA or set of mRNA species. The translation profile can be used to determine such characteristics as kinetics of initiation, kinetic of elongation, identity of the polypeptide product, and the like. Analysis of translation profiles may be used to determine differential gene expression, optimization of mRNA sequences for expression, screening drug candidates for an effect on translation.
Person: Chris Stoeckert, Jie Zheng
Group: ArrayExpress production team
translation profiling design
OBI:0001411
cell type comparison design
A study design that compares cells of different type, for example different cell lines.
Person: Chris Stoeckert, Jie Zheng
MO_764 cell_type_comparison_design
cell type comparison design
OBI:0001417
ChIP-chip by tiling array design
A study design which aims to identify protein binding sites in genomic DNA by a combination of chromatin immunoprecipitation and tiling microarray (chip) assays.
Person: Chris Stoeckert, Jie Zheng
Group: ArrayExpress production team
ChIP-chip by tiling array design
OBI:0001418
dose response design
A study design that examines the relationship between the size of the administered dose and the extent of the response.
Person: Chris Stoeckert, Jie Zheng
MO_485 dose_response_design
dose response design
OBI:0001419
ChIP-chip by tiling array assay
An assay where chromatin immunoprecipitation (ChIP) is used in combination with tiling microarray technology
Group: ArrayExpress production team
EFO_0002762 ChIP-chip by tiling array
ChIP-chip by tiling array assay
OBI:0001422
organism part comparison design
A study design that compares tissues, regions, organs within or between organisms
Person: Chris Stoeckert, Jie Zheng
MO_953 organism_part_comparison_design
organism part comparison design
OBI:0001425
protein binding site identification design
A study design that investigates protein binding sites on nucleic acids.
Person: Chris Stoeckert, Jie Zheng
MO_933 binding_site_identification_design
protein binding site identification design
OBI:0001426
sex comparison design
A study design that assays differences associated with an organism's sex, gender or mating type.
Person: Chris Stoeckert, Jie Zheng
MO_575 sex_design
sex comparison design
OBI:0001427
transcription profiling by tiling array design
A study design in which gene expression on a genome-wide basis is evaluated, without bias toward coding or noncoding regions, using tiling arrays containing oligonucleotides that are either overlapping or spaced at regular intervals.
Person: Chris Stoeckert, Jie Zheng
MO_507 tiling_path_design
transcription profiling by tiling array design
OBI:0001429
cell differentiation design
A study design that assays events associated with cell development or differentiation.
Person: Chris Stoeckert, Jie Zheng
MO_892 development_or_differentiation_design
cell differentiation design
OBI:0001430
transcription profiling design
A study design that identifies forms and abundance of transcripts in the genome.
Person: Chris Stoeckert, Jie Zheng
MO_533 transcript_identification_design
transcription profiling design
OBI:0001432
operon identification design
A study design that identifies locations and members of operons in a genome.
Person: Chris Stoeckert, Jie Zheng
MO_772 operon_identification_design
operon identification design
OBI:0001435
DNA methylation profiling by high throughput sequencing design
A study design in which the methylation state of DNA is determined and is compared between samples using high throughput sequencing technology.
Person: Chris Stoeckert, Jie Zheng
GROUP: ArrayExpress production team
DNA methylation profiling by high throughput sequencing design
OBI:0001440
all pairs design
A study design in which all specimens are compared to every other specimen.
Person: Chris Stoeckert, Jie Zheng
MO_565 all_pairs
all pairs design
OBI:0001441
proteomic profiling by array design
A study design in which proteins in a sample are detected, quantified or otherwise analysed, e.g. antibody profiling using an array based technology
Person: Chris Stoeckert, Jie Zheng
Group: ArrayExpress production team
proteomic profiling by array design
OBI:0001444
genotyping design
A study design that classifies an individual or group of individuals on the basis of alleles, haplotypes, SNPs.
Person: Chris Stoeckert, Jie Zheng
MO_560 genotyping_design
genotyping design
OBI:0001448
individual genetic characteristics comparison design
A study design where genotype, haplotype, or other individual genetic characteristics are compared.
Person: Chris Stoeckert, Jie Zheng
MO_527 individual_genetic_characteristics_design
individual genetic characteristics comparison design
OBI:0001454
pathogenicity design
A study design in which an infective agent such as a bacterium, virus, protozoan, fungus etc. infects a host organism(s) and the infective agent is assayed.
Person: Chris Stoeckert, Jie Zheng
MO_807 pathogenicity_design
pathogenicity design
OBI:0001460
genetic modification design
A study design in which an organism(s) is studied that has had genetic material removed, rearranged, mutagenized or added, such as in a knock out.
Person: Chris Stoeckert, Jie Zheng
MO_447 genetic_modification_design
genetic modification design
OBI:0001463
transcription profiling by array assay
An assay in which the transcriptome of a biological sample is analysed using array technology.
Person: James Malone
EFO_0002768: transcription profiling by array
transcription profiling by array assay
OBI:0001464
strain comparison design
A study design that assays differences between multiple strains, cultivars, serovars, isolates, lines from organisms of a single species.
Person: Chris Stoeckert, Jie Zheng
MO_462 strain_or_line_design
strain comparison design
OBI:0001468
cell specimen
A specimen primarily composed of cells collected from a multicellular organism or a cell culture
PERSON: Chris Stoeckert, Jie Zheng
MO_612 cell
cell specimen
OBI:0001472
specimen with known storage state
A specimen for which it is known whether it has been subjected to storage of a specified type.
PERSON: Chris Stoeckert, Jie Zheng
MO_95 BiosourceType
specimen with known storage state
OBI:0001474
lowess group transformation
A lowess transformation where a potentially different normalization curve is generated and used for two or more groups (delineated by some criteria); criteria could include blocks (e.g. print-tip groups) on an array, or the day on which mass spectrometry was performed.
Person: Elisabetta Manduchi
MO_861 lowess_group_normalization
lowess group transformation
OBI:0001477
lowess transformation
A data transformation of normalizing ratio data by using a locally weighted polynomial regression (typically after a log transformation). The regression can be performed on log ratios resulting from the relation of two data sets versus the average log intensity data from the same two data sets or it can be performed on raw or log transformed values from one data set versus values from another. The goal could be to remove intensity-dependent dye-specific effects from the set of pair wise ratios. This method can be applied globally, or limited by one or more specified criteria.
Person: Elisabetta Manduchi
MO_720 lowess_normalization
lowess transformation
OBI:0001479
tissue specimen
A specimen that derives from an anatomical part or substance arising from an organism. Examples of tissue specimen include tissue, organ, physiological system, blood, or body location (arm).
PERSON: Chris Stoeckert, Jie Zheng
MO_954 organism_part
tissue specimen
OBI:0001481
lowess global transformation
A lowess transformation where the same normalization curve is used for all members of the data set; e.g. Features on an array, picked spots on a gel, or measured metabolites in a sample.
Person: Elisabetta Manduchi
MO_692 lowess_global_normalization
lowess global transformation
OBI:0001483
cell collecting
A planned process that collects cells from culture.
PERSON: Chris Stoeckert, Jie Zheng
MO_982 harvest
cell collecting
OBI:0001494
linear amplification
An example is the use of the T7 promoter for amplification by transcribing many RNA copies.
An enzymatic amplification which amplifies nucleic acid sequence by making many copies off the same template.
PERSON: Chris Stoeckert, Jie Zheng
MO_997 linear_amplification
linear amplification
OBI:0001498
atmosphere
A growth environment pertaining to the atmospheric conditions that is used to culture or grow an organism.
PERSON: Chris Stoeckert, Jie Zheng
MO_219 atmosphere
atmosphere
OBI:0001504
dissection
A planned process that separates and isolates tissues for surgical purposes, or for the analysis or study of their structures.
PERSON: Chris Stoeckert, Jie Zheng
EFO_0003856 dissection
MO_374 dissect
dissection
OBI:0001505
purification
A planned process to separate a material entity into different compositions of which one or more have are purified fractions that contain higher concentration of a desired component, while others contain impurities and are not of interest
PERSON: Chris Stoeckert, Jie Zheng
MO_406 purify
purification
OBI:0001506
specimen with pre- or post-mortem status
A specimen that has been established to be taken from a live (pre-mortem) or dead (post-mortem) organism.
organizational term, used in description of specimen that is created from known pre- or post-mortem status
PERSON: Chris Stoeckert, Jie Zheng
MO_84 OrganismStatus
specimen with pre- or post-mortem status
OBI:0001508
sampling time measurement datum
A time measurement datum when an observation is made or a sample is taken from a material as measured from some reference point.
Person: Chris Stoeckert
time point
MO_738 timepoint
sampling time measurement datum
OBI:0001573
DNA sequence data
The part of a FASTA file that contains the letters ACTGGGAA
A sequence data item that is about the primary structure of DNA
OBI call; Bjoern Peters
OBI call; Melanie Courtout
8/29/11 call: This is added after a request from Melanie and Yu. They should review it further. This should be a child of 'sequence data', and as of the current definition will infer there.
DNA sequence data
OBI:0001588
binding
A peptide binding to an MHC molecule to form a complex.
The process of material entities forming complexes.
9/28/11 BP: The disposition referenced is the one of the ligand to bind the molecule. This along with binding as a function / process needs to be figured out with GO which is inconsistent at this point.
PERSON: Bjoern Peters, Randi Vita
IEDB
binding
OBI:0001617
PubMed ID
A CRID symbol that is sufficient to look up a citation from the PubMed, a literature database of life sciences and biomedical information.
Person: Chris Stoeckert, Jie Zheng
PMID
PubMed Identifier
Website: http://en.wikipedia.org/wiki/Wikipedia:PMID
Publication Citation
NIAID GSCID-BRC
PubMed ID
OBI:0001674
cap analysis of gene expression
5' end-centered expression profiling using cap-analysis gene expression and next-generation sequencing.
Takahashi H, Lassmann T, Murata M, Carninci P.
Nat Protoc. 2012 Feb 23;7(3):542-61. doi: 10.1038/nprot.2012.005.
PMID: 22362160
An assay which aims at monitoring RNA transcript abundances in biological samples by extracting 5' ends of capped transcripts, RTPCR and sequence those. Copy numbers of CAGE tags provide a way of quantification and provide a measure of expression of the transcriptome
PERSON:Philippe Rocca-Serra; Marcus Chibucos
CAGE
PMID:14663149
cap analysis of gene expression
OBI:0001700
immunoprecipitation assay
Determining if a cell is producing a protein using a protein specific antibody to immunoprecipitate the cell lysate. Determining if the serum of a patient contains antibodies against HBV core protein by immunoprecipitating purified HBV core protein with the patients serum.
An assay with the objective to determine presence of an analyte by mixing a solution of antigen and antibody and separating out bound antigen:antibody complexes using immunoprecipitation. Either the antibody has known specificy, and the antigen mixture is tested for the presence of a specific antigen, or the antigen solution is well defined and the antibody solution is tested for the presence of antigen specific antibodies.
PERSON:Bjoern Peters, Randi Vita
IEDB
immunoprecipitation assay
OBI:0001848
chromatin interaction analysis by paired-end tag sequencing
Zhang, et al. ChIA-PET analysis of transcriptional chromatin interactions. Methods. 2012 Nov;58(3):289-99. [PMID:22926262]
An assay that incorporates chromatin immunoprecipitation (ChIP)-based enrichment, chromatin proximity ligation, Paired-End Tags, and high-throughput sequencing to determine de novo long-range chromatin interactions genome-wide.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
ChIA-PET
ChIA-PET assay
http://en.wikipedia.org/wiki/ChIA-PET
ENCODE project
chromatin interaction analysis by paired-end tag sequencing
OBI:0001849
structural analysis by paired-end tag sequencing
Yao, et al. Long Span DNA Paired-End-Tag (DNA-PET) Sequencing Strategy for the Interrogation of Genomic Structural Mutations and Fusion-Point-Guided Reconstruction of Amplicons. PLoS One. 2012;7(9):e46152 [PMID:23029419]
An assay that incorporates Paired-End Tags and sequencing technology to determine structural variants.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
DNA-PET
DNA-PET assay
Yao, et al. Long Span DNA Paired-End-Tag (DNA-PET) Sequencing Strategy for the Interrogation of Genomic Structural Mutations and Fusion-Point-Guided Reconstruction of Amplicons. PLoS One. 2012;7(9):e46152 [PMID:23029419]
ENCODE project
structural analysis by paired-end tag sequencing
OBI:0001850
transcript analysis by paired-end tag sequencing
Ruan, et al. Genome wide full-length transcript analysis using 5' and 3' paired-end-tag next generation sequencing (RNA-PET). Methods Mol Biol. 2012;809:535-62. [PMID:22113299]
An assay that incorporates Paired-End Tags and sequencing technology to determine transcripts, gene structures, and gene expressions.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
RNA-PET
RNA-PET assay
Ruan, et al. Genome wide full-length transcript analysis using 5' and 3' paired-end-tag next generation sequencing (RNA-PET). Methods Mol Biol. 2012;809:535-62. [PMID:22113299]
ENCODE project
transcript analysis by paired-end tag sequencing
OBI:0001851
transcription start site identification objective
A transcription profiling identification objective that aims to characterize the transcription start sites of genes.
Person: Chris Stoeckert, Jie Zheng
Penn Group
transcription start site identification objective
OBI:0001852
paired-end library preparation
A library preparation that results in the creation of a library of the 5' and 3' ends of DNA or cDNA fragments using adaptors and endonucleases. The preparation may or may not include cloning process.
Person: Venkat Malladi, Jie Zheng
Venkat Malladi, Jie Zheng
ENCODE project
paired-end library preparation
OBI:0001853
DNase I hypersensitive sites sequencing assay
Sabo, et al. Discovery of functional noncoding elements by digital analysis of chromatin structure. Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16837-42. [PMID:15550541]
An assay to identify the location of regulatory regions, based on the genome-wide sequencing of regions super sensitive to cleavage by DNase I.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
DNase-seq
DNase-seq assay
http://en.wikipedia.org/wiki/DNase-Seq
ENCODE project
DNase I hypersensitive sites sequencing assay
OBI:0001854
protein and RNA interaction identification objective
A sequence feature identification objective that aims to characterize the interactions between protein and RNA.
JZ: Term added for ENCODE project requested assays. Definition adapted from 'protein and DNA interaction identification objective'.
Person: Jie Zheng
Jie Zheng
protein and RNA interaction identification objective
OBI:0001857
RNP (ribonuclear particle) immunoprecipitation high- throughput sequencing assay
Zhao et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Molecular Cell (2010) vol. 40 (6) pp. 939-53 [PMID:21172659]
An assay that combines immunoprecipitation of an RNA-binding protein and RNA-seq to identify mRNAs associated with selected RNA binding proteins (RBPs).
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
RIP-seq
RIP-seq assay
Zhao et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Molecular Cell (2010) vol. 40 (6) pp. 939-53 [PMID:21172659]
ENCODE project
RNP (ribonuclear particle) immunoprecipitation high- throughput sequencing assay
OBI:0001858
cross-linking immunoprecipitation high-throughput sequencing assay
Heulga et al. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep. 2012 Feb 23;1(2):167-78. [PMID:22574288]
An assay that employs UV-crosslinking between RNA and the protein, followed by immunoprecipitation with antibodies for the protein, fragmentation, and high-throughput used for screening for RNA sequences that interact with a particular RNA-binding protein.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
CLIP-seq
CLIP-seq assay
HITS-CLIP
Licatalosi et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature. 2008 Nov 27 456: 464-469 [PMID:18978773]
ENCODE project
cross-linking immunoprecipitation high-throughput sequencing assay
OBI:0001859
formaldehyde-assisted isolation of regulatory elements assay
Giresi, et al. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Research 17 (6): 877–85. [PMID:17179217]
An assay to determine the sequences of those DNA regions in the genome associated with regulatory activity.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
FAIRE-seq
FAIRE-seq assay
http://en.wikipedia.org/wiki/FAIRE-Seq
ENCODE project
formaldehyde-assisted isolation of regulatory elements assay
OBI:0001861
methylation-sensitive restriction enzyme sequencing assay
Maunakea et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010 Jul 8;466(7303):253-7. [PMID:20613842]
An assay that identifies unmethylated CpGs by use of methylation sensitive restriction enzymes to fragment DNA.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
MRE-seq
MRE-seq assay
Maunakea et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010 Jul 8;466(7303):253-7. [PMID:20613842]
ENCODE project
methylation-sensitive restriction enzyme sequencing assay
OBI:0001862
reduced representation bisulfite sequencing assay
Meissner et al. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. 2005; 33(18): 5868–5877. [PMCID: PMC1258174]
A bisulfite sequencing assay that identifies genomic methylation patterns by using a bisulfite based protocol that enriches CG-rich parts of the genome.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
RRBS
RRBS assay
reduced representation bisulfite-seq
Meissner et al. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. 2005; 33(18): 5868–5877. [PMCID: PMC1258174]
ENCODE project
reduced representation bisulfite sequencing assay
OBI:0001863
shotgun bisulfite-seq assay
Cokus et al. Shotgun bisulfite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature. 2008 Mar 13;452(7184):215-9. [PMID:18278030].
A bisulfite sequencing assay that identifies methylated cytosines across the genome using high throughput sequencing.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
Shotgun bisulfite sequencing
WGBS
WGSBS
whole genome bisulfite sequencing
whole-genome shotgun bisulfite sequencing
Cokus et al. Shotgun bisulfite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature. 2008 Mar 13;452(7184):215-9. [PMID:18278030]
ENCODE project
shotgun bisulfite-seq assay
OBI:0001864
RNA Annotation and Mapping of Promoters for the Analysis of Gene Expression assay
Batut et al. High-fidelity promoter profiling reveals widespread alternative promoter usage and transposon-driven developmental gene expression. Genome Research. 2013 Jan;23(1):169-80. [PMID:22936248]
An assay that identifies transcription start sites (TSS), the quantification of their expression and the characterization
of their transcripts using high throughput sequencing.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
RAMPAGE
Batut et al. High-fidelity promoter profiling reveals widespread alternative promoter usage and transposon-driven developmental gene expression. Genome Research. 2013 Jan;23(1):169-80. [PMID:22936248]
ENCODE project
RNA Annotation and Mapping of Promoters for the Analysis of Gene Expression assay
OBI:0001865
assay array
A device made to be used in an analyte assay for immobilization of substances that bind the analyte at regular spatial positions on a surface.
PERSON: Chris Stoeckert, Jie Zheng, Alan Ruttenberg
Penn Group
assay array
OBI:0001866
secondary cultured cell
A cultured cell that has been passaged or derives from a cell that has been passaged in culture.
The term 'secondary cell culture' is generally used in biological texts/protocols to refer to any culture following an initial passage. We include it here because there are often a number of passages between a primary culture and the establishment of a stable, homogenous cell line. Such cultures are considered to be 'secondary cultures' but not 'cell lines' during this intermediate passaging/selection period between their derivation from a 'primary cell culture' and derivation into a 'cell line', which is a more specific type of secondary culture.
Person: Matthew Brush
PERSON: Matthew Brush
A secondary cultured cell has been passaged in culture or is a descendant of such a cell that is derived through propagation in culture.
secondary cultured cell
OBI:0001867
establishing cell line
a process whereby a new type of cell line is created, either through passaging of a primary cell culture to relative genetic stability and compositional homogeneity, or through some experimental modification of an existing cell line to produce a new line with novel characteristics (e.g. immortalization or some other stable genetic modification, or selection of some defined subset).
2013-4-20 MHB: For cases of initial establilshment of a line from a primary culture, successive passaging and/or selection processes can confer increasing degrees of genetic stability and compositional homogeneity as compared to the input primary culture. Historically, many texts consider the first passage as the clearest point to define the beginning of a line. However, in practice it is more often that case that more than one passage, and possibly additional selective techniques, may be required before a culture is deemed to have sufficient stability and homogeneity to be considered cell line. This is the view taken in OBI. Regardless, what is important is that some intentional, experimental step has been taken to establish a more homogenous and stable culture that can be characterized and progatated over time.
Person: Matthew Brush
PERSON:Matthew Brush
establishing cell line
OBI:0001905
secondary cultured cell population
A cultured cell population that is derived through one or more passages in culture.
The term 'secondary cell culture' is generally used in biological texts/protocols to refer to any culture of cells following an initial passage. We include it here because there are often a number of passages between a primary culture and the establishment of a stable, homogenous cell line. Such cultures are considered to be 'secondary cultures' but not 'cell lines' during this intermediate passaging/selection period between their derivation from a 'primary cell culture' and derivation into a 'cell line', which is a more specific type of secondary culture.
PERSON:Matthew Brush
secondary cell culture sample
PERSON:Matthew Brush
The concept of a 'secondary cultured cell population' covers cell lines as well as cultured cell populations more immediately derived from a primary culture which have yet to achieve adequate genetic stability and compositional homogeneity to be considered a cell line. The extent of the collection of cells in a 'secondary cultured cell population' is restricted only in that all cell members must share a propagation history (ie be derived through a common lineage of passages from an initial culture). Secondary cultured cell populations can be under active culture, stored in a quiescent state for future use, or applied experimentally.
secondary cultured cell population
OBI:0001909
conclusion based on data
The conclusion that a gene is upregulated in a tissue sample based on the band intensity in a western blot. The conclusion that a patient has a infection based on measurement of an elevated body temperature and reported headache. The conclusion that there were problems in an investigation because data from PCR and microarray are conflicting.
The following are NOT conclusions based on data: data themselves; results from pure mathematics, e.g. "13 is prime".
An information content entity that is inferred from data.
In the Philly 2013 workshop, we recognized the limitations of "conclusion textual entity", and we introduced this as more general. The need for the 'textual entity' term going forward is up for future debate.
Group:2013 Philly Workshop group
Group:2013 Philly Workshop group
conclusion based on data
OBI:0001912
cell freezing medium
A processed material that serves as a liquid vehicle for freezing cells for long term quiescent stroage, which contains chemicls needed to sustain cell viability across freeze-thaw cycles.
PERSON: Matthew Brush
cell freezing medium
OBI:0001914
multiplex ligation-mediated amplification
A polymerase chain reaction that amplifies multiple targets with a single primer pair mediated by hybridization of a primer with its target sequence using ligation.
Chris Stoeckert, Jie Zheng
LMA
MLPA
Multiplex ligation-dependent probe amplification
web: http://en.wikipedia.org/wiki/Multiplex_Ligation-dependent_Probe_Amplification
Pubmed: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1867615/
multiplex ligation-mediated amplification
OBI:0001916
DNA replication identification objective
A molecular feature identification objective that aims to examine charateristics of DNA replication, such as replication time.
Chris Stoeckert, Jie Zheng
Group: Penn Group
DNA replication identification objective
OBI:0001917
chromosome conformation identification objective
A molecular feature identification objective that aims to determine spatial organization of chromatin.
Chris Stoeckert, Jie Zheng
Group: Penn Group
chromosome conformation identification objective
OBI:0001919
Carbon-copy chromosome conformation capture assay
van Berkum et al. Determining spatial chromatin organization of large genomic regions using 5C technology. Methods Mol Biol (2009) vol. 567 pp. 189-213 [PMID:19588094]
An assay that is used to analyze the organization of chromosomes at the genome-wide scale.
Venkat Malladi, Chris Stoeckert, Jie Zheng
5C
5C assay
"Dostie et al. Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res. 2006 October; 16(10):1299-309.[PMID:16954542]"
ENCODE project
Carbon-copy chromosome conformation capture assay
OBI:0001920
DNA replication timing by sequencing assay
Hansen et al. Sequencing newly replicated DNA reveals widespread plasticity in human replication timing. Proc Natl Acad Sci U S A. 2010 January 5; 107(1): 139–144. [PMID:19966280]
An assay in which timing of DNA replication is quantified as a function of genome position based on genome-wide sequencing.
Venkat Malladi, Chris Stoeckert, Jie Zheng
Repli-seq
Repli-seq assay
Hansen et al. Sequencing newly replicated DNA reveals widespread plasticity in human replication timing. Proc Natl Acad Sci U S A. 2010 January 5; 107(1): 139–144. [PMID:19966280]
ENCODE project
DNA replication timing by sequencing assay
OBI:0001922
microRNA profiling by high throughput sequencing assay
Juhlia et al. MicroRNA expression profiling reveals miRNA families regulating
specific biological pathways in mouse frontal cortex and hippocampus. PLoS One. 2011;6(6). [PMID: 21731767]
A RNA-seq assay in which high throughput sequencing technology is used to analyse the microRNA component of the transcriptome.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
miRNA-seq
microRNA-seq
microRNA-seq assay
http://www.ebi.ac.uk/efo/EFO_0002896
ENCODE project
microRNA profiling by high throughput sequencing assay
OBI:0001923
protein sequencing by tandem mass spectrometry assay
Taylor et al.Implementation and uses of automated de novo peptide sequencing by tandem mass spectrometry. Anal Chem. 2001 Jun;73(11):2594-604. [PMID:11403305]
A sequencing assay in which amino acid sequences of proteins is determined using multiple rounds of mass spectrometry and molecule fragmentation.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
Hunt et al. Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci U S A. 1986;83(17): 6233–6237. [PMID:3462691]
ENCODE project
protein sequencing by tandem mass spectrometry assay
OBI:0001924
micrococcal nuclease digestion followed by high throughput sequencing assay
Cui et al.Genome-wide approaches to determining nucleosome occupancy in metazoans using MNase-Seq. Methods Mol Biol. 2012;833:413-9. [PMID:22183607]
An assay to identify nucleosome positioning by genome wide sequencing of regions senstative to digestion by micrococal nuclease
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
MNase-seq
MNase-seq assay
Johnson et al. Flexibility and constraint in the nucleosome core landscape of Caenorhabditis elegans chromatin. Genome Res. 2006 Dec;16(12):1505-16. [PMID:17038564]
JZ: should be inferred as 'DNA sequencing'. Will check in the future.
ENCODE project
micrococcal nuclease digestion followed by high throughput sequencing assay
OBI:0001925
chromatin immunoprecipitation with exonuclease sequencing assay
Rhee et al. Comprehensive Genome-wide Protein-DNA Interactions Detected at Single-Nucleotide Resolution. Cell. 2011 Dec;147(6):1408-19. [PMID:22153082]
A ChIP-seq assay to identify protein binding sites using an exonuclease to provide greater binding resolution of immunoprecipitation assay by genome wide sequencing.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
ChIP-exo assay
Rhee et al. Comprehensive Genome-wide Protein-DNA Interactions Detected at Single-Nucleotide Resolution. Cell. 2011 Dec;147(6):1408-19. [PMID:22153082]
ENCODE project
chromatin immunoprecipitation with exonuclease sequencing assay
OBI:0001926
microRNA profiling assay
A transcription profiling assay in which aims to quantify the microRNA species within a biological sample.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
miRNA expression assay
microRNA expression assay
Kolbert et al. Multi-Platform Analysis of MicroRNA Expression Measurements in RNA from Fresh Frozen and FFPE Tissues. PLoS One. 2013;8(1):e52517 [PMID: 23382819]
ENCODE project
microRNA profiling assay
1
1
OBI:0001931
scalar value specification
A value specification that consists of two parts: a numeral and a unit label
PERSON:Bjoern Peters
scalar value specification
OBI:0001933
value specification
The value of 'positive' in a classification scheme of "positive or negative"; the value of '20g' on the quantitative scale of mass.
An information content entity that specifies a value within a classification scheme or on a quantitative scale.
This term is currently a descendant of 'information content entity', which requires that it 'is about' something. A value specification of '20g' for a measurement data item of the mass of a particular mouse 'is about' the mass of that mouse. However there are cases where a value specification is not clearly about any particular. In the future we may change 'value specification' to remove the 'is about' requirement.
PERSON:Bjoern Peters
value specification
OBI:0001936
molecular-labeled material
a material entity that is the specified output of an addition of molecular label process that aims to label some molecular target to allow for its detection in a detection of molecular label assay
PERSON:Matthew Brush
OBI developer call, 3-12-12
molecular-labeled material
OBI:0001956
assay using chromatin immunoprecipitation
http://www.lifetechnologies.com/uk/en/home/life-science/epigenetics-noncoding-rna-research/chromatin-remodeling/chromatin-immunoprecipitation-chip.html
an assay which uses immunoprecipitation and which produces data about protein-DNA interaction or DNA epigenetic modification
as per user (pployd) request and proposal by Alan Ruttenberg
http://sourceforge.net/p/obi/obi-terms/707/
PERSON: Philippe Rocca-Serra
assay using chromatin immunoprecipitation
OBI:0001957
hardware testing design
A study design that aims to compare different types of hardware for performance, reproducibility, accuracy and precision.
Person: Jie Zheng
MO_734 hardware_variation_design
hardware testing design
OBI:0001958
systematic review study design
Red blood cell transfusion in patients with traumatic brain injury: a systematic review protocol. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090399/
The effect of moderate gestational alcohol consumption during pregnancy on speech and language outcomes in children: a systematic review. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892059/
A study design for identifying in the literature prior studies of a pre-determined phenomenon or set of related phenomena according to certain criteria, extracting findings from these studies, and summarizing these findings and/or attempting to draw new conclusions from them which were not justified by any of the individual, prior studies. Many systematic reviews also assess the quality of the studies so reviewed.
PERSON: Bill Hogan
systematic review study design
OBI:0001960
taxonomic diversity assessment by targeted gene survey
http://www.ncbi.nlm.nih.gov/pubmed/20679230
http://www.ncbi.nlm.nih.gov/pubmed/25367129
is an assay which aims to provide information about taxonomic information and community diversity by mean of sequencing specific genomic regions used as marker of identity or diversity.
PERSON:Philippe Rocca-Serra
targeted gene survey DNA barcoding
OBI
environmental gene survey
targeted gene survey
taxonomic diversity assessment by targeted gene survey
OBI:0001964
decision-theoretic analysis objective
An objective specification which what includes a description of two or more alternative actions to take in a particular situation and a metric that enables comparisons of the two actions. The objective specified is achieved in a planned process which includes a data transformation, the output of which is an identification of the 'best' choice according to the metric.
The best action to take is typically defined as the one that maximizes expected utility.
PERSON: Bill Hogan
decision analysis objective
PERSON: Bill Hogan
decision-theoretic analysis objective
OBI:0001965
decision analysis study design
a study design that has a decision analysis objective specification as part
PERSON: Bill Hogan
PERSON: Bill Hogan
decision analysis study design
OBI:0001969
biodiversity assessment objective
biodiversity assessment objective is an objective of a planned process aimed at producing data item whose interpretation should provide insight about variety of biological species found in a biological sample at macroscopic or microscopic level
PERSON:Philippe Rocca-Serra
PRS for OBI
biodiversity assessment objective
OBI:0002014
DNA methylation profiling by ChIP-chip assay
A ChIP-chip assay that identifies sites of DNA methylation.
Person: Chris Stoeckert, Jie Zheng
DNA methylation ChIP-chip
Penn group
Beta Cell Biology Consoritum
DNA methylation profiling by ChIP-chip assay
OBI:0002015
transcription profiling by MPSS assay
An assay in which the transcriptome of a biological sample is analysed using Massive Parallel Signature Sequencing (MPSS).
Person: Chris Stoeckert, Jie Zheng
expression MPSS
http://en.wikipedia.org/wiki/Massively_parallel_signature_sequencing
Beta Cell Biology Consoritum
transcription profiling by MPSS assay
OBI:0002016
histone modification identification by ChIP-chip assay
A ChIP-chip assay to identify regions containing specific histones and their modifications.
Person: Chris Stoeckert, Jie Zheng
histone modification ChIP-chip
Penn group
Beta Cell Biology Consoritum
histone modification identification by ChIP-chip assay
OBI:0002017
histone modification identification by ChIP-Seq assay
A ChIP-seq assay to identify regions containing specific histones and their modifications.
Person: Chris Stoeckert, Jie Zheng
histone modification ChIP-Seq
Penn group
Beta Cell Biology Consoritum
histone modification identification by ChIP-Seq assay
OBI:0002018
transcription factor binding site identification by ChIP-chip assay
A ChIP-chip assay to identify binding sites for transcription factors.
Person: Chris Stoeckert, Jie Zheng
TF Binding ChIP-chip
Penn group
Beta Cell Biology Consoritum
transcription factor binding site identification by ChIP-chip assay
OBI:0002019
transcription factor binding site identification by ChIP-Seq assay
A ChIP-seq assay to identify binding sites for transcription factors.
Person: Chris Stoeckert, Jie Zheng
TF Binding ChIP-Seq
Penn group
Beta Cell Biology Consoritum
transcription factor binding site identification by ChIP-Seq assay
OBI:0002020
epigenetic modification assay
An assay that identifies epigenetic modification including histone modifications, open chromatin, and DNA methylation.
Person: Chris Stoeckert, Jie Zheng
Penn group
Beta Cell Biology Consoritum
epigenetic modification assay
OBI:0002021
NextSeq 500
A DNA sequencer which is a desktop sequencer ideal for smaller-scale studies manufactured by the Illumina corporation. It supports sequencing of single, long or short insert paired end clone libraries relying on sequencing by synthesis technology.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
Illumina NextSeq 500
http://systems.illumina.com/systems/nextseq-sequencer.html
ENCODE project
NextSeq 500
OBI:0002033
translation-associated transcript leader sequencing
pmid:23580730
An RNA-seq assay that combines TL-seq with polysome fractionation
Details see tracker: https://sourceforge.net/p/obi/obi-terms/725/
Janos Demeter, Chris Stoeckert
TATL-seq
pmid:23580730
Saccharomyces Genome Database (SGD)
translation-associated transcript leader sequencing
OBI:0002034
transcript leader sequencing
pmid:23580730
An RNA-seq assay combining enzymatic capture of m(7)G-capped mRNA 5' ends with high-throughput sequencing.
Details see tracker: https://sourceforge.net/p/obi/obi-terms/725/
Janos Demeter, Chris Stoeckert
TL-seq
pmid:23580730
Saccharomyces Genome Database (SGD)
transcript leader sequencing
OBI:0002038
ribosomal profiling by sequencing assay
Aspden et al., (August 2014). "Extensive translation of small open reading frames revealed by poly-ribo-seq." eLIFE 2014;3:e03528
A RNA-seq assay to sequence only mRNA protected by the ribosome during translation.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
Ribo-seq
Ribo-seq assay
ribosomal profiling
Ingolia, Nicholas T. (28 January 2014). "Ribosome profiling: new views of translation, from single codons to genome scale". Nature Reviews Genetics 15 (3): 205-213. doi:10.1038/nrg3645. PMID 24468696.
ENCODE project
ribosomal profiling by sequencing assay
OBI:0002041
self-transcribing active regulatory region sequencing assay
Bohla et al., (September 2014). "A functional insulator screen identifies NURF and dREAM components to be required for enhancer-blocking." PLoS One 9(9):e107765. doi: 10.1371/journal.pone.0107765.
A RNA-seq assay to identify the sequences that act as transcriptional enhancers in a direct, quantitative, and genome-wide manner from sheared genomic DNA.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
STARR-seq
STARR-seq assay
self-transcribing active regulatory region sequencing
Arnold et al. (January 2013). "Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq". Science 339 (6123): 1074-7.
ENCODE project
self-transcribing active regulatory region sequencing assay
OBI:0002042
carbon-copy chromosome conformation capture assay followed by sequencing assay
Fudenberg et al., (November 2014). "High order chromatin architecture shapes the landscape of chromosomal alterations in cancer." Nat Biotechol 29(12):1109-13. doi: 10.1038/nbt.2049.
A carbon-copy chromosome conformation capture assay to analyze the organization of chromosomes in an unbiased, genome-wide manner using high throughput sequening following carbon-copy chromosome conformation capture.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
Carbon-copy chromosome conformation capture assay followed by sequencing
HiC
HiC assay
Lieberman-Aiden E, et al. (2009). Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326: 289-293.
ENCODE project
carbon-copy chromosome conformation capture assay followed by sequencing assay
OBI:0002043
individual-nucleotide resolution cross-linking and immunoprecipitation sequencing assay
König et al., (18 January 2012). "Protein-RNA interactions: new genomic technologies and perspectives". Nature Reviews Genetics 13 (2): 77-83. doi:10.1038/nrg3141
A cross-linking immunoprecipitation high-throughput sequencing assay to identify protein-RNA interactions by using UV light to covalently bind proteins and RNA molecules, allowing for a very stringent purification of the linked protein-RNA complexes.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
iCLIP
iCLIP assay
individual-nucleotide resolution cross-linking and immunoprecipitation
Huppertz et al., (February 2014). "iCLIP: protein-RNA interactions at nucleotide resolution.". Methods (San Diego, Calif.) 65 (3): 274-87. doi:10.1016/j.ymeth.2013.10.011
ENCODE project
individual-nucleotide resolution cross-linking and immunoprecipitation sequencing assay
OBI:0002044
RNA Bind-n-Seq assay
A RNA-seq assay that comprehensively characterizes sequence and structural specificity of RNA binding proteins (RBPs)
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
RBNS
RNA Bind-n-Seq
RNBS assay
Lambert et al., (June 2014). "RNA Bind-n-Seq: quantitative assessment of the sequence and structural binding specificity of RNA binding proteins." Mol Cell. 2014 Jun 5;54(5):887-900. doi: 10.1016/j.molcel.2014.04.016
ENCODE project
RNA Bind-n-Seq assay
OBI:0002045
poly(A)-site sequencing assay
Wu et al., (July 2014). "Genome-wide determination of poly(A) sites in Medicago truncatula: evolutionary conservation of alternative poly(A) site choice. BMC Genomics. 2014 Jul 21;15:615. doi: 10.1186/1471-2164-15-615.
A RNA-seq assay for quantitatively profiling RNA polyadenylation at the transcriptome level.
Person: Venkat Malladi, Chris Stoeckert, Jie Zheng
PAS-seq
PAS-seq assay
Poly(A)-site sequencing
Shepard et al., (April 2011). "Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq." RNA. 2011 Apr;17(4):761-72. doi: 10.1261/rna.2581711
ENCODE project
poly(A)-site sequencing assay
OBI:0100026
organism
Drosophila melanogaster
animal
fungus
plant
virus
A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs.
10/21/09: This is a placeholder term, that should ideally be imported from the NCBI taxonomy, but the high level hierarchy there does not suit our needs (includes plasmids and 'other organisms')
13-02-2009:
OBI doesn't take position as to when an organism starts or ends being an organism - e.g. sperm, foetus.
This issue is outside the scope of OBI.
GROUP: OBI Biomaterial Branch
James Malone
Jie Zheng
Tomasz Adamusiak
MO_508
NIFSTD:birnlex_376
WEB: http://en.wikipedia.org/wiki/Organism
A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs.
A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs. E.g Drosophila melanogaster
organism
organism
EFO_URI: http://www.ebi.ac.uk/efo/EFO_0000634
OBI:0100051
specimen
Biobanking of blood taken and stored in a freezer for potential future investigations stores specimen.
A material entity that has the specimen role.
Note: definition is in specimen creation objective which is defined as an objective to obtain and store a material entity for potential use as an input during an investigation.
PERSON: James Malone
PERSON: Philippe Rocca-Serra
GROUP: OBI Biomaterial Branch
specimen
OBI:0100060
cultured cell population
A cultured cell population applied in an experiment: "293 cells expressing TrkA were serum-starved for 18 hours and then neurotrophins were added for 10 min before cell harvest." (Lee, Ramee, et al. "Regulation of cell survival by secreted proneurotrophins." Science 294.5548 (2001): 1945-1948).
A cultured cell population maintained in vitro: "Rat cortical neurons from 15 day embryos are grown in dissociated cell culture and maintained in vitro for 8–12 weeks" (Dichter, Marc A. "Rat cortical neurons in cell culture: culture methods, cell morphology, electrophysiology, and synapse formation." Brain Research 149.2 (1978): 279-293).
A processed material comprised of a collection of cultured cells that has been continuously maintained together in culture and shares a common propagation history.
2013-6-5 MHB: This OBI class was formerly called 'cell culture', but label changed and definition updated following CLO alignment efforts in spring 2013, during which the intent of this class was clarified to refer to portions of a culture or line rather than a complete cell culture or line.
PERSON:Matthew Brush
cell culture sample
PERSON:Matthew Brush
The extent of a 'cultured cell population' is restricted only in that all cell members must share a propagation history (ie be derived through a common lineage of passages from an initial culture). In being defined in this way, this class can be used to refer to the populations that researchers actually use in the practice of science - ie are the inputs to culturing, experimentation, and sharing. The cells in such populations will be a relatively uniform population as they have experienced similar selective pressures due to their continuous co-propagation. And this population will also have a single passage number, again owing to their common passaging history. Cultured cell populations represent only a collection of cells (ie do not include media, culture dishes, etc), and include populations of cultured unicellular organisms or cultured multicellular organism cells. They can exist under active culture, stored in a quiescent state for future use, or applied experimentally.
cultured cell population
OBI:0100066
organ section
A liver slice used in a perfusion experiment.
Thyroidectomy during laryngectomy for advanced laryngeal carcinoma--whole organ section study with long-term functional evaluation. Clin Otolaryngol Allied Sci. 1995 Apr;20(2):145-9. PMID: 7634521
A processed material which derives from an organ and results from a process of dissection or histological sample preparation a portion(formerly an organ section is portion of an organ removed from the context of the organ)
PERSON: Helen Parkinson
PERSON: Philippe Rocca-Serra
GROUP: CEBS
GROUP: OBI Biomaterial Branch
organ section
OBI:0200000
data transformation
The application of a clustering protocol to microarray data or the application of a statistical testing method on a primary data set to determine a p-value.
A planned process that produces output data from input data.
Elisabetta Manduchi
Helen Parkinson
James Malone
Melanie Courtot
Philippe Rocca-Serra
Richard Scheuermann
Ryan Brinkman
Tina Hernandez-Boussard
data analysis
data processing
Branch editors
data transformation
OBI:0200005
feature extraction objective
A feature extraction objective is a data transformation objective where the aim of the data transformation is to generate quantified values from a scanned image.
Elisabetta Manduchi
James Malone
TERM: http://mged.sourceforge.net/ontologies/MGEDOntology.owl#feature_extraction
feature extraction objective
OBI:0200021
linlog transformation
This can be used for microarray normalization, e.g. to normalize the data from a two-channel expression microarray assay, as described in PMID 16646782.
A linlog transformation is a data transformation, described in PMID 16646782, whose input is a matrix [y_ik] and whose output is a matrix obtained by applying formula (9) of this paper, where values below an appropriately determined threshold (dependent on the row i) are transformed via a polynomial of degree 1, and values above this threshold are transformed via a logarithm.
Elisabetta Manduchi
Philippe Rocca-Serra
PMID: 16646782
linlog transformation
OBI:0200023
loess global transformation
A loess global transformation is a loess transformation where only one loess fitting is performed, utilizing one subset of (or possibly all of) the data points in the input so that there is only one resulting loess curve y=f(x) which is used for the transformation.
Elisabetta Manduchi
James Malone
Melanie Courtot
Philippe Rocca-Serra
OTHER: Editor's generalization based on MGED Ontology term
loess global transformation
OBI:0200024
loess group transformation
A loess group transformation is a loess transformation where the input is partitioned into groups and for each group a loess fitting is performed, utilizing a subset of (or possibly all of) the data points in that group. Thus, a collection of loess curves y=f_i(x) is generated, one per group. Each (x, y) in the input is transformed into (x, y-f_i(x)), where f_i(x) is the curve corresponding to the group to which that data point belongs.
Elisabetta Manduchi
James Malone
Melanie Courtot
Philippe Rocca-Serra
OTHER: Editor's generalization based on MGED Ontology term
loess group transformation
OBI:0200025
loess scale group transformation
A loess scale group transformation is a data transformation consisting in the application of a scale adjustment following a loess group transformation, to render the group variances for the second variable (y) similar. Has objective scaling.
Elisabetta Manduchi
James Malone
Melanie Courtot
OTHER: Editor's generalization based on MGED Ontology term
loess scale group transformation
OBI:0200026
total intensity transformation single
This can be used as a simple normalization method for expression microarray assays. For example, each intensity from a one-channel microarray assay is multiplied by a constant so that the output mean intensity over the microarray equals a desired target T (the multiplicative constant in this case is the T/(mean intensity)).
A total intensity transformation single is a data transformation that takes as input an n-dimensional (real) vector and multiplies each component of this vector by a coefficient, where the coefficient is obtained by taking the sum of the input components or of a subset of these, multiplied by a constant of choice.
Elisabetta Manduchi
Helen Parkinson
James Malone
Melanie Courtot
Philippe Rocca-Serra
OTHER: Adjusted from MGED Ontology
Note that if the word "sum" is replaced by the word "mean" in the definition, the resulting definition is equivalent.
total intensity transformation single
OBI:0200027
total intensity transformation paired
This can be used as a simple normalization method for the two channels from a two-channel expression microarray assay or from two related one-channel expression microarray assays.
A total intensity transformation paired is a data transformation that takes as input two n-dimensional (real) vectors and multiplies each component of the first vector by a coefficient, where the coefficient is obtained by taking the ratio of the sum of the second input components or of a subset of these by the sum of the first input components or of a subset of these (the same subset is used for the two vectors).
Elisabetta Manduchi
Philippe Rocca-Serra
OTHER: Adjusted from MGED Ontology
Note that if the word "sum" is replaced by the word "mean" in the definition, the resulting definition is equivalent.
total intensity transformation paired
OBI:0200028
quantile transformation
This can be used for expression microarray assay normalization and it is referred to as "quantile normalization", according to the procedure described e.g. in PMID 12538238.
A quantile transformation is a data transformation that takes as input a collection of data sets, where each can be thought as an n-dimensional (real) vector, and which transforms each data set so that the resulting output data sets have equal quantiles.
Elisabetta Manduchi
PERSON: Elisabetta Manduchi
quantile transformation
OBI:0200031
differential expression analysis objective
Analyses implemented by the SAM (http://www-stat.stanford.edu/~tibs/SAM), PaGE (www.cbil.upenn.edu/PaGE) or GSEA (www.broad.mit.edu/gsea/) algorithms and software
A differential expression analysis objective is a data transformation objective whose input consists of expression levels of entities (such as transcripts or proteins), or of sets of such expression levels, under two or more conditions and whose output reflects which of these are likely to have different expression across such conditions.
Elisabetta Manduchi
PERSON: Elisabetta Manduchi
differential expression analysis objective
OBI:0200055
dye swap merge
A dye swap merge is a replicate analysis which takes as input data from paired two-channel microarray assays where the sample labeled with one dye in the first assay is labeled with the other dye in the second assay and vice versa. The output for each reporter is obtained by combining its (raw or possibly pre-processed) M values in the two assays, where the M value in an assay is defined as the difference of the log intensities in the two channels. This can be used as a normalization step, when appropriate assumptions are met.
Elisabetta Manduchi
James Malone
PERSON: Elisabetta Manduchi
PERSON: James Malone
dye swap merge
OBI:0200056
moving average
The moving average is often used to handle data from tiling arrays.
A moving average is a data transformation in which center calculations, usually mean calculations, are performed on values within a sliding window across the input data set.
Elisabetta Manduchi
Helen Parkinson
Philippe Rocca-Serra
PERSON: Elisabetta Manduchi
PERSON: Helen Parkinson
moving average
OBI:0200057
replicate analysis
Replicate analysis can be used in microarray analysis to identify and potentially exclude low quality data.
A replicate analysis is a data transformation in which data from replicates are combined, e.g. through descriptive statistics calculations, and the results might be utilized for a variety of purposes, like assessing reproducibility, identifying outliers, normalizing, etc.
Elisabetta Manduchi
Helen Parkinson
PERSON: Helen Parkinson
PERSON:Elisabetta Manduchi
replicate analysis
OBI:0200071
loess transformation
A loess transformation is a data transformation that takes as input a collection of real number pairs (x, y) and, after performing (one or more) loess fittings, utilizes the resulting curves to transform each (x, y) in the input into (x, y-f(x)) where f(x) is one of the fitted curves.
Elisabetta Manduchi
James Malone
Melanie Courtot
Philippe Rocca-Serra
OTHER: Editor's generalization based on MGED Ontology term
loess transformation
OBI:0200089
multiple testing correction method
A multiple testing correction method is a hypothesis test performed simultaneously on M > 1 hypotheses. Multiple testing procedures produce a set of rejected hypotheses that is an estimate for the set of false null hypotheses while controlling for a suitably define Type I error rate
Monnie McGee
multiple testing procedure
PAPER: Dudoit, Sandrine and van der Laan, Mark J. (2008) Multiple Testing Procedures with Applications to Genomics. New York: Springer , p. 9-10.
multiple testing correction method
OBI:0200166
data transformation objective
normalize objective
An objective specification to transformation input data into output data
Modified definition in 2013 Philly OBI workshop
James Malone
PERSON: James Malone
data transformation objective
OBI:0200167
data normalization objective
Quantile transformation which has normalization objective can be used for expression microarray assay normalization and it is referred to as "quantile normalization", according to the procedure described e.g. in PMID 12538238.
A normalization objective is a data transformation objective where the aim is to remove
systematic sources of variation to put the data on equal footing in order
to create a common base for comparisons.
Elisabetta Manduchi
Helen Parkinson
James Malone
PERSON: Elisabetta Manduchi
PERSON: Helen Parkinson
PERSON: James Malone
data normalization objective
OBI:0200168
correction objective
Type I error correction
A correction objective is a data transformation objective where the aim is to correct for error, noise or other impairments to the input of the data transformation or derived from the data transformation itself
James Malone
PERSON: James Malone
PERSON: Melanie Courtot
correction objective
OBI:0200169
normalization data transformation
A normalization data transformation is a data transformation that has objective normalization.
James Malone
PERSON: James Malone
normalization data transformation
OBI:0200170
averaging data transformation
An averaging data transformation is a data transformation that has objective averaging.
James Malone
PERSON: James Malone
averaging data transformation
OBI:0200175
class discovery data transformation
A class discovery data transformation (sometimes called unsupervised classification) is a data transformation that has objective class discovery.
James Malone
clustering data transformation
unsupervised classification data transformation
PERSON: James Malone
class discovery data transformation
OBI:0200177
center calculation objective
A mean calculation which has center calculation objective is a data transformation in which the center of the input data is discovered through the calculation of a mean average.
A center calculation objective is a data transformation objective where the aim is to calculate the center of an input data set.
James Malone
PERSON: James Malone
center calculation objective
OBI:0200178
class discovery objective
A class discovery objective (sometimes called unsupervised classification) is a data transformation objective where the aim is to organize input data (typically vectors of attributes) into classes, where the number of classes and their specifications are not known a priori. Depending on usage, the class assignment can be definite or probabilistic.
James Malone
clustering objective
discriminant analysis objective
unsupervised classification objective
PERSON: Elisabetta Manduchi
PERSON: James Malone
class discovery objective
OBI:0200181
center calculation data transformation
A center calculation data transformation is a data transformation that has objective of center calculation.
James Malone
PERSON: James Malone
center calculation data transformation
OBI:0200183
scaling objective
Scaling gene expression data for cross platform analysis http://www.springerprotocols.com/Abstract/doi/10.1007/978-1-59745-454-4_13
is a data transformation objective where all, or some of a data set is adjusted by some data transformation according to some scale, for example a user defined minimum or maximum
Awaiting English definition from Monnie McGee
James Malone
Person:Helen Parkinson
scaling objective
OBI:0200185
scaling data transformation
A scaling data transformation is a data transformation that has objective scaling.
James Malone
PERSON: James Malone
scaling data transformation
OBI:0200186
error correction objective
Application of a multiple testing correction method
An error correction objective is a data transformation objective where the aim is to remove (correct for) erroneous contributions arising from the input data, or the transformation itself.
James Malone, Helen Parkinson
PERSON: James Malone
error correction objective
OBI:0300310
sequential design
PMID: 17710740.Pharm Stat. 2007 Aug 20.Sequential design approaches for bioequivalence studies with crossover designs.
Any design in which the decision as to whether to enroll the next patient, pair of patients, or block of patients is determined by whether the cumulative treatment difference for all previous patients is within specified limits. Enrollment is continued if the difference does not exceed the limits. It is terminated if it does
Philippe Rocca-Serra
MUSC
Provenance: OCI
sequential design
OBI:0300311
observation design
PMID: 12387964.Lancet. 2002 Oct 12;360(9340):1144-9.Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.
observation design is a study design in which subjects are monitored in the absence of any active intervention by experimentalists.
Philippe Rocca-Serra
OBI branch derived
observation design
OBI:0302716
pool of specimens
A pool of specimens is a mixture of a population of samples which have been gathered from one or more sample populations, obtained by the physical process of mixing individual specimens, e.g. mixing the DNA collected from the individual fish.
check with advisors as to how to represent multiple instances of any class? a set of specimens which have been gathered from one or more sample_populations, obtained by the physical process of mixing individual specimens, e.g. mixing the DNA collected from the individual fish
PERSON: Jennifer Fostel
GROUP: CEBS
pool of specimens
OBI:0302859
genetically modified organism
A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis.
Nat Protoc. 2008;3(10):1550-8. PMID: 18802436
an organism that is the output of a genetic transformation process
PERSON: Philippe Rocca-Serra
OBI Biomaterial
genetically modified organism
OBI:0302884
extraction
nucleic acid extraction using phenol chloroform
A material separation in which a desired component of an input material is separated from the remainder
Current the output of material processing defined as the molecular entity, main component in the output material entity, rather than the material entity that have grain molecular entity.
'nucleic acid extract' is the output of 'nucleic acid extraction' and has grain 'nucleic acid'. However, the output of 'nucleic acid extraction' is 'nucleic acid' rather than 'nucleic acid extract'. We are aware of this issue and will work it out in the future.
Person:Bjoern Peters
Philippe Rocca-Serra
extraction
OBI:0302886
centrifugation
PMID: 18428461.Purification of oligodendrocytes and their progenitors using immunomagnetic separation and Percoll gradient centrifugation. Curr Protoc Neurosci. 2001 May;Chapter 3:Unit 3.12.
centrifugation is a process separating molecules by size or density using centrifugal forces generated by a spinning rotor. G-forces of several hundred thousand times gravity are generated in ultracentrifugation
Philippe Rocca-Serra
adapted from http://www.fao.org/DOCREP/003/X3910E/X3910E06.htm
centrifugation
OBI:0302887
staining
PMID: 18540298. Role of modified bleach method in staining of acid-fast bacilli in lymph node aspirates. Acta Cytol. 2008 May-Jun;52(3):325-8.
Staining is a process which results in the addition a class-specific (DNA, proteins, lipids, carbohydrates) dye to a substrate to qualify or quantify the presence of a specific compound.
Philippe Rocca-Serra
adapted from Wikipedia: http://en.wikipedia.org/wiki/Staining
staining
OBI:0302888
washing
PMID: 6874122. Dialysis leucopenia--no correction after prolonged washing of the membrane. Int J Artif Organs. 1983 May;6(3):113-4.
washing is a process by which a material entity acting as contaminant (e.g. excess staining reagent) is removed by application of one or more cycles of solution in flow.
Philippe Rocca-Serra
OBI-Branch
washing
OBI:0302889
irradiation
PMID: 18563778.Histological and modeling study of skin thermal injury to 2.0 mum laser irradiation.Lasers Surg Med. 2008 Jun 18;40(5):358-370.
irradiation is a process by which a material entity is exposed to radiative energy, which could be ionizing radiation (such as gamma rays or X-rays) or not such as UV light or microwaves
Philippe Rocca-Serra
adapted from wikipedia (http://en.wikipedia.org/wiki/Irradiation)
irradiation
OBI:0302892
enzymatic ligation
PMID: 17853876. Enzymatic ligation assisted by nucleases: simultaneous ligation and digestion promote the ordered assembly of DNA. Nat Protoc. 2007;2(9):2198-202.
An enzymatic ligation is a planned process in which molecules are joined by covalent bonds through the action of an material entity with a ligase activity
Philippe Rocca-Serra
OBI-Branch
enzymatic ligation
OBI:0302893
storage
PMID: 18550121.Total Prostate Specific Antigen Stability Confirmed After Long-Term Storage of Serum at -80C. J Urol. 2008 Jun 10.
A maintenance process by which material entities that are not actively metabolizing are placed in well identified location and possibly under controlled environment in ad-hoc devices/structures in order to preserve and protect them from decay/alteration and maintain availability
Philippe Rocca-Serra
OBI-Branch
storage
OBI:0302894
cell lysis
PMID: 18484276.Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay. Free Radic Res. 2008 May;42(5):435-41.
cell lysis is a process by which cell membrane integrity of live cells is compromised and leads to cell death. Cell lysis may be achieved by means of viral action or osmotic shock.
BP, JG, RV: There is also a need for the unplanned cell lysis, which is probably not in the scope of OBI, but should be linked to from this process.
Philippe Rocca-Serra
adapted from wikipedia [http://en.wikipedia.org/wiki/Lysis]
cell lysis
OBI:0302902
immobilization
PMID: 18562258. The immobilization of proteins on biodegradable fibers via biotin-streptavidin bridges.Acta Biomater. 2008 May 23.
immbolization is a process by which material entity become (possibly covalently but not necessarily) attached to the surface of another material entity used a substratum.
Philippe Rocca-Serra
OBI-Branch
immobilization
OBI:0302903
nucleic acid hybridization
PMID: 18555787.Quantitative analysis of DNA hybridization in a flowthrough microarray for molecular testing. Anal Biochem. 2008 May 27.
a planned process by which totally or partially complementary, single-stranded nucleic acids are combined into a single molecule called heteroduplex or homoduplex to an extent depending on the amount of complementarity.
Philippe Rocca-Serra
adapted from wikipedia [http://en.wikipedia.org/wiki/Nucleic_acid_hybridization]
hybridization assay
nucleic acid hybridization
OBI:0400043
flow cell
Biofilm Flow Cell
Aparatus in the fluidic subsystem where the sheath and sample meet. Can be one of several types; jet-in-air, quartz cuvette, or a hybrid of the two. The sample flows through the center of a fluid column of sheath fluid in the flow cell.
Person:John Quinn
flow_cell
http://www.flocyte.com/FRTP/Resources/flow_cytometry_glossary.htm
flow cell
OBI:0400044
flow cytometer
FACS Calibur
A flow_cytometer is an instrument for counting, examining and sorting microscopic particles in suspension. It allows simultaneous multiparametric analysis of the physical and/or chemical characteristics of single cells flowing through an optical and/or electronic detection apparatus. A flow cytometer is an instrument that can be used to quantitatively measure the properties of individual cells in a flowing medium.
John Quinn
http://en.wikipedia.org/wiki/Flow_cytometer
flow cytometer
OBI:0400065
light source
A light source is an optical subsystem that provides light for use in a distant area using a delivery system (e.g., fiber optics). Light sources may include one of a variety of lamps (e.g., xenon, halogen, mercury). Most light sources are operated from line power, but some may be powered from batteries. They are mostly used in endoscopic, microscopic, and other examination and/or in surgical procedures. The light source is part of the optical subsystem. In a flow cytometer the light source directs high intensity light at particles at the interrogation point. The light source in a flow cytometer is usually a laser.
Elizabeth M. Goralczyk
John Quinn
Olga Tchuvatkina
Practical Flow Cytometry 4th Edition, Howard Shapiro, ISBN-10: 0471411256, ISBN-13: 978-0471411253
light source
OBI:0400078
obscuration bar
obscuration bar in a flow cytometer
An obscuration bar is a an optical subsystem which is a strip of metal or other material that serves to block out direct light from the illuminating beam. The obscuration bar prevents the bright light scattered in the forward directions from burning out the collection device.
Daniel Schober
Flow Cytometry: First Principles, by Alice Longobardi Givan, ISBN-10: 0471382248, ISBN-13: 978-0471382249
John Quinn
obscuration bar
OBI:0400079
optical filter
720 LP filter, 580/30 BP filter
An optical filter is an optical subsystem that selectively transmits light having certain properties (often, a particular range of wavelengths, that is, range of colours of light), while blocking the remainder. They are commonly used in photography, in many optical instruments, and to colour stage lighting Optical filters can be arranged to segregate and collect light by wave length.
John Quinn
http://en.wikipedia.org/wiki/Optical_filter
optical filter
OBI:0400082
photodetector
A photomultiplier tube, a photo diode
A photodetector is a device used to detect and measure the intensity of radiant energy through photoelectric action. In a cytometer, photodetectors measure either the number of photons of laser light scattered on impact with a cell (for example), or the flourescence emitted by excitation of a fluorescent dye.
John Quinn
http://einstein.stanford.edu/content/glossary/glossary.html
photodetector
OBI:0400099
flow cytometer sorter
BioSorter2000, LSR2
A flow_cytometer_sorter is a flow_cytometer that analyzes and separates or sorts particles passing through (based on properties measured during analysis) to collect cells of interest.
John Quinn
Melanie Courtot
http://www.flocyte.com/FRTP/Resources/flow_cytometry_glossary.htm
flow cytometer sorter
OBI:0400103
DNA sequencer
ABI 377 DNA Sequencer, ABI 310 DNA Sequencer
A DNA sequencer is an instrument that determines the order of deoxynucleotides in deoxyribonucleic acid sequences.
Trish Whetzel
MO
DNA sequencer
OBI:0400104
array scanner
GenePix 4200A, GenePix4000B
An processed material which acquires images of fluorescence (induced with lasers) from labeled molecules on the surface of the microarray chip
Trish Whetzel
GROUP: MGED Ontology
array scanner
OBI:0400105
arrayer
BioRobotics Microgrid II TAS, Affymetrix GMS 417
a device which deposits biological material onto a substrate in a defined pattern.
Trish Whetzel
MO_697 arrayer
arrayer
OBI:0400106
centrifuge
A device with a rapidly rotating container that applies centrifugal force to its contents
Melanie Courtot
Person: Jennifer Fostel
Trish Whetzel
http://en.wikipedia.org/wiki/Centrifuge
centrifuge
OBI:0400107
computer
Apple PowerBook, Dell OptiPlex
A computer is an instrument which manipulates (stores, retrieves, and processes) data according to a list of instructions.
Melanie Courtot
Trish Whetzel
http://en.wikipedia.org/wiki/Computer
computer
OBI:0400108
heating block
An instrument used to heat and/or maintain material at a set temperature.
A heating block is an instrument or part of an instrument which raises or maintains the temperature of a sample to a defined constant temperature during certain parts of an assay
Daniel Schober
MO
heating block
OBI:0400109
homogenizer
mortar, blender
A homogenizer is an instrument for the homogenization of various types of material, such as tissue, plant, food, soil, and many others.
Melanie Courtot
Trish Whetzel
http://en.wikipedia.org/wiki/Homogenizer
homogenizer
OBI:0400110
hybridization chamber
Glass Array Hybridization Cassette
A device which is used to maintain constant contact of a liquid on an array. This can be either a glass vial or slide.
Trish Whetzel
MO_563 hybridization_chamber
hybridization chamber
OBI:0400111
hybridization station
Labnet Problot12
A device which is used to maintain the temperature of one or more hybridization_chamber(s) at a defined, constant temperature.
Trish Whetzel
MO_497 hybridization station
hybridization station
OBI:0400112
liquid handler
Beckman BioMek 2000
a device that is used for automated liquid transfer and handling.
liquid_handling_instrument
MO_868 liquid_handler
DS: Is this class justified? Its a unnamed class. If so, put a fluidic_system and the fluidic_subsystem as subclasses.
TW: This is required by MO.
FG & DS: Capture as function.
All: Needs to be reviewed, according to query use case. If we keep it its kept as unnamed owl class.
The liquid handling class remains but as an undefined class with are unlikely to have children. It is expected that the reasoner would classifiy appropriate classes under this class that meet the have the liquid_handling function relation.
DS: Is this class justified? Its a unnamed class. If so, put a fluidic_system and the fluidic_subsystem as subclasses.
TW: This is required by MO.
FG: Or as function.
liquid handler
OBI:0400113
oligonucleotide synthesizer
Automated Multiplex Oligonucleotide Synthesizer
An instrument used to chemically synthesize oligonucleotides.
Trish Whetzel
MO
oligonucleotide synthesizer
OBI:0400114
sonicator
Sonicator 3000
A device that converts a variable electrical current to mechanical vibration of a metallic probe. The device is used for the lysis of cells, the mixing of compounds or solutions, to framgent molecules of DNA, or to create emulsions.
Trish Whetzel
MO
sonicator
OBI:0400115
spectrophotometer
Helios Gamma Spectrophotometer
A spectrophotometer is an instrument that measures the intensity of light as a function of the color, or more specifically, the wavelength of light, transmitted by a substance.
Melanie Courtot
Trish Whetzel
MO
spectrophotometer
OBI:0400116
thermal cycler
Piko(tm) 96-well Thermal Cycler
An instrument that is capable of repeatedly altering and maintaining specific temperatures for defined periods of time.
Melanie Courtot
Trish Whetzel
DNA_amplifier
PCR_machine
Polymerase_Chain_Reaction_ machine
thermocycler
MO
thermal cycler
OBI:0400118
vortexer
VWR Genie 2
A vortexer is an instrument that mixes small vials of liquid by creating a rotation of the liquid around its own center. It consists of an electric motor with the drive shaft oriented vertically and attached to a cupped rubber piece mounted slightly off-center. As the motor runs the rubber piece oscillates rapidly in a circular motion. When a test tube or other appropriate container is pressed into the rubber cup (or touched to its edge) the motion is transmitted to the liquid inside and a vortex is created.
Melanie Courtot
Trish Whetzel
vortex_mixer
http://en.wikipedia.org/wiki/Vortex_mixer
vortexer
OBI:0400119
microarray wash station
ArrayIt(r) Microarray Wash Station
a device that is used to wash Affymetrix-type arrays.
Trish Whetzel
MO_626 wash_station
microarray wash station
OBI:0400120
temperature control bath
VWR Signature Deep-Chamber Heated Water Bath. A water bath is used for temperatures up to 100 degrees C. An oil bath is employed for temperatures over 100 degrees C.
A temperature_control_bath is a device that has the function to regulate the temperature of a material, the function to contain fluid and the function to vary and maintain the temperature of the contained fluid. Heat exchange (energy transfer) between the material and the heating element is facilitated via the contained fluid. A temperature_control_bath is composed of a container, a heating element and/or a cooling element and a means to adjust the needed temperature. In most cases also a timer and a means to stir the fluid is provided as well.
Alan Ruttenburg
Daniel Schober
Frank Gibson
OBI Instrument branch
DS: This was heated_bath. It was renamed to reflect the possability that the same bath can be used for cooling. We can now define the temperature variables and based on that infer if it is a cooling device or a heating device (also quite relative to surrounding temperature).
temperature control bath
OBI:0400137
cytometer
A cytometer is an instrument for counting and measuring cells.
Melanie Courtot
http://medical.merriam-webster.com/medical/cytometer
cytometer
OBI:0400147
microarray
An affymetrix U133 array is a microarray. Microarrays include 1 and 2-color arrays, custom and commercial arrays (e.g, Affymetrix, Agilent, Nimblegen, Illumina, etc.) for expression profiling, DNA variant detection, protein binding, and other genomic and functional genomic assays.
A processed material that is made to be used in an analyte assay. It consists of a physical immobilisation matrix in which substances that bind the analyte are placed in regular spatial position.
Daniel Schober
PERSON: Chris Stoeckert
microarray
OBI:0400148
DNA microarray
Moran G, Stokes C, Thewes S, Hube B, Coleman DC, Sullivan D (2004). "Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis". Microbiology 150: 3363-3382. doi:10.1099/mic.0.27221-0. PMID 15470115
A DNA-microarray is a microarray that is used as a physical 2D immobilisation matrix for DNA sequences. DNA microarray-bound DNA fragments are used as targets for a hybridising probed sample.
PERSON: Daniel Schober
PERSON: Frank Gibson
DNA Chip
DNA-array
Web:<http://en.wikipedia.org/wiki/DNA_microarray>@2008/03/03
DNA microarray
OBI:0400149
protein microarray
The most common protein microarray is the antibody microarray, where antibodies are spotted onto the protein chip and are used as capture molecules to detect proteins from cell lysate solutions.
A protein-microarray is a microarray, ususlly a piece of glass, on which different molecules of protein have been affixed at separate locations in an ordered manner. These are used to identify protein-protein or protein-small molecule interactions.
Daniel Schober
PERSON: Daniel Schober
protein microarray
OBI:0400153
droplet sorter
A droplet sorter is part_of a flow cytometer sorter that converts the carrier fluid stream into individual droplets, and these droplets are directed into separate locations for recovery (enriching the original
sample for particles of interest based on qualities determined by gating) or disposal.
OBI Instrument branch
OBI Instrument branch
droplet sorter
OBI:0400155
water bath
A water bath was used to allow for cell incubation at 38 degree centigrade for 8 hours.
A water bath is a temperature control bath in which a water acts as contact medium enabling temperature transfer from the heating element or cooling element to the sample. The temperature can be controlled in the 0 to 100 degree centigrade range (under normal pressure).
Daniel Schober
PERSON: Daniel Schober
water bath
OBI:0400168
microtome
PMID: 9974145.Serial sectioning of thick tissue with a novel vibrating blade microtome. Brain Res Brain Res Protoc. 1999 Jan;3(3):302-7.
A microtome is a mechanical instrument used to cut biological specimens into very thin segments for further treatment (e.g. ISH) and ultimately microscopic or histologic examination. Most microtomes provide cooling facilities (cryo-microtome) and use a steel blade to cut a slice of defined thickness. Some are automatic, and some are driven by hand.
PERSON: Phillippe Rocca-Serra
PERSON: Daniel Schober
microtome
OBI:0500000
study design
a matched pairs study design describes criteria by which subjects are identified as pairs which then undergo the same protocols, and the data generated is analyzed by comparing the differences between the paired subjects, which constitute the results of the executed study design.
A plan specification comprised of protocols (which may specify how and what kinds of data will be gathered) that are executed as part of an investigation and is realized during a study design execution.
Editor note: there is at least an implicit restriction on the kind of data transformations that can be done based on the measured data available.
PERSON: Chris Stoeckert
experimental design
rediscussed at length (MC/JF/BP). 12/9/08). The definition was clarified to differentiate it from protocol.
study design
OBI:0500001
clinical study design
PMID: 17655677.J Cardiovasc Electrophysiol. 2007 Aug;18(9):965-71.Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): clinical study design and rationale.
Plan for the precise procedure to be followed in a clinical trial, including planned and actual timing of events, choice of control group, method of allocating treatments, blinding methods; assigns a subject to pass through one or more epochs in the course of a trial. Specific design elements, e.g., crossover, parallel; dose-escalation [Modified from Pocock, Clinical Trials: A Practical Approach]
The definition needs to be extended to other things than simply patients
PlanAndPlannedProcess Branch
Clinical Research Glossary Version 4.0 CDICS glossary group
clinical study design
OBI:0500002
repeated measure design
PMID: 10959922.J Biopharm Stat. 2000 Aug;10(3):433-45.Equivalence in test assay method comparisons for the repeated-measure, matched-pair design in medical device studies: statistical considerations.
a study design which use the same individuals and exposure them to a set of conditions. The effect of order and practice can be confounding factor in such designs
PlanAndPlannedProcess Branch
http://www.holah.karoo.net/experimentaldesigns.htm
repeated measure design
OBI:0500003
cross over design
PMID: 17601993-Objective: HIV-infected patients with lipodystrophy (HIV-lipodystrophy) are insulin resistant and have elevated plasma free fatty acid (FFA) concentrations. We aimed to explore the mechanisms underlying FFA-induced insulin resistance in patients with HIV-lipodystrophy. Research Design and Methods: Using a randomized placebo-controlled cross-over design, we studied the effects of an overnight acipimox-induced suppression of FFA on glucose and FFA metabolism by using stable isotope labelled tracer techniques during basal conditions and a two-stage euglycemic, hyperinsulinemic clamp (20 mU insulin/m(2)/min; 50 mU insulin/m(2)/min) in nine patients with nondiabetic HIV-lipodystrophy. All patients received antiretroviral therapy. Biopsies from the vastus lateralis muscle were obtained during each stage of the clamp. Results: Acipimox treatment reduced basal FFA rate of appearance by 68.9% (52.6%-79.5%) and decreased plasma FFA concentration by 51.6 % (42.0%-58.9%), (both, P < 0.0001). Endogenous glucose production was not influenced by acipimox. During the clamp the increase in glucose-uptake was significantly greater after acipimox treatment compared to placebo (acipimox: 26.85 (18.09-39.86) vs placebo: 20.30 (13.67-30.13) mumol/kg/min; P < 0.01). Insulin increased phosphorylation of Akt (Thr(308)) and GSK-3beta (Ser(9)), decreased phosphorylation of glycogen synthase (GS) site 3a+b and increased GS-activity (I-form) in skeletal muscle (P < 0.01). Acipimox decreased phosphorylation of GS (site 3a+b) (P < 0.02) and increased GS-activity (P < 0.01) in muscle. Conclusion: The present study provides direct evidence that suppression of lipolysis in patients with HIV-lipodystrophy improves insulin-stimulated peripheral glucose-uptake. The increased glucose-uptake may in part be explained by increased dephosphorylation of GS (site 3a+b) resulting in increased GS activity.
a repeated measure design which ensures that experimental units receive, in sequence, the treatment (or the control), and then, after a specified time interval (aka *wash-out periods*), switch to the control (or treatment). In this design, subjects (patients in human context) serve as their own controls, and randomization may be used to determine the ordering which a subject receives the treatment and control
Philippe Rocca-Serra
(source: http://www.sbu.se/Filer/Content0/publikationer/1/literaturesearching_1993/glossary.html)
cross over design
OBI:0500004
n-to-1 design
N-of-1 design is a cross-over design in which the same patient is repeatedly randomised to receive either the experimental treatment or its control (Senn, 1993).
Philippe Rocca-Serra
Adapted from http://www.childrens-mercy.org/stats/definitions/crossover.htm and source:http://symptomresearch.nih.gov/chapter_6/sec1/csss1pg1.htm)
n-to-1 design
OBI:0500005
matched pairs design
PMID: 17288613-BSTRACT: BACKGROUND: Physicians in Canadian emergency departments (EDs) annually treat 185,000 alert and stable trauma victims who are at risk for cervical spine (C-spine) injury. However, only 0.9% of these patients have suffered a cervical spine fracture. Current use of radiography is not efficient. The Canadian C-Spine Rule is designed to allow physicians to be more selective and accurate in ordering C-spine radiography, and to rapidly clear the C-spine without the need for radiography in many patients. The goal of this phase III study is to evaluate the effectiveness of an active strategy to implement the Canadian C-Spine Rule into physician practice. Specific objectives are to: 1) determine clinical impact, 2) determine sustainability, 3) evaluate performance, and 4) conduct an economic evaluation. METHODS: We propose a matched-pair cluster design study that compares outcomes during three consecutive 12-months before, after, and decay periods at six pairs of intervention and control sites. These 12 hospital ED sites will be stratified as teaching or community hospitals, matched according to baseline C-spine radiography ordering rates, and then allocated within each pair to either intervention or control groups. During the after period at the intervention sites, simple and inexpensive strategies will be employed to actively implement the Canadian C-Spine Rule. The following outcomes will be assessed: 1) measures of clinical impact, 2) performance of the Canadian C-Spine Rule, and 3) economic measures. During the 12-month decay period, implementation strategies will continue, allowing us to evaluate the sustainability of the effect. We estimate a sample size of 4,800 patients in each period in order to have adequate power to evaluate the main outcomes. DISCUSSION: Phase I successfully derived the Canadian C-Spine Rule and phase II confirmed the accuracy and safety of the rule, hence, the potential for physicians to improve care. What remains unknown is the actual change in clinical behaviors that can be affected by implementation of the Canadian C-Spine Rule, and whether implementation can be achieved with simple and inexpensive measures. We believe that the Canadian C-Spine Rule has the potential to significantly reduce health care costs and improve the efficiency of patient flow in busy Canadian EDs.
A matched pair design is a study design which use groups of individuals associated (hence matched) to each other based on a set of criteria, one member going to one treatment, the other member receiving the other treatment.
Philippe Rocca-Serra
http://www.holah.karoo.net/experimentaldesigns.htm
matched pairs design
OBI:0500006
parallel group design
PMID: 17408389-Purpose: Proliferative vitreoretinopathy (PVR) is the most important reason for blindness following retinal detachment. Presently, vitreous tamponades such as gas or silicone oil cannot contact the lower part of the retina. A heavier-than-water tamponade displaces the inflammatory and PVR-stimulating environment from the inferior area of the retina. The Heavy Silicone Oil versus Standard Silicone Oil Study (HSO Study) is designed to answer the question of whether a heavier-than-water tamponade improves the prognosis of eyes with PVR of the lower retina. Methods: The HSO Study is a multicentre, randomized, prospective controlled clinical trial comparing two endotamponades within a two-arm parallel group design. Patients with inferiorly and posteriorly located PVR are randomized to either heavy silicone oil or standard silicone oil as a tamponading agent. Three hundred and fifty consecutive patients are recruited per group. After intraoperative re-attachment, patients are randomized to either standard silicone oil (1000 cSt or 5000 cSt) or Densiron((R)) as a tamponading agent. The main endpoint criteria are complete retinal attachment at 12 months and change of visual acuity (VA) 12 months postoperatively compared with the preoperative VA. Secondary endpoints include complete retinal attachment before endotamponade removal, quality of life analysis and the number of retina affecting re-operation within 1 year of follow-up. Results: The design and early recruitment phase of the study are described. Conclusions: The results of this study will uncover whether or not heavy silicone oil improves the prognosis of eyes with PVR.
A parallel group design or independent measure design is a study design which uses unique experimental unit each experimental group, in other word no two individuals are shared between experimental groups, hence also known as parallel group design. Subjects of a treatment group receive a unique combination of independent variable values making up a treatment
Philippe Rocca-Serra
independent measure design
http://www.holah.karoo.net/experimentaldesigns.htm
parallel group design
OBI:0500007
randomized complete block design
http://www.stats.gla.ac.uk/steps/glossary/anova.html,(A researcher is carrying out a study of the effectiveness of four different skin creams for the treatment of a certain skin disease. He has eighty subjects and plans to divide them into 4 treatment groups of twenty subjects each. Using a randomised blocks& design, the subjects are assessed and put in blocks of four according to how severe their skin condition is; the four most severe cases are the first block, the next four most severe cases are the second block, and so on to the twentieth block. The four &members of each block are then randomly assigned, one to each of the four treatment groups. http://www.stats.gla.ac.uk/steps/glossary/anova.html#rbd))
A randomized complete block design is_a study design which assigns randomly treatments to block. The number of units per block equals the number of treatment so each block receives each treatment exactly once (hence the qualifier 'complete'). The design was originally devised from field trials used in agronomy and agriculture. The analysis assumes that there is no interaction between block and treatment. The method was then used in other settings So The randomised complete block design is a design in which the subjects are matched according to a variable which the experimenter wishes to control. The subjects are put into groups (blocks) of the same size as the number of treatments. The members of each block are then randomly assigned to different treatment groups.
Philippe Rocca-Serra
http://www.tufts.edu/~gdallal/ranblock.htm
randomized complete block design
OBI:0500008
balanced incomplete block design
PMID: 7622388.Health Educ Q. 1995 May;22(2):201-10.Balanced incomplete block design: description, case study, and implications for practice.
balanced incomplete block design is a kind of factorial design where all treatment pairs occur together within a block an equal number ?? times. ??ii' is the number of times treatment i occurs with i'
Philippe Rocca-Serra
http://en.wikipedia.org/wiki/Block_design and http://www.stat.psu.edu/~jglenn/stat503/05_factorial/02_factorial_IBD.html
balanced incomplete block design
OBI:0500009
loop design
PMID: 12933549
A loop experiment design is where labeled extracts are compared in consecutive pairs. synonym: circular design
Philippe Rocca-Serra on behalf of MO
MO_912
loop design
OBI:0500010
reference design
PMID: 12933549
A reference experiment design type is where all samples are compared to a common reference.
Philippe Rocca-Serra on behalf of MO
MO_699
reference design
OBI:0500011
latin square design
PMID: 17582121-Our objective was to examine the effects of dietary cation-anion difference (DCAD) with different concentrations of dietary crude protein (CP) on performance and acid-base status in early lactation cows. Six lactating Holstein cows averaging 44 d in milk were used in a 6 x 6 Latin square design with a 2 x 3 factorial arrangement of treatments: DCAD of -3, 22, or 47 milliequivalents (Na + K - Cl - S)/100 g of dry matter (DM), and 16 or 19% CP on a DM basis. Linear increases with DCAD occurred in DM intake, milk fat percentage, 4% fat-corrected milk production, milk true protein, milk lactose, and milk solids-not-fat. Milk production itself was unaffected by DCAD. Jugular venous blood pH, base excess and HCO3(-) concentration, and urine pH increased, but jugular venous blood Cl- concentration, urine titratable acidity, and net acid excretion decreased linearly with increasing DCAD. An elevated ratio of coccygeal venous plasma essential AA to nonessential AA with increasing DCAD indicated that N metabolism in the rumen was affected, probably resulting in more microbial protein flowing to the small intestine. Cows fed 16% CP had lower urea N in milk than cows fed 19% CP; the same was true for urea N in coccygeal venous plasma and urine. Dry matter intake, milk production, milk composition, and acid-base status did not differ between the 16 and 19% CP treatments. It was concluded that DCAD affected DM intake and performance of dairy cows in early lactation. Feeding 16% dietary CP to cows in early lactation, compared with 19% CP, maintained lactation performance while reducing urea N excretion in milk and urine.
Latin square design is_a study design which allows in its simpler form controlling 2 levels of nuisance variables (also known as blocking variables).he 2 nuisance factors are divided into a tabular grid with the property that each row and each column receive each treatment exactly once.
Philippe Rocca-Serra
Adapted from: http://www.itl.nist.gov/div898/handbook/pri/section3/pri3321.htm and
latin square design
OBI:0500012
graeco latin square design
PMID: 6846242-Beaton et al (Am J Clin Nutr 1979;32:2546-59) reported on the partitioning of variance in 1-day dietary data for the intake of energy, protein, total carbohydrate, total fat, classes of fatty acids, cholesterol, and alcohol. Using the same food intake data and the expanded National Heart, Lung and Blood Institute food composition data base, these analyses of sources of variance have been expanded to include classes of carbohydrate, vitamin A, vitamin C, thiamin, riboflavin, niacin, calcium, iron, total ash, caffeine, and crude fiber. The analyses relate to observed intakes (replicated six times) of 30 adult males and 30 adult females obtained under a paired Graeco-Latin square design with sequence of interview, interviewer, and day of the week as determinants. Neither sequence nor interviewer made consistent contribution to variance. In females, day of the week had a significant effect for several nutrients. The major partitioning of variance was between interindividual variation (between subjects) and intraindividual variation (within subjects) which included both true day-to-day variation in intake and methodological variation. For all except caffeine, the intraindividual variability of 1-day data was larger than the interindividual variability. For vitamin A, almost all of the variance was associated with day-to-day variability. One day data provide a very inadequate estimate of usual intake of individuals. In the design of nutrition studies it is critical that the intended use of dietary data be a major consideration in deciding on methodology. There is no ideal dietary method. There may be preferred methods for particular purposes.
Greco-Latin square design is a study design which relates to Latin square design
Philippe Rocca-Serra
Adapted from: http://www.itl.nist.gov/div898/handbook/pri/section3/pri3321.htm and
only 2 articles in pubmed ->probably irrelevant
graeco latin square design
OBI:0500013
hyper graeco latin square design
PRS to do
Philippe Rocca-Serra
Adapted from: http://www.itl.nist.gov/div898/handbook/pri/section3/pri3321.htm and
no example found in pubmed->not in use in the community
hyper graeco latin square design
OBI:0500014
factorial design
PMID: 17582121-Our objective was to examine the effects of dietary cation-anion difference (DCAD) with different concentrations of dietary crude protein (CP) on performance and acid-base status in early lactation cows. Six lactating Holstein cows averaging 44 d in milk were used in a 6 x 6 Latin square design with a 2 x 3 factorial arrangement of treatments: DCAD of -3, 22, or 47 milliequivalents (Na + K - Cl - S)/100 g of dry matter (DM), and 16 or 19% CP on a DM basis. Linear increases with DCAD occurred in DM intake, milk fat percentage, 4% fat-corrected milk production, milk true protein, milk lactose, and milk solids-not-fat. Milk production itself was unaffected by DCAD. Jugular venous blood pH, base excess and HCO3(-) concentration, and urine pH increased, but jugular venous blood Cl- concentration, urine titratable acidity, and net acid excretion decreased linearly with increasing DCAD. An elevated ratio of coccygeal venous plasma essential AA to nonessential AA with increasing DCAD indicated that N metabolism in the rumen was affected, probably resulting in more microbial protein flowing to the small intestine. Cows fed 16% CP had lower urea N in milk than cows fed 19% CP; the same was true for urea N in coccygeal venous plasma and urine. Dry matter intake, milk production, milk composition, and acid-base status did not differ between the 16 and 19% CP treatments. It was concluded that DCAD affected DM intake and performance of dairy cows in early lactation. Feeding 16% dietary CP to cows in early lactation, compared with 19% CP, maintained lactation performance while reducing urea N excretion in milk and urine.
factorial design is_a study design which is used to evaluate two or more factors simultaneously. The treatments are combinations of levels of the factors. The advantages of factorial designs over one-factor-at-a-time experiments is that they are more efficient and they allow interactions to be detected. In statistics, a factorial design experiment is an experiment whose design consists of two or more factors, each with discrete possible values or levels, and whose experimental units take on all possible combinations of these levels across all such factors. Such an experiment allows studying the effect of each factor on the response variable, as well as the effects of interactions between factors on the response variable.
Philippe Rocca-Serra
http://www.stats.gla.ac.uk/steps/glossary/anova.html#facdes And from wikipedia (01/03/2007): http://en.wikipedia.org/wiki/Factorial_experiment)
factorial design
OBI:0500015
2x2 factorial design
PMID: 17561240-The present experiment evaluates the effects of intermittent exposure to a social stimulus on ethanol and water drinking in rats. Four groups of rats were arranged in a 2x2 factorial design with 2 levels of Social procedure (Intermittent Social vs Continuous Social) and 2 levels of sipper Liquid (Ethanol vs Water). Intermittent Social groups received 35 trials per session. Each trial consisted of the insertion of the sipper tube for 10 s followed by lifting of the guillotine door for 15 s. The guillotine door separated the experimental rat from the conspecific rat in the wire mesh cage during the 60 s inter-trial interval. The Continuous Social groups received similar procedures except that the guillotine door was raised during the entire duration of the session. For the Ethanol groups, the concentrations of ethanol in the sipper [3, 4, 6, 8, 10, 12, 14, and 16% (vol/vol)] increased across sessions, while the Water groups received 0% ethanol (water) in the sipper throughout the experiment. Both Social procedures induced more intake of ethanol than water. The Intermittent Social procedure induced more ethanol intake at the two highest ethanol concentration blocks (10-12% and 14-16%) than the Continuous Social procedure, but this effect was not observed with water. Effects of social stimulation on ethanol drinking are discussed.
a factorial design which has 2 experimental factors (aka independent variables) and 2 factor levels per experimental factors
Philippe Rocca-Serra
PMID: 17561240
2x2 factorial design
OBI:0500016
fractional factorial design
A fractional factorial design is_a study design in which only an adequately chosen fraction of the treatment combinations required for the complete factorial experiment is selected to be run
Philippe Rocca-Serra
http://www.itl.nist.gov/div898/handbook/pri/section3/pri334.htm From ASQC (1983) Glossary & Tables for Statistical Quality Control
fractional factorial design
OBI:0500017
dye swap design
PMID: 17411393-Dye-specific bias effects, commonly observed in the two-color microarray platform, are normally corrected using the dye swap design. This design, however, is relatively expensive and labor-intensive. We propose a self-self hybridization design as an alternative to the dye swap design. In this design, the treated and control samples are labeled with Cy5 and Cy3 (or Cy3 and Cy5), respectively, without dye swap, along with a set of self-self hybridizations on the control sample. We compare this design with the dye swap design through investigation of mouse primary hepatocytes treated with three peroxisome proliferator-activated receptor-alpha (PPARalpha) agonists at three dose levels. Using Agilent's Whole Mouse Genome microarray, differentially expressed genes (DEG) were determined for both the self-self hybridization and dye swap designs. The DEG concordance between the two designs was over 80% across each dose treatment and chemical. Furthermore, 90% of DEG-associated biological pathways were in common between the designs, indicating that biological interpretations would be consistent. The reduced labor and expense for the self-self hybridization design make it an efficient substitute for the dye swap design. For example, in larger toxicogenomic studies, only about half the chips are required for the self-self hybridization design compared to that needed in the dye swap design.
An experiment design type where the label orientations are reversed. exact synonym: flip dye, dye flip
Philippe Rocca-Serra on behalf of MO
MO_858
dye swap design
OBI:0500018
replicate design
A replicate experimental design type is where a series of replicates are performed to evaluate reproducibility or as a pilot study to determine the appropriate number of replicates for a subsequent experiments.
Philippe Rocca-Serra on behalf of MO
MO_885
replicate design
OBI:0500019
self vs self design
PMID: 17411393-Dye-specific bias effects, commonly observed in the two-color microarray platform, are normally corrected using the dye swap design. This design, however, is relatively expensive and labor-intensive. We propose a self-self hybridization design as an alternative to the dye swap design. In this design, the treated and control samples are labeled with Cy5 and Cy3 (or Cy3 and Cy5), respectively, without dye swap, along with a set of self-self hybridizations on the control sample. We compare this design with the dye swap design through investigation of mouse primary hepatocytes treated with three peroxisome proliferator-activated receptor-alpha (PPARalpha) agonists at three dose levels. Using Agilent's Whole Mouse Genome microarray, differentially expressed genes (DEG) were determined for both the self-self hybridization and dye swap designs. The DEG concordance between the two designs was over 80% across each dose treatment and chemical. Furthermore, 90% of DEG-associated biological pathways were in common between the designs, indicating that biological interpretations would be consistent. The reduced labor and expense for the self-self hybridization design make it an efficient substitute for the dye swap design. For example, in larger toxicogenomic studies, only about half the chips are required for the self-self hybridization design compared to that needed in the dye swap design.
A study design that investigates variance and error estimates in the experimental system, and is where the same extract is compared.
Philippe Rocca-Serra on behalf of MO
MO_490
self vs self design
OBI:0500020
time series design
PMID: 14744830-Microarrays are powerful tools for surveying the expression levels of many thousands of genes simultaneously. They belong to the new genomics technologies which have important applications in the biological, agricultural and pharmaceutical sciences. There are myriad sources of uncertainty in microarray experiments, and rigorous experimental design is essential for fully realizing the potential of these valuable resources. Two questions frequently asked by biologists on the brink of conducting cDNA or two-colour, spotted microarray experiments are 'Which mRNA samples should be competitively hybridized together on the same slide?' and 'How many times should each slide be replicated?' Early experience has shown that whilst the field of classical experimental design has much to offer this emerging multi-disciplinary area, new approaches which accommodate features specific to the microarray context are needed. In this paper, we propose optimal designs for factorial and time course experiments, which are special designs arising quite frequently in microarray experimentation. Our criterion for optimality is statistical efficiency based on a new notion of admissible designs; our approach enables efficient designs to be selected subject to the information available on the effects of most interest to biologists, the number of arrays available for the experiment, and other resource or practical constraints, including limitations on the amount of mRNA probe. We show that our designs are superior to both the popular reference designs, which are highly inefficient, and to designs incorporating all possible direct pairwise comparisons. Moreover, our proposed designs represent a substantial practical improvement over classical experimental designs which work in terms of standard interactions and main effects. The latter do not provide a basis for meaningful inference on the effects of most interest to biologists, nor make the most efficient use of valuable and limited resources.
Groups of assays that are related as part of a time series.
Philippe Rocca-Serra on behalf of MO
MO_887
time series design
OBI:0600002
tumor grading
Determination of the grade (severity/stage) of a tumor sample, used in cancer biology to describe abnormalities/qualities of tumor cells or tissues. Values can be described by terms from NCI Thesaurus.
Compiled by Helen Parkinson for Transcriptomics thanks to Adam Witney
grading of tumor
OBI branch derived; submitted by MO
tumor grading
OBI:0600005
collecting specimen from organism
taking a sputum sample from a cancer patient, taking the spleen from a killed mouse, collecting a urine sample from a patient
a process with the objective to obtain a material entity that was part of an organism for potential future use in an investigation
PERSON:Bjoern Peters
IEDB
collecting specimen from organism
OBI:0600006
killing
Terminal sacrifice of animals by cervical dislocation at the end of an investigation.
A protocol application in which an organism is intentionally put to death
difficult to place this properly - JG. Death process (e.g. unscheduled death) is out of scope but should be added somewhere. All killings have death process as a part, but not all death processes are part of a killing.
Jennifer Fostel
Philippe Rocca-Serra
death status type
euthanisia
life termination
sacrifice
CEBS, Biomaterial_branch
killing
1
OBI:0600007
administering substance in vivo
Balb/c mice received an intracameral or subconjunctival injection of trinitrophenylated spleen cells
injecting mice with 10 ug morphine intranasally, a patient taking two pills of 1 mg aspirin orally
A process by which a substance is intentionally given to an organism resulting in exposure of the organism to that substance.
2009-11-10. Tracker: https://sourceforge.net/tracker/?func=detail&aid=2893050&group_id=177891&atid=886178
Different routes and means of administration should go as children underneath this
Update the definition based on the discussion. Details see the tracker:
https://sourceforge.net/p/obi/obi-terms/738/
needs roles such as perturber and perturbee (children of input role). Perturb is too strong. Host might be the name for one role. Others considered: Doner, Donated, Acceptor.
Bjoern Peters
Person:Bjoern Peters
IEDB
administering substance in vivo
OBI:0600009
exposure of material to environment
Putting cells in a freezer at -80C. Cy5-labeled DNA is irradiated with a laser to excite the fluorophore. Inducing a phase transition in a material by putting it in an environment with a specific temperature. Oxygen deprivation in a chamber.
a planned process in which an input material is exposed to a defined set of conditions in a controlled environment. The environment is a specified input.
Bjoern Peters
IEDB
Alan says there will be problmes, e.g. with selection by survival
exposure of material to environment
OBI:0600011
acclimatization
placing mice in animal facility for 2 weeks prior to an experiment to accustom them to their environment, reducing stress
A protocol application in which an object is left in an environment for some period of time, until some qualities of interest are in equilibrium with that environment.
Jennifer Fostel
CEBS, Biomaterial_branch
acclimatization
OBI:0600014
material component separation
Using a cell sorter to separate a mixture of T cells into two fractions; one with surface receptor CD8 and the other lacking the receptor, or purification
a material processing in which components of an input material become segregated in space
Bjoern Peters
IEDB
material component separation
2
OBI:0600016
pooling specimens
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=104564; Combining spleens of 20 mice, Combining supernatant from a cell culture obtained at different time points
physical combination of several instances of like material
PlanAndPlannedProcess Branch
sample pooling
OBI branch derived
like' is one of the things that you should be controling for in a well-designed experiment. The instances of material need to have the same class.
pooling specimens
OBI:0600018
material portioning
pouring 50 mL aliquots of fetal calf serum into conical tubes from a 500 mL stock
a material processing in which the input substance is partitioned into a number of portions that are similar in composition.
PERSON:Bjoern Peters
aliquoting
apportioning
OBI branch derived
material portioning
OBI:0600020
histology
the counting of the number of cells with fluorescent label at their surface to determine the percentage of the population which was activated
the visual examination of cells or tissue (or images of them) with an assessment regarding a quality of the cells or tissue. Parts are: staining, imaging, judgement
PERSON:Compiled by Helen Parkinson for Transcriptomics thanks to Adam Witney
histopathology
OBI branch derived
PRS:20090901: addition of alternative term = histopathology
need to incorporate parts\n---\nThis is a very vague term, it should be in the same place as transcriptomics, proteomics metaboloimcs. It is the 'study' of tissues, not the process of studying tissues\n
histology
OBI:0600022
excision
Cutting out the portion of a gel which contains a DNA fragment
the use physical means to remove a portion of a substance from the rest
Alan Ruttenberg, Kevin Clancy
www.crohnsresource.com/glossary.jsp (via google define:resection)
excision
OBI:0600023
non specific enzymatic cleavage
The use of agarase to digest an agar gel
a protocol application to digest the fraction of input material that is susceptible to that enzyme
PERSON:Kevin Clancy
OBI branch derived
non specific enzymatic cleavage
OBI:0600024
maintaining cell culture
When harvesting blood from a human, isolating T cells, and then limited dilution cloning of the cells, the maintaining_cell_culture step comprises all steps after the initial dilution and plating of the cells into culture, e.g. placing the culture into an incubator, changing or adding media, and splitting a cell culture
a protocol application in which cells are kept alive in a defined environment outside of an organism. part of cell_culturing
PlanAndPlannedProcess Branch
OBI branch derived
maintaining cell culture
OBI:0600028
artificially induced reverse transcription
The use of M-MLV reverse transcriptase from the Moloney murine leukemia virus to transcribe an RNA sample into cDNA
a protocol with the objective to transcribe single-stranded RNA into complementary DNA (cDNA)
It could also be added that the reverse transcriptase is bearer of a GO:0003964 RNA-directed DNA polymerase activity, which is realized in this process.
We need to indicate the relationship between the cDNA generated and the RNA that was used as a template. This may be outside of the OBI scope
PERSON:Kevin Clancy
OBI branch derived
artificially induced reverse transcription
OBI:0600033
cell permeabilization
Electroporation of HeLa cells to allow transfection with pUC19.
A protocol application to permeabilize cell membranes, allowing molecules to more easily pass through the membrane than was possible prior to the protocol application
need to add output cell has_quality permeable
PERSON:Bjoern Peters
OBI branch derived
definition blessed by Jay, Alan, Randi
cell permeabilization
OBI:0600036
establishing cell culture
a process through which a new type of cell culture or cell line is created, either through the isolation and culture of one or more cells from a fresh source, or the deliberate experimental modification of an existing cell culture (e.g passaging a primary culture to become a secondary culture or line, or the immortalization or stable genetic modification of an existing culture or line).
PERSON:Matthew Brush
PERSON:Matthew Brush
A 'cell culture' as used here referes to a new lineage of cells in culture deriving from a single biological source.. New cultures are established through the initial isolation and culturing of cells from an organismal source, or through changes in an existing cell culture or line that result in a new culture with unique characteristics. This can occur through the passaging/selection of a primary culture into a secondary culture or line, or experimental modifications of an existing cell culture or line such as an immortalization process or other stable genetic modification. This class covers establishment of cultures of either multicellular organism cells or unicellular organisms.
establishing cell culture
OBI:0600037
cell culture splitting
The act of taking a cell culture of high density, counting the cells, removing part of the cells, and re-seeding a select number of the cells into new flasks with fresh tissue culture media.
The act of taking part of a homogeneous cell culture and creating one or more additional separate cultures of similar qualities. input: cell_culture, output cell_culture min cardinality 2. part of cell culturing
PlanAndPlannedProcess Branch
cell culture passaging
OBI branch derived
An active cell culture is typically split when it has grown to confluence in its culture dish. Cell culture splitting of a cell culture sample results in an increase in its passage number, which measures how long a sample has been propagated in vitro, and therefore how many selective or genetic changes it is likely to have undergone.
cell culture splitting
OBI:0600038
addition of molecular label
The addition of phycoerytherin label to an anti-CD8 antibody, to label all antibodies. The addition of anti-CD8-PE to a population of cells, to label the subpopulation cells that are CD8+.
a material processing technique intended to add a molecular label to some input material entity, to allow detection of the molecular target of this label in a detection of molecular label assay
PERSON:Matthew Brush
labeling
OBI developer call, 3-12-12
addition of molecular label
OBI:0600041
concentrate
Evaporation of the solution containing DNA to increase the concentration of the DNA molecules
a protocol application to create an output material with an increased density of a material of interest that is part of the input material by separating other parts of the input material
PERSON:Kevin Clancy
OBI branch derived
concentrate
OBI:0600043
genetic transformation
The transduction of E. coli through the introduction of a plasmid encoding for M. avium p35
the introduction. alteration or integration of genetic material into a cell or organism
PERSON:Kevin Clancy
genetic modification
OBI branch derived
genetic transformation
OBI:0600047
sequencing assay
The use of the Sanger method of DNA sequencing to determine the order of the nucleotides in a DNA template
the use of a chemical or biochemical means to infer the sequence of a biomaterial
has_output should be sequence of input; we don't have sequence well defined yet
PlanAndPlannedProcess Branch
OBI branch derived
sequencing assay
OBI:0600048
vector mediated amplification
E coli expressing the gene for M avium p35 were cultured in order to produce p35.
The process of creating a copy of some biological entity in cell culture
PERSON:Kevin Clancy
OBI branch derived
vector mediated amplification
OBI:0600050
specific enzymatic cleavage
The use of a protease to digest a protein into peptides
a protocol application to digest the fraction of input material that is susceptible to that enzyme
PERSON:Kevin Clancy
OBI branch derived
specific enzymatic cleavage
OBI:0600056
protease cleavage
the use of trypsin to cleave pepsin into peptide fragments
protease cleavage is an enzymatic cleavage which relies on enzyme with protease activity to act on proteins and produce polypeptides (protein fragments).
enzymatic digestion
PlanAndPlannedProcess Branch
OBI branch derived
protease cleavage
OBI:0600058
enzymatic amplification
the use of a polymerase chain reaction to amplify a fragment of DNA
the use of enzymes to increase the number of molecules of a biomaterial
PERSON:Kevin Clancy
OBI branch derived
enzymatic amplification
OBI:0600064
recombinant vector cloning
a planned process with the objective to insert genetic material into a cloning vector for future replication of the inserted material
pa_branch (Alan, Randi, Kevin, Jay, Bjoern)
molecular cloning
OBI branch derived
recombinant vector cloning
OBI:0666666
RNA extraction
A RNA extraction is a nucleic acid extraction where the desired output material is RNA
PlanAndPlannedProcess Branch
OBI branch derived
requested by Helen Parkinson for MO
RNA extraction
OBI:0666667
nucleic acid extraction
Phenol / chlorophorm extraction disolvation of protein content folllowed by ethanol precipitation of the nucleic acid fraction over night in the fridge followed by centrifugation to obtain a nucleic acid pellet.
a material separation to recover the nucleic acid fraction of an input material
PlanAndPlannedProcess Branch
OBI branch derived
requested by Helen Parkinson for MO. Could be defined class
nucleic acid extraction
OBI:1000029
phage display library
PMID: 15905471.Nucleic Acids Res. 2005 May 19;33(9):e81.Oligonucleotide-assisted cleavage and ligation: a novel directional DNA cloning technology to capture cDNAs. Application in the construction of a human immune antibody phage-display library. [Phage display library encoding fragments of human antibodies. m-rna library encoding for 9-mer peptides]
a phage display library is a collection of materials in which a mixture of genes or gene fragments is expressed and can be individually selected and amplified.
PERSON: Bjoern Peters
PERSON: Philippe Rocca-Serra
display library
WEB: http://www.immuneepitope.org/home.do
PRS: 22022008. class moved under population,
modification of definition and replacement of biomaterials in previous definition with 'material'
addition of has_role restriction
phage display library
OBI:1000036
cell lysate
The effect of vaccination with the lysate of heat-shocked tumor cells on nitric oxide production in BALB/c mice with fibrosarcoma tumor. Cell Biol Int. 2008 Jul;32(7):835-40. PMID: 18455932
a cell lysate is a material entity which is output of a cell lysis process
PRS:22-02-2008: is a material which has output_role during lysis protocol-application.
old defintion: A mixture (collection) of cell components created by rupturing of the cell wall resulting from a lysis process
PERSON: Susanna Sansone
lysate
lysed material
GROUP: PSI
cell lysate
OBI:1000207
assay bead
Dynabeads are commercially available magnetic beads which are precoated with antibodies specific for select cellular receptors and are used to separate cell populations.
A globular or round particle of defined physicochemical properties and size which can be exploited as either the primary substance for detection or as a secondary solid platform for the attachment of bioactive molecules.
DS: Probably better modeled as a role.
OBI
bead
assay bead
OBI:1110021
infection
the detrimental process in which an infectious agent colonizes or replicates in a host environment
IEDB
IEDB
infection
OBI:1110022
adaptive immune receptor
is a receptor produced by cells of the adaptive immune system with the purpose of binding epitopes.
IEDB
IEDB
adaptive immune receptor
OBI:1110055
obsolete_disease
placeholder to be imported from disease ontology
IEDB
IEDB
http://purl.obolibrary.org/obo/OGMS_0000031
obsolete_disease
1
OBI:1110093
disposition to infect an organism
Is a role borne by an agent, and realized when in contact with or inside another organism in which it is capable of replicating and causing disease
IEDB
IEDB
disposition to infect an organism
OBI:1110108
material to be added
A mixture of peptides that is being added into a cell culture.
a material that is added to another one in a material combination process
10/26/09: This defined class is used as a 'macro expression' to reduce the size of the IEDB export
2010/02/24 Alan Ruttenberg: I think this might generate confusion as the common use of the term would consider something to be a specimen during the realization of the role, not only if it bears it. However having this class as a probe, or for display, or as a macro might be useful. Ideally we would mark or segregate such classes
IEDB
material to be added
OBI:1110109
target of material addition
A cell culture into which a mixture of peptides is being added.
A material entity into which another is being added in a material combinatino process
10/26/09: This defined class is used as a 'macro' to reduce the size of the IEDB export.
IEDB
target of material addition
OBI:1110122
pathologic process
abnormal, harmful processes caused by or associated with a disease
IEDB
IEDB
pathologic process
OGMS:0000015
A series of statements representing health-relevant qualities of a patient and of a patient's family.
clinical history
OGMS:0000023
A (combination of) quality(ies) of an organism determined by the interaction of its genetic make-up and environment that differentiates specific instances of a species from other instances of the same species.
phenotype
OGMS:0000031
A disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism.
disease
OGMS:0000063
The totality of all processes through which a given disease instance is realized.
disease course
OGMS:0000090
A processual entity whose completion is hypothesized (by a healthcare provider) to alleviate the signs and symptoms associated with a disorder
treatment
A dependent entity that inheres in a bearer by virtue of how the bearer is related to other entities.
PATO:0000072
trait
quality
PATO:0000001
quality
PATO:0000001
A time quality inhering in a bearer by virtue of how long the bearer has existed.
quality
PATO:0000011
age
PATO:0000011
A single physical entity inhering in an bearer by virtue of the bearer's quantities or relative ratios of subparts.
PATO:0002015
compositionality
content
structure, composition
quality
PATO:0000025
For example calcium composition (which may inhere in bone), haemoglobin composition (which may inhere in blood).
composition
PATO:0000025
A quality inhering in a substance by virtue of the amount of the bearer's there is mixed with another substance.
concentration
quality
PATO:0000033
concentration of
PATO:0000033
An organismal quality inhering in a bearer by virtue of the bearer's ability to undergo sexual reproduction in order to differentiate the individuals or types involved.
quality
PATO:0000047
biological sex
PATO:0000047
A quality of a single physical entity inhering in the bearer by virtue of the bearer's size or shape or structure.
quality
PATO:0000051
morphology
PATO:0000051
A morphological quality inhering in a bearer by virtue of the bearer's ratios of distances between its features (points, edges, surfaces and also holes etc).
PATO:0001647
relational shape quality
quality
PATO:0000052
Shapes are invariant on size transformations. Shapes can be subdivided into 2D and 3D shapes, We can also make a distinction between shapes of complete self-connected objects, and shapes of parts of objects.
shape
PATO:0000052
quality
PATO:0000068
TODO: define this or obsolete it and move children somewhere else.
qualitative
PATO:0000068
A quality inhering in a bearer by virtue of the whether the bearer differs from normal or average.
quality
PATO:0000069
deviation(from_normal)
PATO:0000069
A morphology quality inhering in a bearer by virtue of the bearer's physical magnitude.
quality
PATO:0000117
size
PATO:0000117
A morphology quality inhering in a bearer by virtue of the bearer's relative position, shape, arrangements and connectivity of an organism's various parts; the pattern underlying its form.
PATO:0001452
relational structural quality
quality
PATO:0000141
structure
PATO:0000141
A physical quality of the thermal energy of a system.
quality
PATO:0000146
temperature
PATO:0000146
A quality in which events occur in sequence.
quality
PATO:0000165
time
PATO:0000165
An organismal quality inhering in a bearer or a population by virtue of the bearer's disposition to survive and develop normally or the number of surviving individuals in a given population.
quality
PATO:0000169
viability
PATO:0000169
A quality of a single physical entity which is held by a bearer when the latter exhibits complete growth, differentiation, or development.
quality
PATO:0000261
maturity
PATO:0000261
A biological sex quality inhering in an individual or a population that only produces gametes that can be fertilised by male gametes.
quality
PATO:0000383
female
PATO:0000383
A biological sex quality inhering in an individual or a population whose sex organs contain only male gametes.
quality
PATO:0000384
male
PATO:0000384
A shape quality inhering in a bearer by virtue of the bearer's being such that every part of the surface or the circumference is equidistant from the center.
quality
round
rounded
PATO:0000411
circular
PATO:0000411
A quality inhering in a bearer by virtue of the bearer's exhibiting no deviation from normal or average.
quality
average
PATO:0000461
normal
PATO:0000461
A size quality which is relatively high.
PATO:0001202
quality
big
enlarged
expanded
great
large
PATO:0000586
increased size
PATO:0000586
A spheroid quality inhering in a bearer by virtue of the bearer's being oval with two axes of symmetry, as produced by a conical section.
ellipse-shaped
ellipsoid
elliptical
quality
oval
ovoid
PATO:0000947
elliptic
PATO:0000947
A quality of a physical entity that exists through action of continuants at the physical level of organisation in relation to other entities.
PATO:0002079
Wikipedia:Physical_property
relational physical quality
quality
PATO:0001018
physical quality
PATO:0001018
A quality which inheres in a continuant.
PATO:0001237
PATO:0001238
snap:Quality
monadic quality of a continuant
multiply inhering quality of a physical entity
quality of a continuant
quality of a single physical entity
quality of an object
quality of continuant
monadic quality of an object
monadic quality of continuant
quality
PATO:0001241
Relational qualities are qualities that hold between multiple entities. Normal (monadic) qualities such as the shape of a eyeball exist purely as a quality of that eyeball. A relational quality such as sensitivity to light is a quality of that eyeball (and connecting nervous system) as it relates to incoming light waves/particles.
physical object quality
PATO:0001241
A mating type that indicates whether the F plasmid has integrated into the chromosome.
quality
PATO:0001335
bacterial mating type
PATO:0001335
A yeast mating type.
quality
PATO:0001337
yeast mating type
PATO:0001337
A biological sex quality inhering in a population of multiple sexes.
quality
PATO:0001338
For example a mixture of females and male or males and hermaphrodites.
mixed sex
PATO:0001338
A composition quality inhering in an bearer by virtue of the bearer's homogeneity of a biomaterial.
quality
PATO:0001339
biomaterial purity
PATO:0001339
A biological sex quality inhering in an organism or a population with both male and female sexual organs in one individual.
intersex
quality
PATO:0001340
hermaphrodite
PATO:0001340
A S. cerevisiae mating type cells that secrete a pheromone that in alpha haploids stimulates processes that lead to mating.
a
quality
PATO:0001341
a mating type (yeast)
PATO:0001341
A S. cerevisiae mating type.
quality
PATO:0001342
Saccharomyces cerevisiae mating type
PATO:0001342
A S. pombe mating type determined by the gene configuration on the mat1 locus.
quality
PATO:0001343
Schizosaccharomyces pombe mating type
PATO:0001343
A S. cerevisiae mating type cells that secrete a pheromone that stimulates a haploids.
alpha
quality
PATO:0001344
alpha mating type (yeast)
PATO:0001344
A S. pombe mating type determined by the mat1-Mc and mat1-Mi on the mat1 locus.
M
h -
quality
PATO:0001345
h minus
PATO:0001345
A S. pombe mating type determined by the mat1-Pc and mat1-Pi on the mat1 locus.
P
h+
quality
PATO:0001346
h plus
PATO:0001346
A bacterial mating type indicating the presence of F plasmid in a bacterial cell.
quality
PATO:0001347
F mating type
PATO:0001347
A bacterial mating type indicating the absence of F plasmid in a bacterial cell.
F-
quality
PATO:0001348
F minus mating type
PATO:0001348
A cellular quality inhering in a bearer by virtue of the bearer's number of homologous sets of chromosomes in the nucleus or primary chromosome-containing compartment of the cell, each set essentially coding for all the biological traits of the organism.
quality
PATO:0001374
ploidy
PATO:0001374
A ploidy quality inhering in a bearer by virtue of the bearer's containing a single set of homologous chromosomes.
quality
PATO:0001375
haploid
PATO:0001375
A ploidy quality inhering in a bearer by virtue of the bearer's containing more than two homologous sets of chromosomes.
quality
PATO:0001377
polyploid
PATO:0001377
A ploidy quality inhering in a bearer by virtue of the bearer's containing a non-integral multiple of the monoploid number, due to extra or missing chromosomes.
quality
PATO:0001385
aneuploid
PATO:0001385
A ploidy quality inhering in a bearer by virtue of the bearer's containing an integral multiple of the monoploid number, possibly excluding the sex-determining chromosomes.
quality
PATO:0001393
euploid
PATO:0001393
A ploidy quality inhering in a bearer by virtue of the bearer's having two copies (homologs) of each chromosome, usually one from the mother and one from the father.
quality
PATO:0001394
The exact number may be one or two different from the 2n number and still be classified as diploidy (although with aneuploidy). Nearly all mammals are diploid organisms, although all individuals have some small fracton of cells that are polyploidy.
diploid
PATO:0001394
A monadic quality of continuant that exists at the cellular level of organisation.
quality
PATO:0001396
cellular quality
PATO:0001396
A cellular quality that arises by virtue of whether the bearer's disposition to differentiate into one or more mature cell types.
quality
PATO:0001397
cellular potency
PATO:0001397
A cellular potency that is the capacity to produce only one differentiated cell type.
quality
PATO:0001400
Unipotent cells have the quality of self-renewal which distinguishes them from non-stem cells.
unipotent
PATO:0001400
A cellular potency that is the capacity to form multiple differentiated cell types of a specific lineage and lack self renewing capacity.
quality
PATO:0001401
Less potent than multipotent, often thought of as precursor or progenitor cell status.
oligopotent
PATO:0001401
A cellular potency that is the capacity to form multiple differentiated cell types.
quality
PATO:0001402
multipotent
PATO:0001402
A cellular quality inhering in a bearer by virtue of bearer's number of nuclei.
quality
PATO:0001404
nucleate quality
PATO:0001404
A nucleate quality inhering in a bearer by virtue of the bearer's having no nucleus.
quality
PATO:0001405
anucleate
PATO:0001405
A nucleate quality inhering in a bearer by virtue of the bearer's having one nucleus.
quality
PATO:0001407
mononucleate
PATO:0001407
A shape quality inhering in a bearer by virtue of the bearer's being marked by narrow lines or grooves, usually parallel.
quality
PATO:0001410
striated
PATO:0001410
A viability quality inhering in a bearer by virtue of the bearer's condition before death.
quality
PATO:0001421
alive
PATO:0001421
A viability quality inhering in a bearer by virtue of the cessation of the bearer's life.
quality
PATO:0001422
dead
PATO:0001422
A quality inhering in a bearer by virtue of the bearer's lacking complete growth, differentiation, or development.
quality
underdeveloped
PATO:0001501
immature
PATO:0001501
A quality inhering in a bearer by virtue of the bearer's exhibiting complete growth, differentiation, or development.
quality
PATO:0001701
mature
PATO:0001701
A shape quality in a bearer by virtue of the bearer's curving inward.
quality
PATO:0001857
concave
PATO:0001857
A convex 3-D shape quality inhering in a bearer by virtue of the bearer's exhibiting a consistently-sized round cross section.
PATO:0001203
rod-like
rod-shaped
tubulate
quality
PATO:0001873
cylindrical
PATO:0001873
A shape quality inhering in a bearer by virtue of the bearer's being cylindrical, in which the height is less than the diameter.
disc-shaped
disk-shaped
quality
PATO:0001874
discoid
PATO:0001874
quality
PATO:0001894
phenotypic sex
PATO:0001894
A biological sex quality inhering in an individual or a population that undergo sexual reproduction.
quality
PATO:0001895
mating type
PATO:0001895
A quality inhering in a bearer by virtue of the bearer's being kept below its freezing point.
quality
PATO:0001985
frozen
PATO:0001985
A quality that inheres in an entire organism or part of an organism.
quality
PATO:0001995
organismal quality
PATO:0001995
A quality that inheres in an entire population or part of a population.
quality
PATO:0002003
population quality
PATO:0002003
Surface shape that refers to the inward or outward curvature of the surface.
quality
PATO:0002005
concavity
PATO:0002005
A shape that inheres in a 2 dimensional entity, such as a cross section or projection of a 3 dimensional entity.
quality
2-D projection
cross-sectional
PATO:0002006
2-D shape
PATO:0002006
A complete three dimensional shape in which for every line connecting pair of points on the object is within the object. Or: a shape lacking cavities. Contrast: concave.
Image:http://upload.wikimedia.org/wikipedia/commons/0/06/Convex_polygon_illustration1.png
quality
PATO:0002007
Use this term or an is_a child of this term when the entire shape of the object is known.
convex 3-D shape
PATO:0002007
A concave quality inhering in a bearer by virtue of the bearer's curving inward on both sides or surfaces.
quality
PATO:0002039
biconcave
PATO:0002039
A molecular quality that arises from the molecular attraction exerted between two atoms or compounds.
George Gkoutos
2009-09-18T01:16:16Z
quality
PATO:0002070
affinity
PATO:0002070
An affinity inhering in a tissue constituent by virtue of the bearer exhibiting a molecular interaction for basic dyes under specific ph conditions.
george
2009-10-05T12:05:23Z
quality
PATO:0002094
basophilic
PATO:0002094
A quality which inheres in a molecular entity, a single molecule, atom, ion, radical etc.
George Gkoutos
2010-03-10T03:18:15Z
PATO:0002061
relational molecular quality
quality
PATO:0002182
molecular quality
PATO:0002182
A shape that inheres in a 3 dimensional entity.
george
2010-10-05T12:31:16Z
quality
PATO:0002266
3-D shape
PATO:0002266
A quality that has a value that is increased compared to normal or average.
George Gkoutos
2011-06-16T06:39:43Z
quality
PATO:0002300
increased quality
PATO:0002300
A quality of an object that has a value that is increased compared to normal or average.
George Gkoutos
2011-06-16T06:54:01Z
quality
PATO:0002305
increased object quality
PATO:0002305
A shape constituting a transition between a rectangle and a circle; a closed curve, of which the circle and ellipse are special cases, whose parametric equation is x = a.cos2/rt, y = b.cos2/rt
George Gkoutos
2011-10-12T12:45:16Z
Lamé curve
quality
PATO:0002318
superelliptic
PATO:0002318
A shape quality inhering in a bearer by virtue of the bearer's being marked by narrow lines or grooves, usually parallel, that are oriented transversely relative to the long axis of the bearer.
gkoutos
2013-09-15T12:29:15Z
quality
PATO:0002478
transversely striated
PATO:0002478
PR:000000001
An amino acid chain that is produced de novo by ribosome-mediated translation of a genetically-encoded mRNA.
protein
PR:000001002
A protein that is a translation product of the human CD19 gene or a 1:1 ortholog thereof. It is composed of an N-terminal extracellular domain containing two Ig-like C2-type (immunoglobulin-like) domains, followed by a single-pass transmembrane segment and a cytoplasmic C-terminal tail. CD19 expression is restricted to members of the B cell lineage. It functions as a co-receptor for B-cell antigen receptor (BCR), regulating signal transduction.
CD19 molecule
PR:000001003
A protein that is a translation product of the human CD34 gene or a 1:1 ortholog thereof. It is a leukocyte membrane protein expressed specifically by lymphohematopoietic progenitor cells. It contains a single-pass transmembrane domain and that show distinct expression on early hematopoietic precursors and vascular-associated tissue. Acts as a scaffold that presents selectin carbohydrate ligands in a clustered, tissue specific manner to allow for higher avidity interactions between leukocytes and endothelial cells during the inflammatory process. In common with related sialomucins (endoglycan and podocalyxin), the extracellular region is dominated by an N-terminal mucin-like domain, which is densely substituted with sialylated O-linked carbohydrates. The mucin-like region is followed by a cysteine-containing and presumably globular domain. This domain may fold into an immunoglobulin-like structure as the positions of 2 of the cysteines are conserved in the C2 set of the immunoglobulin superfamily. The cytoplasmic domain is around 73-76 residues long and highly conserved.
CD34 molecule
PR:000001004
A protein that is a translation product of the human CD4 gene or a 1:1 ortholog thereof. CD4 is an accessory protein for MHC class-II antigen/T-cell receptor interaction. It is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence.
CD4 molecule
PR:000001006
A protein that is a translation product of the human PTPRC gene or a 1:1 ortholog thereof. It is composed of an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic protein-tyrosine phosphatase domains. Contains 1 to 3 copies of the Fibronectin type III domain (Pfam:PF00041) followed by two copies of the Protein-tyrosine phosphatase (Pfam:PF00102) domain. Receptor-type tyrosine-protein phosphatase C (CD45) regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T and B cells. Multiple isoforms of CD45 (180-235 kDa) can be generated asa result of alternative splicing of three variable exons 4(A), 5(B) and 6(C), encoding sequences at the N-terminal extracellular domain of the molecule.
receptor-type tyrosine-protein phosphatase C
PR:000001012
An integrin alpha with A domain that is a translation product of the human ITGAM gene or a 1:1 ortholog thereof. They constitute subunits of the integrin alpha-M/beta-2 receptor. This receptor is implicated in various adhesive interactions of monocytes, macrophages and granulocytes as well as in mediating the uptake of complement-coated particles. It is also a receptor for fibrinogen, factor X and ICAM1.
integrin alpha-M
PR:000001015
A receptor-type tyrosine-protein phosphatase C that is a translation product of a mature transcript of the PTPRC gene, that includes the region encoded by the variable exon 4(A), and lacks the region encoded by exons 5(B) and 6(C).
receptor-type tyrosine-protein phosphatase C isoform CD45RA
PR:000001020
A CD3 subunit that is a translation product of the human CD3E gene or a 1:1 ortholog thereof.
CD3 epsilon
PR:000001024
A neural cell adhesion molecule NCAM that is a translation product of the human NCAM1 gene or a 1:1 ortholog thereof.
neural cell adhesion molecule 1
PR:000001083
A protein that is a translation product of the human CD2 gene or a 1:1 ortholog thereof.
CD2 molecule
PR:000001084
A protein that is a translation product of the human CD8A gene or a 1:1 ortholog thereof. CD8 is a transmembrane that is a co-receptor for MHC class-I antigen/T-cell receptor interaction. The most common form of CD8 is composed of a CD8 alpha and a CD8 beta chain.
T-cell surface glycoprotein CD8 alpha chain
PR:000001197
A rhodopsin-like G-protein coupled receptor that is a translation product of the CCR1, CCR3, or CCR1L1 genes (the last found so far only in mouse).
chemokine receptor CCR1/3/1L
PR:000001254
A chemokine receptor CCR1/3/1L that is a translation product of the human CCR1 gene or a 1:1 ortholog thereof.
C-C chemokine receptor type 1
PR:000001255
A chemokine receptor CCR1/3/1L that is a translation product of the human CCR3 gene or a 1:1 ortholog thereof.
C-C chemokine receptor type 3
PR:000001289
A protein that is a translation product of the human MS4A1 gene or a 1:1 ortholog thereof.
membrane-spanning 4-domains subfamily A member 1
PR:000001307
A protein that is a translation product of the human CD44 gene or a 1:1 ortholog thereof.
CD44 molecule
PR:000001332
A protein that is a translation product of the human CEACAM8 gene or a 1:1 ortholog thereof.
carcinoembryonic antigen-related cell adhesion molecule 8
PR:000001343
A protein that is a translation product of the human CD69 gene or a 1:1 ortholog thereof. A type II transmembrane protein with a C-type lectin binding domain in the extracellular portion of the molecule. Involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes, natural killer (NK) cells, and platelets.
CD69 molecule
PR:000001344
A protein that is a translation product of the human ENPP3 gene or a 1:1 ortholog thereof.
ectonucleotide pyrophosphatase/phosphodiesterase family member 3
PR:000001345
A protein that is a translation product of the human ENG gene or a 1:1 ortholog thereof.
endoglin
PR:000001355
A protein with a core domain architecture consisting of an extracellular domain containing two copies of the Immunoglobulin domain (Pfam:PF00047), followed by a single-pass transmembrane region and a small intracellular domain. The active protein is a low affinity receptor for immunoglobulin gamma chain Fc region. Human II-a, II-b, and II-c represent a recent gene expansion and are equally related to mouse II, III, and IV. Human III-A and III-B are closely related and closer to mouse IV than to mouse III.
immunoglobulin gamma Fc receptor II/III/IV
PR:000001381
A protein that is a translation product of the human IL2RB gene or a 1:1 ortholog thereof.
interleukin-2 receptor subunit beta
PR:000001408
An ADP-ribosyl cyclase that is a translation product of the human CD38 gene or a 1:1 ortholog thereof.
ADP-ribosyl cyclase 1
PR:000001444
A cadherin that is a translation product of the human CDH5 gene or a 1:1 ortholog thereof.
cadherin-5
PR:000001456
A fucosyltransferase that is a translation product of the human FUT4 gene or a 1:1 ortholog thereof.
alpha-(1,3)-fucosyltransferase FUT4
PR:000001479
An immunoglobulin gamma Fc receptor II/III/IV that is a translation product of the mouse Fcgr2 gene or a 1:1 ortholog thereof.
low affinity immunoglobulin gamma Fc region receptor II
PR:000001483
An immunoglobulin gamma Fc receptor II/III/IV that is a translation product of the mouse Fcgr3 gene or a 1:1 ortholog thereof.
low affinity immunoglobulin gamma Fc region receptor III
PR:000001559
A tumor-associated calcium signal transducer that is a translation product of the human EPCAM gene or a 1:1 ortholog thereof.
epithelial cell adhesion molecule
PR:000001786
A prominin that is a translation product of the human PROM1 gene or a 1:1 ortholog thereof.
prominin-1
PR:000001800
A protein that is a translation product of the human NT5E gene or a 1:1 ortholog thereof.
5'-nucleotidase
PR:000001809
A protein that is a translation product of the CD59 or closely related gene. This gene is present as a single copy in human and has undergone a lineage-specific duplication in mouse. CD59 antigen has a core architecture consisting of one UPAR/Ly-6 domain (Pfam:PF00021), a small domain of about 70 amino acids and containing 5 conserved disulfide bonds. It is both N- and O-glycosylated and is a GPI-anchored protein that releases soluble forms in some tissues.
CD59-like glycoprotein
PR:000001836
A protein that is a translation product of the human CD7 gene or a 1:1 ortholog thereof.
CD7 molecule
PR:000001839
A protein that is a translation product of the human CD5 gene or a 1:1 ortholog thereof.
T-cell surface glycoprotein CD5
PR:000001843
A protein that is a translation product of the human THY1 gene or a 1:1 ortholog thereof.
Thy-1 membrane glycoprotein
PR:000001865
A protein that is a translation product of the human IL3RA gene or a 1:1 ortholog thereof.
interleukin-3 receptor class 2 alpha chain
PR:000001867
A protein that is a translation product of the human IL5RA gene or a 1:1 ortholog thereof.
interleukin-5 receptor subunit alpha
PR:000001869
A protein that is a translation product of the human IL7R gene or a 1:1 ortholog thereof.
interleukin-7 receptor subunit alpha
PR:000001874
A protein that is a translation product of the KLRB1 gene or its closely related paralogs (KLRB1A-F). There are lineage-specific expansions in mouse and rat.
KLRB1-like protein
PR:000001879
A protein that is a translation product of the human SPN gene or a 1:1 ortholog thereof.
leukosialin
PR:000001889
A protein that is a translation product of the human CD14 gene or a 1:1 ortholog thereof.
CD14 molecule
PR:000001892
A protein that is a translation product of the human CD33 gene or a 1:1 ortholog thereof.
CD33 molecule
PR:000001898
A protein that is a translation product of the human MME gene or a 1:1 ortholog thereof.
neprilysin
PR:000001903
A protein that is a translation product of the human PAX5 gene or a 1:1 ortholog thereof.
paired box protein PAX-5
PR:000001932
A protein that is a translation product of the human CD24 gene or a 1:1 ortholog thereof.
signal transducer CD24
PR:000001944
A protein that is a translation product of the human SPI1 gene or a 1:1 ortholog thereof.
transcription factor PU.1
PR:000001945
A protein that is a translation product of the human TFRC gene or a 1:1 ortholog thereof.
transferrin receptor protein 1
PR:000001950
A protein that is a translation product of the human CD40LG gene or a 1:1 ortholog thereof.
tumor necrosis factor ligand superfamily member 5
PR:000001969
A protein that is a translation product of the human PLAUR gene or a 1:1 ortholog thereof.
urokinase plasminogen activator surface receptor
PR:000002065
A CSF-1/PDGF receptor-type tyrosine-protein kinase that is a translation product of the human KIT gene or a 1:1 ortholog thereof.
mast/stem cell growth factor receptor
PR:000002112
A vascular endothelial growth factor receptor that is a translation product of the human KDR gene or a 1:1 ortholog thereof.
vascular endothelial growth factor receptor 2
PR:000002978
A ly-6-like protein that is a translation product of the mouse Ly6g gene or a 1:1 ortholog thereof.
lymphocyte antigen 6G
PR:000002981
A protein that is a translation product of the mouse Ly76 gene or a 1:1 ortholog thereof.
lymphocyte antigen 76
PR:000005178
A tetraspanin that is a translation product of the human CD9 gene or a 1:1 ortholog thereof.
CD9 molecule
PR:000005307
A protein that is a translation product of the human CEBPA gene or a 1:1 ortholog thereof.
CCAAT/enhancer-binding protein alpha
PR:000006611
A protein that is a translation product of the human DNTT gene or a 1:1 ortholog thereof.
DNA nucleotidylexotransferase
PR:000007431
An immunoglobulin gamma Fc receptor II/III/IV that is a translation product of the human FCER1A gene or a 1:1 ortholog thereof.
high affinity immunoglobulin epsilon receptor subunit alpha
PR:000007602
A protein that is a translation product of the human FOXA1 gene or a 1:1 ortholog thereof.
hepatocyte nuclear factor 3-alpha
PR:000007603
A protein that is a translation product of the human FOXA2 gene or a 1:1 ortholog thereof.
hepatocyte nuclear factor 3-beta
PR:000007857
A protein that is a translation product of the human GATA1 gene or a 1:1 ortholog thereof.
erythroid transcription factor
PR:000007858
A protein that is a translation product of the human GATA2 gene or a 1:1 ortholog thereof.
endothelial transcription factor GATA-2
PR:000007891
A protein that is a translation product of the human GCG gene or a 1:1 ortholog thereof.
glucagon
PR:000008652
A protein that is a translation product of the human HNF1A gene or a 1:1 ortholog thereof.
hepatocyte nuclear factor 1-alpha
PR:000008654
A protein that is a translation product of the human HNF4A gene or a 1:1 ortholog thereof.
hepatocyte nuclear factor 4-alpha
PR:000009054
A protein that is a translation product of the human INS gene or a 1:1 ortholog thereof.
insulin
PR:000009062
A protein that is a translation product of the human INSM1 gene or a 1:1 ortholog thereof.
insulinoma-associated protein 1
PR:000009116
A protein that is a translation product of the human ISL1 gene or a 1:1 ortholog thereof.
insulin gene enhancer protein ISL-1
PR:000010047
A protein that is a translation product of the human MAFA gene or a 1:1 ortholog thereof.
transcription factor MafA
PR:000011152
A protein that is a translation product of the human NEUROD1 gene or a 1:1 ortholog thereof.
neurogenic differentiation factor 1
PR:000011158
A protein that is a translation product of the human NEUROG3 gene or a 1:1 ortholog thereof.
neurogenin-3
PR:000011242
A protein that is a translation product of the human NKX2-2 gene or a 1:1 ortholog thereof.
homeobox protein Nkx-2.2
PR:000011250
A protein that is a translation product of the human NKX6-1 gene or a 1:1 ortholog thereof.
homeobox protein Nkx-6.1
PR:000011639
A protein that is a translation product of the human ONECUT1 gene or a 1:1 ortholog thereof.
hepatocyte nuclear factor 6
PR:000012523
A protein that is a translation product of the human PDX1 gene or a 1:1 ortholog thereof.
pancreas/duodenum homeobox protein 1
PR:000013418
A protein that is a translation product of the human PTF1A gene or a 1:1 ortholog thereof.
pancreas transcription factor 1 subunit alpha
PR:000013824
A protein that is a translation product of the human RBPJ gene or a 1:1 ortholog thereof.
recombining binding protein suppressor of hairless
PR:000013825
A protein that is a translation product of the human RBPJL gene or a 1:1 ortholog thereof.
recombining binding protein suppressor of hairless-like protein
PR:000015424
A protein that is a translation product of the human SOX17 gene or a 1:1 ortholog thereof.
transcription factor SOX-17
PR:000016043
A protein that is a translation product of the human TAL1 gene or a 1:1 ortholog thereof.
T-cell acute lymphocytic leukemia protein 1
PR:000023089
A protein that is a translation product of the Escherichia coli K-12 ligA gene or a 1:1 ortholog thereof.
DNA ligase
REO:0000002
antibody reagent
REO:0000171
a reagent role inhering in a molecular entity intended to associate with some molecular target to serve as a proxy for the presence, abundance, or location of this target in a detection of molecular label assay.
molecular label role
REO:0000280
a molecular reagent intended to associate with some molecular target to serve as a proxy for the presence, abundance, or location of this target in a detection of molecular label assay
molecular label
REO:0000383
a cell that is the output of some malignant cell transformation process whereby a cell in vivo becomes capable of causing cancer in an organism. Such cells are typically able to proliferate indefinitely if cultured in vitro.
cancer cell
REO:0000501
An antibody reagent produced by clonal hybridoma cells deriving from the fusion of a single activasted B-cell with a neoplastic cell, such that antibodies isolated from such cells are monospecific for a single epitope. A collection of such antibodies has specificity for a single epitopes on its target antigen - versus a collection of 'polyclonal antibodies', which recognize various different epitopes. But at the structural level of the individual molecular reagent, there is of course no distinction between mono- and poly-clonal antibodies.
monoclonal antibody
REO:0000502
an antibody reagent that is output from an antibody production process that yields a heterogenous collection of antibodies that are not mono-specific (ie individual antibodies in the collection may recognize different epitopes becasue they arise from more than one clone of B-lymphocyte cells). Polyclonal antibodies are typically manufactured through an antibody production technique in which a host organism is immunized with a specific immunogen and antibodies purified from serum collected following the induced immune response. A collection of such antibodies has specificity for various different epitopes on its target antigen - versus a collection of 'monoclonal antibodies', which all recognize a single epitope. But at the structural level of the individual molecular reagent, there is of course no distinction between mono- and poly-clonal antibodies.
polyclonal antibody
RS:0002307
ICR
SO:0000001
A sequence_feature with an extent greater than zero. A nucleotide region is composed of bases and a polypeptide region is composed of amino acids.
region
SO:0000104
A sequence of amino acids linked by peptide bonds which may lack appreciable tertiary structure and may not be liable to irreversible denaturation.
polypeptide
SO:0000110
Any extent of continuous biological sequence.
sequence_feature
SO:0000150
A sequence obtained from a single sequencing experiment. Typically a read is produced when a base calling program interprets information from a chromatogram trace file produced from a sequencing machine.
read
SO:0000165
A cis-acting sequence that increases the utilization of (some) eukaryotic promoters, and can function in either orientation and in any location (upstream or downstream) relative to the promoter.
enhancer
SO:0000276
Small, ~22-nt, RNA molecule that is the endogenous transcript of a miRNA gene (or the product of other non coding RNA genes. Micro RNAs are produced from precursor molecules (SO:0000647) that can form local hairpin structures, which ordinarily are processed (usually via the Dicer pathway) such that a single miRNA molecule accumulates from one arm of a hairpin precursor molecule. Micro RNAs may trigger the cleavage of their target molecules or act as translational repressors.
miRNA
SO:0000336
A sequence that closely resembles a known functional gene, at another locus within a genome, that is non-functional as a consequence of (usually several) mutations that prevent either its transcription or translation (or both). In general, pseudogenes result from either reverse transcription of a transcript of their "normal" paralog (SO:0000043) (in which case the pseudogene typically lacks introns and includes a poly(A) tail) or from recombination (SO:0000044) (in which case the pseudogene is typically a tandem duplication of its "normal" paralog).
pseudogene
SO:0000443
An attribute to describe the kind of biological sequence.
polymer_attribute
SO:0000462
A non-functional descendant of a functional entity.
pseudogenic_region
SO:0000590
The signal recognition particle (SRP) is a universally conserved ribonucleoprotein. It is involved in the co-translational targeting of proteins to membranes. The eukaryotic SRP consists of a 300-nucleotide 7S RNA and six proteins: SRPs 72, 68, 54, 19, 14, and 9. Archaeal SRP consists of a 7S RNA and homologues of the eukaryotic SRP19 and SRP54 proteins. In most eubacteria, the SRP consists of a 4.5S RNA and the Ffh protein (a homologue of the eukaryotic SRP54 protein). Eukaryotic and archaeal 7S RNAs have very similar secondary structures, with eight helical elements. These fold into the Alu and S domains, separated by a long linker region. Eubacterial SRP is generally a simpler structure, with the M domain of Ffh bound to a region of the 4.5S RNA that corresponds to helix 8 of the eukaryotic and archaeal SRP S domain. Some Gram-positive bacteria (e.g. Bacillus subtilis), however, have a larger SRP RNA that also has an Alu domain. The Alu domain is thought to mediate the peptide chain elongation retardation function of the SRP. The universally conserved helix which interacts with the SRP54/Ffh M domain mediates signal sequence recognition. In eukaryotes and archaea, the SRP19-helix 6 complex is thought to be involved in SRP assembly and stabilizes helix 8 for SRP54 binding.
SRP_RNA
SO:0000655
An RNA transcript that does not encode for a protein rather the RNA molecule is the gene product.
ncRNA
SO:0000673
An RNA synthesized on a DNA or RNA template by an RNA polymerase.
transcript
SO:0000704
A region (or regions) that includes all of the sequence elements necessary to encode a functional transcript. A gene may include regulatory regions, transcribed regions and/or other functional sequence regions.
gene
SO:0000771
A quantitative trait locus (QTL) is a polymorphic locus which contains alleles that differentially affect the expression of a continuously distributed phenotypic trait. Usually it is a marker described by statistical association to quantitative variation in the particular phenotypic trait that is thought to be controlled by the cumulative action of alleles at multiple loci.
QTL
SO:0000831
A region of a gene.
gene_member_region
SO:0000902
A transgene is a gene that has been transferred naturally or by any of a number of genetic engineering techniques from one organism to another.
transgene
SO:0000988
A quality of a nucleotide polymer that has no terminal nucleotide residues.
circular
SO:0000999
A region of sequence from the end of a BAC clone that may provide a highly specific marker.
BAC_end
SO:0001217
protein_coding_gene
SO:0001263
ncRNA_gene
SO:0001265
miRNA_gene
SO:0001266
scRNA_gene
SO:0001267
snoRNA_gene
SO:0001268
snRNA_gene
SO:0001272
tRNA_gene
SO:0001411
A region defined by its disposition to be involved in a biological process.
biological_region
SO:0001498
A region of sequence from the end of a YAC clone that may provide a highly specific marker.
YAC_end
SO:0001500
A biological_region characterized as a single heritable trait in a phenotype screen. The heritable phenotype may be mapped to a chromosome but generally has not been characterized to a specific gene locus.
heritable_phenotypic_marker
SO:0001637
A gene that encodes for ribosomal RNA.
rRNA_gene
SO:0001639
A gene that encodes an RNase P RNA.
RNase_P_RNA_gene
SO:0001640
A gene that encodes a RNase_MRP_RNA.
RNase_MRP_RNA_gene
SO:0001641
A gene that encodes large intervening non-coding RNA.
lincRNA_gene
SO:0001643
A telomerase RNA gene is a non coding RNA gene the RNA product of which is a component of telomerase.
telomerase_RNA_gene
SO:0001741
A gene segment which when incorporated by somatic recombination in the final gene transcript results in a nonfunctional product.
pseudogenic_gene_segment
SO:3000000
A gene component region which acts as a recombinational unit of a gene whose functional form is generated through somatic recombination.
gene_segment
UBERON:0000002
uterine cervix
Lower, narrow portion of the uterus where it joins with the top end of the vagina.
uterine cervix
UBERON:0000006
islet of Langerhans
the clusters of hormone-producing cells that are scattered throughout the pancreas
islet of Langerhans
UBERON:0000007
pituitary gland
The pituitary gland is an endocrine gland that secretes hormones that regulate many other glands [GO]. An endocrine gland located ventral to the diencephalon and derived from mixed neuroectodermal and non neuroectodermal origin [ZFIN].
pituitary gland
UBERON:0000014
zone of skin
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
zone of skin
UBERON:0000016
endocrine pancreas
The part of the pancreas that is part of the endocrine system and is made up of islet cells, which produce insulin, glucagon and somatostatin.
endocrine pancreas
UBERON:0000017
exocrine pancreas
The part of the pancreas that is part of the exocrine system and which produces and store zymogens of digestive enzymes, such as chymotrypsinogen and trypsinogen in the acinar cells [GO].
exocrine pancreas
UBERON:0000020
sense organ
An organ that is capable of transducing sensory stimulus to the nervous system.
sense organ
UBERON:0000025
tube
Any hollow cylindrical anatomical structure containing a lumen through which substances are transported.
tube
UBERON:0000029
lymph node
Any of the rounded masses of lymphoid tissue that are surrounded by a capsule of connective tissue, are distributed along the lymphatic vessels, and contain numerous lymphocytes which filter the flow of lymph.
lymph node
UBERON:0000033
head
The head is the anterior-most division of the body [GO].
head
UBERON:0000042
serous membrane
multi-tissue structure that is comprised of a secretory epithelial layer (mesothelium) and a connective tissue layer.
serous membrane
UBERON:0000044
dorsal root ganglion
* Sensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain. (MSH) * ganglion found on the posterior root of each spinal nerve, composed of the unipolar nerve cell bodies of the sensory neurons of the nerve. (CSP)
dorsal root ganglion
UBERON:0000045
ganglion
A biological tissue mass, most commonly a mass of nerve cell bodies.
ganglion
UBERON:0000058
duct
A tubular structure that transports or secretes substances.
duct
UBERON:0000059
large intestine
A subdivision of the digestive tract that connects the small intestine to the cloaca or anus. Lacks or has few villi[Kardong].
large intestine
UBERON:0000061
anatomical structure
Material anatomical entity that is a single connected structure with inherent 3D shape generated by coordinated expression of the organism's own genome.
anatomical structure
UBERON:0000062
organ
Anatomical structure that performs a specific function or group of functions [WP].
organ
UBERON:0000063
organ segment
Organ region with one or more fixed or anchored fiat boundaries. Examples: artery, trunk of nerve, cervical part of esophagus, pelvic part of vagina, horn of thyroid cartilage, anterior segment of eyeball[FMA].
organ segment
UBERON:0000064
organ part
Anatomical structure which has as its direct parts two or more types of tissue and is continuous with one or more anatomical structures likewise constituted by two or more portions of tissues distinct from those of their complement. Examples: osteon, cortical bone, neck of femur, bronchopulmonary segment, left lobe of liver, anterior right side of heart, interventricular branch of left coronary artery, right atrium, mitral valve, head of pancreas[FMA].
organ part
UBERON:0000065
respiratory tract
Anatomical structure that is part of the respiratory system. In mammals consists of upper and lower tracts
respiratory tract
UBERON:0000068
embryo stage
A life cycle stage that starts with fertilization and ends with the fully formed embryo.
embryo stage
UBERON:0000072
segment of respiratory tract
An organ segment that is part of a respiratory tract [Automatically generated definition].
segment of respiratory tract
UBERON:0000077
mixed endoderm/mesoderm-derived structure
An anatomical structure that develops from the endoderm and the mesoderm.
mixed endoderm/mesoderm-derived structure
UBERON:0000078
mixed ectoderm/mesoderm/endoderm-derived structure
An anatomical structure that develops from the ectoderm, mesoderm and endoderm.
mixed ectoderm/mesoderm/endoderm-derived structure
UBERON:0000092
post-embryonic stage
stage succeeding embryo, including mature structure
post-embryonic stage
UBERON:0000105
life cycle stage
A spatiotemporal region encompassing some part of the life cycle of an organism.
life cycle stage
UBERON:0000112
sexually immature stage
sexually immature stage
UBERON:0000113
post-juvenile adult stage
The stage of being a sexually mature adult animal.
post-juvenile adult stage
UBERON:0000115
lung epithelium
The epithelial layer of the lung.
lung epithelium
UBERON:0000117
respiratory tube
A tube in the respiratory system. Examples: bronchus, bronchiole, trachea.
respiratory tube
UBERON:0000122
neuron projection bundle
A fasciculated bundle of neuron projections (GO:0043005), largely or completely lacking synapses.
neuron projection bundle
UBERON:0000160
intestine
Segment of the alimentary canal extending from the stomach to the anus and, in humans and other mammals, consists of two segments, the small intestine and the large intestine.
intestine
UBERON:0000168
segment of colon
An organ segment that is part of a colon [Automatically generated definition].
segment of colon
UBERON:0000178
blood
Circulating body substance which consists of blood plasma and hemoglobin-carrying red blood cells. Excludes blood analogues (see UBERON:0000179 haemolymphatic fluid).
blood
UBERON:0000200
gyrus
A ridge on the cerebral cortex. It is generally surrounded by one or more sulci .
gyrus
UBERON:0000359
preputial gland
A aired, lobulated, modified sebaceous glands located in the inguinal region adjacent to the penis and vagina, with pheromonal functions in male rodents; in males, the preputial gland empties into the preputial cavity and in females, the preputial (aka clitoral) gland duct empties into the clitoral fossa.
preputial gland
UBERON:0000451
prefrontal cortex
The anterior part of the frontal lobes of the brain, lying in front of the motor and premotor areas.nnThis brain region has been implicated in planning complex cognitive behaviors, personality expression, decision making and moderating correct social behavior. The basic activity of this brain region is considered to be orchestration of thoughts and actions in accordance with internal goals.nnThe most typical psychological term for functions carried out by the pre-frontal cortex area is executive function. Executive function relates to abilities to differentiate among conflicting thoughts, determine good and bad, better and best, same and different, future consequences of current activities, working toward a defined goal, prediction of outcomes, expectation based on actions, and social 'control' (the ability to suppress urges that, if not suppressed, could lead to socially-unacceptable outcomes).nnMany authors have indicated an integral link between a person's personality and the functions of the prefrontal cortex. - definition adapted from Wikipedia
prefrontal cortex
UBERON:0000463
organism substance
Material anatomical entity in a gaseous, liquid, semisolid or solid state; produced by anatomical structures or derived from inhaled and ingested substances that have been modified by anatomical structures as they pass through the body.
organism substance
UBERON:0000465
material anatomical entity
Anatomical entity that has mass.
material anatomical entity
UBERON:0000468
multicellular organism
Anatomical structure that is an individual member of a species and consists of more than one cell.
multicellular organism
UBERON:0000471
compound organ component
Multi-tissue structure that is part of a compound organ.
compound organ component
UBERON:0000473
testis
A gonad of a male animal. A gonad produces and releases sperm.
testis
UBERON:0000475
organism subdivision
Anatomical structure which is a subdivision of a whole organism, consisting of components of multiple anatomical systems, largely surrounded by a contiguous region of integument.
organism subdivision
UBERON:0000477
anatomical cluster
Anatomical group that has its parts adjacent to one another.
anatomical cluster
UBERON:0000478
extraembryonic structure
A multicellular anatomical structure that is associated with an embryo and derived from the zygote from which it develops, but which does not contribute to the embryo proper or to structures that are part of the same organism after embryogenesis.
extraembryonic structure
UBERON:0000479
tissue
Multicellular anatomical structure that consists of many cells of one or a few types, arranged in an extracellular matrix such that their long-range organisation is at least partly a repetition of their short-range organisation.
tissue
UBERON:0000481
multi-tissue structure
Anatomical structure that has as its parts two or more portions of tissue of at least two different types and which through specific morphogenetic processes forms a single distinct structural unit demarcated by bona-fide boundaries from other distinct structural units of different types.
multi-tissue structure
UBERON:0000483
epithelium
Portion of tissue, that consists of one or more layers of epithelial cells connected to each other by cell junctions and which is underlain by a basal lamina. Examples: simple squamous epithelium, glandular cuboidal epithelium, transitional epithelium, myoepithelium[CARO].
epithelium
UBERON:0000485
simple columnar epithelium
Unilaminar epithelium, which consists of a single layer of columnar cells. Examples: ciliated columnar epithelium, gastric epithelium, microvillus columnar epithelium.[FMA]
simple columnar epithelium
UBERON:0000487
simple squamous epithelium
Unilaminar epithelium which consists of a single layer of squamous cells. Examples: pulmonary alveolar epithelium, endothelium.[FMA]
simple squamous epithelium
UBERON:0000489
cavitated compound organ
Compound organ that contains one or more macroscopic anatomical spaces.
cavitated compound organ
UBERON:0000490
unilaminar epithelium
Epithelium which consists of a single layer of epithelial cells. Examples: endothelium, mesothelium, glandular squamous epithelium.[FMA]
unilaminar epithelium
UBERON:0000922
embryo
Anatomical entity that comprises the organism in the early stages of growth and differentiation that are characterized by cleavage, the laying down of fundamental tissues, and the formation of primitive organs and organ systems. For example, for mammals, the process would begin with zygote formation and end with birth. For insects, the process would begin at zygote formation and end with larval hatching. For plant zygotic embryos, this would be from zygote formation to the end of seed dormancy. For plant vegetative embryos, this would be from the initial determination of the cell or group of cells to form an embryo until the point when the embryo becomes independent of the parent plant.
embryo
UBERON:0000923
germ layer
A layer of cells produced during the process of gastrulation during the early development of the animal embryo, which is distinct from other such layers of cells, as an early step of cell differentiation. The three types of germ layers are the endoderm, ectoderm, and mesoderm.
germ layer
UBERON:0000924
ectoderm
Primary germ layer that is the outer of the embryo's three germ layers and gives rise to epidermis and neural tissue.
ectoderm
UBERON:0000925
endoderm
Primary germ layer that lies remote from the surface of the embryo and gives rise to internal tissues such as gut.
endoderm
UBERON:0000926
mesoderm
The middle germ layer of the embryo, between the endoderm and ectoderm.
mesoderm
UBERON:0000945
stomach
An expanded region of the vertebrate alimentary tract that serves as a food storage compartment and digestive organ. A stomach is lined, in whole or in part by a glandular epithelium.
stomach
UBERON:0000947
aorta
The main trunk of the systemic arterial system that carries blood from the heart to all the organs and other structures of the body, bringing oxygenated blood to all parts of the body in the systemic circulation
aorta
UBERON:0000948
heart
A myogenic muscular circulatory organ found in the vertebrate cardiovascular system composed of chambers of cardiac muscle. It is the primary circulatory organ.
heart
UBERON:0000955
brain
The brain is the center of the nervous system in all vertebrate, and most invertebrate, animals. Some primitive animals such as jellyfish and starfish have a decentralized nervous system without a brain, while sponges lack any nervous system at all. In vertebrates, the brain is located in the head, protected by the skull and close to the primary sensory apparatus of vision, hearing, balance, taste, and smell[WP].
brain
UBERON:0000956
cerebral cortex
The thin layer of gray matter on the surface of the cerebral hemisphere that develops from the telencephalon. It consists of the neocortex (6 layered cortex or isocortex), the hippocampal formation and the olfactory cortex.
cerebral cortex
UBERON:0000966
retina
The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.
retina
UBERON:0000970
eye
An organ that detects light.
eye
UBERON:0000981
femur
Endochondral longbone connecting the pelvic girdle with posterior zeugopodium skeleton.[VSAO, modified].
femur
UBERON:0000982
skeletal joint
Anatomical cluster that consists of two or more adjacent skeletal structures, which may be interconnected by various types of tissue[VSAO].
skeletal joint
UBERON:0000988
pons
Brainstrem structure that has as its parts the pontine tegmentum and basal part of pons[FMA].
pons
UBERON:0000991
gonad
Reproductive organ that produces and releases eggs (ovary) or sperm (testis).
gonad
UBERON:0000992
female gonad
the gonad of a female organism which contains germ cells
female gonad
UBERON:0000995
uterus
the female muscular organ of gestation in which the developing embryo or fetus is nourished until birth
uterus
UBERON:0000996
vagina
A fibromuscular tubular tract leading from the uterus to the exterior of the body in female placental mammals and marsupials, or to the cloaca in female birds, monotremes, and some reptiles[WP].
vagina
UBERON:0000998
seminal vesicle
Either of a pair of glandular pouches that lie one on either side of the male reproductive tract and in the human male secrete a sugar- and protein-containing fluid into the ejaculatory duct.
seminal vesicle
UBERON:0001003
skin epidermis
The outer layer of the skin[WP]. cellular, multilayered epithelium derived from the ectoderm[ZFA].
skin epidermis
UBERON:0001013
adipose tissue
Portion of connective tissue composed of adipocytes enmeshed in areolar tissue
adipose tissue
UBERON:0001018
axon tract
A group of axons linking two or more neuropils and having a common origin, termination[FBbt].
axon tract
UBERON:0001040
yolk sac
A sac-like expansion of the ventral wall of the intestine, narrowed into a yolk stalk near the body[Hyman's]. Membranous sac attached to an embryo, providing early nourishment in the form of yolk in bony fishes, sharks, reptiles, birds, and primitive mammals. It functions as the developmental circulatory system of the human embryo, before internal circulation begins. In the mouse, the yolk sac is the first site of blood formation, generating primitive macrophages and erythrocytes[WP].
yolk sac
UBERON:0001044
saliva-secreting gland
saliva-secreting exocrine glands of the oral cavity[GO]
saliva-secreting gland
UBERON:0001062
anatomical entity
Biological entity that is either an individual member of a biological species or constitutes the structural organization of an individual member of a biological species.
anatomical entity
UBERON:0001064
ventral pancreatic duct
A duct joining the pancreas to the common bile duct to supply pancreatic juices which aid in digestion provided by the exocrine pancreas. The pancreatic duct joins the common bile duct just prior to the ampulla of Vater, after which both ducts perforate the medial side of the second portion of the duodenum at the major duodenal papilla.
ventral pancreatic duct
UBERON:0001088
urine
Excretion that is the output of a kidney
urine
UBERON:0001091
calcareous tooth
Organ with a cavity which consist of dentine surrounded by enamel. Examples: incisor, molar.
calcareous tooth
UBERON:0001103
diaphragm
A thin musculomebranous barrier that separates the abdominal and thoracic cavities. Often used for breathing control
diaphragm
UBERON:0001132
parathyroid gland
The parathyroid gland is an endocrine gland for secretion of parathyroid hormone, usually found as a pair, embedded in the connective tissue capsule on the posterior surface of the thyroid gland. Parathyroid regulates calcium and phosphorous metabolism.
parathyroid gland
UBERON:0001133
cardiac muscle tissue
Muscle composed of cardiac muscle cells that is part of the heart[ZFA]. involuntary striated muscle found in the walls of the heart, specifically the myocardium[Wikipedia]. Tissue which consists of cardiac myocytes surrounded by cardiac endomysium. Examples: Cardiac muscle tissue proper, conducting tissue of heart[FMA].
cardiac muscle tissue
UBERON:0001134
skeletal muscle tissue
Muscle tissue that consists primarily of skeletal muscle fibers.
skeletal muscle tissue
UBERON:0001135
smooth muscle tissue
Muscle tissue which is unstriated, composed primarily of smooth muscle fibers surrounded by a reticulum of collagen and elastic fibers. Smooth muscle differs from striated muscle in the much higher actin/myosin ratio, the absence of conspicuous sarcomeres and the ability to contract to a much smaller fraction of its resting length[GO]. Tissue which consists of smooth muscle . Examples: Arrector muscle of hair, Muscularis mucosae.
smooth muscle tissue
UBERON:0001153
caecum
A pouch in the digestive tract that connects the ileum with the ascending colon of the large intestine. It is separated from the ileum by the ileocecal valve, and is the beginning of the large intestine. It is also separated from the colon by the cecocolic junction.
caecum
UBERON:0001154
vermiform appendix
A blind-ended tube connected to the cecum, from which it develops embryologically[WP].
vermiform appendix
UBERON:0001155
colon
Last portion of the large intestine before it becomes the rectum.
colon
UBERON:0001156
ascending colon
Segment of the colon which is continuous with the cecum proximally and the transverse colon distally.[FMA,modified]
ascending colon
UBERON:0001159
sigmoid colon
The part of the large intestine that is closest to the rectum and anus. It forms a loop that averages about 40 cm. in length, and normally lies within the pelvis, but on account of its freedom of movement it is liable to be displaced into the abdominal cavity.
sigmoid colon
UBERON:0001165
pyloric antrum
the area at the bottom of the stomach on the caudal side of the pyloric canal that contains gastrin-producing G cells, which stimulate acid production, and the luminal pH-sensitive population of somatostatin-producing D cells
pyloric antrum
UBERON:0001235
adrenal cortex
the thick outer layer of the adrenal gland that produces and secretes steroid hormones such as corticosterone, estrone and aldosterone
adrenal cortex
UBERON:0001255
urinary bladder
distensible musculomembranous organ situated in the anterior part of the pelvic cavity in which urine collects before excretion[MP].
urinary bladder
UBERON:0001263
pancreatic acinus
The secretory units of the exocrine pancreas, where fluid containing digestive enzymes is produced; consists of a group of secretory cells surrounding a luminal space that connects to the pancreatic duct.
pancreatic acinus
UBERON:0001264
pancreas
An endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes[GO].
pancreas
UBERON:0001296
myometrium
the smooth muscle coat of the uterus, which forms the main mass of the organ and surrounds and supports the endometrium
myometrium
UBERON:0001301
epididymis
the elongated structure connected to the posterior surface of the testis that transports, stores, and matures spermatozoa between testis and vas deferens
epididymis
UBERON:0001343
seminiferous tubule of testis
the tubules in the testes where spermatogenesis occurs
seminiferous tubule of testis
UBERON:0001347
white adipose tissue
Connective tissue consisting of fat-storing cells and arranged in lobular groups or along minor blood vessels[MP,modified]
white adipose tissue
UBERON:0001348
brown adipose tissue
A thermogenic form of adipose tissue that is composed of brown adipocytes[MP,modified]
brown adipose tissue
UBERON:0001388
gastrocnemius
The most superficial muscle of the triceps surae group, in the posterior portion of the lower hindleg.
gastrocnemius
UBERON:0001389
soleus muscle
A deep muscle of the triceps surae group, in the superficial posterior compartment of the leg.
soleus muscle
UBERON:0001474
bone element
Skeletal element that is composed of bone tissue.
bone element
UBERON:0001485
knee joint
The knee joint joins the thigh with the leg and consists of two articulations: one between the femur and tibia, and one between the femur and patella. It is the largest and most complicated joint in the human body. The knee is a mobile trocho-ginglymus (i.e. a pivotal hinge joint), which permits flexion and extension as well as a slight medial and lateral rotation[WP,unvetted].
knee joint
UBERON:0001515
thoracic aorta
the part of the aorta that extends from the origin at the heart to the diaphragm, and from which arises numerous branches that supply oxygenated blood to the chest cage and the organs within the chest
thoracic aorta
UBERON:0001516
abdominal aorta
Abdominal part of aorta: the distal part of the descending aorta, which is the continuation of the thoracic part and gives rise to the inferior phrenic, lumbar, median sacral, superior and inferior mesenteric, middle suprarenal, renal, and testicular or ovarian arteries, and celiac trunk[BTO]. The abdominal aorta is the largest artery in the abdominal cavity. As part of the aorta, it is a direct continuation of descending aorta(of the thorax). [WP,unvetted].
abdominal aorta
UBERON:0001558
lower respiratory tract
The segment of respiratory tract from the trachea to the lungs[WP,modified]
lower respiratory tract
UBERON:0001630
muscle organ
Organ consisting of a tissue made up of various elongated cells that are specialized to contract and thus to produce movement and mechanical work[GO]. Nonparenchymatous organ that primarily consists of skeletal muscle tissue aggregated into macroscopic fasciculi by connective tissue; together with other muscles, it constitutes the muscular system. Examples: biceps, diaphragm, masseter, right third external intercostal muscle, external oblique, levator ani, serratus anterior[FMA].
muscle organ
UBERON:0001637
artery
An epithelial tube or tree of tibes that transports blood away from the heart[modified from AEO definition].
artery
UBERON:0001638
vein
Any of the tubular branching vessels that carry blood from the capillaries toward the heart.
vein
UBERON:0001684
mandible
A dentary bone that is the only bone in one of the lateral halves of the lower jaw skeleton.
mandible
UBERON:0001723
tongue
A muscular organ in the floor of the mouth.
tongue
UBERON:0001736
submandibular gland
Either of the paired compound tubuloalveolar (aka tubuloacinar) major salivary glands composed of both serous and mucous secretory cells and situated beneath the mandible.
submandibular gland
UBERON:0001805
autonomic ganglion
ganglion that has dendrites that form a junction between autonomic nerves originating from the central nervous system and autonomic nerves innervating their target organs in the periphery. There are two subtypes, sympathetic ganglion and parasympathetic ganglion.
autonomic ganglion
UBERON:0001806
sympathetic ganglion
A ganglion of the sympathetic nervous system. Examples: paravertebral and the prevertebral ganglia, which include the sympathetic chain ganglia, the superior, middle, and inferior cervical ganglia, and the aorticorenal, celiac, and stellate ganglia
sympathetic ganglion
UBERON:0001807
paravertebral ganglion
Trunk ganglion which is part of a bilaterally paired set of sympathetic ganglia located anterior and lateral to the spinal cord.
paravertebral ganglion
UBERON:0001808
parasympathetic ganglion
Ganglion containing neurons that receive innervation from parasympathetic neurons in the central nervous system and subserves parasympathetic functions through innervation of smooth muscle, cardiac muscle and glands.
parasympathetic ganglion
UBERON:0001817
lacrimal gland
The lacrimal glands are paired almond-shaped glands, located in or near the orbital region, that secrete the aqueous layer of the tear film.[WP].
lacrimal gland
UBERON:0001821
sebaceous gland
A holocrine gland that secretes sebum into the hair follicles, or in hairless areas into ducts.[MP].
sebaceous gland
UBERON:0001829
major salivary gland
One of the three largest glands of the oral cavity that secrete most of the saliva, including the parotid, submandibular, and sublingual glands.
major salivary gland
UBERON:0001831
parotid gland
The parotid gland is the largest of the salivary glands. It is found wrapped around the mandibular ramus, and it secretes saliva through Stensen's duct into the oral cavity, to facilitate mastication and swallowing. [WP,unvetted].
parotid gland
UBERON:0001870
frontal cortex
Anterior portion of the neocortex, lying anterior to the central sulcus in humans. It is bounded by the parietal cortex posteriorly and the temporal cortex laterally[NIFSTD,modified].
frontal cortex
UBERON:0001872
parietal lobe
Upper central part of the cerebral hemisphere. (MSH)
parietal lobe
UBERON:0001873
caudate nucleus
Subcortical nucleus of telecephalic origin consisting of an elongated gray mass lying lateral to and bordering the lateral ventricle. It is divided into a head, body and tail in some species.
caudate nucleus
UBERON:0001875
globus pallidus
Subcortical nucleus, functionally part of the basal ganglia, which consists of two segments the external (or lateral) and internal (or medial) separated by the medial medullary lamina in primates. In rodents, The globus pallidus lateral is separated from the medial segment by the fibers of the internal capsule/cerebral peduncle.
globus pallidus
UBERON:0001876
amygdala
Subcortical brain region lying anterior to the hippocampal formation in the temporal lobe and anterior to the temporal horn of the lateral ventricle in some species. It is usually subdivided into several groups. Functionally, it is not considered a unitary structure (MM).
amygdala
UBERON:0001891
midbrain
Organ component of neuraxis that has as its parts the tectum, cerebral peduncle, midbrain tegmentum and cerebral aqueduct[FMA]. The brain region between the forebrain anteriorly and the hindbrain posteriorly, including the tectum dorsally and the midbrain tegmentum ventrally[ZFA]. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles)[GO].
midbrain
UBERON:0001896
medulla oblongata
Organ component of neuraxis that has as its parts the medullary reticular formation, inferior olivary complex and cochlear nuclear complex, among other structures[FMA]. The medulla oblongata lies directly above the spinal cord and controls vital autonomic functions such as digestion, breathing and the control of heart rate[GO].
medulla oblongata
UBERON:0001897
dorsal plus ventral thalamus
Subcortical brain region consisting of paired gray matter bodies in the dorsal diencephalon and forming part of the lateral wall of the third ventricle of the brain. The thalamus represents the major portion of the diencephalon and is commonly divided into cellular aggregates known as nuclear groups.(MeSH). The dorsal topographic division of the interbrain. The macrodissected adult human thalamus was clearly illustrated by Vesalius in 1543 and the term as defined here was introduced by His in 1893. It includes the traditional epithalamus, dorsal thalamus, and ventral thalamus of Herrick (1910, pp. 494, 498). Also see Kuhlenbeck (1927, Ch. 9) and Jones (1985, p. 87).
dorsal plus ventral thalamus
UBERON:0001898
hypothalamus
A specialized brain region of the ventral diencephalon arising near the end of the segmentation period; the embryonic hypothalamic region will give rise to the posterior pituitary gland as well as a number of brain nuclei. [ZFA]. One of the most important functions of the hypothalamus is to link the nervous system to the endocrine system via the pituitary gland (hypophysis).[Wikipedia].
hypothalamus
UBERON:0001906
subthalamic nucleus
The subthalamic nucleus is the lens-shaped nucleus located in the ventral part of the subthalamus on the inner aspect of the internal capsule that is concerned with the integration of somatic motor function[GO].
subthalamic nucleus
UBERON:0001911
mammary gland
A specialized accessory gland of the skin of mammals that secretes milk. The gland is typically only developed in females, and regresses in males.
mammary gland
UBERON:0001917
endothelium of artery
An endothelium that is part of an artery [Automatically generated definition].
endothelium of artery
UBERON:0001928
preoptic area
Area of the forebrain anterior to the posterior tuberculum and the hypothalamus and ventral to the ventral thalamus[ZFA].
preoptic area
UBERON:0001954
Ammon's horn
A part of the brain consisting of a three layered cortex located in the forebrain bordering the medial surface of the lateral ventricle. The term hippocampus is often used synonymously with hippocampal formation which consists of the hippocampus proper or Cornu Ammonis, the dentate gyrus and the subiculum.
Ammon's horn
UBERON:0001981
blood vessel
A vessel through which blood circulates in the body.
blood vessel
UBERON:0001986
endothelium
A layer of epithelium that lines the heart, blood vessels (endothelium, vascular), lymph vessels (endothelium, lymphatic), and the serous cavities of the body[MESH]. Simple squamous epithelium which lines blood and lymphatic vessels and the heart[FMA]
endothelium
UBERON:0001987
placenta
organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin[GO]. The fetal portion of the placenta is known as the villous chorion. The maternal portion is known as the decidua basalis. The two portions are held together by anchoring villi that are anchored to the decidua basalis by the cytotrophoblastic shell.
placenta
UBERON:0001989
superior cervical ganglion
Trunk ganglion which is bilaterally paired and located at the anterior end of the sympathetic ganglion chain.
superior cervical ganglion
UBERON:0001997
olfactory epithelium
A sensory epithelium inside the nasal cavity that is responsible for detecting odors[WP].
olfactory epithelium
UBERON:0002020
gray matter
A nervous system structure composed primarily of nerve cell bodies (somas). May also include dendrites and the initial unmyelinated portion of axons.
gray matter
UBERON:0002028
hindbrain
The most posterior of the three principal regions of the brain. In mammals and birds the hindbrain is divided into a rostral metencephalon and a caudal myelencephalon. In zebrafish, with the exception of the cerebellum, the ventral remainder of the metencephalon can be separated only arbitrarily from the more caudal myelencephalic portion of the medulla oblongata (From: Neuroanatomy of the Zebrafish Brain)[ZFA]. Organ component of neuraxis that has as its parts the pons, cerebellum and medulla oblongata[FMA].
hindbrain
UBERON:0002031
epithelium of bronchus
An epithelium that is part of a bronchus [Automatically generated definition].
epithelium of bronchus
UBERON:0002036
striated muscle tissue
Tissue which consists of striated muscle fibers surrounded by endomysium. Examples: Skeletal muscle tissue, Cardiac muscle tissue[FMA].
striated muscle tissue
UBERON:0002037
cerebellum
Part of the metencephalon that lies in the posterior cranial fossa behind the brain stem. It is concerned with the coordination of movement[MESH]. A large dorsally projecting part of the brain concerned especially with the coordination of muscles and the maintenance of bodily equilibrium, situated between the brain stem and the back of the cerebrum , and formed in humans of two lateral lobes and a median lobe[BTO]. Brain structure derived from the anterior hindbrain, and perhaps including posterior midbrain. The cerebellum plays a role in somatic motor function, the control of muscle tone, and balance[ZFA].
cerebellum
UBERON:0002046
thyroid gland
A two-lobed endocrine gland found in all vertebrates, located in front of and on either side of the trachea in humans, and producing various hormones, such as triiodothyronine and calcitonin[BTO].
thyroid gland
UBERON:0002048
lung
Respiration organ that develops as an oupocketing of the esophagus.
lung
UBERON:0002050
embryonic structure
Anatomical structure that is part of an embryo.
embryonic structure
UBERON:0002058
ciliary ganglion
The ciliary ganglion is a parasympathetic ganglion located in the posterior orbit. It measures 1P2 millimeters in diameter and contains approximately 2,500 neurons (adapted from Wikipedia)
ciliary ganglion
UBERON:0002066
umbilical vein
The umbilical vein is a blood vessel present during fetal development that carries oxygenated blood from the placenta to the growing fetus. [WP,unvetted].
umbilical vein
UBERON:0002072
hypodermis
Lowermost layer of the integumentary system in vertebrates. Types of cells that are found in the hypodermis are fibroblasts, adipose cells, and macrophages. It is derived from the mesoderm, but unlike the dermis, it is not derived from the dermatome region of the mesoderm. The hypodermis is used mainly for fat storage[WP].
hypodermis
UBERON:0002075
viscus
An organ that is located within the body cavity (or in its extension, in the scrotum); it consists of organ parts that are embryologically derived from endoderm, splanchnic mesoderm or intermediate mesoderm; together with other organs, the viscus constitutes the respiratory, gastrointestinal, urinary, reproductive and immune systems, or is the central organ of the cardiovascular system. Examples: heart, lung, esophagus, kidney, ovary, spleen.
viscus
UBERON:0002106
spleen
the organ that functions to filter blood and to store red corpuscles and platelets
spleen
UBERON:0002107
liver
An exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes[GO].
liver
UBERON:0002108
small intestine
Subdivision of digestive tract that connects the stomach to the large intestine and is where much of the digestion and absorption of food takes place (with the exception of ruminants). The mammalian small intestine is long and coiled and can be differentiated histologically into: duodenum, jejunem, ileum[WP,cjm,Kardong].
small intestine
UBERON:0002110
gall bladder
An organ that aids digestion and stores bile produced by the liver[WP].
gall bladder
UBERON:0002113
kidney
A paired organ of the urinary tract which has the production of urine as its primary function.
kidney
UBERON:0002114
duodenum
The first part of the small intestine. At the junction of the stomach and the duodenum the alimentary canal is inflected. The duodenum first goes anteriorly for a short distance, turns dorsally, and eventually caudally, thus it is a U-shaped structure with two horizontal sections (a ventral and a dorsal one).
duodenum
UBERON:0002116
ileum
the portion of the small intestine that extends from the jejunum to the colon
ileum
UBERON:0002124
medulla of thymus
Medullary portion of thymus. The reticulum is coarser than in the cortex, the lymphoid cells are relatively fewer in number, and there are found peculiar nest-like bodies, the concentric corpuscles of Hassall. These concentric corpuscles are composed of a central mass, consisting of one or more granular cells, and of a capsule formed of epithelioid cells. They are the remains of the epithelial tubes, which grow out from the third branchial pouches of the embryo to form the thymus. Each follicle is surrounded by a vascular plexus, from which vessels pass into the interior, and radiate from the periphery toward the center, forming a second zone just within the margin of the medullary portion. In the center of the medullary portion there are very few vessels, and they are of minute size.
medulla of thymus
UBERON:0002185
bronchus
the upper conducting airways of the lung; these airways arise from the terminus of the trachea
bronchus
UBERON:0002240
spinal cord
Part of the central nervous system located in the vertebral canal continuous with and caudal to the brain; demarcated from brain by plane of foramen magnum. It is composed of an inner core of gray matter in which nerve cells predominate, and an outer layer of white matter in which myelinated nerve fibers predominate, and surrounds the central canal. (CUMBO)
spinal cord
UBERON:0002255
vomeronasal organ
An organ thought to supplement the olfactory system in receiving pheromonic communication. The sensory part of the organ is in two long, thin sacs, situated on either side of the nasal septum at its base.
vomeronasal organ
UBERON:0002264
olfactory bulb
A bulbous anterior projection of the olfactory lobe that is the place of termination of the olfactory nerves and is especially well developed in lower vertebrates (as fishes)[BTO].
olfactory bulb
UBERON:0002285
telencephalic ventricle
A brain ventricle that is part of a telencephalon. In mammals and species with an evaginated telencephalon, this is one of a pair of lateral structures, one in each hemisphere
telencephalic ventricle
UBERON:0002308
nucleus of brain
A neural nucleus that is part of the brain.
nucleus of brain
UBERON:0002331
umbilical cord
The connecting cord from the developing embryo to the placenta.
umbilical cord
UBERON:0002336
corpus callosum
White matter structure containing massive numbers of commissural fibers connecting cortical areas in the two cerebral hemispheres.it is subdivided into a genu, a rostrum, a body, and a splenium. (MM)
corpus callosum
UBERON:0002342
neural crest
A specialized region of ectoderm found between the neural ectoderm (neural plate) and non-neural ectoderm and composed of highly migratory pluripotent cells that delaminate in early embryonic development from the dorsal neural tube and give rise to an astounding variety of differentiated cell types[MP].
neural crest
UBERON:0002352
atrioventricular node
Subdivision of conducting system of heart which is located in the muscular part of the interatrial septum that is continuous with the atrioventricular bundle.[FMA]
atrioventricular node
UBERON:0002358
peritoneum
A serous membrane that lines the peritoneal cavity[VHOG,modified].
peritoneum
UBERON:0002365
exocrine gland
A gland that secretes products (excluding hormones and other chemical messengers) into ducts (duct glands) which lead directly into the external environment[WP]. Typical exocrine glands include sweat glands, salivary glands, mammary glands, stomach, liver, pancreas
exocrine gland
UBERON:0002367
prostate gland
The prostate gland is a partly muscular, partly glandular body that is situated near the base of the mammalian male urethra and secretes an alkaline viscid fluid which is a major constituent of the ejaculatory fluid.
prostate gland
UBERON:0002368
endocrine gland
Endocrine glands are glands of the endocrine system that secrete their products directly into the circulatory system rather than through a duct.[WP, modified].
endocrine gland
UBERON:0002369
adrenal gland
Either of a pair of complex endocrine organs near the anterior medial border of the kidney consisting of a mesodermal cortex that produces glucocorticoid, mineralocorticoid, and androgenic hormones and an ectodermal medulla that produces epinephrine and norepinephrine[BTO].
adrenal gland
UBERON:0002370
thymus
Anatomical structure of largely lymphoid tissue that functions in cell-mediated immunity by being the site where T cells develop.
thymus
UBERON:0002371
bone marrow
the soft tissue that fills the cavities of bones
bone marrow
UBERON:0002372
tonsil
either of the two small almond-shaped masses of lymph tissue found on either side of the oropharynx
tonsil
UBERON:0002384
connective tissue
Tissue with cells that deposit non-polarized extracellular matrix including connective tissue fibers and ground substance.
connective tissue
UBERON:0002385
muscle tissue
Muscle tissue is a contractile tissue made up of actin and myosin fibers[GO].
muscle tissue
UBERON:0002394
bile duct
Any of the ducts that form the biliary tree, carrying bile from the liver to the small intestine.
bile duct
UBERON:0002405
immune system
Anatomical system that protects the body from foreign substances, cells, and tissues by producing the immune response and that includes especially the thymus, spleen, lymphoid tissue, lymphocytes including the B cells and T cells, and antibodies.
immune system
UBERON:0002407
pericardium
The combination of pericardial sac (a double-walled sac containing the heart and the roots of the great vessels) plus fibrous pericardium.
pericardium
UBERON:0002419
skin gland
A gland that is part of a skin of body [Automatically generated definition].
skin gland
UBERON:0002420
basal ganglion
An individual member of a collection of basal ganglia. Basal ganglia are subcortical masses of gray matter in the forebrain and midbrain that are richly interconnected and so viewed as a functional system. The nuclei usually included are the caudate nucleus (caudoputamen in rodents), putamen, globus pallidus, substantia nigra (pars compacta and pars reticulata) and the subthalamic nucleus. Some also include the nucleus accumbens and ventral pallidum[NIF,modified].
basal ganglion
UBERON:0002428
limb bone
A bone that is part of a limb [Automatically generated definition].
limb bone
UBERON:0002435
striatum
A region of the forebrain consisting of the caudate nucleus, putamen and fundus striati.[GO].
striatum
UBERON:0002513
endochondral bone
Replacement bone that forms within cartilage.
endochondral bone
UBERON:0002530
gland
an organ that functions as a secretory or excretory organ
gland
UBERON:0002544
digit
A subdivision of the autopod that has as part a series of phalanges together with associated vasculature, musculature, integument and nerves. It is continuous with the metapodial subdivision of the autopod, but does not include the metapodials. In species such as humans, fully formed digits are distinct, whereas in other species the digits may be connected by interdigital webbing, or may be completely unseparated (for example, in cetaceans).
digit
UBERON:0002616
regional part of brain
Anatomical divisons of the brain according to one or more criteria, e.g. cytoarchitectural, gross anatomy. Parts may be contiguous in 3D or not, e.g., basal ganglia. Regions of brain across multiple species are contained within this category.
regional part of brain
UBERON:0002623
cerebral peduncle
Synonym for macrodissected adult human tegmentum (Vicq d'Azyr, 1784; Swanson, 2000); pp. 555-556. Later used thus by for example His (1893b, p. 178), Herrick (1915, p. 160), Strong & Elwyn (1943, p. 17), Carpenter (1976, p. 367), Williams & Warwick (1980, p. 935).
cerebral peduncle
UBERON:0002691
ventral tegmental area
Unpaired midbrain region situated in the ventromedial portion of the reticular formation. The VTA is medial to the substantia nigra and ventral to the red nucleus, and extends caudally from the posterior hypothalamus in the diencephalon. The VTA contains dopamine neurons that project to various limbic and cortical areas and is a critical component of the brain's reward circuitry.
ventral tegmental area
UBERON:0002967
cingulate gyrus
One of the convolutions on the medial surface of the cerebral hemisphere. It surrounds the rostral part of the brain and interhemispheric commissure and forms part of the limbic system. (MSH) One of three essential structures comprising the limbic lobe, the other two being the hippocampus and parahippocampal gyrus. (CSP)
cingulate gyrus
UBERON:0003102
surface structure
Anatomical structure that overlaps the outer epithelial layer and is adjacent to the space surrounding the organism.
surface structure
UBERON:0003103
compound organ
Anatomical structure that has as its parts two or more multi-tissue structures of at least two different types and which through specific morphogenetic processes forms a single distinct structural unit demarcated by bona fide boundaries from other distinct anatomical structures of different types.
compound organ
UBERON:0003126
trachea
The trachea is the portion of the airway that attaches to the bronchi as it branches [GO:dph].
trachea
UBERON:0003129
skull
Anatomical structure that is part of the head consisting entirely of cranium and mandible[WP].
skull
UBERON:0003133
reproductive organ
An organ involved in reproduction
reproductive organ
UBERON:0003258
endoderm of foregut
An endoderm that is part of a foregut [Automatically generated definition].
endoderm of foregut
UBERON:0003283
mesentery of oesophagus
A mesentery that is part of a esophagus [Automatically generated definition].
mesentery of oesophagus
UBERON:0003296
gland of diencephalon
Any gland that is part of the diencephalon. Examples: pineal gland, neurohypophysis.
gland of diencephalon
UBERON:0003297
gland of integumental system
A gland that is part of a integumental system [Automatically generated definition].
gland of integumental system
UBERON:0003408
gland of gut
A gland that is part of a digestive tract [Automatically generated definition].
gland of gut
UBERON:0003457
head bone
A bone that is part of a head [Automatically generated definition].
head bone
UBERON:0003462
facial bone
A bone that is part of a facial skeleton [Automatically generated definition].
facial bone
UBERON:0003464
hindlimb bone
A bone that is part of a hindlimb region. Examples: any pes phalanx, femur. Counter-examples: ischium, pubis (they are part of the pelvic girdle)
hindlimb bone
UBERON:0003469
respiratory system artery
An artery that is part of a respiratory system [Automatically generated definition].
respiratory system artery
UBERON:0003509
arterial blood vessel
A blood vessel that is part of the arterial system. Includes artery, arteriole and aorta.
arterial blood vessel
UBERON:0003528
brain gray matter
A gray matter that is part of a brain [Automatically generated definition].
brain gray matter
UBERON:0003606
limb long bone
A long bone that is part of a limb [Automatically generated definition].
limb long bone
UBERON:0003608
hindlimb long bone
A long bone that is part of a hindlimb [Automatically generated definition].
hindlimb long bone
UBERON:0003643
respiratory system arterial blood vessel
An arterial blood vessel that is part of a respiratory system [Automatically generated definition].
respiratory system arterial blood vessel
UBERON:0003657
limb joint
Any joint that is part of a (free) limb.
limb joint
UBERON:0003729
mouth mucosa
A mucous membrane that lines the mouth.
mouth mucosa
UBERON:0003889
fallopian tube
Initial section of the oviduct through which the ova pass from the ovary to the uterus
fallopian tube
UBERON:0003913
tooth-like structure
hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
tooth-like structure
UBERON:0003914
epithelial tube
Epithelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system.
epithelial tube
UBERON:0003915
endothelial tube
Any endothelium that has the quality of being cylindrical [Automatically generated definition].
endothelial tube
UBERON:0003922
pancreatic epithelial bud
The embryonic pancreas develops from two separate anlagen in the foregut epithelium, one dorsal and two ventral pancreatic buds[PMID].
pancreatic epithelial bud
UBERON:0003924
ventral pancreatic bud
pancreatic bud that gives rise to the major pancreatic duct.
ventral pancreatic bud
UBERON:0003928
digestive system duct
A duct that is part of a digestive system [Automatically generated definition].
digestive system duct
UBERON:0003937
sex gland
Any of the organized aggregations of cells that function as secretory or excretory organs and are associated with reproduction.
sex gland
UBERON:0003947
brain ventricle/choroid plexus
The brain ventricles or their associated choroid plexuses
brain ventricle/choroid plexus
UBERON:0004086
brain ventricle
one of the system of communicating cavities in the brain that are continuous with the central canal of the spinal cord, that like it are derived from the medullary canal of the embryo, that are lined with an epithelial ependyma, and that contain a serous fluid
brain ventricle
UBERON:0004111
anatomical conduit
Any tube, opening or passage that connects two distinct anatomical spaces.
anatomical conduit
UBERON:0004119
endoderm-derived structure
An anatomical structure that develops (entirely or partially) from the endoderm.
endoderm-derived structure
UBERON:0004120
mesoderm-derived structure
An anatomical structure that develops (entirely or partially) from the mesoderm.
mesoderm-derived structure
UBERON:0004121
ectoderm-derived structure
An anatomical structure that develops (entirely or partially) from the ectoderm.
ectoderm-derived structure
UBERON:0004177
hemopoietic organ
Organ that is part of the hematopoietic system.
hemopoietic organ
UBERON:0004256
hindlimb zeugopod muscle
A muscle organ that is part of a hindlimb zeugopod (lower leg) [Automatically generated definition].
hindlimb zeugopod muscle
UBERON:0004363
pharyngeal arch artery
One of a series of paired embryological vascular structures formed within a pharyngeal arch; in the adult, some of these vessels give rise to the great vessels[MP]
pharyngeal arch artery
UBERON:0004375
bone of free limb or fin
A bone that is part of an appendage [Automatically generated definition].
bone of free limb or fin
UBERON:0004457
cavity lining
cavity lining
UBERON:0004638
blood vessel endothelium
An endothelium that lines the blood vasculature. Other endothelia may line lymph vessels, the heart
blood vessel endothelium
UBERON:0004700
arterial system endothelium
An endothelium that is part of an arterial system [Automatically generated definition].
arterial system endothelium
UBERON:0004742
dentary
The dentary is a dermal bone that forms the antero-lateral part of the lower jaw in fishes and amphibians, extending to the whole lower jaw in mammals[VHOG,modified].
dentary
UBERON:0004756
dermal skeletal element
dermis-derived entity that is made of skeletal tissue.
dermal skeletal element
UBERON:0004765
skeletal element
Organ consisting of skeletal tissue. Encompasses whole bones, fused bones, cartilaginious elements, teeth, dermal denticles.
skeletal element
UBERON:0004768
bone of lower jaw
Any bone that is part of the lower jaw skeleton. This includes (when present): the dentary/mandible, the articular, the splenial, the suprangular
bone of lower jaw
UBERON:0004802
respiratory tract epithelium
the pseudostratified ciliated epithelium that lines much of the conducting portion of the airway, including part of the nasal cavity and larynx, the trachea, and bronchi
respiratory tract epithelium
UBERON:0004807
respiratory system epithelium
An epithelium that is part of a respiratory system [Automatically generated definition].
respiratory system epithelium
UBERON:0004815
lower respiratory tract epithelium
An epithelium that is part of a lower respiratory tract [Automatically generated definition].
lower respiratory tract epithelium
UBERON:0004851
aorta endothelium
the thin layer of flat cells that line the aorta and form a barrier between circulating blood in the lumen and the rest of the vessel wall
aorta endothelium
UBERON:0004852
cardiovascular system endothelium
An endothelium that is part of the cardiovascular system.
cardiovascular system endothelium
UBERON:0004921
subdivision of digestive tract
A proximal-distal subdivision of the digestive tract.
subdivision of digestive tract
UBERON:0004923
organ component layer
A part of a wall of an organ that forms a layer.
organ component layer
UBERON:0005020
mucosa of tongue
A mucosa that is part of a tongue [Automatically generated definition].
mucosa of tongue
UBERON:0005057
immune organ
An organ that is part of a immune system [Automatically generated definition].
immune organ
UBERON:0005156
reproductive structure
An anatomical structure that is part of the reproductive system.
reproductive structure
UBERON:0005162
multi cell part structure
A structure consisting of multiple cell components but which is not itself a cell and does not have (complete) cells as a part.
multi cell part structure
UBERON:0005172
abdomen element
An organ or element that is in the abdomen. Examples: spleen, intestine, kidney, abdominal mammary gland.
abdomen element
UBERON:0005177
trunk region element
An organ or element that part of the trunk region. The trunk region can be further subdividied into thoracic (including chest and thoracic cavity) and abdominal (including abdomen and pelbis) regions.
trunk region element
UBERON:0005181
thoracic segment organ
An organ that part of the thoracic segment region. This region can be further subdividied chest and thoracic cavity regions.
thoracic segment organ
UBERON:0005291
embryonic tissue
A portion of tissue that is part of an embryo.
embryonic tissue
UBERON:0005301
male preputial gland
One of the sebaceous glands of the corona and neck of the glans penis.
male preputial gland
UBERON:0005384
nasal cavity epithelium
An epithelium that lines the nasal cavity.
nasal cavity epithelium
UBERON:0005399
male reproductive gland
A sex gland that is part of a male reproductive system.
male reproductive gland
UBERON:0005401
cerebral hemisphere gray matter
A gray matter that is part of a cerebral hemisphere.
cerebral hemisphere gray matter
UBERON:0005439
definitive endoderm
definitive endoderm
UBERON:0005631
extraembryonic membrane
Intrinsic membrane that arises from embryonic germ layers and grow to surround the developing embryo.
extraembryonic membrane
UBERON:0005800
segment of aorta
Any portion of the aorta including the ascending and descending aorta, and aortic arch or a portion of the aortic orifice of the left ventricle.
segment of aorta
UBERON:0005902
occipital region
Anatomical cluster that is located in the posterior region of the cranium and forms the margin of the foramen magnum and occipital condyles.
occipital region
UBERON:0005904
duct of male reproductive system
Any of the ducts that are part of a male reproductive system.
duct of male reproductive system
UBERON:0005911
endo-epithelium
Epithelium that derives from the endoderm. Examples: urothelium, transitional epithelium of ureter, epithelium of prostatic gland.[FMA]
endo-epithelium
UBERON:0006003
integumentary adnexa
Anatomical structure embedded in or located in the integument that is part of the integumental system. Examples: hair, follicles, skin glands, claws, nails, feathers.
integumentary adnexa
UBERON:0006799
glandular epithelium
An epithelium that is composed primarily of secretory cells.
glandular epithelium
UBERON:0006858
adrenal/interrenal gland
This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells[GO]
adrenal/interrenal gland
UBERON:0006914
squamous epithelium
An epithelium characterised by its most superficial layer consisting of squamous epithelial cells.
squamous epithelium
UBERON:0006925
digestive gland
A gland, such as the liver or pancreas, that secretes into the alimentary canal substances necessary for digestion.
digestive gland
UBERON:0007100
primary circulatory organ
A hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood or analogs[GO,modified].
primary circulatory organ
UBERON:0007196
tracheobronchial tree
The structure from the trachea, bronchi, and bronchioles that forms the airways that supply air to the lungs. The lining of the tracheobronchial tree consists of ciliated columnar epithelial cells.
tracheobronchial tree
UBERON:0007329
pancreatic duct
A duct that is part of the pancreas and connected to the duodenum.
pancreatic duct
UBERON:0007376
outer epithelium
The epidermis is the entire outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species[GO].
outer epithelium
UBERON:0007499
epithelial sac
An epithelial tube that is open at one end only.
epithelial sac
UBERON:0007592
ciliated columnar epithelium
Simple columnar epithelium in which the luminal side of the cells bears cilia. Examples: epithelium of trachea, epithelium of uterine tube.[FMA]
ciliated columnar epithelium
UBERON:0007827
external nose
External part of the olfactory apparatus.
external nose
UBERON:0008907
dermal bone
Skeletal element that forms superficially in the organism, usually in association with the ectoderm[VSAO].
dermal bone
UBERON:0009663
telencephalic nucleus
A nucleus of brain that is part of a telencephalon.
telencephalic nucleus
UBERON:0009842
glandular acinus
The many-lobed berry cluster of cells that is the terminous of a gland where the secretion is produced is acinar in form.
glandular acinus
UBERON:0009854
digestive tract diverticulum
Branch or outpocketing of the digestive tract.
digestive tract diverticulum
UBERON:0009856
sac
sac
UBERON:0010000
multicellular anatomical structure
An anatomical structure that has more than one cell as a part.
multicellular anatomical structure
UBERON:0010047
oral gland
Gland of the epithelium lining the oral cavity. The most common are the salivary glands.
oral gland
UBERON:0010147
male accessory sex gland
Any gland, other than the gonad, associated with the genital tract, such as the ampulla of the ductus deferens and the bulbourethral, prostate and vesicular glands of the male.
male accessory sex gland
UBERON:0010313
neural crest-derived structure
An anatomical structure that develops from the neural crest.
neural crest-derived structure
UBERON:0010314
structure with developmental contribution from neural crest
An anatomical structure that has some part that develops from the neural crest.
structure with developmental contribution from neural crest
UBERON:0010316
germ layer / neural crest
germ layer / neural crest
UBERON:0010363
endochondral element
A skeletal element that has the potential to participate in endochondral ossification, and may participate in intramembranous ossification.
endochondral element
UBERON:0010371
ecto-epithelium
Epithelium that derives from the ectoderm. Examples: epithelium of acinus of lactiferous duct, subscapular lens epithelium, epithelium of posterior surface of cornea.
ecto-epithelium
UBERON:0010499
pseudostratified ciliated columnar epithelium
Epithelium composed of a single layer of cells, appearing as layered because the column-shaped cells vary in height so the nuclei are at different levels. The basal portions of all the cells are in contact with the basement membrane. It lines the respiratory system and the male reproductive tract. The cilia in the respiratory tract are motile, while the stereocilia in the male reproductive tract are immobile.
pseudostratified ciliated columnar epithelium
UBERON:0010740
bone of appendage girdle complex
A bone that is part of an appendage girdle complex (i.e. any bone in a limb, fin or girdle).
bone of appendage girdle complex
UBERON:0011139
synovial limb joint
Any synovial joint that is part of a (free) limb.
synovial limb joint
UBERON:0011215
central nervous system cell part cluster
A multi cell part structure that is part of a central nervous system.
central nervous system cell part cluster
UBERON:0011300
gray matter of telencephalon
A portion of gray matter that is part of a telencephalon.
gray matter of telencephalon
UBERON:0012275
meso-epithelium
Epithelium that derives from the mesoderm. [Automatically generated definition].
meso-epithelium
UBERON:0012360
bone of jaw
A bone element that is part of a jaw region.
bone of jaw
UBERON:0012429
hemopoietic tissue
Blood-forming tissue, consisting of reticular fibers and cells. Also known as hemopoietic tissue
hemopoietic tissue
UBERON:0013515
subdivision of uterine tube
subdivision of uterine tube
UBERON:0013522
subdivision of tube
subdivision of tube
UBERON:0013697
exocrine pancreas epithelium
Epithelium lining the exocrine pancreas.
exocrine pancreas epithelium
UBERON:0013765
digestive system element
Any of the organs or elements that are part of the digestive system. Examples: tongue, esophagus, spleen, crop, lunge feeding organ, tooth elements.
digestive system element
UBERON:0014374
embryoid body
Embryoid bodies (EBs) are three-dimensional aggregates of pluripotent stem cells.
embryoid body
UBERON:0014892
skeletal muscle organ
A muscle organ that consists of skeletal muscle tissue ensheathed in epimysium, that develops from myotome and that is innervated by some somatic motor neuron. Skeletal muscles are typically attached (via a tendon) to a bone but there are exceptions (e.g. intrinsic tongue muscles).
skeletal muscle organ
UBERON:0015022
hindlimb endochondral element
A hindlimb bone or its cartilage or pre-cartilage precursor.
hindlimb endochondral element
UBERON:0015061
limb endochondral element
A limb bone or its cartilage or pre-cartilage precursor.
limb endochondral element
UBERON:0015212
lateral structure
Any structure that is placed on one side of the left-right axis of a bilaterian.
lateral structure
UBERON:0015787
upper respiratory conduit
Any anatomical conduit which is part of the upper respiratory tract
upper respiratory conduit
UBERON:0016526
lobe of cerebral hemisphere
Subdivision of telencephalon which is one of a number of subdivisions of each hemisphere separated by both real landmarks (sulci and fissures) and arbitrary boundaries[FMA,modified].
lobe of cerebral hemisphere
UBERON:0017672
abdominal viscera
A viscus that is part of a abdomen.
abdominal viscera
UBERON:0018707
bladder organ
A membranous sac in animals that serves as the receptacle of a liquid or contains gas.
bladder organ
UBERON:0019306
nose epithelium
nose epithelium
UBERON:0019319
exocrine gland of integumental system
An exocrine gland that is part of a integumental system.
exocrine gland of integumental system
UBERON:0034769
lymphomyeloid tissue
lymphomyeloid tissue
UBERON:0034921
multi organ part structure
An multicellular anatomical structure that has subparts of multiple organs as a part.
multi organ part structure
UBERON:0034922
cell cluster
A cluster of cells, largely surrounded by a morphological boundary.
cell cluster
UO:0000001
length unit
A unit which is a standard measure of the distance between two points.
length unit
UO:0000002
mass unit
A unit which is a standard measure of the amount of matter/energy of a physical object.
mass unit
UO:0000003
time unit
A unit which is a standard measure of the dimension in which events occur in sequence.
time unit
UO:0000005
temperature unit
A unit which is a standard measure of the average kinetic energy of the particles in a sample of matter.
temperature unit
UO:0000006
substance unit
A unit which is a standardised quantity of an element or compound with uniform composition.
substance unit
UO:0000008
meter
A length unit which is equal to the length of the path traveled by light in vacuum during a time interval of 1/299 792 458 of a second.
meter
UO:0000009
kilogram
A mass unit which is equal to the mass of the International Prototype Kilogram kept by the BIPM at Svres, France.
kilogram
UO:0000010
second
A time unit which is equal to the duration of 9 192 631 770 periods of the radiation corresponding to the transition between the two hyperfine levels of the ground state of the caesium 133 atom.
second
UO:0000012
kelvin
A thermodynamic temperature unit which is equal to the fraction 1/273.16 of the thermodynamic temperature of the triple point of water.
kelvin
UO:0000013
mole
A substance unit which is equal to the amount of substance of a molecular system which contains as many elementary entities as there are atoms in 0.012 kilogram of carbon 12.
mole
UO:0000015
centimeter
A length unit which is equal to one hundredth of a meter or 10^[-2] m.
centimeter
UO:0000016
millimeter
A length unit which is equal to one thousandth of a meter or 10^[-3] m.
millimeter
UO:0000017
micrometer
A length unit which is equal to one millionth of a meter or 10^[-6] m.
micrometer
UO:0000018
nanometer
A length unit which is equal to one thousandth of one millionth of a meter or 10^[-9] m.
nanometer
UO:0000021
gram
A mass unit which is equal to one thousandth of a kilogram or 10^[-3] kg.
gram
UO:0000022
milligram
A mass unit which is equal to one thousandth of a gram or 10^[-3] g.
milligram
UO:0000023
microgram
A mass unit which is equal to one millionth of a gram or 10^[-6] g.
microgram
UO:0000024
nanogram
A mass unit which is equal to one thousandth of one millionth of a gram or 10^[-9] g.
nanogram
UO:0000025
picogram
A mass unit which is equal to 10^[-12] g.
picogram
UO:0000027
degree Celsius
A temperature unit which is equal to one kelvin degree. However, they have their zeros at different points. The centigrade scale has its zero at 273.15 K.
degree Celsius
UO:0000028
millisecond
A time unit which is equal to one thousandth of a second or 10^[-3] s.
millisecond
UO:0000029
microsecond
A time unit which is equal to one millionth of a second or 10^[-6] s.
microsecond
UO:0000031
minute
A time unit which is equal to 60 seconds.
minute
UO:0000032
hour
A time unit which is equal to 3600 seconds or 60 minutes.
hour
UO:0000033
day
A time unit which is equal to 24 hours.
day
UO:0000034
week
A time unit which is equal to 7 days.
week
UO:0000035
month
A time unit which is approximately equal to the length of time of one of cycle of the moon's phases which in science is taken to be equal to 30 days.
month
UO:0000036
year
A time unit which is equal to 12 months which is science is taken to be equal to 365.25 days.
year
UO:0000039
micromole
A substance unit equal to a millionth of a mol or 10^[-6] mol.
micromole
UO:0000041
nanomole
A substance unit equal to one thousandth of one millionth of a mole or 10^[-9] mol.
nanomole
UO:0000042
picomole
A substance unit equal to 10^[-12] mol.
picomole
UO:0000043
femtomole
A substance unit equal to 10^[-15] mol.
femtomole
UO:0000044
attomole
A substance unit equal to 10^[-18] mol.
attomole
UO:0000045
base unit
A unit which is one of a particular measure to which all measures of that type can be related.
base unit
UO:0000051
concentration unit
A unit which represents a standard measurement of how much of a given substance there is mixed with another substance.
concentration unit
UO:0000052
mass density unit
A density unit which is a standard measure of the mass of a substance in a given volume.
mass density unit
UO:0000061
unit of molarity
A concentration unit which is a standard measure of the number of moles of a given substance per liter of solution.
unit of molarity
UO:0000062
molar
A unit of concentration which expresses a concentration of 1 mole of solute per liter of solution (mol/L).
molar
UO:0000063
millimolar
A unit of molarity which is equal to one thousandth of a molar or 10^[-3] M.
millimolar
UO:0000064
micromolar
A unit of molarity which is equal to one millionth of a molar or 10^[-6] M.
micromolar
UO:0000066
picomolar
A unit of molarity which is equal to 10^[-12] M.
picomolar
UO:0000095
volume unit
A unit which is a standard measure of the amount of space occupied by any substance, whether solid, liquid, or gas.
volume unit
UO:0000097
cubic centimeter
A volume unit which is equal to one millionth of a cubic meter or 10^[-9] m^[3], or to 1 ml.
cubic centimeter
UO:0000098
milliliter
A volume unit which is equal to one thousandth of a liter or 10^[-3] L, or to 1 cubic centimeter.
milliliter
UO:0000099
liter
A volume unit which is equal to one thousandth of a cubic meter or 10^[-3] m^[3], or to 1 decimeter.
liter
UO:0000101
microliter
A volume unit which is equal to one millionth of a liter or 10^[-6] L.
microliter
UO:0000102
nanoliter
A volume unit which is equal to one thousandth of one millionth of a liter or 10^[-9] L.
nanoliter
UO:0000103
picoliter
A volume unit which is equal to 10^[-12] L.
picoliter
UO:0000104
femtoliter
A volume unit which is equal to 10^[-15] L.
femtoliter
UO:0000127
radiation unit
A unit which is a standard measure of the amount of radiation emitted by a given radiation source as well as the amount of radiation absorbed or deposited in a specific material by a radiation source.
radiation unit
UO:0000128
activity (of a radionuclide) unit
A unit which is a standard measure of the transformation (disintegration) rate of a radioactive substance.
activity (of a radionuclide) unit
UO:0000133
curie
An activity (of a radionuclide) unit which is equal to the activity of a quantity of radioactive material in which there are 3.7 x 10^[10] atom disintegration per second (dps).
curie
UO:0000136
roentgen
An exposure unit which is equal to the amount of radiation required to liberate positive and negative charges of one electrostatic unit of charge in 1 cm^[3] of air at standard temperature and pressure (STP). This corresponds to the generation of approximately 2.0810^[9] ion pairs.
roentgen
UO:0000140
Roentgen equivalent man
A dose equivalent unit which when multiplied by hundred is equal to one sievert or 1 Sv. 1 Sv is equal to 100 rem.
Roentgen equivalent man
UO:0000147
disintegrations per minute
An activity (of a radionuclide) unit which is equal to the activity of a quantity of radioactive material in which one nucleus decays per minute or there is one atom disintegration per minute.
disintegrations per minute
UO:0000148
counts per minute
An activity (of a radionuclide) unit which is equal to the number of light emissions produced by ionizing radiation in one minute.
counts per minute
UO:0000157
light unit
A unit which is a standard measure of the intensity of light.
light unit
UO:0000163
mass percentage
A dimensionless concentration unit which denotes the mass of a substance in a mixture as a percentage of the mass of the entire mixture.
mass percentage
UO:0000164
mass volume percentage
A dimensionless concentration unit which denotes the mass of the substance in a mixture as a percentage of the volume of the entire mixture.
mass volume percentage
UO:0000165
volume percentage
A dimensionless concentration unit which denotes the volume of the solute in mL per 100 mL of the resulting solution.
volume percentage
UO:0000175
gram per liter
A mass unit density which is equal to mass of an object in grams divided by the volume in liters.
gram per liter
UO:0000176
milligram per milliliter
A mass unit density which is equal to mass of an object in milligrams divided by the volume in milliliters.
milligram per milliliter
UO:0000186
dimensionless unit
A unit which is a standard measure of physical quantity consisting of only a numerical number without any units.
dimensionless unit
UO:0000187
percent
A dimensionless ratio unit which denotes numbers as fractions of 100.
percent
UO:0000189
count unit
A dimensionless unit which denotes a simple count of things.
count unit
UO:0000195
degree Fahrenheit
A temperature unit which is equal to 5/9ths of a kelvin. Negative 40 degrees Fahrenheit is equal to negative 40 degrees Celsius.
degree Fahrenheit
UO:0000196
pH
A dimensionless concentration notation which denotes the acidity of a solution in terms of activity of hydrogen ions (H+).
pH
UO:0000205
volume per unit volume
A dimensionless concentration unit which denotes the given volume of the solute in the total volume of the resulting solution.
volume per unit volume
UO:0000207
milliliter per liter
A volume per unit volume unit which is equal to one millionth of a liter of solute in one liter of solution.
milliliter per liter
UO:0000208
gram per deciliter
A mass density unit which is equal to mass of an object in grams divided by the volume in deciliters.
gram per deciliter
UO:0000209
deciliter
A volume unit which is equal to one tenth of a liter or 10^[-1] L.
deciliter
UO:0000213
colony forming unit per milliliter
A colony forming unit which a measure of viable bacterial numbers in one milliliter.
colony forming unit per milliliter
UO:0000232
bit
An information unit which refers to a digit in the binary numeral system, which consists of base 2 digits (ie there are only 2 possible values: 0 or 1).
bit
VT:0005215
Any measurable or observable characteristic related to the shape, structure, color or pattern of the cellular masses consisting of several to several hundred cells in the interstitial tissue of the pancreas; they are composed of five different cell types that make up the endocrine portion of the pancreas.
islet of Langerhans morphology trait
efo:EFO_0000220
A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.
Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the precursor B lymphoblastic leukemia and precursor T lymphoblastic leukemia.
When the disease process is confined to a mass lesion with no or minimal evidence of blood and less than 25% marrow involvement, the diagnosis is lymphoblastic lymphoma; with blood and greater than 25% marrow involvement, ALL is the appropriate term.
acute lymphoblastic leukemia
efo:EFO_0000222
Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
acute myeloid leukemia
efo:EFO_0000224
An acute myeloid leukemia (AML) in which abnormal promyelocytes predominate. It is characterized by the t(15;17)(q22;q12) translocation. There are two variants: the typical and micro granular (hypo granular) variant. This AML is particularly sensitive to treatment with all trans-retinoic acid and has a favorable prognosis. (WHO, 2001) -- 2003
An acute myeloid leukemia (AML) in which abnormal promyelocytes predominate. It is characterized by the t(15;17)(q22;q12) translocation. There are two variants: the typical and microgranular variant. This AML is particularly sensitive to treatment with all trans-retinoic acid and has a favorable prognosis. (WHO, 2001)
acute promyelocytic leukemia
efo:EFO_0000270
A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors resulting in recurring periods of wheezing (a whistling sound while breathing), chest tightness, shortness of breath, mucus production and coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, excercise, stress, reflux disease, medications, foods and emotional anxiety.
A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
asthma
efo:EFO_0000309
A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
Burkitts lymphoma
efo:EFO_0000311
A malignant neoplasm in which new abnormal tissue grow by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease.
cancer
efo:EFO_0000339
Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
chronic myelogenous leukemia
efo:EFO_0000365
A malignant tumor usually arising from the epithelium lining the large intestinal mucosa. Colon carcinoma is one of the most common malignancies in both males and females, and is especially common in North America and Europe. Grossly, most colon carcinomas are polypoid or ulcerating lesions. Microscopically, adenocarcinoma is the most frequently seen morphologic subtype. Prognosis depends on the stage of the disease (depth of invasion, metastasis to regional/distal lymph nodes or other anatomic sites). -- 2004
An adenocarcinoma arising from the colon. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits. According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well differentiated, moderately, and poorly differentiated. Morphologic variants include the mucinous adenocarcinoma and signet-ring adenocarcinoma. Lymphatic or hematogenous spread can occur early in the process and lead to systemic disease.
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
colorectal adenocarcinoma
efo:EFO_0000369
A treatment process in which a chemical compound is administered to the subject under investigation.
compound based treatment
efo:EFO_0000400
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.
diabetes mellitus
efo:EFO_0000493
Family history is a form of clinicaly history specifically about relevant aspects of genetic preconditions or family member's clinical history.
family history
efo:EFO_0000549
A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
A usually benign, well circumscribed neoplasm arising from the beta cells of the pancreas. Patients exhibit symptoms related to hypoglycemia due to inappropriate secretion of insulin.
insulinoma
efo:EFO_0000565
A cancer that affects the blood or bone marrow characterized by an abnormal proliferation of blood cells.
A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
leukemia
efo:EFO_0000616
A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.
neoplasm
efo:EFO_0000647
An individual who does some experimental process.
experiment performer
efo:EFO_0001359
A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
An autoimmune disease of endocrine system and is_a diabetes mellitus that results from autoimmune destruction of insulin-producing beta cells of the pancreas.
Diabetes mellitus characterized by insulin deficiency, sudden onset, severe hyperglycemia, rapid progression to ketoacidosis, and death unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
type I diabetes mellitus
efo:EFO_0001360
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.
type II diabetes mellitus
efo:EFO_0001642
Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
lymphoid neoplasm
efo:EFO_0001734
data analyst
efo:EFO_0001739
investigator
efo:EFO_0001741
submitter
efo:EFO_0001799
A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. (MSH); A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI); Ethnicity - an arbitrary classification of the social group a person belongs to, and either identifies with or is identified with by others, as a result of a complex of cultural, biological, geographical and other factors such as linguistic, dietary and religion traditions; ancestry, background, allegiance, or association; and physical characteristics traditionally associated with race. Increasingly the concept is used synonymously with race but this use trend has a pragmatic basis rather than scientific. (NCI); The concept of ethnic origin is an attempt to classify people, not according to their current ethnicity, but according to where their ancestors came from. Ethnic origin has become a popular classification in statistics, where the concept of race has been largely discarded. (from Wikipedia) (NCI); a group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. (CSP)
An ethnic group is a population whose members have a common heritage that is real or presumed such as common culture, language, religion, behaviour or biological trait.
ethnic group
efo:EFO_0002427
myeloid neoplasm
efo:EFO_0002529
Pancreatic beta -cell line of rat origin.
INS-1
efo:EFO_0002543
mouse prenatal
efo:EFO_0002547
NOD mouse
efo:EFO_0002582
Theiler stage 11
efo:EFO_0002583
Theiler stage 17
efo:EFO_0002584
Theiler stage 21
efo:EFO_0002585
Theiler stage 22
efo:EFO_0002586
Theiler stage 24
efo:EFO_0002587
Theiler stage 26
efo:EFO_0002588
Theiler stage 28 is a mouse postnatal stage characterised by postnatal development after a mouse is newly born.
Theiler stage 28
efo:EFO_0002756
Abstaining from food.
fasting
efo:EFO_0002829
The murine MIN6 cell line derived from in vivo immortalized insulin-secreting pancreatic beta cells.
MIN6
efo:EFO_0002927
International Unit
efo:EFO_0002966
pancreatic cell
efo:EFO_0004390
mouse postnatal
efo:EFO_0004391
Theiler stage 27 is a newborn mouse.
Theiler stage 27
efo:EFO_0004393
Theiler stage 1
efo:EFO_0004394
Theiler stage 2
efo:EFO_0004395
Theiler stage 3
efo:EFO_0004396
Theiler stage 4
efo:EFO_0004397
Theiler stage 5
efo:EFO_0004398
Theiler stage 6
efo:EFO_0004399
Theiler stage 7
efo:EFO_0004400
Theiler stage 8
efo:EFO_0004401
Theiler stage 9
efo:EFO_0004402
Theiler stage 10
efo:EFO_0004403
Theiler stage 12
efo:EFO_0004404
Theiler stage 13
efo:EFO_0004405
Theiler stage 14
efo:EFO_0004406
Theiler stage 15
efo:EFO_0004407
Theiler stage 16
efo:EFO_0004408
Theiler stage 18
efo:EFO_0004409
Theiler stage 19
efo:EFO_0004410
Theiler stage 20
efo:EFO_0004411
Theiler stage 23
efo:EFO_0004412
Theiler stage 25
Feature Extraction Software
oboInOwl:ObsoleteClass
Obsolete Class
owl:Thing
15.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 15.5
16.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 16.5
8.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 8.5
17.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 17.5
8.25 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 8.25
18.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 18.5
8 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 8
18 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 18
11.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 11.5
0 day after birth
Person: Jie Zheng
postnatal day 0
12.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 12.5
4 days after birth
Person: Jie Zheng
postnatal day 4
9.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 9.5
12 days after birth
Person: Jie Zheng
postnatal day 12
10.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 10.5
60 days after birth
Person: Jie Zheng
postnatal day 60
13.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 13.5
14.5 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 14.5
1 day after birth
Person: Jie Zheng
postnatal day 1
8 days after birth
Person: Jie Zheng
postnatal day 8
11.25 days after fertilization
Person: Chris Stoeckert, Jie Zheng
embryonic day 11.25
4 weeks after birth
Person: Jie Zheng
age 4 weeks
age 8 weeks
Person: Jie Zheng
age 8 weeks
age 10 weeks
Person: Jie Zheng
age 10 weeks
age of an organism that fully grown or developed.
Person: Jie Zheng
adult
example to be eventually removed
example to be eventually removed
failed exploratory term
The term was used in an attempt to structure part of the ontology but in retrospect failed to do a good job
Person:Alan Ruttenberg
failed exploratory term
metadata complete
Class has all its metadata, but is either not guaranteed to be in its final location in the asserted IS_A hierarchy or refers to another class that is not complete.
metadata complete
organizational term
term created to ease viewing/sort terms for development purpose, and will not be included in a release
PERSON:Alan Ruttenberg
organizational term
ready for release
Class has undergone final review, is ready for use, and will be included in the next release. Any class lacking "ready_for_release" should be considered likely to change place in hierarchy, have its definition refined, or be obsoleted in the next release. Those classes deemed "ready_for_release" will also derived from a chain of ancestor classes that are also "ready_for_release."
ready for release
metadata incomplete
Class is being worked on; however, the metadata (including definition) are not complete or sufficiently clear to the branch editors.
metadata incomplete
uncurated
Nothing done yet beyond assigning a unique class ID and proposing a preferred term.
uncurated
pending final vetting
All definitions, placement in the asserted IS_A hierarchy and required minimal metadata are complete. The class is awaiting a final review by someone other than the term editor.
pending final vetting
placeholder removed
placeholder removed
terms merged
An editor note should explain what were the merged terms and the reason for the merge.
terms merged
term imported
This is to be used when the original term has been replaced by a term imported from an other ontology. An editor note should indicate what is the URI of the new term to use.
term imported
term split
This is to be used when a term has been split in two or more new terms. An editor note should indicate the reason for the split and indicate the URIs of the new terms created.
term split
to be replaced with external ontology term
Terms with this status should eventually replaced with a term from another ontology.
Alan Ruttenberg
group:OBI
to be replaced with external ontology term
requires discussion
A term that is metadata complete, has been reviewed, and problems have been identified that require discussion before release. Such a term requires editor note(s) to identify the outstanding issues.
Alan Ruttenberg
group:OBI
requires discussion
Helicos
Philippe Rocca-Serra
Helicos
Roche
Philippe Rocca-Serra
Roche
Illumina
Philippe Rocca-Serra
Illumina
Li-Cor
Philippe Rocca-Serra
Li-Cor
Applied Biosystems
Philippe Rocca-Serra
Applied Biosystems
## Elucidation
This is used when the statement/axiom is assumed to hold true 'eternally'
## How to interpret (informal)
First the "atemporal" FOL is derived from the OWL using the standard
interpretation. This axiom is temporalized by embedding the axiom
within a for-all-times quantified sentence. The t argument is added to
all instantiation predicates and predicates that use this relation.
## Example
Class: nucleus
SubClassOf: part_of some cell
forall t :
forall n :
instance_of(n,Nucleus,t)
implies
exists c :
instance_of(c,Cell,t)
part_of(n,c,t)
## Notes
This interpretation is *not* the same as an at-all-times relation
axiom holds for all times
## Elucidation
This is used when the first-order logic form of the relation is
binary, and takes no temporal argument.
## Example:
Class: limb
SubClassOf: develops_from some lateral-plate-mesoderm
forall t, t2:
forall x :
instance_of(x,Limb,t)
implies
exists y :
instance_of(y,LPM,t2)
develops_from(x,y)
relation has no temporal argument
Person:Alan Ruttenberg
a produces b if some process that occurs_in a has_output b and amount of b is low relative to normal cases, where a and b are material entities. Examples: defective beta ccell line produces less amount of insulin
Person: Jie Zheng
produces_low_amount
a produces b if some process that occurs_in a has_output b and amount of b is high relative to generally cases, where a and b are material entities.
Person: Jie Zheng
produces_high_amount
has part
my body has part my brain (continuant parthood, two material entities)
my stomach has part my stomach cavity (continuant parthood, material entity has part immaterial entity)
this year has part this day (occurrent parthood)
a core relation that holds between a whole and its part
Everything has itself as a part. Any part of any part of a thing is itself part of that thing. Two distinct things cannot have each other as a part.
Occurrents are not subject to change and so parthood between occurrents holds for all the times that the part exists. Many continuants are subject to change, so parthood between continuants will only hold at certain times, but this is difficult to specify in OWL. See https://code.google.com/p/obo-relations/wiki/ROAndTime
Parthood requires the part and the whole to have compatible classes: only an occurrent have an occurrent as part; only a process can have a process as part; only a continuant can have a continuant as part; only an independent continuant can have an independent continuant as part; only a specifically dependent continuant can have a specifically dependent continuant as part; only a generically dependent continuant can have a generically dependent continuant as part. (This list is not exhaustive.)
A continuant cannot have an occurrent as part: use 'participates in'. An occurrent cannot have a continuant as part: use 'has participant'. An immaterial entity cannot have a material entity as part: use 'location of'. An independent continuant cannot have a specifically dependent continuant as part: use 'bearer of'. A specifically dependent continuant cannot have an independent continuant as part: use 'inheres in'.
has_part
has part
realizes
this disease course realizes this disease
this investigation realizes this investigator role
this shattering realizes this fragility
to say that b realizes c at t is to assert that there is some material entity d & b is a process which has participant d at t & c is a disposition or role of which d is bearer_of at t& the type instantiated by b is correlated with the type instantiated by c. (axiom label in BFO2 Reference: [059-003])
Paraphrase of elucidation: a relation between a process and a realizable entity, where there is some material entity that is bearer of the realizable entity and participates in the process, and the realizable entity comes to be realized in the course of the process
realizes
preceded by
An example is: translation preceded_by transcription; aging preceded_by development (not however death preceded_by aging). Where derives_from links classes of continuants, preceded_by links classes of processes. Clearly, however, these two relations are not independent of each other. Thus if cells of type C1 derive_from cells of type C, then any cell division involving an instance of C1 in a given lineage is preceded_by cellular processes involving an instance of C. The assertion P preceded_by P1 tells us something about Ps in general: that is, it tells us something about what happened earlier, given what we know about what happened later. Thus it does not provide information pointing in the opposite direction, concerning instances of P1 in general; that is, that each is such as to be succeeded by some instance of P. Note that an assertion to the effect that P preceded_by P1 is rather weak; it tells us little about the relations between the underlying instances in virtue of which the preceded_by relation obtains. Typically we will be interested in stronger relations, for example in the relation immediately_preceded_by, or in relations which combine preceded_by with a condition to the effect that the corresponding instances of P and P1 share participants, or that their participants are connected by relations of derivation, or (as a first step along the road to a treatment of causality) that the one process in some way affects (for example, initiates or regulates) the other.
is preceded by
preceded_by
http://www.obofoundry.org/ro/#OBO_REL:preceded_by
preceded by
precedes
precedes
To say that each spatiotemporal region s temporally_projects_onto some temporal region t is to say that t is the temporal extension of s. (axiom label in BFO2 Reference: [080-003])
To say that spatiotemporal region s spatially_projects_onto spatial region r at t is to say that r is the spatial extent of s at t. (axiom label in BFO2 Reference: [081-003])
To say that each spatiotemporal region s temporally_projects_onto some temporal region t is to say that t is the temporal extension of s. (axiom label in BFO2 Reference: [080-003])
To say that spatiotemporal region s spatially_projects_onto spatial region r at t is to say that r is the spatial extent of s at t. (axiom label in BFO2 Reference: [081-003])
is about
This document is about information artifacts and their representations
is_about is a (currently) primitive relation that relates an information artifact to an entity.
7/6/2009 Alan Ruttenberg. Following discussion with Jonathan Rees, and introduction of "mentions" relation. Weaken the is_about relationship to be primitive.
We will try to build it back up by elaborating the various subproperties that are more precisely defined.
Some currently missing phenomena that should be considered "about" are predications - "The only person who knows the answer is sitting beside me" , Allegory, Satire, and other literary forms that can be topical without explicitly mentioning the topic.
person:Alan Ruttenberg
Smith, Ceusters, Ruttenberg, 2000 years of philosophy
is about
is quality measurement of
m is a quality measurement of q at t when
q is a quality
there is a measurement process p that has specified output m, a measurement datum, that is about q
8/6/2009 Alan Ruttenberg: The strategy is to be rather specific with this relationship. There are other kinds of measurements that are not of qualities, such as those that measure time. We will add these as separate properties for the moment and see about generalizing later
From the second IAO workshop [Alan Ruttenberg 8/6/2009: not completely current, though bringing in comparison is probably important]
This one is the one we are struggling with at the moment. The issue is what a measurement measures. On the one hand saying that it measures the quality would include it "measuring" the bearer = referring to the bearer in the measurement. However this makes comparisons of two different things not possible. On the other hand not having it inhere in the bearer, on the face of it, breaks the audit trail.
Werner suggests a solution based on "Magnitudes" a proposal for which we are awaiting details.
--
From the second IAO workshop, various comments, [commented on by Alan Ruttenberg 8/6/2009]
unit of measure is a quality, e.g. the length of a ruler.
[We decided to hedge on what units of measure are, instead talking about measurement unit labels, which are the information content entities that are about whatever measurement units are. For IAO we need that information entity in any case. See the term measurement unit label]
[Some struggling with the various subflavors of is_about. We subsequently removed the relation represents, and describes until and only when we have a better theory]
a represents b means either a denotes b or a describes
describe:
a describes b means a is about b and a allows an inference of at least one quality of b
We have had a long discussion about denotes versus describes.
From the second IAO workshop: An attempt at tieing the quality to the measurement datum more carefully.
a is a magnitude means a is a determinate quality particular inhering in some bearer b existing at a time t that can be represented/denoted by an information content entity e that has parts denoting a unit of measure, a number, and b. The unit of measure is an instance of the determinable quality.
From the second meeting on IAO:
An attempt at defining assay using Barry's "reliability" wording
assay:
process and has_input some material entity
and has_output some information content entity
and which is such that instances of this process type reliably generate
outputs that describes the input.
This one is the one we are struggling with at the moment. The issue is what a measurement measures. On the one hand saying that it measures the quality would include it "measuring" the bearer = referring to the bearer in the measurement. However this makes comparisons of two different things not possible. On the other hand not having it inhere in the bearer, on the face of it, breaks the audit trail.
Werner suggests a solution based on "Magnitudes" a proposal for which we are awaiting details.
Alan Ruttenberg
is quality measurement of
is_supported_by_data
The relation between the conclusion "Gene tpbA is involved in EPS production" and the data items produced using two sets of organisms, one being a tpbA knockout, the other being tpbA wildtype tested in polysacharide production assays and analyzed using an ANOVA.
The relation between a data item and a conclusion where the conclusion is the output of a data interpreting process and the data item is used as an input to that process
OBI
OBI
Philly 2011 workshop
is_supported_by_data
has_specified_input
see is_input_of example_of_usage
A relation between a planned process and a continuant participating in that process that is not created during the process. The presence of the continuant during the process is explicitly specified in the plan specification which the process realizes the concretization of.
8/17/09: specified inputs of one process are not necessarily specified inputs of a larger process that it is part of. This is in contrast to how 'has participant' works.
PERSON: Alan Ruttenberg
PERSON: Bjoern Peters
PERSON: Larry Hunter
PERSON: Melanie Coutot
has_specified_input
has_specified_output
A relation between a planned process and a continuant participating in that process. The presence of the continuant at the end of the process is explicitly specified in the objective specification which the process realizes the concretization of.
PERSON: Alan Ruttenberg
PERSON: Bjoern Peters
PERSON: Larry Hunter
PERSON: Melanie Courtot
has_specified_output
is_specified_output_of
A relation between a planned process and a continuant participating in that process. The presence of the continuant at the end of the process is explicitly specified in the objective specification which the process realizes the concretization of.
Alan Ruttenberg
PERSON:Bjoern Peters
is_specified_output_of
achieves_planned_objective
A cell sorting process achieves the objective specification 'material separation objective'
This relation obtains between a planned process and a objective specification when the criteria specified in the objective specification are met at the end of the planned process.
BP, AR, PPPB branch
PPPB branch derived
modified according to email thread from 1/23/09 in accordince with DT and PPPB branch
achieves_planned_objective
has grain
the relation of the cells in the finger of the skin to the finger, in which an indeterminate number of grains are parts of the whole by virtue of being grains in a collective that is part of the whole, and in which removing one granular part does not nec- essarily damage or diminish the whole. Ontological Whether there is a fixed, or nearly fixed number of parts - e.g. fingers of the hand, chambers of the heart, or wheels of a car - such that there can be a notion of a single one being missing, or whether, by contrast, the number of parts is indeterminate - e.g., cells in the skin of the hand, red cells in blood, or rubber molecules in the tread of the tire of the wheel of the car.
Discussion in Karslruhe with, among others, Alan Rector, Stefan Schulz, Marijke Keet, Melanie Courtot, and Alan Ruttenberg. Definition take from the definition of granular parthood in the cited paper. Needs work to put into standard form
PERSON: Alan Ruttenberg
PAPER: Granularity, scale and collectivity: When size does and does not matter, Alan Rector, Jeremy Rogers, Thomas Bittner, Journal of Biomedical Informatics 39 (2006) 333-349
has grain
has value specification
A relation between an information content entity and a value specification that specifies its value.
PERSON: James A. Overton
OBI
has value specification
inheres in
this fragility inheres in this vase
this red color inheres in this apple
a relation between a specifically dependent continuant (the dependent) and an independent continuant (the bearer), in which the dependent specifically depends on the bearer for its existence
A dependent inheres in its bearer at all times for which the dependent exists.
inheres_in
inheres in
bearer of
this apple is bearer of this red color
this vase is bearer of this fragility
a relation between an independent continuant (the bearer) and a specifically dependent continuant (the dependent), in which the dependent specifically depends on the bearer for its existence
A bearer can have many dependents, and its dependents can exist for different periods of time, but none of its dependents can exist when the bearer does not exist.
bearer_of
is bearer of
bearer of
participates in
this blood clot participates in this blood coagulation
this input material (or this output material) participates in this process
this investigator participates in this investigation
a relation between a continuant and a process, in which the continuant is somehow involved in the process
participates_in
participates in
has participant
this blood coagulation has participant this blood clot
this investigation has participant this investigator
this process has participant this input material (or this output material)
a relation between a process and a continuant, in which the continuant is somehow involved in the process
Has_participant is a primitive instance-level relation between a process, a continuant, and a time at which the continuant participates in some way in the process. The relation obtains, for example, when this particular process of oxygen exchange across this particular alveolar membrane has_participant this particular sample of hemoglobin at this particular time.
has_participant
http://www.obofoundry.org/ro/#OBO_REL:has_participant
has participant
this catalysis function is a function of this enzyme
a relation between a function and an independent continuant (the bearer), in which the function specifically depends on the bearer for its existence
A function inheres in its bearer at all times for which the function exists, however the function need not be realized at all the times that the function exists.
function_of
is function of
function of
this enzyme has function this catalysis function (more colloquially: this enzyme has this catalysis function)
a relation between an independent continuant (the bearer) and a function, in which the function specifically depends on the bearer for its existence
A bearer can have many functions, and its functions can exist for different periods of time, but none of its functions can exist when the bearer does not exist. A function need not be realized at all the times that the function exists.
has_function
has function
this person has role this investigator role (more colloquially: this person has this role of investigator)
a relation between an independent continuant (the bearer) and a role, in which the role specifically depends on the bearer for its existence
A bearer can have many roles, and its roles can exist for different periods of time, but none of its roles can exist when the bearer does not exist. A role need not be realized at all the times that the role exists.
has_role
has role
this cell derives from this parent cell (cell division)
this nucleus derives from this parent nucleus (nuclear division)
a relation between two distinct material entities, the new entity and the old entity, in which the new entity begins to exist when the old entity ceases to exist, and the new entity inherits the significant portion of the matter of the old entity
This is a very general relation. More specific relations are preferred when applicable, such as 'directly develops from'.
derives_from
This relation is taken from the RO2005 version of RO. It may be obsoleted and replaced by relations with different definitions. See also the 'develops from' family of relations.
derives from
David Osumi-Sutherland
starts_at_end_of
X immediately_preceded_by Y iff: end(X) simultaneous_with start(Y)
immediately preceded by
Every B cell[CL_0000236] has plasma membrane part some immunoglobulin complex[GO_0019814]
Holds between a cell c and a protein complex or protein p if and only if that cell has as part a plasma_membrane[GO:0005886], and that plasma membrane has p as part.
Alexander Diehl
Chris Mungall
Lindsay Cowell
PMID:19243617
<http://purl.obolibrary.org/obo/BFO_0000051> some (<http://purl.obolibrary.org/obo/GO_0005886> and <http://purl.obolibrary.org/obo/BFO_0000051> some ?Y)
has plasma membrane part
Chris Mungall
David Osumi-Sutherland
Terry Meehan
develops into
mechanosensory neuron capable of detection of mechanical stimulus involved in sensory perception (GO:0050974)
osteoclast SubClassOf 'capable of' some 'bone resorption'
A relation between a material entity (such as a cell) and a process, in which the material entity has the ability to carry out the process.
Chris Mungall
has function realized in
PMID:20123131
PMID:21208450
For compatibility with BFO, this relation has a shortcut definition in which the expression "capable of some P" expands to "bearer_of (some realized_by only P)".
RO_0000053 some (RO_0000054 only ?Y)
capable of
Elisabetta Manduchi
Emily Greenfest-Allen
Chris Stoeckert
Jie Zheng
The ontology is built based on OBI release 2015-04-13
This file is based on checkout of our SVN repository revision $Revision: 204$
https://github.com/obi-bcgo/bcgo
A relation between a cell and molecule or complex such that every instance of the cell has a high number of instances of that molecule expressed on the cell surface. For the formal definition, see Masci et al (PMID:19243617).
has_high_plasma_membrane_amount
A relation between a cell and molecule or complex such that every instance of the cell has a low number of instances of that molecule expressed on the cell surface. For the formal definition, see Masci et al (PMID:19243617).
has_low_plasma_membrane_amount
http://purl.obolibrary.org/obo/BFO_0000051 exactly 0 ?Y
lacks_part
http://purl.obolibrary.org/obo/BFO_0000051 exactly 0 (http://purl.obolibrary.org/obo/GO_0005886 and http://purl.obolibrary.org/obo/BFO_0000051 some ?Y)
lacks_plasma_membrane_part
s3 has_cross_section s3 if and only if : there exists some 2d plane that intersects the bearer of s3, and the impression of s3 upon that plane has shape quality s2.
quality
has_cross_section
Example: a spherical object has the quality of being spherical, and the spherical quality has_cross_section round.
has_cross_section
q1 increased_in_magnitude_relative_to q2 if and only if magnitude(q1) > magnitude(q2). Here, magnitude(q) is a function that maps a quality to a unit-invariant scale.
quality
increased_in_magnitude_relative_to
This relation is used to determine the 'directionality' of relative qualities such as 'increased strength', relative to the parent type, 'strength'.
increased_in_magnitude_relative_to